Researcher Profile and Settings

Researcher

• Name

  HANDA Hiroshi

Profile and Settings

• Name

  Handa, Hiroshi

Alternate Names

• Handa Hiroshi

Foreign language

• Use in presentation

  English

• Use in publication

  English

Affiliation

• Gunma University Graduate School of Medicine, Department of Hematology, Associate Professor, Associate Professor

Education

• 1990, Gunma University, Faculty of Medicine
• 1990, Gunma University, Faculty of Medicine, School of Medicine

Degree

• MD,PhD

Association Memberships

• Japanese Society of Internal Medicine
• Japanese Society of Hematology

Research Experience

• 2018, Gunma University Graduate School of Medicine, Department of Hematology, Prof lv
• 2015, 2018, Gunma University Hospital, Department of Hematology, Division Chief, Associate prof lecturer lv, Clinical Professor
• 2010, 2015, Gunma University Hospital, The Third Department of Internal Medicine, Assistant Professor, Associate prof lecturer lv, Assistant Professor
• 2002, 2010, Gunma University, Department of Health Sciences
• 2001, 2002, Gunma University, University Hospital, Hematology
• 1996, 1998, Gunma University, University Hospital
• 1993, 1996
• 1996, 1998, Gunma University Hospital, Kusatsu Branch Hospital
• 2001, 2002, Gunma University Hospital, Division of Hematology
• 2002, - Gunma University, Faculty of Medicine, School of Health Science

Research Activities

Research Areas

• Other, Other, Laboratory medicine

Research Interests

• Hematology Oncology
• Laboratory Hematology

Published Papers

• A novel CYCS mutation in the α-helix of the CYCS C-terminal domain causes non-syndromic thrombocytopenia., Yuri Uchiyama,Kunio Yanagisawa,Shinji Kunishima,Masaaki Shiina,Yoshiyuki Ogawa,Mitsuko Nakashima,Junko Hirato,Eri Imagawa,Atsushi Fujita,Kohei Hamanaka,Satoko Miyatake,Satomi Mitsuhashi,Atsushi Takata,Noriko Miyake,Kazuhiro Ogata,Hiroshi Handa,Naomichi Matsumoto,Takeshi Mizuguchi, Dec. 2018, Clinical genetics, 94, 6, 548, 553, Scientific journal

  DOI
• Association between OGG1 S326C CC genotype and elevated relapse risk in acute myeloid leukemia., Nanami Gotoh,Takayuki Saitoh,Noriyuki Takahashi,Tetsuhiro Kasamatsu,Yusuke Minato,Alkebsi Lobna,Tsukasa Oda,Takumi Hoshino,Toru Sakura,Hiroaki Shimizu,Makiko Takizawa,Hiroshi Handa,Akihiko Yokohama,Norifumi Tsukamoto,Hirokazu Murakami, Sep. 2018, International journal of hematology, 108, 3, 246, 253

  DOI
• Short-term administration of recombinant human erythropoietin decreases B cell number in human peripheral blood., Tomomi Nagashima,Akihiko Yokohama,Kie Nagai,Tetsuhiro Kasamatsu,Nanami Gotoh,Hirono Iriuchishima,Tomomi Sekigami,Takayuki Saitoh,Hiroshi Handa,Norifumi Tsukamoto,Hirokazu Murakami, Apr. 2018, Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis, 57, 2, 208, 214

  DOI
• Clinical management and outcomes of completely resected stage I follicular lymphoma., Akihiko Yokohama,Yoko Hashimoto,Makiko Takizawa,Hiroaki Shimizu,Yuri Miyazawa,Akio Saitoh,Kohtaro Toyama,Takuma Ishizaki,Takeki Mitsui,Takayuki Saitoh,Kayoko Murayama,Morio Matsumoto,Morio Sawamura,Hirokazu Murakami,Junko Hirato,Masaru Kojima,Yoshihisa Nojima,Hiroshi Handa,Norifumi Tsukamoto, 16 Mar. 2018, Journal of clinical and experimental hematopathology : JCEH, 58, 1, 10, 16

  DOI
• PDCD1 and CTLA4 polymorphisms affect the susceptibility to, and clinical features of, chronic immune thrombocytopenia., Tetsuhiro Kasamatsu,Rumi Ino,Noriyuki Takahashi,Nanami Gotoh,Yusuke Minato,Makiko Takizawa,Akihiko Yokohama,Hiroshi Handa,Takayuki Saitoh,Norifumi Tsukamoto,Hirokazu Murakami, Mar. 2018, British journal of haematology, 180, 5, 705, 714

  DOI
• Tumor long-axis diameter and SUVmax predict long-term responders in 90Y-ibritumomab tiuxetan monotherapy., Norifumi Tsukamoto,Akihiko Yokohama,Tetsuya Higuchi,Takeki Mitsui,Hiromi Koiso,Makiko Takizawa,Hiroaki Shimizu,Takuma Ishizaki,Morio Matsumoto,Kohtaro Toyama,Tohru Sakura,Hidemi Ogura,Takayuki Saitoh,Fumihiro Ishida,Hirokazu Murakami,Yoshito Tsushima,Hiroshi Handa, Jan. 2019, International journal of hematology, 109, 1, 91, 97

  DOI
• Unsuppressed serum albumin levels may jeopardize the clinical relevance of the international staging system to patients with light chain myeloma., Tetsuhiro Kasamatsu,Shuji Ozaki,Takayuki Saitoh,Jun Konishi,Kazutaka Sunami,Mitsuhiro Itagaki,Hideki Asaoku,Takaaki Cho,Hiroshi Handa,Shotaro Hagiwara,Toshio Wakayama,Akiko Negoro,Naoki Takezako,Naoko Harada,Yoshiaki Kuroda,Chiaki Nakaseko,Takaaki Miyake,Nobumasa Inoue,Hiroyuki Hata,Chihiro Shimazaki,Tatsuharu Ohno,Junya Kuroda,Tohru Murayama,Takahiro Kobayashi,Masahiro Abe,Tadao Ishida,Eiich Nagura,Kazuyuki Shimizu, Dec. 2018, Hematological oncology, 36, 5, 792, 800

  DOI
• Autologous Peripheral Blood Stem Cell Transplantation to Treat CHOP-Refractory Aggressive Subcutaneous Panniculitis-Like T Cell Lymphoma, Hirotaka Nakahashi,Norifumi Tsukamoto,Arito Yamane,Takayuki Saitoh,Hideki Uchiumi,Hiroshi Handa,Masamitsu Karasawa,Hirokazu Murakami,Masaru Kojima,Yoshihisa Nojima, 2009, ACTA HAEMATOLOGICA, 121, 4, 239, 242, Scientific journal

  DOI
• Characterization of CD56(+) Dendritic-Like Cells: A Normal Counterpart of Blastic Plasmacytoid Dendritic Cell Neoplasm?, Yohei Osaki,Akihiko Yokohama,Akio Saito,Kenichi Tahara,Kunio Yanagisawa,Yoshiyuki Ogawa,Takuma Ishizaki,Takeki Mitsui,Hiromi Koiso,Makiko Takizawa,Hideki Uchiumi,Takayuki Saitoh,Hiroshi Handa,Hirokazu Murakami,Norifumi Tsukamoto,Yoshihisa Nojima, Nov. 2013, PLOS ONE, 8, 11, e81722, Scientific journal

  DOI
• IL17A and IL23R gene polymorphisms affect the clinical features and prognosis of patients with multiple myeloma., Tetsuhiro Kasamatsu,Mari Kimoto,Noriyuki Takahashi,Yusuke Minato,Nanami Gotoh,Makiko Takizawa,Morio Matsumoto,Morio Sawamura,Akihiko Yokohama,Hiroshi Handa,Norifumi Tsukamoto,Takayuki Saitoh,Hirokazu Murakami, Feb. 2018, Hematological oncology, 36, 1, 196, 201

  DOI
• Recurrent Gemella haemolysans Meningitis in a Patient with Osteomyelitis of the Clivus, Toshimasa Hayashi,Hideki Uchiumi,Kunio Yanagisawa,Yoshiyuki Ogawa,Hiroshi Handa,Norifumi Tsukamoto,Yoshihisa Nojima, 2013, INTERNAL MEDICINE, 52, 18, 2145, 2147, Scientific journal

  DOI
• DNMT3B7 expression related to MENT expression and its promoter methylation in human lymphomas, Lobna Alkebsi,Hiroshi Handa,Yoshiko Sasaki,Yohei Osaki,Kunio Yanagisawa,Yoshiaki Ogawa,Akihiko Yokohama,Hikaru Hattori,Hiromi Koiso,Takayuki Saitoh,Takeki Mitsui,Norifumi Tsukamoto,Yoshihisa Nojima,Hirokazu Murakami, Dec. 2013, LEUKEMIA RESEARCH, 37, 12, 1662, 1667, Scientific journal

  DOI
• Prevalence of extramedullary relapses is higher after allogeneic stem cell transplantation than after chemotherapy in adult patients with acute myeloid leukemia, Hiroaki Shimizu,Takayuki Saitoh,Nahoko Hatsumi,Satoru Takada,Hiroshi Handa,Takahiro Jimbo,Toru Sakura,Shuichi Miyawaki,Yoshihisa Nojima, Nov. 2013, LEUKEMIA RESEARCH, 37, 11, 1477, 1481, Scientific journal

  DOI
• Flow cytometric detection of human telomerase reverse transcriptase (hTERT) expression in a subpopulation of bone marrow cells, Hiroshi Handa,Takafumi Matsushima,Natsumi Nishimoto,Madoka Inoue,Takayuki Saitoh,Akihiko Yokohama,Norifumi Tsukamoto,Takeki Mitsui,Hirotaka Nakahashi,Kotaro Toyama,Masamitsu Karasawa,Hatsue Ogawara,Yoshihisa Nojima,Hirokazu Murakami, Feb. 2010, LEUKEMIA RESEARCH, 34, 2, 177, 183, Scientific journal

  DOI
• A novel GFI1B mutation at the first zinc finger domain causes congenital macrothrombocytopenia., Yuri Uchiyama,Yoshiyuki Ogawa,Shinji Kunishima,Masaaki Shiina,Mitsuko Nakashima,Kunio Yanagisawa,Akihiko Yokohama,Eri Imagawa,Satoko Miyatake,Takeshi Mizuguchi,Atsushi Takata,Noriko Miyake,Kazuhiro Ogata,Hiroshi Handa,Naomichi Matsumoto, Jun. 2018, British journal of haematology, 181, 6, 843, 847

  DOI
• PRIMARY HODGKINS-DISEASE OF THE BONE PRESENTING WITH AN EXTRADURAL TUMOR, K MORIDAIRA,H HANDA,H MURAKAMI,T UCHIYAMA,T TAKEUCHI,S SATO,J TAMURA,T NARUSE,J TSUCHIYA, 1994, ACTA HAEMATOLOGICA, 92, 3, 148, 149

  DOI
• Identification of inherited macrothrombocytopenias based on mean platelet volume among patients diagnosed with idiopathic thrombocytopenia, Fumito Gohda,Hideki Uchiumi,Hiroshi Handa,Takafumi Matsushima,Norifumi Tsukamoto,Kimio Morita,Hatsuo Amagai,Masami Murakami,Hirokazu Murakami,Yoshihisa Nojima,Masamitsu Karasawa, 2007, THROMBOSIS RESEARCH, 119, 6, 741, 746, Scientific journal

  DOI
• Hodgkin lymphoma accompanied by aplastic anemia and polyclonal expansion of large granular lymphocytes, Takayuki Saitoh,Takafumi Matsushima,Arito Yamane,Masataka Sakuraya,Hiroyuki Irisawa,Akihiko Yokohama,Hiroshi Handa,Norifumi Tsukamoto,Masamitsu Karasawa,Yoshihisa Nojima,Hirokazu Murakami, 2007, ACTA HAEMATOLOGICA, 117, 4, 238, 241, Scientific journal

  DOI
• The usefulness of F-18-fluorodeoxyglucose positron emission tomography (F-18-FDG-PET) and a comparison of F-18-FDG-PET with (67)gallium scintigraphy in the evaluation of lymphoma - Relation to histologic subtypes-based on the World Health Organization Classification, Norifumi Tsukamoto,Masaru Kojima,Masatoshi Hasegawa,Noboru Oriuchi,Takafumi Matsushima,Akihiko Yokohama,Takayuki Saitoh,Hiroshi Handa,Keigo Endo,Hirokazu Murakami, Aug. 2007, CANCER, 110, 3, 652, 659, Scientific journal

  DOI
• The relative extent and propensity of CD34(+) vs. CD34(-) cells to undergo apoptosis in myelodysplastic marrows, S Mundle,P Venugopal,Shetty\, V,A Ali,H Chopra,H Handa,S Rose,BY Mativi,SA Gregory,HD Preisler,A Raza, Apr. 1999, INTERNATIONAL JOURNAL OF HEMATOLOGY, 69, 3, 152, 159, Scientific journal
• Effects of physical therapy on cytokines and two color analysis-lymphocyte subsets in patients with cerebrovascular diseases, H Kurabayashi,Machida\, I,H Handa,Y Yoshida,T Akiba,K Itoh,J Tamura,K Kubota, 1999, JOURNAL OF MEDICINE, 30, 1-2, 31, 37, Scientific journal
• Characteristic expansion of CD45RA(+) CD27(-) CD28(-) CCR7(-) lymphocytes with stable natural killer (NK) receptor expression in NK- and T-cell type lymphoproliferative disease of granular lymphocytes, T Mitsui,Maekawa\, I,A Yamane,T Ishikawa,H Koiso,A Yokohama,H Handa,T Matsushima,N Tsukamoto,H Murakami,Y Nojima,M Karasawa, Jul. 2004, BRITISH JOURNAL OF HAEMATOLOGY, 126, 1, 55, 62, Scientific journal

  DOI
• Raltegravir is safely used with long-term viral suppression for HIV-infected patients on hemodialysis: a pharmacokinetic study, Kunio Yanagisawa,Daisuke Nagano,Yoshiyuki Ogawa,Hideki Uchiumi,Tetsuya Shigehara,Kazuhisa Saruki,Hiroshi Handa,Takuya Araki,Koujirou Yamamoto,Yoshihisa Nojima, Mar. 2016, AIDS, 30, 6, 970, 972

  DOI
• Chromosome 16q genes CDH1, CDH13 and ADAMTS18 are correlated and frequently methylated in human lymphoma, Lobna Alkebsi,Hiroshi Handa,Akihiko Yokohama,Takayuki Saitoh,Norifumi Tsukamoto,Hirokazu Murakami, Nov. 2016, ONCOLOGY LETTERS, 12, 5, 3523, 3530, Scientific journal

  DOI
• Incidence and clinical background of hepatitis B virus reactivation in multiple myeloma in novel agents' era, Yutaka Tsukune,Makoto Sasaki,Takeshi Odajima,Atsushi Isoda,Morio Matsumoto,Michiaki Koike,Hideto Tamura,Keiichi Moriya,Shigeki Ito,Maki Asahi,Yoichi Imai,Junji Tanaka,Hiroshi Handa,Hiromi Koiso,Sakae Tanosaki,Jian Hua,Masao Hagihara,Yuriko Yahata,Satoko Suzuki,Sumio Watanabe,Hiroki Sugimori,Norio Komatsu, Sep. 2016, ANNALS OF HEMATOLOGY, 95, 9, 1465, 1472, Scientific journal

  DOI
• Successful Treatment of Epstein-Barr Virus-Associated Lymphoproliferative Disorder with Rituximab in a Patient Undergoing Immunosuppressive Therapy for Aplastic Anemia, Hiroaki Shimizu,Nobuhiko Kobayashi,Masahiro Mihara,Hirono Iriuchishima,Takuma Ishizaki,Yoshihisa Kojima,Hiroshi Handa, 2016, ACTA HAEMATOLOGICA, 136, 3, 174, 177, Scientific journal

  DOI
• SUCCESSFUL TREATMENT OF CONCOMITANT ACUTE MYELOBLASTIC-LEUKEMIA AND ADENOID CYSTIC CARCINOMA OF THE PALATE, H HANDA,J TAMURA,H TAKE,S IKEDA,T MATSUSHIMA,H MURAKAMI,K KUBOTA,T NARUSE,J TSUCHIYA, Mar. 1993, JOURNAL OF INTERNATIONAL MEDICAL RESEARCH, 21, 2, 102, 104

  DOI
• Philadelphia chromosome-positive mixed phenotype acute leukemia in the imatinib era, Hiroaki Shimizu,Akihiko Yokohama,Nahoko Hatsumi,Satoru Takada,Hiroshi Handa,Toru Sakura,Yoshihisa Nojima, Oct. 2014, EUROPEAN JOURNAL OF HAEMATOLOGY, 93, 4, 297, 301, Scientific journal

  DOI
• Clinical features and prognostic impact of PRDM16 expression in adult acute myeloid leukemia, Genki Yamato,Hiroki Yamaguchi,Hiroshi Handa,Norio Shiba,Machiko Kawamura,Satoshi Wakita,Koiti Inokuchi,Yusuke Hara,Kentaro Ohki,Jun Okubo,Myoung-Ja Park,Manabu Sotomatsu,Hirokazu Arakawa,Yasuhide Hayashi, Nov. 2017, GENES CHROMOSOMES & CANCER, 56, 11, 800, 809, Scientific journal

  DOI
• Recurrent alterations of the WW domain containing oxidoreductase gene spanning the common fragile site FRA16D in multiple myeloma and monoclonal gammopathy of undetermined significance, Hiroshi Handa,Yoshiko Sasaki,Hikaru Hattori,Lobna Alkebsi,Tetsuhiro Kasamatsu,Takayuki Saitoh,Takeki Mitsui,Akihiko Yokohama,Norifumi Tsukamoto,Morio Matsumoto,Hirokazu Murakami, Oct. 2017, ONCOLOGY LETTERS, 14, 4, 4372, 4378, Scientific journal

  DOI
• The cytokine polymorphisms affecting Th1/Th2 increase the susceptibility to, and severity of, chronic ITP, Noriyuki Takahashi,Takayuki Saitoh,Nanami Gotoh,Yasuhiro Nitta,Lobna Alkebsi,Tetsuhiro Kasamatsu,Yusuke Minato,Akihiko Yokohama,Norifumi Tsukamoto,Hiroshi Handa,Hirokazu Murakami, May 2017, BMC IMMUNOLOGY, 18, 1, 26, Scientific journal

  DOI
• Long non-coding RNA MALAT1 is an inducible stress response gene associated with extramedullary spread and poor prognosis of multiple myeloma, Hiroshi Handa,Yuko Kuroda,Kei Kimura,Yuta Masuda,Hikaru Hattori,Lobna Alkebsi,Morio Matsumoto,Tetsuhiro Kasamatsu,Nobuhiko Kobayashi,Ken-ichi Tahara,Makiko Takizawa,Hiromi Koiso,Takuma Ishizaki,Hiroaki Shimizu,Akihiko Yokohama,Norifumi Tsukamoto,Takayuki Saito,Hirokazu Murakami, Nov. 2017, BRITISH JOURNAL OF HAEMATOLOGY, 179, 3, 449, 460, Scientific journal

  DOI
• Polymorphism of IL-10 receptor beta affects the prognosis of multiple myeloma patients treated with thalidomide and/or bortezomib, Tetsuhiro Kasamatsu,Takayuki Saitoh,Rumi Ino,Nanami Gotoh,Takeki Mitsui,Hiroaki Shimizu,Morio Matsumoto,Morio Sawamura,Akihiko Yokohama,Hiroshi Handa,Norifumi Tsukamoto,Hirokazu Murakami, Dec. 2017, HEMATOLOGICAL ONCOLOGY, 35, 4, 711, 718, Scientific journal

  DOI
• Management of infection during chemotherapy for acute leukemia in Japan: a nationwide questionnaire-based survey by the Japan Adult Leukemia Study Group, Shun-ichi Kimura,Hiroyuki Fujita,Hideaki Kato,Nobuhiro Hiramoto,Naoko Hosono,Tsutomu Takahashi,Kazuyuki Shigeno,Naoko Hatsumi,Hitoshi Minamiguchi,Junichi Miyatake,Hiroshi Handa,Nobu Akiyama,Yoshinobu Kanda,Minoru Yoshida,Hitoshi Kiyoi,Yasushi Miyazaki,Tomoki Naoe, Nov. 2017, SUPPORTIVE CARE IN CANCER, 25, 11, 3515, 3521, Scientific journal

  DOI
• Phase 1 study of ixazomib alone or combined with lenalidomide-dexamethasone in Japanese patients with relapsed/refractory multiple myeloma, Kenshi Suzuki,Hiroshi Handa,Takaaki Chou,Kenichi Ishizawa,Takatoshi Takubo,Yoichi Kase, Apr. 2017, INTERNATIONAL JOURNAL OF HEMATOLOGY, 105, 4, 445, 452, Scientific journal

  DOI
• Successful Management of a Patient with Autoimmune Hemorrhaphilia due to Anti-Factor XIII/13 Antibodies Complicated by Pulmonary Thromboembolism, Yoshiyuki Ogawa,Kunio Yanagisawa,Masayoshi Souri,Masahiro Mihara,Chiaki Naito,Makiko Takizawa,Takuma Ishizaki,Takeki Mitsui,Hiroshi Handa,Tsukasa Osaki,Yoshihisa Nojima,Akitada Ichinose, 2017, ACTA HAEMATOLOGICA, 137, 3, 141, 147, Scientific journal

  DOI
• Retrospective analysis of prognostic factors for Waldenstrom macroglobulinemia: a multicenter cooperative study in Japan, Akio Saito,Atsushi Isoda,Masaru Kojima,Akihiko Yokohama,Yutaka Tsukune,Makoto Sasaki,Shigeki Ito,Akihiro Ohtsu,Michiaki Koike,Kayoko Murayama,Keiichi Moriya,Hideto Tamura,Morio Matsumoto,Hirotaka Nakahashi,Sakae Tanosaki,Tohru Sakura,Toshihide Kawamura,Tomomi Miyanaga,Naoya Nakamura,Hirokazu Murakami,Hiroshi Handa,Norifumi Tsukamoto, Nov. 2017, INTERNATIONAL JOURNAL OF HEMATOLOGY, 106, 5, 681, 690, Scientific journal

  DOI
• Epigenetic repression of miR-375 is the dominant mechanism for constitutive activation of the PDPK1/RPS6KA3 signalling axis in multiple myeloma, Shotaro Tatekawa,Yoshiaki Chinen,Masaki Ri,Tomoko Narita,Yuji Shimura,Yayoi Matsumura-Kimoto,Taku Tsukamoto,Tsutomu Kobayashi,Eri Kawata,Nobuhiko Uoshima,Tomohiko Taki,Masafumi Taniwaki,Hiroshi Handa,Shinsuke Iida,Junya Kuroda, Aug. 2017, BRITISH JOURNAL OF HAEMATOLOGY, 178, 4, 534, 546, Scientific journal

  DOI
• Clinical characteristics and outcomes of acquired hemophilia A: experience at a single center in Japan, Yoshiyuki Ogawa,Kunio Yanagisawa,Hideki Uchiumi,Takuma Ishizaki,Takeki Mitsui,Fumito Gouda,Masahiro Ieko,Akitada Ichinose,Yoshihisa Nojima,Hiroshi Handa, Jul. 2017, INTERNATIONAL JOURNAL OF HEMATOLOGY, 106, 1, 82, 89, Scientific journal

  DOI
• Successful management of perioperative hemostasis in a patient with Glanzmann thrombasthenia who underwent a right total mastectomy, Yoshiyuki Ogawa,Shinji Kunishima,Kunio Yanagisawa,Yohei Osaki,Yuri Uchiyama,Naomichi Matsumoto,Hideaki Tokiniwa,Jun Horiguchi,Yoshihisa Nojima,Hiroshi Handa, Feb. 2017, INTERNATIONAL JOURNAL OF HEMATOLOGY, 105, 2, 221, 225, Scientific journal

  DOI
• Successful hemostatic management of major surgery for cervical spondylotic myelopathy in a patient with severe factor XI deficiency., Ogawa Y,Yanagisawa K,Uchiyama Y,Akashi N,Mieda T,Iizuka H,Inoue M,Shizuka R,Murakami M,Matsumoto N,Handa H, Oct. 2018, International journal of hematology, 108, 4, 443, 446

  DOI
• Darunavir concentration in PBMCs may be a better indicator of drug exposure in HIV patients., Nagano D,Araki T,Yanagisawa K,Ogawa Y,Gohda F,Uchiumi H,Handa H,Nakamura T,Yamamoto K, Aug. 2018, European journal of clinical pharmacology, 74, 8, 1055, 1060

  DOI
• Switching to nilotinib is associated with deeper molecular responses in chronic myeloid leukemia chronic phase with major molecular responses to imatinib: STAT1 trial in Japan., Noguchi S,Nakaseko C,Nishiwaki K,Ogasawara H,Ohishi K,Tokuhira M,Noguchi M,Kimura H,Handa H,Mitani K,Miura M,Wakita H,Takahashi N,STAT study group, Aug. 2018, International journal of hematology, 108, 2, 176, 183

  DOI
• Bortezomib maintenance therapy in transplant-ineligible myeloma patients who plateaued after bortezomib-based induction therapy: a multicenter phase II clinical trial., Isoda A,Murayama K,Ito S,Kohara Y,Iino M,Miyazawa Y,Matsumoto M,Handa H,Imai Y,Ishiguro T,Izumita W,Kitano K,Hirabayashi Y,Nakazawa H,Ishida F,Mitsumori T,Kirito K,Chou T,Murakami H,Kanshinetsu Multiple Myeloma Study Group, Jul. 2018, International journal of hematology, 108, 1, 39, 46

  DOI
• Infectious complications in adults undergoing intensive chemotherapy for acute myeloid leukemia in 2001-2005 using the Japan Adult Leukemia Study Group AML201 protocols., Kato H,Fujita H,Akiyama N,Kimura SI,Hiramoto N,Hosono N,Takahashi T,Shigeno K,Minamiguchi H,Miyatake J,Handa H,Kanda Y,Yoshida M,Miyawaki S,Ohtake S,Naoe T,Kiyoi H,Matsumura I,Miyazaki Y,Japan Adult Leukemia,Study Group, Jun. 2018, Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer

  DOI
• Role of exosomes as a proinflammatory mediator in the development of EBV-associated lymphoma., Higuchi H,Yamakawa N,Imadome KI,Yahata T,Kotaki R,Ogata J,Kakizaki M,Fujita K,Lu J,Yokoyama K,Okuyama K,Sato A,Takamatsu M,Kurosaki N,Alba SM,Azhim A,Horie R,Watanabe T,Kitamura T,Ando K,Kashiwagi T,Matsui T,Okamoto A,Handa H,Kuroda M,Nakamura N,Kotani A, Jun. 2018, Blood, 131, 23, 2552, 2567

  DOI
• A Rare Case of Chronic Active Epstein-Barr Virus (EBV) Infection Accompanied by the Infiltration of EBV-infected CD8+ T Cells into the Muscle., Kobayashi N,Mitsui T,Ogawa Y,Iriuchishima H,Takizawa M,Yokohama A,Saitoh T,Koiso H,Tsukamoto N,Murakami H,Nojima Y,Handa H, Apr. 2018, Journal of pediatric hematology/oncology, 40, 3, e171, e175

  DOI
• Effect of ruxolitinib therapy on the quality-of-life of Japanese patients with myelofibrosis., Oritani K,Ohishi K,Okamoto S,Kirito K,Komatsu N,Tauchi T,Handa H,Saito S,Takenaka K,Shimoda K,Okada H,Amagasaki T,Wakase S,Shimozuma K,Akashi K, Mar. 2018, Current medical research and opinion, 34, 3, 531, 537

  DOI
• Collision of metastatic malignant melanoma and acute myelogenous leukemia in the bone marrow., Kobayashi N,Shimizu H,Hirato J,Handa H, Mar. 2018, International journal of hematology, 107, 3, 257, 259

  DOI
• Ruxolitinib is effective and safe in Japanese patients with hydroxyurea-resistant or hydroxyurea-intolerant polycythemia vera with splenomegaly., Kirito K,Suzuki K,Miyamura K,Takeuchi M,Handa H,Okamoto S,Gadbaw B,Yamauchi K,Amagasaki T,Ito K,Hino M, Feb. 2018, International journal of hematology, 107, 2, 173, 184

  DOI
• Clonal evolution detected with conventional cytogenetic analysis is a potent prognostic factor in adult patients with relapsed AML., Shimizu H,Yokohama A,Ishizaki T,Hatsumi N,Takada S,Saitoh T,Sakura T,Nojima Y,Handa H, Feb. 2018, Hematological oncology, 36, 1, 252, 257

  DOI
• Evaluation of the dose and efficacy of ruxolitinib in Japanese patients with myelofibrosis., Kirito K,Okamoto S,Ohishi K,Tauchi T,Handa H,Saito S,Takenaka K,Shimoda K,Oritani K,Akashi K,Okada H,Amagasaki T,Suzuki K,Yonezu T,Komatsu N, Jan. 2018, International journal of hematology, 107, 1, 92, 97

  DOI
• [Congenital factor V and factor VIII deficiency discovered in an elderly patient with abnormal bleeding after trauma]., Ogawa Y,Yanagisawa K,Uchiyama Y,Matsumoto A,Inoue M,Toyama K,Miyazawa Y,Matsumoto N,Handa H, 2018, [Rinsho ketsueki] The Japanese journal of clinical hematology, 59, 4, 383, 388

  DOI
• [Giant hemophilic pseudotumors in brothers with non-severe hemophilia B]., Matsumura I,Yanagisawa K,Ogawa Y,Shimizu H,Ishizaki T,Mitsui T,Uchiumi H,Uchiyama Y,Matsumuto N,Handa H, 2018, [Rinsho ketsueki] The Japanese journal of clinical hematology, 59, 3, 287, 292

  DOI
• Overexpression of B-cell lymphoma 6 alters gene expression profile in a myeloma cell line and is associated with decreased DNA damage response., Tahara K,Takizawa M,Yamane A,Osaki Y,Ishizaki T,Mitsui T,Yokohama A,Saitoh T,Tsukamoto N,Matsumoto M,Murakami H,Nojima Y,Handa H, Aug. 2017, Cancer science, 108, 8, 1556, 1564

  DOI
• Cytomegalovirus retinitis followed by immune recovery uveitis in an elderly patient with rheumatoid arthritis undergoing administration of methotrexate and tofacitinib combination therapy., Yanagisawa K,Ogawa Y,Hosogai M,Todokoro D,Mitsui T,Yokohama A,Kishi S,Handa H, Aug. 2017, Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy, 23, 8, 572, 575

  DOI
• Histone deacetylase inhibitors suppress ABO transcription in vitro, leading to reduced expression of the antigens., Takahashi Y,Kubo R,Sano R,Nakajima T,Takahashi K,Kobayashi M,Handa H,Tsukada J,Kominato Y, Mar. 2017, Transfusion, 57, 3, 554, 562

  DOI
• Acquired immune-mediated von Willebrand syndrome accompanied by antiphospholipid syndrome., Kobayashi N,Ogawa Y,Yanagisawa K,Ishizaki T,Uchiumi H,Suzuki N,Matsushita T,Ichinose A,Handa H, 2017, [Rinsho ketsueki] The Japanese journal of clinical hematology, 58, 6, 613, 618

  DOI
• Refractory thrombotic thrombocytopenic purpura achieving complete remission with rituximab treatment., Iino H,Ogawa Y,Yanagisawa K,Shimizu H,Mitsui T,Ishizaki T,Hayakawa M,Matsumoto M,Nojima Y,Handa H, 2017, [Rinsho ketsueki] The Japanese journal of clinical hematology, 58, 3, 204, 209

  DOI
• Acquired thrombotic thrombocytopenic purpura with a smoldering clinical course., Naito C,Ogawa Y,Yanagisawa K,Ishizaki T,Mihara M,Hayakawa M,Matsumoto M,Nojima Y,Handa H, 2017, [Rinsho ketsueki] The Japanese journal of clinical hematology, 58, 2, 108, 112

  DOI
• Late-onset neutropenia after rituximab therapy in patients with autoimmune thrombotic and hemostatic disorders: a single center analysis., Ogawa Y,Yanagisawa K,Ishizaki T,Shimizu H,Mitsui T,Ichinose A,Nojima Y,Handa H, 2017, [Rinsho ketsueki] The Japanese journal of clinical hematology, 58, 1, 42, 46

  DOI
• [Development of acquired hemophilia A during maintenance therapy for immune thrombocytopenia]., Ogawa Y,Yanagisawa K,Ishizaki T,Naito C,Mihara M,Handa H,Shizuka R,Inoue M,Naito S,Ieko M,Ichinose A,Nojima Y, Apr. 2016, [Rinsho ketsueki] The Japanese journal of clinical hematology, 57, 4, 456, 460

  DOI
• [Remission of acquired hemophilia A following radiation therapy for esophageal cancer]., Yanagisawa K,Ogawa Y,Mitsui T,Noguchi H,Shimizu H,Ishizaki T,Handa H,Ieko M,Ichinose A,Nojima Y, Apr. 2016, [Rinsho ketsueki] The Japanese journal of clinical hematology, 57, 4, 451, 455

  DOI
• [Acquired thrombotic thrombocytopenic purpura after vascular prosthesis implantation for impending rupture of an abdominal aortic aneurysm]., Naito C,Ogawa Y,Yanagisawa K,Ishizaki T,Mihara M,Handa H,Isonishi A,Hayakawa M,Matsumoto M,Nojima Y, Mar. 2016, [Rinsho ketsueki] The Japanese journal of clinical hematology, 57, 3, 364, 368

  DOI
• [Monomorphic post-transplant T-lymphoproliferative disorder after autologous stem cell transplantation for multiple myeloma]., Ishikawa T,Shimizu H,Takei T,Koya H,Iriuchishima H,Hosiho T,Hirato J,Kojima M,Handa H,Nojima Y,Murakami H, Jan. 2016, [Rinsho ketsueki] The Japanese journal of clinical hematology, 57, 1, 36, 40

  DOI
• [Relapsed primary intraocular lymphoma treated with intravitreal methotrexate and high-dose chemotherapy followed by autologous stem cell rescue]., Kamio T,Yokohama A,Hayashi T,Toyama K,Koya H,Hoshino T,Saitoh T,Hanyuda N,Mukai R,Handa H,Murakami H,Tsukamoto N,Nojima Y, Feb. 2014, [Rinsho ketsueki] The Japanese journal of clinical hematology, 55, 2, 244, 248

  DOI
• Prognostic importance of the soluble form of IL-2 receptorα (sIL-2Rα) and its relationship with surface expression of IL-2Rα (CD25) of lymphoma cells in diffuse large B-cell lymphoma treated with CHOP-like regimen with or without rituximab: a retrospectiv, Hashimoto Y,Yokohama A,Saitoh A,Nakahashi H,Toyama K,Mitsui T,Koiso H,Saitoh T,Handa H,Uchiumi H,Jinbo T,Murayama K,Matsumoto M,Sawamura M,Karasawa M,Murakami H,Hirato J,Nojima Y,Kojima M,Tsukamoto N, 2013, Journal of clinical and experimental hematopathology : JCEH, 53, 3, 197, 205

  DOI
• [IgM-lambda multiple myeloma presenting with systemic amyloidosis]., Higeta D,Yokohama A,Osaki Y,Tahara K,Mawatari M,Sekigami T,Koiso H,Saito T,Uchiumi H,Handa H,Karasawa M,Murakami H,Hirato J,Tsukamoto N,Nojima Y, Dec. 2009, [Rinsho ketsueki] The Japanese journal of clinical hematology, 50, 12, 1711, 1714

  DOI
• [Development of an extramedullary plasmacytoma despite disappearing M protein in multiple myeloma by bortezomib treatment]., Koiso H,Tahara K,Osaki Y,Mawatari M,Sekigami T,Yokohama A,Saitoh T,Uchiumi H,Handa H,Tsukamoto N,Karasawa M,Nojima Y,Murakami H, Feb. 2009, [Rinsho ketsueki] The Japanese journal of clinical hematology, 50, 2, 78, 82

  DOI
• [Successful treatment of azole-refractory Candida guilliermondii fungemia with a combination therapy of micafungin and liposomal amphotericin B]., Saitoh T,Matsushima T,Shimizu H,Osaki Y,Yamane A,Irisawa H,Yokohama A,Uchiumi H,Handa H,Tsukamoto N,Karasawa M,Nojima Y,Murakami H, Feb. 2008, [Rinsho ketsueki] The Japanese journal of clinical hematology, 49, 2, 94, 98

  DOI
• [Diagnosis and management guideline for multiple myeloma]., Murakami H,Handa H,Saitoh T, Dec. 2007, Nihon rinsho. Japanese journal of clinical medicine, 65, 12, 2167, 2176
• [Acquired hemophilia A developed at relapse of minimal change nephrotic syndrome]., Shimizu H,Saitoh T,Osaki Y,Yamane A,Gohda F,Irisawa H,Yokohama A,Uchiumi H,Handa H,Matsushima T,Tsukamoto N,Karasawa M,Murakami H,Nojima Y, Jun. 2007, [Rinsho ketsueki] The Japanese journal of clinical hematology, 48, 6, 514, 517

  DOI
• [Deep vein thrombosis and pulmonary embolism in a patient with multiple myeloma treated with thalidomide and dexamethasone]., Miyazawa Y,Irisawa H,Uchiumi H,Saitoh T,Handa H,Matsushima T,Tsukamoto N,Karasawa M,Murakami H,Nojima Y, Jul. 2006, [Rinsho ketsueki] The Japanese journal of clinical hematology, 47, 7, 656, 660

  DOI
• [Reversible posterior leukoencephalopathy syndrome probably caused by L-asparaginase]., Miyazawa Y,Irisawa H,Matsushima T,Mitsui T,Uchiumi H,Saitohi T,Handa H,Karasawa M,Murakami H,Tsukamoto N,Nojima Y, Jun. 2006, [Rinsho ketsueki] The Japanese journal of clinical hematology, 47, 6, 531, 535

  DOI
• [Plasmacytoma with multiple hypervascular lesions revealed by angiography in a patient with multiple myeloma]., Handa H,Irisawa H,Komatsumoto S,Matsushima T,Tsukamoto N,Nojima Y,Murakami H, Jun. 2006, [Rinsho ketsueki] The Japanese journal of clinical hematology, 47, 6, 521, 525

  DOI
• [New treatment strategy of multiple myeloma for cure]., Murakami H,Handa H, Apr. 2006, Gan to kagaku ryoho. Cancer & chemotherapy, 33, 4, 417, 423
• [Unclassified mature T cell leukemia with cerebriform nuclei]., Takizawa M,Matsushima T,Yokohama A,Handa H,Tsukamoto N,Karasawa M,Murakami H,Nojima Y, Jul. 2005, [Rinsho ketsueki] The Japanese journal of clinical hematology, 46, 7, 486, 491

  DOI
• [Urinary 8-hydroxy-2'-deoxyguanosin (8-OHdG) in patients with chronic liver diseases]., Ishizakai M,Yoshida K,Nishimoto N,Saleh AM,Ishii C,Handa H,Ogawara H,Nagamine T,Murakami M,Murakami H, Sep. 2004, Rinsho byori. The Japanese journal of clinical pathology, 52, 9, 732, 736
• [Thalidomide treatment of patients with refractory myeloma in the institutes participating in the Japan Myeloma Study Group]., Murakami H,Handa H,Imai K,Kanakura Y,Kosaka M,Sawamura M,Shimazaki C,Suzuki K,Ishii A,Takagi T,Taniwaki M,Togawa A,Hata H,Wakayama T,Takatsuki K,Japan Myeloma,Study Group, Jun. 2004, [Rinsho ketsueki] The Japanese journal of clinical hematology, 45, 6, 468, 472

  DOI
• [Pancytopenia associated with hyperthyroidism]., Ogaw Y,Maekawa I,Matsushima T,Takizawa M,Uchiumi H,Kawamura T,Ueki K,Handa H,Tsukamoto N,Nojima Y, Apr. 2004, Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine, 93, 4, 777, 779

  DOI
• Th1/Th2 cells in patients with multiple myeloma., Murakami H,Ogawara H,Hiroshi H, Feb. 2004, Hematology (Amsterdam, Netherlands), 9, 1, 41, 45

  DOI
• [Treatment outcome of myelodysplastic syndrome patients younger than 60 years old]., Matsushima T,Handa H,Yokohama A,Sakura T,Okamoto K,Kawamura T,Tsumita Y,Murayama K,Isoda A,Jinbo T,Hirabyashi H,Sawamura M,Karasawa M,Shimano S,Tsukamoto N,Miyawaki S,Nojima Y,Murakami H, Oct. 2003, [Rinsho ketsueki] The Japanese journal of clinical hematology, 44, 10, 1004, 1009

  DOI
• Accuracy of immunohistochemistry and flow cytometry in estimating the proportion of leukemic cells in S phase in chronic myeloid leukemia patients., Hegde U,Kotelnikov VM,Handa H,Burke P,Preisler HD, Aug. 1996, Leukemia & lymphoma, 22, 5-6, 431, 437

  DOI
• Randomized study of induction therapy comparing standard-dose idarubicin with high-dose daunorubicin in adult patients with previously untreated acute myeloid leukemia: the JALSG AML201 Study, Ohtake, Shigeki;Miyawaki, Shuichi;Fujita, Hiroyuki;Kiyoi, Hitoshi;Shinagawa, Katsuji;Usui, Noriko;Okumura, Hirokazu;Miyamura, Koichi;Nakaseko, Chiaki;Miyazaki, Yasushi;Fujieda, Atsushi;Nagai, Tadashi;Yamane, Takahisa;Taniwaki, Masafumi;Takahashi, Masatomo;Yagasaki, Fumiharu;Kimura, Yukihiko;Asou, Norio;Sakamaki, Hisashi;Handa, Hiroshi;Honda, Sumihisa;Ohnishi, Kazunori;Naoe, Tomoki;Ohno, Ryuzo, 2011, BLOOD, 117, 8, 2358, 2365

  DOI
• Randomized trial of response-oriented individualized versus fixed-schedule induction chemotherapy with idarubicin and cytarabine in adult acute myeloid leukemia: the JALSG AML95 study, Ohtake, Shigeki;Miyawaki, Shuichi;Kiyoi, Hitoshi;Miyazaki, Yasushi;Okumura, Hirokazu;Matsuda, Shin;Nagai, Tadashi;Kishimoto, Yuji;Okada, Masaya;Takahashi, Masatomo;Handa, Hiroshi;Takeuchi, Jin;Kageyama, Shinichi;Asou, Norio;Yagasaki, Fumiharu;Maeda, Yasuhiro;Ohnishi, Kazunori;Naoe, Tomoki;Ohno, Ryuzo, 2010, INTERNATIONAL JOURNAL OF HEMATOLOGY, 91, 2, 276, 283

  DOI
• Clinical Significance of Granulocytic Sarcoma in Patients with Acute Myeloid Leukemia, Shimizu, Hiroaki;Saitoh, Takayuki;Hoshino, Takumi;Hatsumi, Naoko;Takada, Satoru;Irisawa, Hiroyuki;Yokohama, Akihiko;Jimbo, Takahiro;Handa, Hiroshi;Matsushima, Takafumi;Sakura, Toru;Tsukamoto, Norifumi;Karasawa, Masamitsu;Miyawaki, Shuichi, 2009, BLOOD, 114, 22, 1207, 1207
• Prognostic Importance of Soluble Form IL-2 Receptor a (sIL-2Ra) and Its Relationship with Surface Expression of IL-2Ra of Lymphoma Cell in Diffuse Large B-Cell Lymphoma Treated with Rituximab-Containing Chemotherapy: a Retrospective Analysis of 409 Cases, Yokohama, Akihiko;Hashimoto, Yoko;Saito, Akio;Nakahashi, Hirotaka;Toyama, Kohtaro;Koiso, Hiromi;Saito, Takayuki;Handa, Hiroshi;Uchiurni, Hideki;Jimbo, Takahiro;Murayama, Kayoko;Sawamura, Morio;Matsumoto, Morio;Karasawa, Masamitsu;Murakami, Hirokazu;Nojima, Yoshihisa;Hirato, Junko;Kojima, Masaru;Tsukamoto, Norifumi, 2009, BLOOD, 114, 22, 767, 768
• The Influence of Polymorphisms of Interleukin-17F Genes On the Susceptibility and Clinical Outcome of Multiple Myeloma., Saitoh, Takayuki;Kasamatsu, Tetsuhiro;Yokohama, Akihiko;Handa, Hiroshi;Tsukamoto, Norifumi;Karasawa, Masamitsu;Ogawara, Hatsue;Nojima, Yoshihisa;Murakami, Hirokazu, 2009, BLOOD, 114, 22, 709, 710
• 末梢血および骨髄に著明な形質細胞の増加を認めた血管免疫芽球性T細胞リンパ腫の2例, ;;;;;;;;;;, Oct. 2015, 63, 補冊, 245
• 【外来で診るリンパ腫・骨髄腫-治癒または長期共存を目指して】骨髄腫診療の進歩　病態　多発性骨髄腫における染色体・遺伝子異常と予後, 半田 寛, Nov. 2015, 52, 12, 2146
• 急性前骨髄性白血病に対する全トランスレチノイン酸治療中に発症した門脈血栓症の1例, ;;;;;;, Nov. 2015, 619回, 29
• 胸骨周囲に髄外造血腫瘤を形成した原発性骨髄線維症, ;;;;;;;;;;;;;, Nov. 2015, 56, 11, 2364
• PDCD1 and PDCD1LG1 polymorphisms affect the susceptibility to multiple myeloma., Kasamatsu Tetsuhiro;Awata Maaya;Ishihara Rei;Murakami Yuki;Gotoh Nanami;Matsumoto Morio;Sawamura Morio;Yokohama Akihiko;Handa Hiroshi;Tsukamoto Norifumi;Saitoh Takayuki;Murakami Hirokazu, 16 Oct. 2019, Clinical and experimental medicine, 20, 1

  DOI
• Successful Management of Acquired Factor V Inhibitor by Monitoring Factor V Activity, Antigen, and Inhibitor Values during Immunosuppressive Therapy., Mihara Masahiro;Ogawa Yoshiyuki;Nagasaka Motoo;Kobayashi Nobuhiko;Shimizu Hiroaki;Shinozawa Keiko;Fukutake Katsuyuki;Inoue Madoka;Murakami Masami;Handa Hiroshi, 27 Sep. 2019, Acta haematologica, 143, 5

  DOI
• The Role and Function of microRNA in the Pathogenesis of Multiple Myeloma., Handa Hiroshi;Murakami Yuki;Ishihara Rei;Kimura-Masuda Kei;Masuda Yuta, 06 Nov. 2019, Cancers, 11, 11

  DOI
• Elotuzumab plus lenalidomide and dexamethasone for newly diagnosed multiple myeloma: a randomized, open-label, phase 2 study in Japan., Kubo Kohmei;Hori Mitsuo;Ohta Kensuke;Handa Hiroshi;Hatake Kiyohiko;Matsumoto Morio;Hagiwara Shotaro;Ohashi Kazuteru;Nakaseko Chiaki;Suzuki Kenshi;Ito Shigeki;Kinoshita Gen;Shelat Suresh G;Miyoshi Masafumi;Takezako Naoki, 07 Nov. 2019, International journal of hematology, 111, 1

  DOI
• RUNX1 mutation in a patient with myelodysplastic syndrome and decreased erythrocyte expression of blood group A antigen., Hayakawa Akira;Sano Rie;Takahashi Yoichiro;Kubo Rieko;Harada Megumi;Omata Masato;Yokohama Akihiko;Handa Hiroshi;Tsukada Junichi;Takeshita Haruo;Tsuneyama Hatsue;Ogasawara Kenichi;Kominato Yoshihiko, 16 Dec. 2019, Transfusion, 60, 1

  DOI
• Safety and pharmacokinetics of quizartinib in Japanese patients with relapsed or refractory acute myeloid leukemia in a phase 1 study., Usuki Kensuke;Handa Hiroshi;Choi Ilseung;Yamauchi Takahiro;Iida Hiroatsu;Hata Tomoko;Ohwada Shoichi;Okudaira Noriko;Nakamura Kota;Sakajiri Sakura, 29 Jul. 2019, International journal of hematology, 110, 6

  DOI
• Evaluation of the Revised International Staging System (R-ISS) in Japanese patients with multiple myeloma., Ozaki Shuji;Handa Hiroshi;Saitoh Takayuki;Murakami Hirokazu;Itagaki Mitsuhiro;Asaoku Hideki;Suzuki Kenshi;Isoda Atsushi;Matsumoto Morio;Sawamura Morio;Sunami Kazutaka;Takezako Naoki;Hagiwara Shotaro;Kuroda Yoshiaki;Chou Takaaki;Nagura Eiichi;Shimizu Kazuyuki, 02 May 2019, Annals of hematology, 98, 7

  DOI
• Human telomerase reverse transcriptase expression in a CD34-positive hematopoietic progenitor of myelodysplastic syndrome and acute myelogenous leukemia., Handa Hiroshi;Nishimoto Natsumi;Inoue Madoka;Yokohama Akihiko;Tsukamoto Norifumi;Saitoh Takayuki;Murakami Hirokazu, 30 May 2019, Hematological oncology, 37, 4

  DOI
• Patients assigned to VGPR, PR, and SD in the IMWG response category are composed of heterogeneous population when assessed by the heavy/light chain assay., Kamiya Yoshikazu;Chou Takaaki;Murakami Hirokazu;Handa Hiroshi;Ozaki Shuji;Shimazaki Chihiro;Fuchida Shin-Ichi;Okada Jun;Itoh Junji;Sugiyama Satoru;Shimizu Kazuyuki, 26 Apr. 2019, Hematological oncology, 37, 3

  DOI
• Malignancy-Associated Hypercalcemia Related with Receptor Activator of NF-κB Ligand (RANKL) Expression in T-Cell Acute Lymphoblastic Leukemia., Tahara Kenichi;Koiso Hiromi;Osaki Yo-Hei;Sekigami Tomomi;Yokohama Akihiko;Saitoh Takayuki;Tsukamoto Norifumi;Murakami Hirokazu;Abe Masahiro;Handa Hiroshi, 15 Feb. 2019, Acta haematologica, 141, 3

  DOI
• Activin A: a novel urinary biomarker of renal impairment in multiple myeloma., Iriuchishima Hirono;Maeshima Akito;Takahashi Shunsuke;Ishizaki Takuma;Yokohama Akihiko;Tsukamoto Norifumi;Saitoh Takayuki;Murakami Hirokazu;Handa Hiroshi, 31 May 2019, Bioscience reports, 39, 5

  DOI
• Thalidomide maintenance therapy in Japanese myeloma patients: a multicenter, phase II clinical trial (COMET study)., Murakami Hirokazu;Kasamatsu Tetsuhiro;Murakami Jun;Kiguchi Toru;Kanematsu Takeshi;Ogawa Daisuke;Takamatsu Hiroyuki;Handa Hiroshi;Ozaki Shuji;Miki Hirokazu;Takahashi Takeshi;Takeo Takaaki;Yamauchi Tatsuya;Morishita Takanobu;Kosugi Hiroshi;Shimizu Kazuyuki, 31 Jan. 2019, International journal of hematology, 109, 4

  DOI
• [Safety and management of adverse events of ixazomib/lenalidomide/dexamethasone therapy in Japanese patients with relapsed/refractory multiple myeloma]., Iida Shinsuke;Izumi Tohru;Aotsuka Nobuyuki;Komeno Takuya;Ishida Tadao;Sunami Kazutaka;Handa Hiroshi;Berg Deborah;Kase Yoichi;Soeda Junpei, [Rinsho ketsueki] The Japanese journal of clinical hematology, 59, 11

  DOI
• Prognostic impact of trisomy 21 in follicular lymphoma., Mitsui Takeki;Yokohama Akihiko;Koiso Hiromi;Saito Akio;Toyama Kohtaro;Shimizu Hiroaki;Ishizaki Takuma;Irisawa Hiroyuki;Takizawa Makiko;Saitoh Takayuki;Murayama Kayoko;Matsumoto Morio;Handa Hiroshi;Hirato Junko;Kojima Masaru;Murakami Hirokazu;Tsukamoto Norifumi, 12 Nov. 2018, British journal of haematology, 184, 4

  DOI
• Clinical impact of serum soluble SLAMF7 in multiple myeloma., Ishibashi Mariko;Soeda Saori;Sasaki Makoto;Handa Hiroshi;Imai Yoichi;Tanaka Norina;Tanosaki Sakae;Ito Shigeki;Odajima Takeshi;Sugimori Hiroki;Asayama Toshio;Sunakawa Mika;Kaito Yuta;Kinoshita Ryosuke;Kuribayashi Yasuko;Onodera Asaka;Moriya Keiichi;Tanaka Junji;Tsukune Yutaka;Komatsu Norio;Inokuchi Koiti;Tamura Hideto, 05 Oct. 2018, Oncotarget, 9, 78

  DOI
• Recurrent CCND3 mutations in MLL-rearranged acute myeloid leukemia., Matsuo Hidemasa;Yoshida Kenichi;Fukumura Kazutaka;Nakatani Kana;Noguchi Yuki;Takasaki Saho;Noura Mina;Shiozawa Yusuke;Shiraishi Yuichi;Chiba Kenichi;Tanaka Hiroko;Okada Ai;Nannya Yasuhito;Takeda June;Ueno Hiroo;Shiba Norio;Yamato Genki;Handa Hiroshi;Ono Yuichiro;Hiramoto Nobuhiro;Ishikawa Takayuki;Usuki Kensuke;Ishiyama Ken;Miyawaki Shuichi;Itonaga Hidehiro;Miyazaki Yasushi;Kawamura Machiko;Yamaguchi Hiroki;Kiyokawa Nobutaka;Tomizawa Daisuke;Taga Takashi;Tawa Akio;Hayashi Yasuhide;Mano Hiroyuki;Miyano Satoru;Kamikubo Yasuhiko;Ogawa Seishi;Adachi Souichi, Blood advances, 2, 21

  DOI
• Correction to: Thalidomide maintenance therapy in Japanese myeloma patients: a multicenter, phase II clinical trial (COMET study)., Murakami Hirokazu;Kasamatsu Tetsuhiro;Murakami Jun;Kiguchi Toru;Kanematsu Takeshi;Ogawa Daisuke;Takamatsu Hiroyuki;Handa Hiroshi;Ozaki Shuji;Miki Hirokazu;Takahashi Takeshi;Takeo Takaaki;Yamauchi Tatsuya;Morishita Takanobu;Kosugi Hiroshi;Shimizu Kazuyuki, International journal of hematology, 110, 1

  DOI
• Unsuppressed serum albumin levels may jeopardize the clinical relevance of the international staging system to patients with light chain myeloma., Kasamatsu Tetsuhiro;Ozaki Shuji;Saitoh Takayuki;Konishi Jun;Sunami Kazutaka;Itagaki Mitsuhiro;Asaoku Hideki;Cho Takaaki;Handa Hiroshi;Hagiwara Shotaro;Wakayama Toshio;Negoro Akiko;Takezako Naoki;Harada Naoko;Kuroda Yoshiaki;Nakaseko Chiaki;Miyake Takaaki;Inoue Nobumasa;Hata Hiroyuki;Shimazaki Chihiro;Ohno Tatsuharu;Kuroda Junya;Murayama Tohru;Kobayashi Takahiro;Abe Masahiro;Ishida Tadao;Nagura Eiich;Shimizu Kazuyuki, 19 Sep. 2018, Hematological oncology, 36, 5

  DOI
• A novel CYCS mutation in the α-helix of the CYCS C-terminal domain causes non-syndromic thrombocytopenia., Uchiyama Yuri;Yanagisawa Kunio;Kunishima Shinji;Shiina Masaaki;Ogawa Yoshiyuki;Nakashima Mitsuko;Hirato Junko;Imagawa Eri;Fujita Atsushi;Hamanaka Kohei;Miyatake Satoko;Mitsuhashi Satomi;Takata Atsushi;Miyake Noriko;Ogata Kazuhiro;Handa Hiroshi;Matsumoto Naomichi;Mizuguchi Takeshi, 03 Sep. 2018, Clinical genetics, 94, 6

  DOI
• Infectious complications in adults undergoing intensive chemotherapy for acute myeloid leukemia in 2001-2005 using the Japan Adult Leukemia Study Group AML201 protocols., Kato Hideaki;Fujita Hiroyuki;Akiyama Nobu;Kimura Shun-Ichi;Hiramoto Nobuhiro;Hosono Naoko;Takahashi Tsutomu;Shigeno Kazuyuki;Minamiguchi Hitoshi;Miyatake Junichi;Handa Hiroshi;Kanda Yoshinobu;Yoshida Minoru;Miyawaki Shuichi;Ohtake Shigeki;Naoe Tomoki;Kiyoi Hitoshi;Matsumura Itaru;Miyazaki Yasushi; , 02 Jun. 2018, Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer, 26, 12

  DOI
• Tumor long-axis diameter and SUVmax predict long-term responders in 90Y-ibritumomab tiuxetan monotherapy., Tsukamoto Norifumi;Yokohama Akihiko;Higuchi Tetsuya;Mitsui Takeki;Koiso Hiromi;Takizawa Makiko;Shimizu Hiroaki;Ishizaki Takuma;Matsumoto Morio;Toyama Kohtaro;Sakura Tohru;Ogura Hidemi;Saitoh Takayuki;Ishida Fumihiro;Murakami Hirokazu;Tsushima Yoshito;Handa Hiroshi, 10 Sep. 2018, International journal of hematology, 109, 1

  DOI
• Association between OGG1 S326C CC genotype and elevated relapse risk in acute myeloid leukemia., Gotoh Nanami;Saitoh Takayuki;Takahashi Noriyuki;Kasamatsu Tetsuhiro;Minato Yusuke;Lobna Alkebsi;Oda Tsukasa;Hoshino Takumi;Sakura Toru;Shimizu Hiroaki;Takizawa Makiko;Handa Hiroshi;Yokohama Akihiko;Tsukamoto Norifumi;Murakami Hirokazu, 08 May 2018, International journal of hematology, 108, 3

  DOI
• Overshoot of FVIII activity in patients with acquired hemophilia A who achieve complete remission., Ogawa Yoshiyuki;Yanagisawa Kunio;Naito Chiaki;Uchiumi Hideki;Ishizaki Takuma;Shimizu Hiroaki;Gohda Fumito;Ieko Masahiro;Ichinose Akitada;Handa Hiroshi, 14 Jan. 2020, International journal of hematology, 111, 4

  DOI
• SLAMF3-Mediated Signaling via ERK Pathway Activation Promotes Aggressive Phenotypic Behaviors in Multiple Myeloma., Ishibashi Mariko;Takahashi Risa;Tsubota Asako;Sasaki Makoto;Handa Hiroshi;Imai Yoichi;Tanaka Norina;Tsukune Yutaka;Tanosaki Sakae;Ito Shigeki;Asayama Toshio;Sunakawa Mika;Kaito Yuta;Kuribayashi-Hamada Yasuko;Onodera Asaka;Moriya Keiichi;Komatsu Norio;Tanaka Junji;Odajima Takeshi;Sugimori Hiroki;Inokuchi Koiti;Tamura Hideto, 23 Jan. 2020, Molecular cancer research : MCR, 18, 4

  DOI
• Integrin α7 and Extracellular Matrix Laminin 211 Interaction Promotes Proliferation of Acute Myeloid Leukemia Cells and Is Associated with Granulocytic Sarcoma., Kobayashi Nobuhiko;Oda Tsukasa;Takizawa Makiko;Ishizaki Takuma;Tsukamoto Norifumi;Yokohama Akihiko;Takei Hisashi;Saitoh Takayuki;Shimizu Hiroaki;Honma Kazuki;Kimura-Masuda Kei;Kuroda Yuko;Ishihara Rei;Murakami Yuki;Murakami Hirokazu;Handa Hiroshi, 05 Feb. 2020, Cancers, 12, 2

  DOI
• PARP1 V762A polymorphism affects the prognosis of myelodysplastic syndromes., Gotoh Nanami;Minato Yusuke;Saitoh Takayuki;Takahashi Noriyuki;Kasamatsu Tetsuhiro;Souma Kana;Oda Tsukasa;Hoshino Takumi;Sakura Toru;Ishizaki Takuma;Shimizu Hiroaki;Takizawa Makiko;Yokohama Akihiko;Tsukamoto Norifumi;Handa Hiroshi;Murakami Hirokazu, 04 Mar. 2020, European journal of haematology, 104, 6

  DOI
• IgG4-related Disease with a Cardiac Mass., Matsumura Ikuko;Mitsui Takeki;Tahara Kenichi;Shimizu Hiroaki;Yanagisawa Kunio;Ishizaki Takuma;Koiso Hiromi;Takizawa Makiko;Yokohama Akihiko;Saitoh Takayuki;Hirato Junko;Murakami Hirokazu;Handa Hiroshi;Tsukamoto Norifumi, 17 Jan. 2020, Internal medicine (Tokyo, Japan), 59, 9

  DOI
• Continuous lenalidomide treatment after bortezomib-melphalan-prednisolone therapy for newly diagnosed multiple myeloma., Ishida Tadao;Kimura Hideo;Ozaki Shuji;Kubo Koumei;Sunami Kazutaka;Takezako Naoki;Fujita Hiroyuki;Hayashi Toshiaki;Kiguchi Toru;Ohashi Kazuteru;Yamamoto Satoshi;Takamatsu Hiroyuki;Kosugi Hiroshi;Ohta Kensuke;Sakai Rika;Handa Hiroshi;Kondo Seiji;Abe Yu;Omoto Eijiro;Mitani Kinuko;Morita Satoshi;Murakami Hirokazu;Shimizu Kazuyuki, 04 Apr. 2020, Annals of hematology, 99, 5

  DOI
• Genomic analysis of multiple myeloma using targeted capture sequencing in the Japanese cohort., Kanamori Takashi;Sanada Masashi;Ri Masaki;Ueno Hiroo;Nishijima Dai;Yasuda Takahiko;Tachita Takuto;Narita Tomoko;Kusumoto Shigeru;Inagaki Atsushi;Ishihara Rei;Murakami Yuki;Kobayashi Nobuhiko;Shiozawa Yusuke;Yoshida Kenichi;Nakagawa Masahiro M;Nannya Yasuhito;Shiraishi Yuichi;Chiba Kenichi;Tanaka Hiroko;Miyano Satoru;Horibe Keizo;Handa Hiroshi;Ogawa Seishi;Iida Shinsuke, 09 May 2020, British journal of haematology

  DOI
• Clinical utility of target capture-based panel sequencing in hematological malignancies: A multicenter feasibility study., Yasuda Takahiko;Sanada Masashi;Nishijima Dai;Kanamori Takashi;Iijima Yuka;Hattori Hiroyoshi;Saito Akiko;Miyoshi Hiroaki;Ishikawa Yuichi;Asou Norio;Usuki Kensuke;Hirabayashi Shinsuke;Kato Motohiro;Ri Masaki;Handa Hiroshi;Ishida Tadao;Shibayama Hirohiko;Abe Masahiro;Iriyama Chisako;Karube Kennosuke;Nishikori Momoko;Ohshima Koichi;Kataoka Keisuke;Yoshida Kenichi;Shiraishi Yuichi;Goto Hiroaki;Adachi Souichi;Kobayashi Ryoji;Kiyoi Hitoshi;Miyazaki Yasushi;Ogawa Seishi;Kurahashi Hiroki;Yokoyama Hisayuki;Manabe Atsushi;Iida Shinsuke;Tomita Akihiro;Horibe Keizo, 17 Jul. 2020, Cancer science, 111, 9

  DOI
• A multicenter, open-label, phase II study of tirabrutinib (ONO/GS-4059) in patients with Waldenström's macroglobulinemia., Sekiguchi Naohiro;Rai Shinya;Munakata Wataru;Suzuki Kenshi;Handa Hiroshi;Shibayama Hirohiko;Endo Tomoyuki;Terui Yasuhito;Iwaki Noriko;Fukuhara Noriko;Tatetsu Hiro;Iida Shinsuke;Ishikawa Takayuki;Shiibashi Ryota;Izutsu Koji, 20 Jul. 2020, Cancer science, 111, 9

  DOI
• Aberrant BUB1 Overexpression Promotes Mitotic Segregation Errors and Chromosomal Instability in Multiple Myeloma., Fujibayashi Yuto;Isa Reiko;Nishiyama Daichi;Sakamoto-Inada Natsumi;Kawasumi Norichika;Yamaguchi Junko;Kuwahara-Ota Saeko;Matsumura-Kimoto Yayoi;Tsukamoto Taku;Chinen Yoshiaki;Shimura Yuji;Kobayashi Tsutomu;Horiike Shigeo;Taniwaki Masafumi;Handa Hiroshi;Kuroda Junya, 06 Aug. 2020, Cancers, 12, 8

  DOI
• Real-world management of infection during chemotherapy for acute leukemia in Japan: from the results of a nationwide questionnaire-based survey by the Japan Adult Leukemia Study Group., Kimura Shun-Ichi;Fujita Hiroyuki;Handa Hiroshi;Hiramoto Nobuhiro;Hosono Naoko;Minamiguchi Hitoshi;Takahashi Tsutomu;Kato Hideaki;Ono Takaaki;Kanda Yoshinobu;Kiyoi Hitoshi;Matsumura Itaru;Miyazaki Yasushi; , 18 Jun. 2020, International journal of hematology, 112, 3

  DOI
• Role of exosomes as a proinflammatory mediator in the development of EBV-associated lymphoma., Higuchi Hiroshi;Yamakawa Natsuko;Imadome Ken-Ichi;Yahata Takashi;Kotaki Ryutaro;Ogata Jun;Kakizaki Masatoshi;Fujita Koji;Lu Jun;Yokoyama Kazuaki;Okuyama Kazuki;Sato Ai;Takamatsu Masako;Kurosaki Natsumi;Alba Syakira Mohamad;Azhim Azran;Horie Ryouichi;Watanabe Toshiki;Kitamura Toshio;Ando Kiyoshi;Kashiwagi Takao;Matsui Toshimitsu;Okamoto Akinao;Handa Hiroshi;Kuroda Masahiko;Nakamura Naoya;Kotani Ai, 22 Apr. 2018, Blood, 131, 23

  DOI
• Successful hemostatic management of major surgery for cervical spondylotic myelopathy in a patient with severe factor XI deficiency., Ogawa Yoshiyuki;Yanagisawa Kunio;Uchiyama Yuri;Akashi Naoki;Mieda Tokue;Iizuka Haku;Inoue Madoka;Shizuka Reiko;Murakami Masami;Matsumoto Naomichi;Handa Hiroshi, 30 Apr. 2018, International journal of hematology, 108, 4

  DOI
• Ruxolitinib is effective and safe in Japanese patients with hydroxyurea-resistant or hydroxyurea-intolerant polycythemia vera with splenomegaly., Kirito Keita;Suzuki Kenshi;Miyamura Koichi;Takeuchi Masahiro;Handa Hiroshi;Okamoto Shinichiro;Gadbaw Brian;Yamauchi Kyosuke;Amagasaki Taro;Ito Kazuo;Hino Masayuki, 27 Sep. 2017, International journal of hematology, 107, 2

  DOI
• Recurrent alterations of the WW domain containing oxidoreductase gene spanning the common fragile site FRA16D in multiple myeloma and monoclonal gammopathy of undetermined significance., Handa Hiroshi;Sasaki Yoshiko;Hattori Hikaru;Alkebsi Lobna;Kasamatsu Tetsuhiro;Saitoh Takayuki;Mitsui Takeki;Yokohama Akihiko;Tsukamoto Norifumi;Matsumoto Morio;Murakami Hirokazu, 26 Jul. 2017, Oncology letters, 14, 4

  DOI
• IL17A and IL23R gene polymorphisms affect the clinical features and prognosis of patients with multiple myeloma., Kasamatsu Tetsuhiro;Kimoto Mari;Takahashi Noriyuki;Minato Yusuke;Gotoh Nanami;Takizawa Makiko;Matsumoto Morio;Sawamura Morio;Yokohama Akihiko;Handa Hiroshi;Tsukamoto Norifumi;Saitoh Takayuki;Murakami Hirokazu, 07 Aug. 2017, Hematological oncology, 36, 1

  DOI
• Long non-coding RNA MALAT1 is an inducible stress response gene associated with extramedullary spread and poor prognosis of multiple myeloma., Handa Hiroshi;Kuroda Yuko;Kimura Kei;Masuda Yuta;Hattori Hikaru;Alkebsi Lobna;Matsumoto Morio;Kasamatsu Tetsuhiro;Kobayashi Nobuhiko;Tahara Ken-Ichi;Takizawa Makiko;Koiso Hiromi;Ishizaki Takuma;Shimizu Hiroaki;Yokohama Akihiko;Tsukamoto Norifumi;Saito Takayuki;Murakami Hirokazu, 02 Aug. 2017, British journal of haematology, 179, 3

  DOI
• Clinical features and prognostic impact of PRDM16 expression in adult acute myeloid leukemia., Yamato Genki;Yamaguchi Hiroki;Handa Hiroshi;Shiba Norio;Kawamura Machiko;Wakita Satoshi;Inokuchi Koiti;Hara Yusuke;Ohki Kentaro;Okubo Jun;Park Myoung-Ja;Sotomatsu Manabu;Arakawa Hirokazu;Hayashi Yasuhide, 11 Aug. 2017, Genes, chromosomes & cancer, 56, 11

  DOI
• Retrospective analysis of prognostic factors for Waldenstrӧm macroglobulinemia: a multicenter cooperative study in Japan., Saito Akio;Isoda Atsushi;Kojima Masaru;Yokohama Akihiko;Tsukune Yutaka;Sasaki Makoto;Ito Shigeki;Ohtsu Akihiro;Koike Michiaki;Murayama Kayoko;Moriya Keiichi;Tamura Hideto;Matsumoto Morio;Nakahashi Hirotaka;Tanosaki Sakae;Sakura Tohru;Kawamura Toshihide;Miyanaga Tomomi;Nakamura Naoya;Murakami Hirokazu;Handa Hiroshi;Tsukamoto Norifumi, 07 Jul. 2017, International journal of hematology, 106, 5

  DOI
• Evaluation of the dose and efficacy of ruxolitinib in Japanese patients with myelofibrosis., Kirito Keita;Okamoto Shinichiro;Ohishi Kohshi;Tauchi Tetsuzo;Handa Hiroshi;Saito Shigeki;Takenaka Katsuto;Shimoda Kazuya;Oritani Kenji;Akashi Koichi;Okada Hikaru;Amagasaki Taro;Suzuki Kazuyuki;Yonezu Toshio;Komatsu Norio, 06 Oct. 2017, International journal of hematology, 107, 1

  DOI
• Management of infection during chemotherapy for acute leukemia in Japan: a nationwide questionnaire-based survey by the Japan Adult Leukemia Study Group., Kimura Shun-Ichi;Fujita Hiroyuki;Kato Hideaki;Hiramoto Nobuhiro;Hosono Naoko;Takahashi Tsutomu;Shigeno Kazuyuki;Hatsumi Naoko;Minamiguchi Hitoshi;Miyatake Junichi;Handa Hiroshi;Akiyama Nobu;Kanda Yoshinobu;Yoshida Minoru;Kiyoi Hitoshi;Miyazaki Yasushi;Naoe Tomoki; , 06 Jun. 2017, Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer, 25, 11

  DOI
• Overexpression of B-cell lymphoma 6 alters gene expression profile in a myeloma cell line and is associated with decreased DNA damage response., Tahara Kenichi;Takizawa Makiko;Yamane Arito;Osaki Yohei;Ishizaki Takuma;Mitsui Takeki;Yokohama Akihiko;Saitoh Takayuki;Tsukamoto Norifumi;Matsumoto Morio;Murakami Hirokazu;Nojima Yoshihisa;Handa Hiroshi, 25 Jun. 2017, Cancer science, 108, 8

  DOI
• The cytokine polymorphisms affecting Th1/Th2 increase the susceptibility to, and severity of, chronic ITP., Takahashi Noriyuki;Saitoh Takayuki;Gotoh Nanami;Nitta Yasuhiro;Alkebsi Lobna;Kasamatsu Tetsuhiro;Minato Yusuke;Yokohama Akihiko;Tsukamoto Norifumi;Handa Hiroshi;Murakami Hirokazu, 16 May 2017, BMC immunology, 18, 1

  DOI
• A novel GFI1B mutation at the first zinc finger domain causes congenital macrothrombocytopenia., Uchiyama Yuri;Ogawa Yoshiyuki;Kunishima Shinji;Shiina Masaaki;Nakashima Mitsuko;Yanagisawa Kunio;Yokohama Akihiko;Imagawa Eri;Miyatake Satoko;Mizuguchi Takeshi;Takata Atsushi;Miyake Noriko;Ogata Kazuhiro;Handa Hiroshi;Matsumoto Naomichi, 25 Apr. 2017, British journal of haematology, 181, 6

  DOI
• Epigenetic repression of miR-375 is the dominant mechanism for constitutive activation of the PDPK1/RPS6KA3 signalling axis in multiple myeloma., Tatekawa Shotaro;Chinen Yoshiaki;Ri Masaki;Narita Tomoko;Shimura Yuji;Matsumura-Kimoto Yayoi;Tsukamoto Taku;Kobayashi Tsutomu;Kawata Eri;Uoshima Nobuhiko;Taki Tomohiko;Taniwaki Masafumi;Handa Hiroshi;Iida Shinsuke;Kuroda Junya, 25 Apr. 2017, British journal of haematology, 178, 4

  DOI
• Cytomegalovirus retinitis followed by immune recovery uveitis in an elderly patient with rheumatoid arthritis undergoing administration of methotrexate and tofacitinib combination therapy., Yanagisawa Kunio;Ogawa Yoshiyuki;Hosogai Mayumi;Todokoro Daisuke;Mitsui Takeki;Yokohama Akihiko;Kishi Shoji;Handa Hiroshi, 25 Apr. 2017, Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy, 23, 8

  DOI
• Collision of metastatic malignant melanoma and acute myelogenous leukemia in the bone marrow., Kobayashi Nobuhiko;Shimizu Hiroaki;Hirato Junko;Handa Hiroshi, 17 Oct. 2017, International journal of hematology, 107, 3

  DOI
• Successful Management of a Patient with Autoimmune Hemorrhaphilia due to Anti-Factor XIII/13 Antibodies Complicated by Pulmonary Thromboembolism., Ogawa Yoshiyuki;Yanagisawa Kunio;Souri Masayoshi;Mihara Masahiro;Naito Chiaki;Takizawa Makiko;Ishizaki Takuma;Mitsui Takeki;Handa Hiroshi;Osaki Tsukasa;Nojima Yoshihisa;Ichinose Akitada, 06 Apr. 2017, Acta haematologica, 137, 3

  DOI
• Clonal evolution detected with conventional cytogenetic analysis is a potent prognostic factor in adult patients with relapsed AML., Shimizu Hiroaki;Yokohama Akihiko;Ishizaki Takuma;Hatsumi Nahoko;Takada Satoru;Saitoh Takayuki;Sakura Toru;Nojima Yoshihisa;Handa Hiroshi, 04 Apr. 2017, Hematological oncology, 36, 1

  DOI
• A Rare Case of Chronic Active Epstein-Barr Virus (EBV) Infection Accompanied by the Infiltration of EBV-infected CD8+ T Cells into the Muscle., Kobayashi Nobuhiko;Mitsui Takeki;Ogawa Yoshiyuki;Iriuchishima Hirono;Takizawa Makiko;Yokohama Akihiko;Saitoh Takayuki;Koiso Hiromi;Tsukamoto Norifumi;Murakami Hirokazu;Nojima Yoshihisa;Handa Hiroshi, Journal of pediatric hematology/oncology, 40, 3

  DOI
• Effect of ruxolitinib therapy on the quality-of-life of Japanese patients with myelofibrosis., Oritani Kenji;Ohishi Kohshi;Okamoto Shinichiro;Kirito Keita;Komatsu Norio;Tauchi Tetsuzo;Handa Hiroshi;Saito Shigeki;Takenaka Katsuto;Shimoda Kazuya;Okada Hikaru;Amagasaki Taro;Wakase Shiho;Shimozuma Kojiro;Akashi Koichi, 04 Jan. 2018, Current medical research and opinion, 34, 3

  DOI
• PDCD1 and CTLA4 polymorphisms affect the susceptibility to, and clinical features of, chronic immune thrombocytopenia., Kasamatsu Tetsuhiro;Ino Rumi;Takahashi Noriyuki;Gotoh Nanami;Minato Yusuke;Takizawa Makiko;Yokohama Akihiko;Handa Hiroshi;Saitoh Takayuki;Tsukamoto Norifumi;Murakami Hirokazu, 23 Jan. 2018, British journal of haematology, 180, 5

  DOI
• Histone deacetylase inhibitors suppress ABO transcription in vitro, leading to reduced expression of the antigens., Takahashi Yoichiro;Kubo Rieko;Sano Rie;Nakajima Tamiko;Takahashi Keiko;Kobayashi Momoko;Handa Hiroshi;Tsukada Junichi;Kominato Yoshihiko, 26 Dec. 2016, Transfusion, 57, 3

  DOI
• Phase 1 study of ixazomib alone or combined with lenalidomide-dexamethasone in Japanese patients with relapsed/refractory multiple myeloma., Suzuki Kenshi;Handa Hiroshi;Chou Takaaki;Ishizawa Kenichi;Takubo Takatoshi;Kase Yoichi, 20 Dec. 2016, International journal of hematology, 105, 4

  DOI
• Chromosome 16q genes CDH1, CDH13 and ADAMTS18 are correlated and frequently methylated in human lymphoma., Alkebsi Lobna;Handa Hiroshi;Yokohama Akihiko;Saitoh Takayuki;Tsukamoto Norifumi;Murakami Hirokazu, 09 Sep. 2016, Oncology letters, 12, 5

  DOI
• Successful management of perioperative hemostasis in a patient with Glanzmann thrombasthenia who underwent a right total mastectomy., Ogawa Yoshiyuki;Kunishima Shinji;Yanagisawa Kunio;Osaki Yohei;Uchiyama Yuri;Matsumoto Naomichi;Tokiniwa Hideaki;Horiguchi Jun;Nojima Yoshihisa;Handa Hiroshi, 01 Oct. 2016, International journal of hematology, 105, 2

  DOI
• Successful Treatment of Epstein-Barr Virus-Associated Lymphoproliferative Disorder with Rituximab in a Patient Undergoing Immunosuppressive Therapy for Aplastic Anemia., Shimizu Hiroaki;Kobayashi Nobuhiko;Mihara Masahiro;Iriuchishima Hirono;Ishizaki Takuma;Kojima Yoshihisa;Handa Hiroshi, 26 Aug. 2016, Acta haematologica, 136, 3

  DOI
• Polymorphism of IL-10 receptor β affects the prognosis of multiple myeloma patients treated with thalidomide and/or bortezomib., Kasamatsu Tetsuhiro;Saitoh Takayuki;Ino Rumi;Gotoh Nanami;Mitsui Takeki;Shimizu Hiroaki;Matsumoto Morio;Sawamura Morio;Yokohama Akihiko;Handa Hiroshi;Tsukamoto Norifumi;Murakami Hirokazu, 13 Jul. 2016, Hematological oncology, 35, 4

  DOI
• Incidence and clinical background of hepatitis B virus reactivation in multiple myeloma in novel agents' era., Tsukune Yutaka;Sasaki Makoto;Odajima Takeshi;Isoda Atsushi;Matsumoto Morio;Koike Michiaki;Tamura Hideto;Moriya Keiichi;Ito Shigeki;Asahi Maki;Imai Yoichi;Tanaka Junji;Handa Hiroshi;Koiso Hiromi;Tanosaki Sakae;Hua Jian;Hagihara Masao;Yahata Yuriko;Suzuki Satoko;Watanabe Sumio;Sugimori Hiroki;Komatsu Norio, 30 Jun. 2016, Annals of hematology, 95, 9

  DOI
• Clinical characteristics and outcomes of acquired hemophilia A: experience at a single center in Japan., Ogawa Yoshiyuki;Yanagisawa Kunio;Uchiumi Hideki;Ishizaki Takuma;Mitsui Takeki;Gouda Fumito;Ieko Masahiro;Ichinose Akitada;Nojima Yoshihisa;Handa Hiroshi, 15 Mar. 2017, International journal of hematology, 106, 1

  DOI
• Short-term administration of recombinant human erythropoietin decreases B cell number in human peripheral blood., Nagashima Tomomi;Yokohama Akihiko;Nagai Kie;Kasamatsu Tetsuhiro;Gotoh Nanami;Iriuchishima Hirono;Sekigami Tomomi;Saitoh Takayuki;Handa Hiroshi;Tsukamoto Norifumi;Murakami Hirokazu, 02 Feb. 2018, Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis, 57, 2

  DOI
• Bortezomib maintenance therapy in transplant-ineligible myeloma patients who plateaued after bortezomib-based induction therapy: a multicenter phase II clinical trial., Isoda Atsushi;Murayama Kayoko;Ito Shigeki;Kohara Yoichi;Iino Masaki;Miyazawa Yuri;Matsumoto Morio;Handa Hiroshi;Imai Yosuke;Ishiguro Takuro;Izumita Wataru;Kitano Kiyoshi;Hirabayashi Yukio;Nakazawa Hideyuki;Ishida Fumihiro;Mitsumori Toru;Kirito Keita;Chou Takaaki;Murakami Hirokazu; , 28 Mar. 2018, International journal of hematology, 108, 1

  DOI
• Raltegravir is safely used with long-term viral suppression for HIV-infected patients on hemodialysis: a pharmacokinetic study., Yanagisawa Kunio;Nagano Daisuke;Ogawa Yoshiyuki;Uchiumi Hideki;Shigehara Tetsuya;Saruki Kazuhisa;Handa Hiroshi;Araki Takuya;Yamamoto Koujirou;Nojima Yoshihisa, AIDS (London, England), 30, 6

  DOI
• Clinical management and outcomes of completely resected stage I follicular lymphoma., Yokohama Akihiko;Hashimoto Yoko;Takizawa Makiko;Shimizu Hiroaki;Miyazawa Yuri;Saitoh Akio;Toyama Kohtaro;Ishizaki Takuma;Mitsui Takeki; ; ;Saitoh Takayuki;Murayama Kayoko;Matsumoto Morio;Sawamura Morio;Murakami Hirokazu;Hirato Junko;Kojima Masaru;Nojima Yoshihisa;Handa Hiroshi;Tsukamoto Norifumi, 08 Feb. 2018, Journal of clinical and experimental hematopathology : JCEH, 58, 1

  DOI
• Switching to nilotinib is associated with deeper molecular responses in chronic myeloid leukemia chronic phase with major molecular responses to imatinib: STAT1 trial in Japan., Noguchi Shinsuke;Nakaseko Chiaki;Nishiwaki Kaichi;Ogasawara Hitoshi;Ohishi Kohshi;Tokuhira Michihide;Noguchi Masaaki;Kimura Hideo;Handa Hiroshi;Mitani Kinuko;Miura Masatomo;Wakita Hisashi;Takahashi Naoto; , 30 Apr. 2018, International journal of hematology, 108, 2

  DOI
• Darunavir concentration in PBMCs may be a better indicator of drug exposure in HIV patients., Nagano Daisuke;Araki Takuya;Yanagisawa Kunio;Ogawa Yoshiyuki;Gohda Fumito;Uchiumi Hideki;Handa Hiroshi;Nakamura Tomonori;Yamamoto Koujirou, 02 May 2018, European journal of clinical pharmacology, 74, 8

  DOI
• Long Noncoding RNA PVT1 Is Regulated by Bromodomain Protein BRD4 in Multiple Myeloma and Is Associated with Disease Progression., Handa Hiroshi;Honma Kazuki;Oda Tsukasa;Kobayashi Nobuhiko;Kuroda Yuko;Kimura-Masuda Kei;Watanabe Saki;Ishihara Rei;Murakami Yuki;Masuda Yuta;Tahara Ken-Ichi;Takei Hisashi;Kasamatsu Tetsuhiro;Saitoh Takayuki;Murakami Hirokazu, 27 Sep. 2020, International journal of molecular sciences, 21, 19

  DOI
• Once-weekly vs. twice-weekly carfilzomib dosing in a subgroup of Japanese relapsed and refractory multiple myeloma patients from a randomized phase 3 trial (A.R.R.O.W.) and comparison with ENDEAVOR., Takezako Naoki;Shibayama Hirohiko;Handa Hiroshi;Hagiwara Shotaro;Ozaki Shuji;Suzuki Kenshi;Kosugi Hiroshi;Ri Masaki;Sugiura Isamu;Choi Ilseung;Miyamoto Toshihiro;Iida Shinsuke, 10 Oct. 2020, International journal of hematology

  DOI
• EWSR1 overexpression is a pro-oncogenic event in multiple myeloma., Nishiyama Daichi;Chinen Yoshiaki;Isa Reiko;Fujibayashi Yuto;Kuwahara-Ota Saeko;Yamaguchi Junko;Takimoto-Shimomura Tomoko;Matsumura-Kimoto Yayoi;Tsukamoto Taku;Shimura Yuji;Kobayashi Tsutomu;Horiike Shigeo;Taniwaki Masafumi;Handa Hiroshi;Kuroda Junya, 23 Oct. 2020, International journal of hematology

  DOI
• Gene polymorphisms of mannose-binding lectin confer susceptibility to Pneumocystis pneumonia in HIV-infected patients., Yanagisawa Kunio;Ogawa Yoshiyuki;Uchiumi Hideki;Gohda Fumito;Mawatari Momoko;Ishizaki Takuma;Mitsui Takeki;Yokohama Akihiko;Handa Hiroshi;Tsukamoto Norifumi;Nojima Yoshihisa, 10 Aug. 2015, Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy, 21, 11

  DOI
• Polymorphisms of IL-10 affect the severity and prognosis of myelodysplastic syndrome., Kasamatsu Tetsuhiro;Saitoh Takayuki;Minato Yusuke;Shimizu Hiroaki;Yokohama Akihiko;Tsukamoto Norifumi;Handa Hiroshi;Sakura Toru;Murakami Hirokazu, 26 May 2015, European journal of haematology, 96, 3

  DOI
• [Aberrant micro RNA and epigenetic network are associated with progression from MGUS to multiple myeloma]., Handa Hiroshi, [Rinsho ketsueki] The Japanese journal of clinical hematology, 56, 8

  DOI
• A new staging system to predict prognosis of patients with multiple myeloma in an era of novel therapeutic agents., Iriuchishima Hirono;Saitoh Takayuki;Handa Hiroshi;Isoda Atsushi;Matsumoto Morio;Sawamura Morio;Iwasaki Atsushi;Ushie Chiaki;Hattori Hikaru;Sasaki Yoshiko;Mitsui Takeki;Yokohama Akihiko;Tsukamoto Norifumi;Murakami Hirokazu;Nojima Yoshihisa, 24 Jul. 2014, European journal of haematology, 94, 2

  DOI
• Philadelphia chromosome-positive mixed phenotype acute leukemia in the imatinib era., Shimizu Hiroaki;Yokohama Akihiko;Hatsumi Nahoko;Takada Satoru;Handa Hiroshi;Sakura Toru;Nojima Yoshihisa, 13 May 2014, European journal of haematology, 93, 4

  DOI
• Primary Plasma Cell Leukemia in the Era of Novel Agents: A Multicenter Study of the Japanese Society of Myeloma., Iriuchishima Hirono;Ozaki Shuji;Konishi Jun;Matsumoto Morio;Murayama Kayoko;Nakamura Fumihiko;Yamamoto Go;Handa Hiroshi;Saitoh Takayuki;Nagura Eiichi;Shimizu Kazuyuki;Nojima Yoshihisa;Murakami Hirokazu, 28 Oct. 2015, Acta haematologica, 135, 2

  DOI
• SF3B1 and IGHV gene mutation status predict poor prognosis in Japanese CLL patients., Mitsui Takeki;Koiso Hiromi;Nakahashi Hirotaka;Saitoh Akio;Shimizu Hiroaki;Ishizaki Takuma;Ogawa Yoshiyuki;Takizawa Makiko;Yokohama Akihiko;Saitoh Takayuki;Jinbo Takahiro;Ogura Hidemi;Handa Hiroshi;Sawamura Morio;Sakura Tohru;Karasawa Masamitsu;Murakami Hirokazu;Nojima Yoshihisa;Tsukamoto Norifumi, 20 Nov. 2015, International journal of hematology, 103, 2

  DOI
• Two Cases of Intravascular Lymphoma Diagnosed by Gastrointestinal Endoscopic Biopsy., Shimoyama Yasuyuki;Sugimoto Kensuke;Kotake Mie;Uehara Daisuke;Kamide Yosuke;Kuribayashi Shiko;Kawamura Osamu;Kusano Motoyasu;Handa Hiroshi;Hirato Junko;Yamada Masanobu, 15 Dec. 2015, Internal medicine (Tokyo, Japan), 54, 24

  DOI
• DNMT3B7 expression related to MENT expression and its promoter methylation in human lymphomas., Alkebsi Lobna;Handa Hiroshi;Sasaki Yoshiko;Osaki Yohei;Yanagisawa Kunio;Ogawa Yoshiaki;Yokohama Akihiko;Hattori Hikaru;Koiso Hiromi;Saitoh Takayuki;Mitsui Takeki;Tsukamoto Norifumi;Nojima Yoshihisa;Murakami Hirokazu, 21 Sep. 2013, Leukemia research, 37, 12

  DOI
• Prevalence of extramedullary relapses is higher after allogeneic stem cell transplantation than after chemotherapy in adult patients with acute myeloid leukemia., Shimizu Hiroaki;Saitoh Takayuki;Hatsumi Nahoko;Takada Satoru;Handa Hiroshi;Jimbo Takahiro;Sakura Toru;Miyawaki Shuichi;Nojima Yoshihisa, 05 Sep. 2013, Leukemia research, 37, 11

  DOI
• Recurrent Gemella haemolysans meningitis in a patient with osteomyelitis of the clivus., Hayashi Toshimasa;Uchiumi Hideki;Yanagisawa Kunio;Ogawa Yoshiyuki;Handa Hiroshi;Tsukamoto Norifumi;Nojima Yoshihisa, Internal medicine (Tokyo, Japan), 52, 18

  DOI
• Development of IgG4-related disease 10 years after chemotherapy for diffuse large B cell lymphoma and longstanding bronchial asthma., Mitsui Takeki;Yokohama Akihiko;Koiso Hiromi;Ishizaki Takuma;Uchiumi Hideki;Saitoh Takayuki;Handa Hiroshi;Hirato Junko;Karasawa Masamitsu;Murakami Hirokazu;Kojima Masaru;Nojima Yoshihisa;Tsukamoto Norifumi, 12 May 2013, International journal of hematology, 98, 1

  DOI
• Characterization of CD56+ dendritic-like cells: a normal counterpart of blastic plasmacytoid dendritic cell neoplasm?, Osaki Yohei;Yokohama Akihiko;Saito Akio;Tahara Kenichi;Yanagisawa Kunio;Ogawa Yoshiyuki;Ishizaki Takuma;Mitsui Takeki;Koiso Hiromi;Takizawa Makiko;Uchiumi Hideki;Saitoh Takayuki;Handa Hiroshi;Murakami Hirokazu;Tsukamoto Norifumi;Nojima Yoshihisa, 29 Nov. 2013, PloS one, 8, 11

  DOI
• Distinctive disease subgroups according to differentiation stages in adult patients with T-cell acute lymphoblastic leukemia., Shimizu Hiroaki;Handa Hiroshi;Hatsumi Nahoko;Takada Satoru;Saitoh Takayuki;Sakura Toru;Miyawaki Shuichi;Nojima Yoshihisa, 26 Feb. 2013, European journal of haematology, 90, 4

  DOI
• Age-related Epstein-Barr Virus-positive lymphoproliferative disorders of the orbit and maxillary sinus : a case report., Mitsui Takeki;Mawatari Momoko;Koiso Hiromi;Yokohama Akihiko;Uchiumi Hideki;Saitoh Takayuki;Handa Hiroshi;Hirato Junko;Karasawa Masamitsu;Murakami Hirokazu;Kojima Masaru;Nakamura Shigeo;Nojima Yoshihisa;Tsukamoto Norifumi, Journal of clinical and experimental hematopathology : JCEH, 52, 3

  DOI
• The murine stem cell virus promoter drives correlated transgene expression in the leukocytes and cerebellar Purkinje cells of transgenic mice., Oue Miho;Handa Hiroshi;Matsuzaki Yasunori;Suzue Kazutomo;Murakami Hirokazu;Hirai Hirokazu, 30 Nov. 2012, PloS one, 7, 11

  DOI
• Prognostic importance of the soluble form of IL-2 receptorα (sIL-2Rα) and its relationship with surface expression of IL-2Rα (CD25) of lymphoma cells in diffuse large B-cell lymphoma treated with CHOP-like regimen with or without rituximab: a retrospective analysis of 338 cases., Hashimoto Yoko;Yokohama Akihiko;Saitoh Akio;Nakahashi Hirotaka;Toyama Kohtaro;Mitsui Takeki;Koiso Hiromi;Saitoh Takayuki;Handa Hiroshi;Uchiumi Hideki;Jinbo Takahiro;Murayama Kayoko;Matsumoto Morio;Sawamura Morio;Karasawa Masamitsu;Murakami Hirokazu;Hirato Junko;Nojima Yoshihisa;Kojima Masaru;Tsukamoto Norifumi, Journal of clinical and experimental hematopathology : JCEH, 53, 3

  DOI
• Follicular lymphoma presenting with marked splenomegaly: report of three cases., Koiso Hiromi;Yokohama Akihiko;Mitsui Takeki;Saitoh Takayuki;Handa Hiroshi;Murakami Hirokazu;Hirato Junko;Kojima Masaru;Nojima Yoshihisa;Tsukamoto Norifumi, 17 May 2012, Acta haematologica, 128, 1

  DOI
• Hodgkin lymphoma presenting with various immunologic abnormalities, including autoimmune hepatitis, Hashimoto's thyroiditis, autoimmune hemolytic anemia, and immune thrombocytopenia., Saitoh Takayuki;Matsushima Takafumi;Saito Yasuyuki;Yamane Arito;Yokohoma Akihiko;Irisawa Hiroyuki;Handa Hiroshi;Tsukamoto Norifumi;Karasawa Masamitsu;Kojima Masaru;Nojima Yoshihisa;Murakami Hirokazu, Clinical lymphoma & myeloma, 8, 1

  DOI
• Clinical significance of regulatory T cells in patients with myelodysplastic syndrome., Hamdi Wedad;Ogawara Hatsue;Handa Hiroshi;Tsukamoto Norifumi;Nojima Yoshihisa;Murakami Hirokazu, 10 Nov. 2008, European journal of haematology, 82, 3

  DOI
• Characterization of immunoglobulin heavy and light chain gene expression in chronic lymphocytic leukemia and related disorders., Nakahashi Hirotaka;Tsukamoto Norifumi;Hashimoto Yoko;Koiso Hiromi;Yokohama Akihiko;Saitoh Takayuki;Uchiumi Hideki;Handa Hiroshi;Murakami Hirokazu;Nojima Yoshihisa;Karasawa Masamitsu, 10 Feb. 2009, Cancer science, 100, 4

  DOI
• Hairy cell leukemia-related disorders consistently show low CD27 expression., Hashimoto Yoko;Tsukamoto Norifumi;Nakahashi Hirotaka;Yokohama Akihiko;Saitoh Takayuki;Handa Hiroshi;Matsushima Takafumi;Murakami Hirokazu;Nojima Yoshihisa;Karasawa Masamitsu, 20 Mar. 2009, Pathology oncology research : POR, 15, 4

  DOI
• Low burden of a JAK2-V617F mutated clone in monoclonal haematopoiesis in a Japanese woman with Budd-Chiari syndrome., Toyama Kohtaro;Karasawa Masamitsu;Yamane Arito;Koiso Hiromi;Yokohama Akihiko;Uchiumi Hideki;Saitoh Takayuki;Handa Hiroshi;Sato Ken;Takagi Hitoshi;Miyawaki Shuichi;Murakami Hirokazu;Nojima Yoshihisa;Tsukamoto Norifumi, 24 Mar. 2009, International journal of hematology, 89, 4

  DOI
• Flow cytometric detection of human telomerase reverse transcriptase (hTERT) expression in a subpopulation of bone marrow cells., Handa Hiroshi;Matsushima Takafumi;Nishimoto Natsumi;Inoue Madoka;Saitoh Takayuki;Yokohama Akihiko;Tsukamoto Norifumi;Mitsui Takeki;Nakahashi Hirotaka;Toyama Kotaro;Karasawa Masamitsu;Ogawara Hatsue;Nojima Yoshihisa;Murakami Hirokazu, 14 Jul. 2009, Leukemia research, 34, 2

  DOI
• Autologous peripheral blood stem cell transplantation to treat CHOP-refractory aggressive subcutaneous panniculitis-like T cell lymphoma., Nakahashi Hirotaka;Tsukamoto Norifumi;Yamane Arito;Saitoh Takayuki;Uchiumi Hideki;Handa Hiroshi;Karasawa Masamitsu;Murakami Hirokazu;Kojima Masaru;Nojima Yoshihisa, 29 Jun. 2009, Acta haematologica, 121, 4

  DOI
• Successful treatment by all-trans retinoic acid in a patient with acute promyelocytic leukemia complicated by liver cirrhosis and polycystic kidney., Yamane Arito;Tsukamoto Norifumi;Saitoh Takayuki;Uchiumi Hideki;Handa Hiroshi;Karasawa Masamitsu;Nojima Yoshihisa;Murakami Hirokazu, 15 Sep. 2009, Internal medicine (Tokyo, Japan), 48, 18

  DOI
• Interleukin-17F gene polymorphism in patients with chronic immune thrombocytopenia., Saitoh Takayuki;Tsukamoto Norifumi;Koiso Hiromi;Mitsui Takeki;Yokohama Akihiko;Handa Hiroshi;Karasawa Masamitsu;Ogawara Hatsue;Nojima Yoshihisa;Murakami Hirokazu, 31 Jul. 2011, European journal of haematology, 87, 3

  DOI
• Successful treatment of autoimmune hemolytic anemia associated with multicentric Castleman disease by anti-interleukin-6 receptor antibody (tocilizumab) therapy., Yuzuriha Akinori;Saitoh Takayuki;Koiso Hiromi;Mitsui Takeki;Uchiumi Hideki;Yokohama Akihiko;Handa Hiroshi;Kojima Masaru;Tsukamoto Norifumi;Karaswa Masamitsu;Murakami Hirokazu;Nojima Yoshihisa, 14 Jul. 2011, Acta haematologica, 126, 3

  DOI
• Differences in the JAK2 and MPL mutation status in the cell lineages of the bcr/abl-negative chronic myeloproliferative neoplasm subtypes., Toyama Kohtaro;Karasawa Masamitsu;Yokohama Akihiko;Mitsui Takeki;Uchiumi Hideki;Saitoh Takayuki;Handa Hiroshi;Murakami Hirokazu;Nojima Yoshihisa;Tsukamoto Norifumi, 01 Nov. 2011, Internal medicine (Tokyo, Japan), 50, 21

  DOI
• Long-term follow-up of EBV-positive lymphoproliferative disorders in a patient with systemic lupus erythematosus., Tsukamoto Norifumi;Handa Hiroshi;Yokohama Akihiko;Mitsui Takeki;Saitoh Takayuki;Koiso Hiromi;Uchiumi Hideki;Hoshino Takumi;Karasawa Masamitsu;Murakami Hirokazu;Kojima Masaru;Nojima Yoshihisa, 17 Dec. 2011, Medical molecular morphology, 44, 4

  DOI
• TCL1A gene involvement in T-cell prolymphocytic leukemia in Japanese patients., Yokohama Akihiko;Saitoh Akio;Nakahashi Hirotaka;Mitsui Takeki;Koiso Hiromi;Kim Yoshitora;Uchiumi Hideki;Saitoh Takayuki;Handa Hiroshi;Jimbo Takahiro;Murayama Kayoko;Sakura Tohru;Murakami Hirokazu;Karasawa Masamitsu;Nojima Yoshihisa;Tsukamoto Norifumi, 23 Dec. 2011, International journal of hematology, 95, 1

  DOI
• Circulating plasmacytoid dendritic cells in patients with primary and Helicobacter pylori-associated immune thrombocytopenia., Saito Akio;Yokohama Akihiko;Osaki Yohei;Ogawa Yoshiyuki;Nakahashi Hirotaka;Toyama Kohtaro;Mitsui Takeki;Hashimoto Yoko;Koiso Hiromi;Uchiumi Hideki;Saitoh Takayuki;Handa Hiroshi;Sawamura Morio;Karasawa Masamitsu;Murakami Hirokazu;Tsukamoto Norifumi;Nojima Yoshihisa, 02 Feb. 2012, European journal of haematology, 88, 4

  DOI
• Primary bilateral adrenal diffuse large B-cell lymphoma demonstrating adrenal failure., Horiguchi Kazuhiko;Hashimoto Koshi;Hashizume Masayuki;Masuo Takashige;Suto Mariko;Okajo Jun;Handa Hiroshi;Kaneko Yoriaki;Yokoo Hideaki;Sasaki Atsushi;Okada Shuichi;Yamada Masanobu;Tsukamoto Norifumi;Nojima Yoshihisa;Nakazato Yoichi;Mori Masatomo, 15 Oct. 2010, Internal medicine (Tokyo, Japan), 49, 20

  DOI
• JAK2-V617F mutation analysis of granulocytes and platelets from patients with chronic myeloproliferative disorders: advantage of studying platelets., Toyama Kohtaro;Karasawa Masamitsu;Yamane Arito;Irisawa Hiroyuki;Yokohama Akihiko;Saitoh Takayuki;Handa Hiroshi;Matsushima Takafumi;Sawamura Morio;Miyawaki Shuichi;Murakami Hirokazu;Nojima Yoshihisa;Tsukamoto Norifumi, British journal of haematology, 139, 1

  DOI
• Identification of inherited macrothrombocytopenias based on mean platelet volume among patients diagnosed with idiopathic thrombocytopenia., Gohda Fumito;Uchiumi Hideki;Handa Hiroshi;Matsushima Takafumi;Tsukamoto Norifumi;Morita Kimio;Amagai Hatsuo;Murakami Masami;Murakami Hirokazu;Nojima Yoshihisa;Karasawa Masamitsu, 17 Aug. 2006, Thrombosis research, 119, 6

  DOI
• X-linked agammaglobulinemia diagnosed in adulthood: a case report., Mitsui Takeki;Tsukamoto Norifumi;Kanegane Hirokazu;Agematsu Kazunaga;Sekigami Tomomi;Irisawa Hiroyuki;Saitoh Takayuki;Uchiumi Hideki;Handa Hiroshi;Matsushima Takafumi;Karasawa Masamitsu;Murakami Hirokazu;Miyawaki Toshio;Nojima Yoshihisa, International journal of hematology, 84, 2

  DOI
• Sacroiliitis as an initial manifestation of acute myelogenous leukemia., Hoshino Takumi;Matsushima Takafumi;Saitoh Yasuyuki;Yamane Arito;Takizawa Makiko;Irisawa Hiroyuki;Saitoh Takayuki;Handa Hiroshi;Tsukamoto Norifumi;Karasawa Masamitsu;Murakami Hirokazu;Nojima Yoshihisa, International journal of hematology, 84, 5

  DOI
• Hodgkin lymphoma accompanied by aplastic anemia and polyclonal expansion of large granular lymphocytes., Saitoh Takayuki;Matsushima Takafumi;Yamane Arito;Sakuraya Masataka;Irisawa Hiroyuki;Yokohama Akihiko;Handa Hiroshi;Tsukamoto Norifumi;Karasawa Masamitsu;Nojima Yoshihisa;Murakami Hirokazu, 23 Feb. 2007, Acta haematologica, 117, 4

  DOI
• The usefulness of (18)F-fluorodeoxyglucose positron emission tomography ((18)F-FDG-PET) and a comparison of (18)F-FDG-pet with (67)gallium scintigraphy in the evaluation of lymphoma: relation to histologic subtypes based on the World Health Organization classification., Tsukamoto Norifumi;Kojima Masaru;Hasegawa Masatoshi;Oriuchi Noboru;Matsushima Takafumi;Yokohama Akihiko;Saitoh Takayuki;Handa Hiroshi;Endo Keigo;Murakami Hirokazu, Cancer, 110, 3

  DOI
• High Th1/Th2 ratio in patients with multiple myeloma., Ogawara Hatsue;Handa Hiroshi;Yamazaki Tohru;Toda Takuma;Yoshida Kensuke;Nishimoto Natsumi;Al-ma'Quol Wedad Hamdi Saleh;Kaneko Yoriaki;Matsushima Takafumi;Tsukamoto Norifumi;Nojima Yoshihisa;Matsumoto Morio;Sawamura Morio;Murakami Hirokazu, Leukemia research, 29, 2

  DOI
• Pericardial graft vs. host disease in a patient with myelodysplastic syndrome following peripheral blood stem cell transplantation., Saito Yasuyuki;Matsushima Takafumi;Doki Noriko;Tsumita Yuki;Takizawa Makiko;Yokohama Akihiko;Handa Hiroshi;Tsukamoto Norifumi;Karasawa Masamitsu;Murakami Hirokazu;Nojima Yoshihisa, European journal of haematology, 75, 1

  DOI
• Characteristic expansion of CD45RA CD27 CD28 CCR7 lymphocytes with stable natural killer (NK) receptor expression in NK- and T-cell type lymphoproliferative disease of granular lymphocytes., Mitsui Takeki;Maekawa Izuru;Yamane Arito;Ishikawa Tomomi;Koiso Hiromi;Yokohama Akihiko;Handa Hiroshi;Matsushima Takafumi;Tsukamoto Norifumi;Murakami Hirokazu;Nojima Yoshihisa;Karasawa Masamitsu, British journal of haematology, 126, 1

  DOI
• Low-dose thalidomide plus low-dose dexamethasone therapy in patients with refractory multiple myeloma., Murakami Hirokazu;Handa Hiroshi;Abe Masahiro;Iida Sinsuke;Ishii Akihiro;Ishikawa Takayuki;Ishida Tadao;Oota Masatsugu;Ozaki Shuji;Kosaka Masaaki;Sakai Akira;Sawamura Morio;Shimazaki Chihiro;Shimizu Kazuyuki;Takagi Toshiyuki;Hata Hiroyuki;Fukuhara Takashi;Fujii Hiroshi;Miyata Akira;Wakayama Toshio;Takatsuki Kiyoshi, 26 Jul. 2007, European journal of haematology, 79, 3

  DOI
• Combination chemotherapy of ranimustine, doxorubicine, and dexamethasone for relapsing multiple myeloma--a pilot study., Murakami Hirokazu;Yamane Arito;Sawamura Morio;Matsumoto Morio;Murayaman Kayoko;Shimano Shunichi;Jinbo Takahiro;Yokohama Akihiko;Uchiumi Hideki;Handa Hiroshi;Matsushima Takafumi;Tsukamoto Norifumi;Morita Kimio;Karasawa Masamitsu;Ogawara Hatsue;Nojima Yoshihisa, Journal of medicine, 34, 1-6
• Prevalence and clinical characteristics of acute myeloid leukemia associated with disseminated intravascular coagulation., Uchiumi Hideki;Matsushima Takafumi;Yamane Arito;Doki Noriko;Irisawa Hiroyuki;Saitoh Takayuki;Sakura Tohru;Jimbo Takahiro;Handa Hiroshi;Tsukamoto Norifumi;Karasawa Masamitsu;Miyawaki Shuichi;Murakami Hirokazu;Nojima Yoshihisa, International journal of hematology, 86, 2

  DOI
• High Th1/Th2 ratio in patients with chronic idiopathic thrombocytopenic purpura., Ogawara Hatsue;Handa Hiroshi;Morita Kimio;Hayakawa Masaki;Kojima Junko;Amagai Hatsuo;Tsumita Yuki;Kaneko Yoriaki;Tsukamoto Norifumi;Nojima Yoshihisa;Murakami Hirokazu, European journal of haematology, 71, 4

  DOI
• TCR Vbeta repertoire analysis in CD56+ CD16(dim/-) T-cell large granular lymphocyte leukaemia: association with CD4 single and CD4/CD8 double positive phenotypes., Karasawa Masamitsu;Mitsui Takeki;Isoda Atsushi;Tsumita Yuki;Irisawa Hiroyuki;Yokohama Akihiko;Handa Hiroshi;Matsushima Takafumi;Tsukamoto Norifumi;Murakami Hirokazu;Nojima Yoshihisa, British journal of haematology, 123, 4

  DOI
• Prevalence and clinical characteristics of myelodysplastic syndrome with bone marrow eosinophilia or basophilia., Matsushima Takafumi;Handa Hiroshi;Yokohama Akihiko;Nagasaki Jun;Koiso Hiromi;Kin Yoshitora;Tanaka Yoko;Sakura Tohru;Tsukamoto Norifumi;Karasawa Masamitsu;Itoh Katsuhiko;Hirabayashi Hisami;Sawamura Morio;Shinonome Shogo;Shimano Shun-ichi;Miyawaki Shuichi;Nojima Yoshihisa;Murakami Hirokazu, 27 Dec. 2002, Blood, 101, 9

  DOI
• CD7+ and CD56+ myeloid/natural killer cell precursor acute leukemia treated with idarubicin and cytosine arabinoside., Handa Hiroshi;Motohashi Sachiko;Isozumi Kazuo;Komatsumoto Satoru;Nara Masaharu, Acta haematologica, 108, 1

  DOI
• Ribosome-lamella complex of leukemic cells in a patient with aggressive NK cell leukemia., Hatsumi Nahoko;Saitoh Takayuki;Yokohama Akihiko;Uchiumi Hideki;Matsushima Takafumi;Tsukamoto Norifumi;Nojima Yoshihisa;Karasawa Masamitsu;Handa Hiroshi;Ogawara Hatsue;Murakami Hirokazu, Ultrastructural pathology, 26, 6

  DOI
• Clinical significance of neutrophil apoptosis in peripheral blood of patients with type 2 diabetes mellitus., Sudo Chiaki;Ogawara Hatsue;Saleh Almaqoul Wedad Hamdi;Nishimoto Natsumi;Utsugi Toshihiro;Ooyama Yoshio;Fukumura Yukihito;Murakami Masami;Handa Hiroshi;Tomono Shoichi;Murakami Hirokazu, Laboratory hematology : official publication of the International Society for Laboratory Hematology, 13, 3

  DOI
• [Retrospective survey on the clinical features of non-Hodgkin lymphomas in Gunma Prefecture, Japan]., Hashimoto Yoko;Yokohama Akihiko;Saitoh Akio;Nakahashi Hirotaka;Toyama Kohtaro;Mitsui Takeki;Koiso Hiromi;Saitoh Takayuki;Handa Hiroshi;Uchiumi Hideki;Jinbo Takahiro;Murayama Kayoko;Tamaki Yoshio;Matsumoto Morio;Sawamura Morio;Karasawa Masamitsu;Murakami Hirokazu;Hirato Junko;Nojima Yoshihisa;Kojima Masaru;Tsukamoto Norifumi, [Rinsho ketsueki] The Japanese journal of clinical hematology, 53, 3
• [Glossitis by mixed infection of cytomegalovirus and herpes simplex virus during therapy for pure red cell aplasia complicated with Good syndrome]., Koya Hiroko;Yokohama Akihiko;Miura Ayaka;Hoshino Takumi;Mitsui Takeki;Koiso Hiromi;Saitoh Takayuki;Uchiumi Hideki;Handa Hiroshi;Hirato Jyunko;Hiromura Keijyu;Karasawa Masamitsu;Murakami Hirokazu;Tsukamoto Norifumi;Nojima Yoshihisa, [Rinsho ketsueki] The Japanese journal of clinical hematology, 52, 8
• [Evaluation of mental stress tests among medical students based on salivary sample collected just before the national license examination]., Ushiki Kazumi;Sato Yuka;Arai Katsuya;Ide Norihumi;Matsui Naoki;Handa Hiroshi;Murakami Hirokazu;Ogawara Hatsue, Rinsho byori. The Japanese journal of clinical pathology, 59, 2
• [IgM-lambda multiple myeloma presenting with systemic amyloidosis]., Higeta Daisuke;Yokohama Akihiko;Osaki Youhei;Tahara Kenichi;Mawatari Momoko;Sekigami Tomomi;Koiso Hiromi;Saito Takayuki;Uchiumi Hideki;Handa Hiroshi;Karasawa Masamitsu;Murakami Hirokazu;Hirato Jyunko;Tsukamoto Norifumi;Nojima Yoshihisa, [Rinsho ketsueki] The Japanese journal of clinical hematology, 50, 12
• Successful treatment with reduced-intensity stem cell transplantation for secondary myelofibrosis following polycythemia vera., TAHARA Kenichi;YOKOHAMA Akihiko;HANDA Hiroshi;SAITOH Takayuki;UCHIUMI Hideki;SEKIGAMI Tomomi;TOYAMA Kohtaro;MAWATARI Momoko;OSAKI Yohei;MATSUSHIMA Takafumi;KARASAWA Masamitsu;MURAKAMI Hirokazu;TSUKAMOTO Norifumi;NOJIMA Yoshihisa, [Rinsho ketsueki] The Japanese journal of clinical hematology, 50, 11
• [Development of an extramedullary plasmacytoma despite disappearing M protein in multiple myeloma by bortezomib treatment]., Koiso Hiromi;Tahara Kenichi;Osaki Yohei;Mawatari Momoko;Sekigami Tomomi;Yokohama Akihiko;Saitoh Takayuki;Uchiumi Hideki;Handa Hiroshi;Tsukamoto Norifumi;Karasawa Masamitsu;Nojima Yoshihisa;Murakami Hirokazu, [Rinsho ketsueki] The Japanese journal of clinical hematology, 50, 2
• [Successful treatment of azole-refractory Candida guilliermondii fungemia with a combination therapy of micafungin and liposomal amphotericin B]., Saitoh Takayuki;Matsushima Takafumi;Shimizu Hiroyuki;Osaki Yohei;Yamane Arito;Irisawa Hiroyuki;Yokohama Akihiko;Uchiumi Hideki;Handa Hiroshi;Tsukamoto Norifumi;Karasawa Masamitsu;Nojima Yoshihisa;Murakami Hirokazu, [Rinsho ketsueki] The Japanese journal of clinical hematology, 49, 2
• [Diagnosis and management guideline for multiple myeloma]., Murakami Hirokazu;Handa Hiroshi;Saitoh Takayuki, Nihon rinsho. Japanese journal of clinical medicine, 65, 12
• [Acquired hemophilia A developed at relapse of minimal change nephrotic syndrome]., Shimizu Hiroaki;Saitoh Takayuki;Osaki Yohei;Yamane Arito;Gohda Fumito;Irisawa Hiroyuki;Yokohama Akihiko;Uchiumi Hideki;Handa Hiroshi;Matsushima Takafumi;Tsukamoto Norifumi;Karasawa Masamitsu;Murakami Hirokazu;Nojima Yoshihisa, [Rinsho ketsueki] The Japanese journal of clinical hematology, 48, 6
• [Deep vein thrombosis and pulmonary embolism in a patient with multiple myeloma treated with thalidomide and dexamethasone]., Miyazawa Yuri;Irisawa Hiroyuki;Uchiumi Hideki;Saitoh Takayuki;Handa Hiroshi;Matsushima Takafumi;Tsukamoto Norifumi;Karasawa Masamitsu;Murakami Hirokazu;Nojima Yoshihisa, [Rinsho ketsueki] The Japanese journal of clinical hematology, 47, 7
• [Reversible posterior leukoencephalopathy syndrome probably caused by L-asparaginase]., Miyazawa Yuri;Irisawa Hiroyuki;Matsushima Takafumi;Mitsui Takeki;Uchiumi Hideki;Saitohi Takayuki;Handa Hiroshi;Karasawa Masamitsu;Murakami Hirokazu;Tsukamoto Norifumi;Nojima Yoshihisa, [Rinsho ketsueki] The Japanese journal of clinical hematology, 47, 6
• [Plasmacytoma with multiple hypervascular lesions revealed by angiography in a patient with multiple myeloma]., Handa Hiroshi;Irisawa Hiroyuki;Komatsumoto Satoru;Matsushima Takafumi;Tsukamoto Norifumi;Nojima Yoshihisa;Murakami Hirokazu, [Rinsho ketsueki] The Japanese journal of clinical hematology, 47, 6
• [New treatment strategy of multiple myeloma for cure]., Murakami Hirokazu;Handa Hiroshi, Gan to kagaku ryoho. Cancer & chemotherapy, 33, 4
• [Unclassified mature T cell leukemia with cerebriform nuclei]., Takizawa Makiko;Matsushima Takafumi;Yokohama Akihiko;Handa Hiroshi;Tsukamoto Norifumi;Karasawa Masamitsu;Murakami Hirokazu;Nojima Yoshihisa, [Rinsho ketsueki] The Japanese journal of clinical hematology, 46, 7
• [Urinary 8-hydroxy-2'-deoxyguanosin (8-OHdG) in patients with chronic liver diseases]., Ishizakai Miki;Yoshida Kensuke;Nishimoto Natsumi;Saleh Al-Ma'Quol Wedad Hamdi;Ishii Chiaki;Handa Hiroshi;Ogawara Hatsue;Nagamine Takeaki;Murakami Masami;Murakami Hirokazu, Rinsho byori. The Japanese journal of clinical pathology, 52, 9
• [Thalidomide treatment of patients with refractory myeloma in the institutes participating in the Japan Myeloma Study Group]., Murakami Hirokazu;Handa Hiroshi;Imai Kohzoh;Kanakura Yuzuru;Kosaka Masaaki;Sawamura Morio;Shimazaki Chihiro;Suzuki Kenshi;Ishii Akihiro;Takagi Toshiyuki;Taniwaki Masashi;Togawa Atsushi;Hata Hiroyuki;Wakayama Toshio;Takatsuki Kiyoshi; , [Rinsho ketsueki] The Japanese journal of clinical hematology, 45, 6
• [Pancytopenia associated with hyperthyroidism]., Ogaw Yoshiyuki;Maekawa Izuru;Matsushima Takafumi;Takizawa Makiko;Uchiumi Hideki;Kawamura Toshihide;Ueki Kazue;Handa Hiroshi;Tsukamoto Norifumi;Nojima Yoshihisa, Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine, 93, 4

  DOI
• [Treatment outcome of myelodysplastic syndrome patients younger than 60 years old]., Matsushima Takafumi;Handa Hiroshi;Yokohama Akihiko;Sakura Tohru;Okamoto Kiyoshi;Kawamura Toshihide;Tsumita Yuki;Murayama Kayoko;Isoda Atsushi;Jinbo Takahiro;Hirabyashi Hisami;Sawamura Morio;Karasawa Masamitsu;Shimano Shun-ichi;Tsukamoto Norifumi;Miyawaki Shuichi;Nojima Yoshihisa;Murakami Hirokazu, [Rinsho ketsueki] The Japanese journal of clinical hematology, 44, 10
• [Diagnosis and prognostic factors in patients with multiple myeloma]., Murakami Hirokazu;Yokohama Akihiko;Saitoh Takayuki;Tsukamoto Norifumi;Handa Hiroshi, Nihon rinsho. Japanese journal of clinical medicine, 70 Suppl 2
• [Emergence of donor-derived anti-HLA antibody and subsequent transfusion-refractory thrombocytopenia after allogeneic hematopoietic stem cell transplantation from an HLA-matched sibling donor in a patient with acute myeloid leukemia]., Uchiyama Yuri;Hoshino Takumi;Mihara Masahiro;Mitsui Takeki;Koiso Hiromi;Takizawa Makiko;Yokohama Akihiko;Saitoh Takayuki;Uchiumi Hideki;Handa Hiroshi;Tsukamoto Norifumi;Murakami Hirokazu;Nojima Yoshihisa, [Rinsho ketsueki] The Japanese journal of clinical hematology, 54, 2
• [Relapsed primary intraocular lymphoma treated with intravitreal methotrexate and high-dose chemotherapy followed by autologous stem cell rescue]., Kamio Tadashi;Yokohama Akihiko;Hayashi Toshimasa;Toyama Kotaro;Koya Hiroko;Hoshino Takumi;Saitoh Takayuki;Hanyuda Naoto;Mukai Ryou;Handa Hiroshi;Murakami Hirokazu;Tsukamoto Norifumi;Nojima Yoshihisa, [Rinsho ketsueki] The Japanese journal of clinical hematology, 55, 2
• [Successful treatment with dasatinib for polycythemia vera patient emerging BCR-ABL positive clone during 13 years of treatment]., Takizawa Makiko;Yokohama Akihiko;Sekigami Tomomi;Koiso Hiromi;Ishizaki Takuma;Mitsui Takeki;Ogawa Yoshiyuki;Saitoh Takayuki;Handa Hiroshi;Tsukamoto Norifumi;Murakami Hirokazu;Nojima Yoshihisa, [Rinsho ketsueki] The Japanese journal of clinical hematology, 55, 6
• Primary leptomeningeal B-cell lymphoma with normal pressure hydrocephalus at diagnosis., Ishizaki Takuma;Mitsui Takeki;Uchiyama Yuri;Ogawa Yoshiyuki;Koiso Hiromi;Takizawa Makiko;Yokohama Akihiko;Saitoh Takayuki;Handa Hiroshi;Tsukamoto Norifumi;Murakami Hirokazu;Nojima Yoshihisa, [Rinsho ketsueki] The Japanese journal of clinical hematology, 56, 12

  DOI
• [Monomorphic post-transplant T-lymphoproliferative disorder after autologous stem cell transplantation for multiple myeloma]., Ishikawa Tetsuya;Shimizu Hiroaki;Takei Toshifumi;Koya Hiroko;Iriuchishima Hirono;Hosiho Takumi;Hirato Junko;Kojima Masaru;Handa Hiroshi;Nojima Yoshihisa;Murakami Hirokazu, [Rinsho ketsueki] The Japanese journal of clinical hematology, 57, 1

  DOI
• [Acquired thrombotic thrombocytopenic purpura after vascular prosthesis implantation for impending rupture of an abdominal aortic aneurysm]., Naito Chiaki;Ogawa Yoshiyuki;Yanagisawa Kunio;Ishizaki Takuma;Mihara Masahiro;Handa Hiroshi;Isonishi Ayami;Hayakawa Masaki;Matsumoto Masanori;Nojima Yoshihisa, [Rinsho ketsueki] The Japanese journal of clinical hematology, 57, 3

  DOI
• [Remission of acquired hemophilia A following radiation therapy for esophageal cancer]., Yanagisawa Kunio;Ogawa Yoshiyuki;Mitsui Takeki;Noguchi Hiroyuki;Shimizu Hiroaki;Ishizaki Takuma;Handa Hiroshi;Ieko Masahiro;Ichinose Akitada;Nojima Yoshihisa, [Rinsho ketsueki] The Japanese journal of clinical hematology, 57, 4

  DOI
• [Development of acquired hemophilia A during maintenance therapy for immune thrombocytopenia]., Ogawa Yoshiyuki;Yanagisawa Kunio;Ishizaki Takuma;Naito Chiaki;Mihara Masahiro;Handa Hiroshi;Shizuka Reiko;Inoue Madoka;Naito Sumiyoshi;Ieko Masahiro;Ichinose Akitada;Nojima Yoshihisa, [Rinsho ketsueki] The Japanese journal of clinical hematology, 57, 4

  DOI
• Late-onset neutropenia after rituximab therapy in patients with autoimmune thrombotic and hemostatic disorders: a single center analysis., Ogawa Yoshiyuki;Yanagisawa Kunio;Ishizaki Takuma;Shimizu Hiroaki;Mitsui Takeki;Ichinose Akitada;Nojima Yoshihisa;Handa Hiroshi, [Rinsho ketsueki] The Japanese journal of clinical hematology, 58, 1

  DOI
• Acquired thrombotic thrombocytopenic purpura with a smoldering clinical course., Naito Chiaki;Ogawa Yoshiyuki;Yanagisawa Kunio;Ishizaki Takuma;Mihara Masahiro;Hayakawa Masaki;Matsumoto Masanori;Nojima Yoshihisa;Handa Hiroshi, [Rinsho ketsueki] The Japanese journal of clinical hematology, 58, 2

  DOI
• Refractory thrombotic thrombocytopenic purpura achieving complete remission with rituximab treatment., Iino Hiromasa;Ogawa Yoshiyuki;Yanagisawa Kunio;Shimizu Hiroaki;Mitsui Takeki;Ishizaki Takuma;Hayakawa Masaki;Matsumoto Masanori;Nojima Yoshihisa;Handa Hiroshi, [Rinsho ketsueki] The Japanese journal of clinical hematology, 58, 3

  DOI
• Acquired immune-mediated von Willebrand syndrome accompanied by antiphospholipid syndrome., Kobayashi Nobuhiko;Ogawa Yoshiyuki;Yanagisawa Kunio;Ishizaki Takuma;Uchiumi Hideki;Suzuki Nobuaki;Matsushita Tadashi;Ichinose Akitada;Handa Hiroshi, [Rinsho ketsueki] The Japanese journal of clinical hematology, 58, 6

  DOI
• [Giant hemophilic pseudotumors in brothers with non-severe hemophilia B]., Matsumura Ikuko;Yanagisawa Kunio;Ogawa Yoshiyuki;Shimizu Hiroaki;Ishizaki Takuma;Mitsui Takeki;Uchiumi Hideki;Uchiyama Yuri;Matsumuto Naomichi;Handa Hiroshi, [Rinsho ketsueki] The Japanese journal of clinical hematology, 59, 3

  DOI
• [Congenital factor V and factor VIII deficiency discovered in an elderly patient with abnormal bleeding after trauma]., Ogawa Yoshiyuki;Yanagisawa Kunio;Uchiyama Yuri;Matsumoto Akira;Inoue Madoka;Toyama Kohtaro;Miyazawa Yuri;Matsumoto Naomichi;Handa Hiroshi, [Rinsho ketsueki] The Japanese journal of clinical hematology, 59, 4

  DOI
• [Recurrence of acquired factor V inhibitor after four years of remission]., Akashi Naoki;Ogawa Yoshiyuki;Yanagisawa Kunio;Osaki Yohei;Shimizu Hiroaki;Ishizaki Takuma;Inoue Madoka;Murakami Masami;Souri Masayoshi;Ichinose Akitada;Handa Hiroshi, [Rinsho ketsueki] The Japanese journal of clinical hematology, 60, 1

  DOI
• [Thyroid storm and exacerbation of autoimmune hemolytic anemia following childbirth]., Sugisaki Manato;Ishizaki Takuma;Iriuchishima Hirono;Shimizu Hiroaki;Yanagisawa Kunio;Ogawa Yoshiyuki;Yokohama Akihiko;Saitoh Takayuki;Tsukamoto Norifumi;Handa Hiroshi, [Rinsho ketsueki] The Japanese journal of clinical hematology, 60, 8

  DOI
• [Mediastinal abscess due to Aspergillus in a patient with atypical chronic myeloid leukemia, BCR-ABL1-negative]., Miyazawa Yuri;Ishikawa Tetsuya;Sugisaki Manato;Matsumoto Akira;Akashi Naoki;Naito Chiaki;Ishizaki Takuma;Handa Hiroshi, [Rinsho ketsueki] The Japanese journal of clinical hematology, 61, 2

  DOI
• [Successful management of acquired factor V deficiency developing shortly after induction of hemodialysis]., Matsumoto Akira;Ogawa Yoshiyuki;Osaki Tsukasa;Souri Masayoshi;Yanagisawa Kunio;Ishizaki Takuma;Naito Chiaki;Ishikawa Tetsuya;Miyazawa Yuri;Shimizu Hiroaki;Inoue Madoka;Hayakawa Masaki;Murakami Masami;Ichinose Akitada;Handa Hiroshi, [Rinsho ketsueki] The Japanese journal of clinical hematology, 61, 5

  DOI
• 左心室内巨大血栓を合併したFIP1L1-PDGFRα陽性慢性好酸球性白血病, ;;;;;;;, Feb. 2016, 621回, 59
• 急性HIV感染に伴う血球貪食症候群に対してDTG+TDF/FTCによるARTが奏功したHIV感染症の1例, ;;;;;;;;;;, Nov. 2015, 17, 4, 496
• 寛解16年後に再発した精巣原発びまん性大細胞型B細胞リンパ腫, ;;;;;;;;;;;;, Dec. 2015, 56, 12, 2447
• 腹部大動脈瘤切迫破裂に対する人工血管置換術後に発症した後天性血栓性血小板減少性紫斑病, ;;;;;;;;;, Mar. 2016, 57, 3, 364
• 併存する食道がんに対する放射線治療後に寛解に至った後天性血友病, ;;;;;;;;;, Apr. 2016, 57, 4, 451
• 多発性骨髄腫におけるエピゲノム異常とmiRNA, ;;, May 2016, 72, 5, 684
• 免疫性血小板減少症の維持療法中に発症した後天性血友病A, ;;;;;;;;;;;, Apr. 2016, 57, 4, 456
• Triple-class refractory多発性骨髄腫に対するXPO1阻害薬selinexor, 半田 寛, May 2020, 80, 5, 739
• 【多発性骨髄腫の最新情報】多発性骨髄腫におけるエピゲノム異常, 半田 寛, Oct. 2017, 34, 4, 46
• 【多発性骨髄腫学-最新の診療と基礎研究-】多発性骨髄腫の治療と支持療法　多発性骨髄腫の治療　高齢者骨髄腫の治療　脆弱性の評価と治療薬の選択・用量調節, ;;, Jul. 2016, 74, 増刊5 多発性骨髄腫学, 416
• 【多発性骨髄腫学-最新の診療と基礎研究-】多発性骨髄腫基礎研究の最新動向　多発性骨髄腫の進展におけるPARP1の関与, ;, Jul. 2016, 74, 増刊5 多発性骨髄腫学, 168
• 【造血器腫瘍における高齢者研究と治療上の注意点】高齢者多発性骨髄腫に対する治療方針と注意点, 半田 寛, Aug. 2020, 81, 2, 174
• 【急性骨髄性白血病(AML)診療update】AMLに対するNEDD8活性化酵素(NAE)阻害薬pevonedistatの有用性と展望, ;;, Jan. 2020, 80, 1, 34
• 高齢多発性骨髄腫患者の治療　最適な治療を選択するために考慮すべきこと(Treatment strategy of elderly multiple myeloma patients　Treatment for elderly multiple myeloma patients-What we evaluate for optimizing therapy?), 半田 寛, May 2019, 9, 1, 184
• 【実臨床における多発性骨髄腫のHot topics】多発性骨髄腫における継続治療を考える　多発性骨髄腫における継続治療の意義・エビデンス　IMiDsによる継続治療の意義と問題点,PIによる継続治療の意義と問題点, 半田 寛, Apr. 2018, 28, 5, 737
• 【多発性骨髄腫-基礎・臨床研究の最新動向-】診断と治療　治療選択・層別化のパラメーター　患者側因子, 半田 寛, Jul. 2018, 76, 7, 1167
• 【多発性骨髄腫診療に対する新たな展開2016-2017】多発性骨髄腫に対する免疫チェックポイント阻害薬の効果, 半田 寛, Oct. 2017, 75, 4, 471
• 高齢者多発性骨髄腫の治療選択　治療法の奏効のみではなく継続可能性を重視して選択, 半田 寛, Jan. 2018, 4890, 59
• 多発性骨髄腫におけるlong non-coding RNAの解析, ;;, Feb. 2018, 33, 2, 158
• 【形質細胞性疾患の病態と治療】多発性骨髄腫における血清RNA測定の意義, 半田 寛, Feb. 2017, 74, 2, 144
• 【多発性骨髄腫:診断のポイントから最新の治療まで】多発性骨髄腫の疫学と予後の変遷　多発性骨髄腫の疫学と予後の変遷, 半田 寛, Jul. 2016, 105, 7, 1202
• 初発移植非適応多発性骨髄腫の微小残存病変(Minimal Residual Disease:MRD)測定の意義, 半田 寛, Jul. 2016, 17, 学術集会, S219
• Low burden of a JAK2-V617F mutated clone in monoclonal haematopoiesis in a Japanese woman with Budd-Chiari syndrome, Toyama, Kohtaro;Karasawa, Masamitsu;Yamane, Arito;Koiso, Hiromi;Yokohama, Akihiko;Uchiumi, Hideki;Saitoh, Takayuki;Handa, Hiroshi;Sato, Ken;Takagi, Hitoshi;Miyawaki, Shuichi;Murakami, Hirokazu;Nojima, Yoshihisa;Tsukamoto, Norifumi, 2009, INTERNATIONAL JOURNAL OF HEMATOLOGY, 89, 4, 517, 522

  DOI
• Copper deficiency pancytopenia with infectious complications after hemolytic anemia, Saitoh, Takayuki;Matsushima, Takafumi;Toyama, Kohtaro;Yamane, Aarito;Irisawa, Hiroyuki;Handa, Hiroshi;Tsukamoto, Norifumi;Karasawa, Masamitsu;Nojima, Yoshihisa;Murakami, Hirokazu, 2006, ANNALS OF HEMATOLOGY, 85, 12, 881, 882

  DOI
• Flow cytometric detection of human telomerase reverse mranscriptase expression in CD34 positive precursor fraction in myelodysplastic syndrome bone marrow., Handa, Hiroshi;Matsushima, Takafumi;Tsukamoto, Norifumi;Karasawa, Masamitsu;Irisawa, Hiroyuki;Saito, Takayuki;Yokohama, Akihiko;Yamane, Arito;Murakami, Hirokazu, 2006, BLOOD, 108, 11, 153B, 153B
• HLA-DRB1 analysis in hairy B-cell lymphoproliferative disorder (HBLD): a Japanese type of benign persistent polyclonal B-cell lymphocytosis., Nakahashi, Hirotaka;Karasawa, Masamitsu;Hashimoto, Yoko;Frisawa, Hiroyuki;Yokohama, Akihiko;Saitoh, Takayuki;Handa, Hiroshi;Matsushima, Takalumi;Murakami, Hirokazu;Tsukamoto, Norifurni;Nojima, Yosihisa, 2006, BLOOD, 108, 11, 182B, 182B
• Utility of FDG-PET and comparison of FDG-PET and Ga-67 scintigraphy in evaluation of B-cell indolent lymphoma., Tsukamoto, Norifumi;Yokohama, Akihiko;Irisawa, Hiroyuki;Saitoh, Takayuki;Uchiumi, Hideki;Matsushima, Takafumi;Nojima, Yoshihisa;Karasawa, Masamitsu;Handa, Hiroshi;Murakami, Hirokazu, 2006, BLOOD, 108, 11, 234B, 234B
• JAK2 mutation in granulocytes and platelets and X-chromosome gene-based clonal analysis in chronic myeloproliferative disorders., Toyama, Kohtaro;Tsukamoto, Norifurni;Hiroyuki, Irisawa;Yokohama, Akihiko;Saitoh, Takayuki;Handa, Hiroshi;Matsushima, Takafumi;Murakami, Hirokazu;Miyawaki, Shuichi;Nojima, Yoshihisa;Karasawa, Masamitsu, 2006, BLOOD, 108, 11, 310B, 310B
• Thalidomide-induced leukopenia in Japanese patients with refractory multiple myeloma., Murakami, Hirokazu;Handa, Hiroshi;Abe, Masahiro;Iida, Shinsuke;Ishii, Akihiro;Ishikawa, Takayuki;Ishida, Tadao;Oota, Masatsugu;Ozaki, Shuji;Kosaka, Masaaki;Sakai, Akira;Sawamura, Morio;Shimizu, Kazuaki;Takagi, Toshiyuki;Hata, Hiroyuki;Fukuhara, Takashi;Fujii, Hiroshi;Miyata, Akira;Wakayama, Toshio;Takatsuki, Kiyoshi, 2006, BLOOD, 108, 11, 361B, 361B
• Small-bowel perforation accompanied by Aspergillus endocarditis in a patient with angioimmunoblastic T-cell lymphoma, Saitoh, Takayuki;Matsushima, Takafumi;Matsuo, Asuka;Yokohama, Akihiko;Irisawa, Hiroyuki;Handa, Hiroshi;Tsukamoto, Norifumi;Karasawa, Masamitsu;Nojima, Yoshihisa;Murakami, Hirokazu, 2007, ANNALS OF HEMATOLOGY, 86, 1, 71, 73

  DOI
• Presentation of extramedullary Philadelphia chromosome-positive biphenotypic acute leukemia as testicular mass: Response to imatinib-combined chemotherapy, Saitoh, Takayuki;Matsushima, Takafumi;Iriuchishima, Hirono;Yamane, Arito;Irisawa, Hiroyuki;Handa, Hiroshi;Tsukamoto, Norifumi;Karasawa, Masamitsu;Nojima, Yoshihisa;Murakami, Hirokazu, 2006, LEUKEMIA & LYMPHOMA, 47, 12, 2667, 2669

  DOI
• X-linked agammaglobulinemia diagnosed in adulthood: A case report, Mitsui, Takeki;Tsukamoto, Norifumi;Kanegane, Hirokazu;Agematsu, Kazunaga;Sekigami, Tomomi;Irisawa, Hiroyuki;Saitoh, Takayuki;Uchiumi, Hideki;Handa, Hiroshi;Matsushima, Takafumi;Karasawa, Masamitsu;Murakami, Hirokazu;Miyawaki, Toshio;Nojima, Yoshihisa, 2006, INTERNATIONAL JOURNAL OF HEMATOLOGY, 84, 2, 154, 157

  DOI
• Identification of inherited macrothrombocytopenias based on mean platelet volume among patients diagnosed with idiopathic thrombocytopenia, Gohda, Fumito;Uchiumi, Hideki;Handa, Hiroshi;Matsushima, Takafumi;Tsukamoto, Norifumi;Morita, Kimio;Amagai, Hatsuo;Murakami, Masami;Murakami, Hirokazu;Nojima, Yoshihisa;Karasawa, Masamitsu, 2007, THROMBOSIS RESEARCH, 119, 6, 741, 746

  DOI
• Sacroiliitis as an initial manifestation of acute myelogenons leukemia, Hoshino, Takumi;Matsushima, Takafumi;Saitoh, Yasuyuki;Yamane, Arito;Takizawa, Makiko;Irisawa, Hiroyuki;Saitoh, Takayuki;Handa, Hiroshi;Tsukamoto, Norifumi;Karasawa, Masamitsu;Murakami, Hirokazu;Nojima, Yoshihisa, 2006, INTERNATIONAL JOURNAL OF HEMATOLOGY, 84, 5, 421, 424

  DOI
• The usefulness of F-18-fluorodeoxyglucose positron emission tomography (F-18-FDG-PET) and a comparison of F-18-FDG-PET with (67)gallium scintigraphy in the evaluation of lymphoma - Relation to histologic subtypes-based on the World Health Organization Classification, Tsukamoto, Norifumi;Kojima, Masaru;Hasegawa, Masatoshi;Oriuchi, Noboru;Matsushima, Takafumi;Yokohama, Akihiko;Saitoh, Takayuki;Handa, Hiroshi;Endo, Keigo;Murakami, Hirokazu, 2007, CANCER, 110, 3, 652, 659

  DOI
• Successful treatment with voriconazole of Aspergillus meningitis in a patient with acute myeloid leukemia, Saitoh, Takayuki;Matsushima, Takafumi;Shimizu, Hiroaki;Yokohama, Akihiko;Irisawa, Hiroyuki;Handa, Hiroshi;Tsukamoto, Norifumi;Karasawa, Masamitsu;Nojima, Yoshihisa;Murakami, Hirokazu, 2007, ANNALS OF HEMATOLOGY, 86, 9, 697, 698

  DOI
• Low-dose thalidomide plus low-dose dexamethasone therapy in patients with refractory multiple myeloma, Murakami, Hirokazu;Handa, Hiroshi;Abe, Masahiro;Iida, Sinsuke;Ishii, Akihiro;Ishikawa, Takayuki;Ishida, Tadao;Oota, Masatsugu;Ozaki, Shuji;Kosaka, Masaaki;Sakai, Akira;Sawamura, Morio;Shimazaki, Chihiro;Shimizu, Kazuyuki;Takagi, Toshiyuki;Hata, Hiroyuki;Fukuhara, Takashi;Fujii, Hiroshi;Miyata, Akira;Wakayama, Toshio;Takatsuki, Kiyoshi, 2007, EUROPEAN JOURNAL OF HAEMATOLOGY, 79, 3, 234, 239

  DOI
• JAK2-V617F mutation analysis of granulocytes and platelets from patients with chronic myeloproliferative disorders: advantage of studying platelets, Toyama, Kohtaro;Karasawa, Masamitsu;Yamane, Arito;Irisawa, Hiroyuki;Yokohama, Akihiko;Saitoh, Takayuki;Handa, Hiroshi;Matsushima, Takafumi;Sawamura, Morio;Miyawaki, Shuichi;Murakami, Hirokazu;Nojima, Yoshihisa;Tsukamoto, Norifumi, 2007, BRITISH JOURNAL OF HAEMATOLOGY, 139, 1, 64, 69

  DOI
• Interleukin-10 gene polymorphism reflects the severity of chronic idiopathic thrombocytopenic purpura, Saitoh, Takayuki;Kasamatsu, Tetsuhiro;Inoue, Madoka;Al-ma'Quol, W. H. S.;Yokohama, Akihiko;Handa, Hiroshi;Matsushima, Takafumi;Tsukamoto, Norifumi;Karasawa, Masamitsu;Ogawara, Hatsue;Nojima, Yoshihisa;Murakami, Hirokazu, 2007, BLOOD, 110, 11, 629A, 629A
• Prevalence and clinical characteristics of acute myeloid leukemia associated with disseminated intravascular coagulation, Uchiumi, Hideki;Matsushima, Takafumi;Yamane, Arito;Doki, Noriko;Irisawa, Hiroyuki;Saitoh, Takayuki;Sakura, Tohru;Jimbo, Takahiro;Handa, Hiroshi;Tsukamoto, Norifumi;Karasawa, Masamitsu;Miyawaki, Shuichi;Murakami, Hirokazu;Nojima, Yoshihisa, 2007, INTERNATIONAL JOURNAL OF HEMATOLOGY, 86, 2, 137, 142

  DOI
• Hodgkin lymphoma presenting with various immunologic abnormalities, including autoimmune hepatitis, Hashimoto's thyroiditis, autoimmune hemolytic anemia, and immune thrombocytopenia, Saitoh, Takayuki;Matsushima, Takafumi;Saito, Yasuyuki;Yamane, Arito;Yokohama, Akihiko;Irisawa, Hiroyuki;Handa, Hiroshi;Tsukamoto, Norifumi;Karasawa, Masamitsu;Kojima, Masaru;Nojima, Yoshihisa;Murakami, Hirokazu, 2008, CLINICAL LYMPHOMA & MYELOMA, 8, 1, 62, 64
• T cell large granular lymphocyte (LGL) leukemia associated with Behcet's disease: high expression of sFasL and IL-18 of CD8 LGL, Saitoh, Takayuki;Matsushima, Takafumi;Kaneko, Yoriaki;Yokohama, Akihiko;Handa, Hiroshi;Tsukamoto, Norifumi;Karasawa, Masamitsu;Nojima, Yoshihisa;Murakami, Hirokazu, 2008, ANNALS OF HEMATOLOGY, 87, 7, 585, 586

  DOI
• Clinical significance of regulatory T cells in patients with myelodysplastic syndrome, Hamdi, Wedad;Ogawara, Hatsue;Handa, Hiroshi;Tsukamoto, Norifumi;Nojima, Yoshihisa;Murakami, Hirokazu, 2009, EUROPEAN JOURNAL OF HAEMATOLOGY, 82, 3, 201, 207

  DOI
• Autologous Peripheral Blood Stem Cell Transplantation to Treat CHOP-Refractory Aggressive Subcutaneous Panniculitis-Like T Cell Lymphoma, Nakahashi, Hirotaka;Tsukamoto, Norifumi;Yamane, Arito;Saitoh, Takayuki;Uchiumi, Hideki;Handa, Hiroshi;Karasawa, Masamitsu;Murakami, Hirokazu;Kojima, Masaru;Nojima, Yoshihisa, 2009, ACTA HAEMATOLOGICA, 121, 4, 239, 242

  DOI
• Successful Treatment by All-Trans Retinoic Acid in a Patient with Acute Promyelocytic Leukemia Complicated by Liver Cirrhosis and Polycystic Kidney, Yamane, Arito;Tsukamoto, Norifumi;Saitoh, Takayuki;Uchiumi, Hideki;Handa, Hiroshi;Karasawa, Masamitsu;Nojima, Yoshihisa;Murakami, Hirokazu, 2009, INTERNAL MEDICINE, 48, 18, 1691, 1694

  DOI
• Azathioprine induced pure red cell aplasia in a systemic sclerosis patient with interstitial pneumonia, Suto, Mariko;Nagai, Yayoi;Hasegawa, Michiko;Handa, Hiroshi;Ishikawa, Osamu, 2010, JOURNAL OF DERMATOLOGY, 37, 68, 69
• A randomized comparison of 4 courses of standard-dose multiagent chemotherapy versus 3 courses of high-dose cytarabine alone in postremission therapy for acute myeloid leukemia in adults: the JALSG AML201 Study, Miyawaki, Shuichi;Ohtake, Shigeki;Fujisawa, Shin;Kiyoi, Hitoshi;Shinagawa, Katsuji;Usui, Noriko;Sakura, Toru;Miyamura, Koichi;Nakaseko, Chiaki;Miyazaki, Yasushi;Fujieda, Atsushi;Nagai, Tadashi;Yamane, Takahisa;Taniwaki, Masafumi;Takahashi, Masatomo;Yagasaki, Fumiharu;Kimura, Yukihiko;Asou, Norio;Sakamaki, Hisashi;Handa, Hiroshi;Honda, Sumihisa;Ohnishi, Kazunori;Naoe, Tomoki;Ohno, Ryuzo, 2011, BLOOD, 117, 8, 2366, 2372

  DOI
• Analysis of bacteremia/fungemia and pneumonia accompanying acute myelogenous leukemia from 1987 to 2001 in the Japan Adult Leukemia Study Group, Yoshida, Minoru;Akiyama, Nobu;Fujita, Hiroyuki;Miura, Katsuhiro;Miyatake, Jun-ichi;Handa, Hiroshi;Kito, Katsuyuki;Takahashi, Masatomo;Shigeno, Kazuyuki;Kanda, Yoshinobu;Hatsumi, Naoko;Ohtake, Shigeki;Sakamaki, Hisashi;Ohnishi, Kazunori;Miyawaki, Shuichi;Ohno, Ryuzo;Naoe, Tomoki, 2011, INTERNATIONAL JOURNAL OF HEMATOLOGY, 93, 1, 66, 73

  DOI
• Association of Interleukin-18 Gene Polymorphism with Severity of Chronic Immune Thrombocytopenia (ITP), Saitoh, Takayuki;Moriyama, Norihiko;Takani, Tomonori;Mitsui, Takeki;Hoshino, Takumi;Koiso, Hiromi;Yokohama, Akihiko;Handa, Hiroshi;Karasawa, Masamitsu;Ogawara, Hatsue;Tsukamoto, Norifumi;Murakami, Hirokazu, 2010, BLOOD, 116, 21, 1515, 1515
• Interleukin-17F gene polymorphism in patients with chronic immune thrombocytopenia, Saitoh, Takayuki;Tsukamoto, Norifumi;Koiso, Hiromi;Mitsui, Takeki;Yokohama, Akihiko;Handa, Hiroshi;Karasawa, Masamitsu;Ogawara, Hatsue;Nojima, Yoshihisa;Murakami, Hirokazu, 2011, EUROPEAN JOURNAL OF HAEMATOLOGY, 87, 3, 253, 258

  DOI
• Long-term follow-up of EBV-positive lymphoproliferative disorders in a patient with systemic lupus erythematosus, Tsukamoto, Norifumi;Handa, Hiroshi;Yokohama, Akihiko;Mitsui, Takeki;Saitoh, Takayuki;Koiso, Hiromi;Uchiumi, Hideki;Hoshino, Takumi;Karasawa, Masamitsu;Murakami, Hirokazu;Kojima, Masaru;Nojima, Yoshihisa, 2011, MEDICAL MOLECULAR MORPHOLOGY, 44, 4, 237, 241

  DOI
• Differences in the JAK2 and MPL Mutation Status in the Cell Lineages of the bcr/abl-negative Chronic Myeloproliferative Neoplasm Subtypes, Toyama, Kohtaro;Karasawa, Masamitsu;Yokohama, Akihiko;Mitsui, Takeki;Uchiumi, Hideki;Saitoh, Takayuki;Handa, Hiroshi;Murakami, Hirokazu;Nojima, Yoshihisa;Tsukamoto, Norifumi, 2011, INTERNAL MEDICINE, 50, 21, 2557, 2561

  DOI
• TCL1A gene involvement in T-cell prolymphocytic leukemia in Japanese patients, Yokohama, Akihiko;Saitoh, Akio;Nakahashi, Hirotaka;Mitsui, Takeki;Koiso, Hiromi;Kim, Yoshitora;Uchiumi, Hideki;Saitoh, Takayuki;Handa, Hiroshi;Jimbo, Takahiro;Murayama, Kayoko;Sakura, Tohru;Murakami, Hirokazu;Karasawa, Masamitsu;Nojima, Yoshihisa;Tsukamoto, Norifumi, 2012, INTERNATIONAL JOURNAL OF HEMATOLOGY, 95, 1, 77, 85

  DOI
• Multicenter validation of a reproducible flow cytometric score for the diagnosis of low-grade myelodysplastic syndromes: results of a European LeukemiaNET study, Della Porta, Matteo G.;Picone, Cristina;Pascutto, Cristiana;Malcovati, Luca;Tamura, Hideto;Handa, Hiroshi;Czader, Magdalena;Freeman, Sylvie;Vyas, Paresh;Porwit, Anna;Saft, Leonie;Westers, Theresia M.;Alhan, Canan;Cali, Claudia;van de Loosdrecht, Arjan A.;Ogata, Kiyoyuki, 2012, HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 97, 8, 1209, 1217

  DOI
• The Cytokine Polymorphisms Affect the Severity of Thrombocytopenia at Diagnosis in Chronic Immune Thrombocytopenia, Saitoh, Takayuki;Ushie, Chiaki;Iwasaki, Atsushi;Moriyama, Norihiko;Takani, Tomonori;Hikaru, Hattori;Handa, Hiroshi;Koiso, Hiromi;Yokohama, Akihiko;Tsukamoto, Norifumi;Ogawara, Hatsue;Murakami, Hirokazu, 2012, BLOOD, 120, 21
• Polymorphisms of IL-10, IL-17A, IL-17F and IL-18 Affect the Clinical Features of Multiple Myeloma in Japanese Patients, Iwasaki, Atsushi;Saitoh, Takayuki;Ushie, Chiaki;Moriyama, Norihiko;Takani, Tomonori;Hattori, Hikaru;Handa, Hiroshi;Matsumoto, Morio;Isoda, Jun;Sawamura, Morio;Ogawara, Hatsue;Murakami, Hirokazu, 2012, BLOOD, 120, 21
• Distinctive disease subgroups according to differentiation stages in adult patients with T-cell acute lymphoblastic leukemia, Shimizu, Hiroaki;Handa, Hiroshi;Hatsumi, Nahoko;Takada, Satoru;Saitoh, Takayuki;Sakura, Toru;Miyawaki, Shuichi;Nojima, Yoshihisa, 2013, EUROPEAN JOURNAL OF HAEMATOLOGY, 90, 4, 301, 307

  DOI
• Prognosis of acute myeloid leukemia transformed from myelodysplastic syndromes: A multicenter retrospective study, Okuyama, Namiko;Sperr, Wolfgang R.;Kadar, Katalin;Bakker, Sietske;Szombath, Gergely;Handa, Hiroshi;Tamura, Hideto;Kondo, Asaka;Valent, Peter;Varkonyi, Judit;van de Loosdrecht, Arjan;Ogata, Kiyoyuki, 2013, LEUKEMIA RESEARCH, 37, 8, 862, 867

  DOI
• Development of IgG4-related disease 10 years after chemotherapy for diffuse large B cell lymphoma and longstanding bronchial asthma, Mitsui, Takeki;Yokohama, Akihiko;Koiso, Hiromi;Ishizaki, Takuma;Uchiumi, Hideki;Saitoh, Takayuki;Handa, Hiroshi;Hirato, Junko;Karasawa, Masamitsu;Murakami, Hirokazu;Kojima, Masaru;Nojima, Yoshihisa;Tsukamoto, Norifumi, 2013, INTERNATIONAL JOURNAL OF HEMATOLOGY, 98, 1, 122, 128

  DOI
• Recurrent Gemella haemolysans Meningitis in a Patient with Osteomyelitis of the Clivus, Hayashi, Toshimasa;Uchiumi, Hideki;Yanagisawa, Kunio;Ogawa, Yoshiyuki;Handa, Hiroshi;Tsukamoto, Norifumi;Nojima, Yoshihisa, 2013, INTERNAL MEDICINE, 52, 18, 2145, 2147

  DOI
• DNMT3B7 expression related to MENT expression and its promoter methylation in human lymphomas, Alkebsi, Lobna;Handa, Hiroshi;Sasaki, Yoshiko;Osaki, Yohei;Yanagisawa, Kunio;Ogawa, Yoshiaki;Yokohama, Akihiko;Hattori, Hikaru;Koiso, Hiromi;Saitoh, Takayuki;Mitsui, Takeki;Tsukamoto, Norifumi;Nojima, Yoshihisa;Murakami, Hirokazu, 2013, LEUKEMIA RESEARCH, 37, 12, 1662, 1667

  DOI
• Characterization of CD56(+) Dendritic-Like Cells: A Normal Counterpart of Blastic Plasmacytoid Dendritic Cell Neoplasm?, Osaki, Yohei;Yokohama, Akihiko;Saito, Akio;Tahara, Kenichi;Yanagisawa, Kunio;Ogawa, Yoshiyuki;Ishizaki, Takuma;Mitsui, Takeki;Koiso, Hiromi;Takizawa, Makiko;Uchiumi, Hideki;Saitoh, Takayuki;Handa, Hiroshi;Murakami, Hirokazu;Tsukamoto, Norifumi;Nojima, Yoshihisa, 2013, PLOS ONE, 8, 11

  DOI
• Normal karyotype acute myeloid leukemia with the CD7+CD15+CD34+HLA-DR + immunophenotype is a clinically distinct entity with a favorable outcome, Iriyama, Noriyoshi;Asou, Norio;Miyazaki, Yasushi;Yamaguchi, Shunichiro;Sato, Shinya;Sakura, Toru;Maeda, Tomoya;Handa, Hiroshi;Takahashi, Masatomo;Ohtake, Shigeki;Hatta, Yoshihiro;Sakamaki, Hisashi;Honda, Sumihisa;Taki, Tomohiko;Taniwaki, Masafumi;Miyawaki, Shuichi;Ohnishi, Kazunori;Kobayashi, Yukio;Naoe, Tomoki, 2014, ANNALS OF HEMATOLOGY, 93, 6, 957, 963

  DOI
• Complete remission achieved by steroid pulse therapy following rituximab treatment in a case with autoimmune haemorrhaphilia due to anti-factor XIII antibodies, Ogawa, Yoshiyuki;Mihara, Masahiro;Souri, Masayoshi;Yanagisawa, Kunio;Hayashi, Toshimasa;Kobayashi, Nobuhiko;Shimizu, Hiroaki;Iriuchishima, Hirono;Ishizaki, Takuma;Handa, Hiroshi;Osaki, Tukasa;Nojima, Yoshihisa;Ichinose, Akitada, 2014, THROMBOSIS AND HAEMOSTASIS, 112, 4, 831, 833

  DOI
• High Percentage of Regulatory T Cells before and after Vitamin B-12 Treatment in Patients with Pernicious Anemia, Watanabe, Satoru;Ide, Norifumi;Ogawara, Hatsue;Yokohama, Akihiko;Mitsui, Takeki;Handa, Hiroshi;Koiso, Hiromi;Tsukamoto, Norifumi;Saitoh, Takayuki;Murakami, Hirokazu, 2015, ACTA HAEMATOLOGICA, 133, 1, 83, 88

  DOI
• Philadelphia chromosome-positive mixed phenotype acute leukemia in the imatinib era, Shimizu, Hiroaki;Yokohama, Akihiko;Hatsumi, Nahoko;Takada, Satoru;Handa, Hiroshi;Sakura, Toru;Nojima, Yoshihisa, 2014, EUROPEAN JOURNAL OF HAEMATOLOGY, 93, 4, 297, 301

  DOI
• Primary Plasma Cell Leukemia in the Era of Novel Agent: Report of Multicenter Study from Japanese Society of Myeloma, Iriuchishima, Hirono;Murakami, Hirokazu;Ozaki, Shuji;Handa, Hiroshi;Saitoh, Takayuki;Nagura, Eiichi;Shimizu, Kazuyuki, 2014, BLOOD, 124, 21
• Interaction Between B7-H1 Molecules on Myeloma Cells and PD-1 Molecules on T Cells Induces Resistance to Antimyeloma Chemotherapy, Ishibashi, Mariko;Tamura, Hideto;Sunakawa, Mika;Kondo-Onodera, Asaka;Moriya, Keiichi;Okuyama, Namiko;Hamada, Yasuko;Isoda, Atsushi;Matsumoto, Morio;Sasaki, Makoto;Komatsu, Norio;Handa, Hiroshi;Imai, Yoichi;Tanaka, Junji;Tanosaki, Sakae;Ito, Shigeki;Ishida, Yoji;Koike, Michiaki;Tamada, Koji;Inokuchi, Koiti, 2014, BLOOD, 124, 21
• The International Multiple Myeloma Research (IMMEnSE) Consortium: Genetics of Multiple Myeloma Risk and Prognosis, Canzian, Federico;Beider, Katia;Buda, Gabriele;de Arriba de la Fuente, Felipe;Dudzinski, Marek;Dumontet, Charles;Garcia-Sanz, Ramon;Handa, Hiroshi;Jamroziak, Krzysztof;Jurado, Manuel;Jurczyszyn, Artur J.;Landi, Stefano;Lesueur, Fabienne;Marques, Herlander;Martinez-Lopez, Joaquin;Moreno, Victor;Murakami, Hirokazu;Nagler, Arnon;Petrini, Mario;Reis, Rui Manuel;Rios, Rafael;Sainz, Juan;Szemraj-Rogucka, Zofia;Vangsted, Annette Juul;Varkonyi, Judit;Vogel, Ulla;Watek, Marzena;Campa, Daniele, 2014, BLOOD, 124, 21
• BCL6 Dose Not Negatively Regulate DNA Damage Response Genes in Multiple Myeloma Cells, Tahara, Kenichi;Takizawa, Makiko;Handa, Hiroshi;Masuda, Yuta;Kaneko, Ayaka;Suda, Itsumi;Kimura, Kei;Kuroda, Yuko;Atsushi, Isoda;Matsumoto, Morio;Koiso, Hiromi;Takuma, Ishizaki;Mitsui, Takeki;Yokohama, Akihiko;Saitoh, Takayuki;Tsukamoto, Norifumi;Murakami, Hirokazu, 2014, BLOOD, 124, 21
• Clinical Significance of Additional Cytogenetic Abnormalities (ACA) Acquired at the First Relapse in Adult Acute Myeloid Leukemia (AML) Patients, Shimizu, Hiroaki;Yokohama, Akihiko;Hatsumi, Nahoko;Takada, Satoru;Saitoh, Takayuki;Handa, Hiroshi;Sakura, Toru;Nojima, Yoshihisa, 2014, BLOOD, 124, 21
• Survival of Multiple Myeloma Patients in the Era of Novel Agents and Autologous Stem Cell Transplantation: A Multicenter Retrospective Collaborative Study of the Japanese Society of Myeloma, Ozaki, Shuji;Handa, Hiroshi;Saitoh, Takayuki;Murakami, Hirokazu;Itagaki, Mitsuhiro;Asaoku, Hideki;Suzuki, Kenshi;Isoda, Atsushi;Sawamura, Morio;Konishi, Jun;Sunami, Kazutaka;Takezako, Naoki;Hagiwara, Shotaro;Kuroda, Yoshiaki;Chou, Takaaki;Shibata, Eiko;Shimizu, Kazuyuki;Nagura, Eiichi, 2014, BLOOD, 124, 21
• Clinical Utility of Slam Family Member CD229 in Identifying Tumor Cells and High-Risk Disease Markers, CD86 (B7-2) and CD126 (IL-6 receptor), Using Flow Cytometric Analysis in Multiple Myeloma, Yamada, Akiko;Tamura, Hideto;Ishibashi, Mariko;Inokuchi, Koiti;Sasaki, Makoto;Yahata, Yuriko;Komatsu, Norio;Isoda, Atsushi;Matsumoto, Morio;Handa, Hiroshi;Imai, Yoichi;Tanaka, Junji;Tanosaki, Sakae;Ito, Shigeki;Ishida, Yoji;Koike, Michiaki, 2014, BLOOD, 124, 21
• Phase 1 Study of the Investigational Proteasome Inhibitor Ixazomib Alone or in Combination with Lenalidomide-Dexamethasone (Rd) in Japanese Patients (Pts) with Relapsed and/or Refractory Multiple Myeloma (RRMM), Handa, Hiroshi;Suzuki, Kenshi;Chou, Takaaki;Matsushima, Takafumi, 2014, BLOOD, 124, 21
• Soluble IL-2 Receptor a Is a More Sensitive Diagnostic Biomarker Than beta 2 Microglobulin and Predicts Survival in Follicular Lymphoma: Retrospective Analysis of 305 Cases, Yokohama, Akihiko;Hashimoto, Yoko;Hiroaki, Shimizu;Saito, Akio;Miyazawa, Yuri;Iriujijima, Hirono;Toyama, Kotaro;Ishizaki, Takuma;Mitsui, Takeki;Koiso, Hiromi;Takizawa, Makiko;Saito, Takayuki;Handa, Hiroshi;Murayama, Kayoko;Matsumoto, Morio;Sawamura, Morio;Murakami, Hirokazu;Nojima, Yoshihisa;Hirato, Junko;Kojima, Masaru;Tsukamoto, Norifumi, 2014, BLOOD, 124, 21
• A new staging system to predict prognosis of patients with multiple myeloma in an era of novel therapeutic agents, Iriuchishima, Hirono;Saitoh, Takayuki;Handa, Hiroshi;Isoda, Atsushi;Matsumoto, Morio;Sawamura, Morio;Iwasaki, Atsushi;Ushie, Chiaki;Hattori, Hikaru;Sasaki, Yoshiko;Mitsui, Takeki;Yokohama, Akihiko;Tsukamoto, Norifumi;Murakami, Hirokazu;Nojima, Yoshihisa, 2015, EUROPEAN JOURNAL OF HAEMATOLOGY, 94, 2, 145, 151

  DOI
• A multinational, open-label, phase 2 study of ruxolitinib in Asian patients with myelofibrosis: Japanese subset analysis, Oritani, Kenji;Okamoto, Shinichiro;Tauchi, Tetsuzo;Saito, Shigeki;Ohishi, Kohshi;Handa, Hiroshi;Takenaka, Katsuto;Gopalakrishna, Prashanth;Amagasaki, Taro;Ito, Kazuo;Akashi, Koichi, 2015, INTERNATIONAL JOURNAL OF HEMATOLOGY, 101, 3, 295, 304

  DOI
• Efficacy and safety of ruxolitinib in Asian patients with myelofibrosis, Jung, Chul Won;Shih, Lee-Yung;Xiao, Zhijian;Jie, Jin;Hou, Hsin-An;Du, Xin;Wang, Ming-Chung;Park, Seonyang;Eom, Ki-Seong;Oritani, Kenji;Okamoto, Shinichiro;Tauchi, Tetsuzo;Kim, Jin Seok;Zhou, Daobin;Saito, Shigeki;Li, Junmin;Handa, Hiroshi;Li Jianyong;Ohishi, Kohshi;Hou, Ming;Wu Depei;Takenaka, Katsuto;Liu, Ting;Hu, Yu;Amagasaki, Taro;Ito, Kazuo;Gopalakrishna, Prashanth;Akashi, Koichi, 2015, LEUKEMIA & LYMPHOMA, 56, 7, 2067, 2074

  DOI
• MUTATION OF THE SF3B1 PREDICT A POOR PROGNOSIS IN JAPANESE CLL PATIENTS, Mitsui, Takeki;Koiso, Hiromi;Namahashi, Hirotaka;Saito, Akio;Ishizaki, Takuma;TAakizawa, Makiko;Yokohama, Akihiko;Saito, Takayuki;Jinbo, Takahiro;Ogura, Hidemi;Handa, Hiroshi;Sawamura, Morio;Sakura, Tohru;Karasawa, Masamitsu;Murakami, Hirokazu;Nojima, Yoshihisa;Tsukamoto, Norifumi, 2015, EXPERIMENTAL HEMATOLOGY, 43, 9, S81, S81
• Gene polymorphisms of mannose-binding lectin confer susceptibility to Pneumocystis pneumonia in HIV-infected patients, Yanagisawa, Kunio;Ogawa, Yoshiyuki;Uchiumi, Hideki;Gohda, Fumito;Mawatari, Momoko;Ishizaki, Takuma;Mitsui, Takeki;Yokohama, Akihiko;Handa, Hiroshi;Tsukamoto, Norifumi;Nojima, Yoshihisa, 2015, JOURNAL OF INFECTION AND CHEMOTHERAPY, 21, 11, 769, 775

  DOI
• Two Cases of Intravascular Lymphoma Diagnosed by Gastrointestinal Endoscopic Biopsy, Shimoyama, Yasuyuki;Sugimoto, Kensuke;Kotake, Mie;Uehara, Daisuke;Kamide, Yosuke;Kuribayashi, Shiko;Kawamura, Osamu;Kusano, Motoyasu;Handa, Hiroshi;Hirato, Junko;Yamada, Masanobu, 2015, INTERNAL MEDICINE, 54, 24, 3145, 3149
• Interim Analysis of Phase II Study of the Bortezomib-Melphalan-Prednisolone Induction Therapy Followed By Lenalidomide-Plus-Dexamethasone Consolidation and Lenalidomide Maintenance in Non-Transplant Eligible Patients with Newly Diagnosed Symptomatic Multiple Myeloma., Ishida, Tadao;Kimura, Hideo;Kubo, Koumei;Sunami, Kazutaka;Ozaki, Shuji;Takezako, Naoki;Handa, Hiroshi;Kosugi, Hiroshi;Murakami, Hirokazu;Shimizu, Kazuyuki, 2015, BLOOD, 126, 23
• The Epigenetic Repression of Mir-375 Is the Dominant Mechanism for the Constitutive Activation of PDPK1/RSK2 Signaling Axis in Multiple Myeloma, Tatekawa, Shotaro;Kuroda, Junya;Chinen, Yoshiaki;Shimura, Yuji;Nagoshi, Hisao;Kobayashi, Tsutomu;Kawata, Eri;Uoshima, Nobuhiko;Handa, Hiroshi;Taniwaki, Masafumi, 2015, BLOOD, 126, 23
• A Revised International Staging System of Multiple Myeloma in the Era of Novel Agents and Autologous Stem Cell Transplantation in Japan: A Multicenter Retrospective Collaborative Study of the Japanese Society of Myeloma, Ozaki, Shuji;Saitoh, Takayuki;Handa, Hiroshi;Murakami, Hirokazu;Suzuki, Kenshi;Takezako, Naoki;Konishi, Jun;Sunami, Kazutaka;Kuroda, Yoshiaki;Itagaki, Mitsuhiro;Asaoku, Hideki;Nagura, Eiichi;Shimizu, Kazuyuki, 2015, BLOOD, 126, 23
• Outcomes after Initial Relapse of Multiple Myeloma: An International Myeloma Working Group Study, Kumar, Shaji K.;Lee, Jae Hoon;Dimopoulos, Meletios A.;Terpos, Evangelos;Kastritis, Efstathios;Chng, Wee Jou;Jurczyszyn, Artur J.;Handa, Hiroshi;Ozaki, Shuji;Leleu, Xavier;Moreau, Philippe;Jose Lahuerta, Juan;Shustik, Chaim;Waller, Daniel Dirck;Beksac, Meral;Vij, Ravi;Kim, Kihyun;Kim, Jin Seok;Badros, Ashraf Z.;Alsina, Melissa;Durie, Brian G. M., 2015, BLOOD, 126, 23
• Retrospective Analysis of Prognostic Factors for Waldenstrom Macroglobulinemia: A Multicenter Cooperative Study in Japan, Saito, Akio;Isoda, Atsushi;Yokohama, Akihiko;Handa, Hiroshi;Tsukamoto, Norifumi;Tsukune, Yutaka;Sasaki, Makoto;Matsumoto, Morio;Sawamura, Morio;Ito, Shigeki;Toyama, Kohtaro;Koike, Michiaki;Murayama, Kayoko;Onodera, Asaka;Moriya, Keiichi;Tamura, Hideto;Nakahashi, Hirotaka;Tanosaki, Sakae;Sakura, Toru;Karasawa, Masamitsu;Iwashina, Masanori;Kojima, Masaru;Nakamura, Naoya;Murakami, Hirokazu, 2015, BLOOD, 126, 23
• SF3B1 and IGHV gene mutation status predict poor prognosis in Japanese CLL patients, Mitsui, Takeki;Koiso, Hiromi;Nakahashi, Hirotaka;Saitoh, Akio;Shimizu, Hiroaki;Ishizaki, Takuma;Ogawa, Yoshiyuki;Takizawa, Makiko;Yokohama, Akihiko;Saitoh, Takayuki;Jinbo, Takahiro;Ogura, Hidemi;Handa, Hiroshi;Sawamura, Morio;Sakura, Tohru;Karasawa, Masamitsu;Murakami, Hirokazu;Nojima, Yoshihisa;Tsukamoto, Norifumi, 2016, INTERNATIONAL JOURNAL OF HEMATOLOGY, 103, 2, 219, 226

  DOI
• Primary Plasma Cell Leukemia in the Era of Novel Agents: A Multicenter Study of the Japanese Society of Myeloma, Iriuchishima, Hirono;Ozaki, Shuji;Konishi, Jun;Matsumoto, Morio;Murayama, Kayoko;Nakamura, Fumihiko;Yamamoto, Go;Handa, Hiroshi;Saitoh, Takayuki;Nagura, Eiichi;Shimizu, Kazuyuki;Nojimaa, Yoshihisa;Murakami, Hirokazu, 2016, ACTA HAEMATOLOGICA, 135, 2, 113, 121

  DOI
• Raltegravir is safely used with long-term viral suppression for HIV-infected patients on hemodialysis: a pharmacokinetic study, Yanagisawa, Kunio;Nagano, Daisuke;Ogawa, Yoshiyuki;Uchiumi, Hideki;Shigehara, Tetsuya;Saruki, Kazuhisa;Handa, Hiroshi;Araki, Takuya;Yamamoto, Koujirou;Nojima, Yoshihisa, 2016, AIDS, 30, 6, 970, 972

  DOI
• Incidence and clinical background of hepatitis B virus reactivation in multiple myeloma in novel agents' era, Tsukune, Yutaka;Sasaki, Makoto;Odajima, Takeshi;Isoda, Atsushi;Matsumoto, Morio;Koike, Michiaki;Tamura, Hideto;Moriya, Keiichi;Ito, Shigeki;Asahi, Maki;Imai, Yoichi;Tanaka, Junji;Handa, Hiroshi;Koiso, Hiromi;Tanosaki, Sakae;Hua, Jian;Hagihara, Masao;Yahata, Yuriko;Suzuki, Satoko;Watanabe, Sumio;Sugimori, Hiroki;Komatsu, Norio, 2016, ANNALS OF HEMATOLOGY, 95, 9, 1465, 1472

  DOI
• Successful Treatment of Epstein-Barr Virus-Associated Lymphoproliferative Disorder with Rituximab in a Patient Undergoing Immunosuppressive Therapy for Aplastic Anemia, Shimizu, Hiroaki;Kobayashi, Nobuhiko;Mihara, Masahiro;Iriuchishima, Hirono;Ishizaki, Takuma;Kojima, Yoshihisa;Handa, Hiroshi, 2016, ACTA HAEMATOLOGICA, 136, 3, 174, 177

  DOI
• Chromosome 16q genes CDH1, CDH13 and ADAMTS18 are correlated and frequently methylated in human lymphoma, Alkebsi, Lobna;Handa, Hiroshi;Yokohama, Akihiko;Saitoh, Takayuki;Tsukamoto, Norifumi;Murakami, Hirokazu, 2016, ONCOLOGY LETTERS, 12, 5, 3523, 3530

  DOI
• Successful management of perioperative hemostasis in a patient with Glanzmann thrombasthenia who underwent a right total mastectomy, Ogawa, Yoshiyuki;Kunishima, Shinji;Yanagisawa, Kunio;Osaki, Yohei;Uchiyama, Yuri;Matsumoto, Naomichi;Tokiniwa, Hideaki;Horiguchi, Jun;Nojima, Yoshihisa;Handa, Hiroshi, 2017, INTERNATIONAL JOURNAL OF HEMATOLOGY, 105, 2, 221, 225

  DOI
• Prognostic Value of Chromosomal Abnormalities for Follicular Lymphoma in the Rituximab-Era, Mitsui, Takeki;Yokohama, Akihiko;Koiso, Hiromi;Saito, Akio;Toyama, Kohtaro;Shimizu, Hiroaki;Ishizaki, Takuma;Irisawa, Hiroyuki;Saito, Takayuki;Murayama, Kayoko;Matsumoto, Morio;Handa, Hiroshi;Murakami, Hirokazu;Tsukamoto, Norifumi, 2016, BLOOD, 128, 22
• The Abnormal Repression of Mir-375 Expression By Overlapping Epigenetic Dysregulations in Myelomas, Tatekawa, Shotaro;Chinen, Yoshiaki;Shimura, Yuji;Matsumura-Kimoto, Yayoi;Nagoshi, Hisao;Kobayashi, Tsutomu;Kawata, Eri;Narita, Tomoko;Ri, Masaki;Handa, Hiroshi;Uoshima, Nobuhiko;Iida, Shinsuke;Kuroda, Junya, 2016, BLOOD, 128, 22
• Safety and Efficacy of Elotuzumab with Lenalidomide/Dexamethasone for Multiple Myeloma in a Japanese Subpopulation Analysis of the Phase 3 Eloquent-2 Trial, Ohashi, Kazuteru;Suzuki, Kenshi;Sunami, Kazutaka;Iida, Shinsuke;Okamoto, Shinichiro;Handa, Hiroshi;Matsue, Kosei;Miyoshi, Masafumi;Bleickardt, Eric;Matsumoto, Morio;Taniwaki, Masafumi, 2016, BLOOD, 128, 22
• Central Nervous System Invasion in Multiple Myeloma: A Nationwide Survey of 75 Patients in Japan, Yamashita, Takeshi;Takamatsu, Hiroyuki;Kawamura, Koji;Sunami, Kazutaka;Hagiwara, Shotaro;Itagaki, Mitsuhiro;Takahashi, Tsutomu;Kondo, Tadakazu;Ikeda, Takashi;Watakabe-Inamoto, Kyoko;Handa, Hiroshi;Imaizumi, Yoshitaka;Kuroda, Junya;Murakami, Jun;Nakamura, Yuichi;Nakazawa, Hideyuki;Ozaki, Shuji;Nakao, Shinji;Tobinai, Kensei;Iida, Shinsuke, 2016, BLOOD, 128, 22
• Stem Cell Mobilization with High-Dose VP-16 Is Not Associated with an Increased Risk of Secondary MDS/AML after Autologous Transplant Against Malignant Lymphoma, Naito, Chiaki;Shimizu, Hiroaki;Miyazawa, Yuri;Toyama, Kohtaro;Mitsui, Takeki;Koiso, Hiromi;Ogura, Hidemi;Matsumoto, Morio;Yokohama, Akihiko;Tsukamoto, Norifumi;Nojima, Yoshihisa;Handa, Hiroshi, 2016, BLOOD, 128, 22
• Risk Factors and Clinical Impact of Chronic Kidney Disease (CKD) after Allogeneic Stem Cell Transplant (allo-SCT), Shimizu, Hiroaki;Ishizaki, Takuma;Hatsumi, Nahoko;Takada, Satoru;Yokohama, Akihiko;Saitoh, Takayuki;Nojima, Yoshihisa;Handa, Hiroshi, 2016, BLOOD, 128, 22
• The Clinical Features and Prognostic Impact of PRDM16 gene Expression in Adult Acute Myeloid Leukemia, Yamato, Genki;Yamaguchi, Hiroki;Handa, Hiroshi;Shiba, Norio;Wakita, Satoshi;Inokuchi, Koiti;Hara, Yusuke;Ohki, Kentaro;Okubo, Jun;Sotomatsu, Manabu;Arakawa, Hirokazu;Hayashi, Yasuhide, 2016, BLOOD, 128, 22
• Histone deacetylase inhibitors suppress ABO transcription in vitro, leading to reduced expression of the antigens, Takahashi, Yoichiro;Kubo, Rieko;Sano, Rie;Nakajima, Tamiko;Takahashi, Keiko;Kobayashi, Momoko;Handa, Hiroshi;Tsukada, Junichi;Kominato, Yoshihiko, 2017, TRANSFUSION, 57, 3, 554, 562

  DOI
• Phase 1 study of ixazomib alone or combined with lenalidomide-dexamethasone in Japanese patients with relapsed/refractory multiple myeloma, Suzuki, Kenshi;Handa, Hiroshi;Chou, Takaaki;Ishizawa, Kenichi;Takubo, Takatoshi;Kase, Yoichi, 2017, INTERNATIONAL JOURNAL OF HEMATOLOGY, 105, 4, 445, 452

  DOI
• Successful Management of a Patient with Autoimmune Hemorrhaphilia due to Anti-Factor XIII/13 Antibodies Complicated by Pulmonary Thromboembolism, Ogawa, Yoshiyuki;Yanagisawa, Kunio;Souri, Masayoshi;Mihara, Masahiro;Naito, Chiaki;Takizawa, Makiko;Ishizaki, Takuma;Mitsui, Takeki;Handa, Hiroshi;Osaki, Tsukasa;Nojima, Yoshihisa;Ichinose, Akitada, 2017, ACTA HAEMATOLOGICA, 137, 3, 141, 147

  DOI
• Clinical characteristics and outcomes of acquired hemophilia A: experience at a single center in Japan, Ogawa, Yoshiyuki;Yanagisawa, Kunio;Uchiumi, Hideki;Ishizaki, Takuma;Mitsui, Takeki;Gouda, Fumito;Ieko, Masahiro;Ichinose, Akitada;Nojima, Yoshihisa;Handa, Hiroshi, 2017, INTERNATIONAL JOURNAL OF HEMATOLOGY, 106, 1, 82, 89

  DOI
• Epigenetic repression of miR-375 is the dominant mechanism for constitutive activation of the PDPK1/RPS6KA3 signalling axis in multiple myeloma, Tatekawa, Shotaro;Chinen, Yoshiaki;Ri, Masaki;Narita, Tomoko;Shimura, Yuji;Matsumura-Kimoto, Yayoi;Tsukamoto, Taku;Kobayashi, Tsutomu;Kawata, Eri;Uoshima, Nobuhiko;Taki, Tomohiko;Taniwaki, Masafumi;Handa, Hiroshi;Iida, Shinsuke;Kuroda, Junya, 2017, BRITISH JOURNAL OF HAEMATOLOGY, 178, 4, 534, 546

  DOI
• Cytomegalovirus retinitis followed by immune recovery uveitis in an elderly patient with rheumatoid arthritis undergoing administration of methotrexate and tofacitinib combination therapy, Yanagisawa, Kunio;Ogawa, Yoshiyuki;Hosogai, Mayumi;Todokoro, Daisuke;Mitsui, Takeki;Yokohama, Akihiko;Kishi, Shoji;Handa, Hiroshi, 2017, JOURNAL OF INFECTION AND CHEMOTHERAPY, 23, 8, 572, 575

  DOI
• Overexpression of B-cell lymphoma 6 alters gene expression profile in a myeloma cell line and is associated with decreased DNA damage response, Tahara, Kenichi;Takizawa, Makiko;Yamane, Arito;Osaki, Yohei;Ishizaki, Takuma;Mitsui, Takeki;Yokohama, Akihiko;Saitoh, Takayuki;Tsukamoto, Norifumi;Matsumoto, Morio;Murakami, Hirokazu;Nojima, Yoshihisa;Handa, Hiroshi, 2017, CANCER SCIENCE, 108, 8, 1556, 1564

  DOI
• Management of infection during chemotherapy for acute leukemia in Japan: a nationwide questionnaire-based survey by the Japan Adult Leukemia Study Group, Kimura, Shun-ichi;Fujita, Hiroyuki;Kato, Hideaki;Hiramoto, Nobuhiro;Hosono, Naoko;Takahashi, Tsutomu;Shigeno, Kazuyuki;Hatsumi, Naoko;Minamiguchi, Hitoshi;Miyatake, Junichi;Handa, Hiroshi;Akiyama, Nobu;Kanda, Yoshinobu;Yoshida, Minoru;Kiyoi, Hitoshi;Miyazaki, Yasushi;Naoe, Tomoki;JALSG, 2017, SUPPORTIVE CARE IN CANCER, 25, 11, 3515, 3521

  DOI
• Clinical features and prognostic impact of PRDM16 expression in adult acute myeloid leukemia, Yamato, Genki;Yamaguchi, Hiroki;Handa, Hiroshi;Shiba, Norio;Kawamura, Machiko;Wakita, Satoshi;Inokuchi, Koiti;Hara, Yusuke;Ohki, Kentaro;Okubo, Jun;Park, Myoung-Ja;Sotomatsu, Manabu;Arakawa, Hirokazu;Hayashi, Yasuhide, 2017, GENES CHROMOSOMES & CANCER, 56, 11, 800, 809

  DOI
• Evaluation of the dose and efficacy of ruxolitinib in Japanese patients with myelofibrosis, Kirito, Keita;Okamoto, Shinichiro;Ohishi, Kohshi;Tauchi, Tetsuzo;Handa, Hiroshi;Saito, Shigeki;Takenaka, Katsuto;Shimoda, Kazuya;Oritani, Kenji;Akashi, Koichi;Okada, Hikaru;Amagasaki, Taro;Suzuki, Kazuyuki;Yonezu, Toshio;Komatsu, Norio, 2018, INTERNATIONAL JOURNAL OF HEMATOLOGY, 107, 1, 92, 97

  DOI
• Ruxolitinib is effective and safe in Japanese patients with hydroxyurea-resistant or hydroxyurea-intolerant polycythemia vera with splenomegaly, Kirito, Keita;Suzuki, Kenshi;Miyamura, Koichi;Takeuchi, Masahiro;Handa, Hiroshi;Okamoto, Shinichiro;Gadbaw, Brian;Yamauchi, Kyosuke;Amagasaki, Taro;Ito, Kazuo;Hino, Masayuki, 2018, INTERNATIONAL JOURNAL OF HEMATOLOGY, 107, 2, 173, 184

  DOI
• Collision of metastatic malignant melanoma and acute myelogenous leukemia in the bone marrow, Kobayashi, Nobuhiko;Shimizu, Hiroaki;Hirato, Junko;Handa, Hiroshi, 2018, INTERNATIONAL JOURNAL OF HEMATOLOGY, 107, 3, 257, 259

  DOI
• Clonal evolution detected with conventional cytogenetic analysis is a potent prognostic factor in adult patients with relapsed AML, Shimizu, Hiroaki;Yokohama, Akihiko;Ishizaki, Takuma;Hatsumi, Nahoko;Takada, Satoru;Saitoh, Takayuki;Sakura, Toru;Nojima, Yoshihisa;Handa, Hiroshi, 2018, HEMATOLOGICAL ONCOLOGY, 36, 1, 252, 257

  DOI
• A Rare Case of Chronic Active Epstein-Barr Virus (EBV) Infection Accompanied by the Infiltration of EBV-infected CD8(+) T Cells into the Muscle, Kobayashi, Nobuhiko;Mitsui, Takeki;Ogawa, Yoshiyuki;Iriuchishima, Hirono;Takizawa, Makiko;Yokohama, Akihiko;Saitoh, Takayuki;Koiso, Hiromi;Tsukamoto, Norifumi;Murakami, Hirokazu;Nojima, Yoshihisa;Handa, Hiroshi, 2018, JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY, 40, 3, E171, E175

  DOI
• Role of exosomes as a proinflammatory mediator in the development of EBV-associated lymphoma, Higuchi, Hiroshi;Yamakawa, Natsuko;Imadome, Ken-Ichi;Yahata, Takashi;Kotaki, Ryutaro;Ogata, Jun;Kakizaki, Masatoshi;Fujita, Koji;Lu, Jun;Yokoyama, Kazuaki;Okuyama, Kazuki;Sato, Ai;Takamatsu, Masako;Kurosaki, Natsumi;Alba, Syakira Mohamad;Azhim, Azran;Horie, Ryouichi;Watanabe, Toshiki;Kitamura, Toshio;Ando, Kiyoshi;Kashiwagi, Takao;Matsui, Toshimitsu;Okamoto, Akinao;Handa, Hiroshi;Kuroda, Masahiko;Nakamura, Naoya;Kotani, Ai, 2018, BLOOD, 131, 23, 2552, 2567

  DOI
• Bortezomib maintenance therapy in transplant-ineligible myeloma patients who plateaued after bortezomib-based induction therapy: a multicenter phase II clinical trial, Isoda, Atsushi;Murayama, Kayoko;Ito, Shigeki;Kohara, Yoichi;Iino, Masaki;Miyazawa, Yuri;Matsumoto, Morio;Handa, Hiroshi;Imai, Yosuke;Ishiguro, Takuro;Izumita, Wataru;Kitano, Kiyoshi;Hirabayashi, Yukio;Nakazawa, Hideyuki;Ishida, Fumihiro;Mitsumori, Toru;Kirito, Keita;Chou, Takaaki;Murakami, Hirokazu;Kanshinetsu Multiple Myeloma Study, 2018, INTERNATIONAL JOURNAL OF HEMATOLOGY, 108, 1, 39, 46

  DOI
• Darunavir concentration in PBMCs may be a better indicator of drug exposure in HIV patients, Nagano, Daisuke;Araki, Takuya;Yanagisawa, Kunio;Ogawa, Yoshiyuki;Gohda, Fumito;Uchiumi, Hideki;Handa, Hiroshi;Nakamura, Tomonori;Yamamoto, Koujirou, 2018, EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 74, 8, 1055, 1060

  DOI
• Switching to nilotinib is associated with deeper molecular responses in chronic myeloid leukemia chronic phase with major molecular responses to imatinib: STAT1 trial in Japan, Noguchi, Shinsuke;Nakaseko, Chiaki;Nishiwaki, Kaichi;Ogasawara, Hitoshi;Ohishi, Kohshi;Tokuhira, Michihide;Noguchi, Masaaki;Kimura, Hideo;Handa, Hiroshi;Mitani, Kinuko;Miura, Masatomo;Wakita, Hisashi;Takahashi, Naoto;STAT Study Grp, 2018, INTERNATIONAL JOURNAL OF HEMATOLOGY, 108, 2, 176, 183

  DOI
• Successful hemostatic management of major surgery for cervical spondylotic myelopathy in a patient with severe factor XI deficiency, Ogawa, Yoshiyuki;Yanagisawa, Kunio;Uchiyama, Yuri;Akashi, Naoki;Mieda, Tokue;Iizuka, Haku;Inoue, Madoka;Shizuka, Reiko;Murakami, Masami;Matsumoto, Naomichi;Handa, Hiroshi, 2018, INTERNATIONAL JOURNAL OF HEMATOLOGY, 108, 4, 443, 446

  DOI
• A novel CYCS mutation in the alpha-helix of the CYCS C-terminal domain causes non-syndromic thrombocytopenia, Uchiyama, Yuri;Yanagisawa, Kunio;Kunishima, Shinji;Shiina, Masaaki;Ogawa, Yoshiyuki;Nakashima, Mitsuko;Hirato, Junko;Imagawa, Eri;Fujita, Atsushi;Hamanaka, Kohei;Miyatake, Satoko;Mitsuhashi, Satomi;Takata, Atsushi;Miyake, Noriko;Ogata, Kazuhiro;Handa, Hiroshi;Matsumoto, Naomichi;Mizuguchi, Takeshi, 2018, CLINICAL GENETICS, 94, 6, 548, 553

  DOI
• Recurrent CCND3 mutations in MLL-rearranged acute myeloid leukemia, Matsuo, Hidemasa;Yoshida, Kenichi;Fukumura, Kazutaka;Nakatani, Kana;Noguchi, Yuki;Takasaki, Saho;Noura, Mina;Shiozawa, Yusuke;Shiraishi, Yuichi;Chiba, Kenichi;Tanaka, Hiroko;Okada, Ai;Nannya, Yasuhito;Takeda, June;Ueno, Hiroo;Shiba, Norio;Yamato, Genki;Handa, Hiroshi;Ono, Yuichiro;Hiramoto, Nobuhiro;Ishikawa, Takayuki;Usuki, Kensuke;Ishiyama, Ken;Miyawaki, Shuichi;Itonaga, Hidehiro;Miyazaki, Yasushi;Kawamura, Machiko;Yamaguchi, Hiroki;Kiyokawa, Nobutaka;Tomizawa, Daisuke;Taga, Takashi;Tawa, Akio;Hayashi, Yasuhide;Mano, Hiroyuki;Miyano, Satoru;Kamikubo, Yasuhiko;Ogawa, Seishi;Adachi, Souichi, 2018, BLOOD ADVANCES, 2, 21, 2879, 2889

  DOI
• Infectious complications in adults undergoing intensive chemotherapy for acute myeloid leukemia in 2001-2005 using the Japan Adult Leukemia Study Group AML201 protocols, Kato, Hideaki;Fujita, Hiroyuki;Akiyama, Nobu;Kimura, Shun-ichi;Hiramoto, Nobuhiro;Hosono, Naoko;Takahashi, Tsutomu;Shigeno, Kazuyuki;Minamiguchi, Hitoshi;Miyatake, Junichi;Handa, Hiroshi;Kanda, Yoshinobu;Yoshida, Minoru;Miyawaki, Shuichi;Ohtake, Shigeki;Naoe, Tomoki;Kiyoi, Hitoshi;Matsumura, Itaru;Miyazaki, Yasushi;Japan Adult Leukemia Study Grp, 2018, SUPPORTIVE CARE IN CANCER, 26, 12, 4187, 4198

  DOI
• Overshoot of FVIII Activity in Patients with Acquired Hemophilia, Ogawa, Yoshiyuki;Yanagisawa, Kunio;Shimizu, Hiroaki;Ishizaki, Takuma;Ichinose, Akitada;Handa, Hiroshi, 2018, BLOOD, 132

  DOI
• Clinical Significance of Clonal Cytogenetic Heterogeneity (CCH) at Diagnosis in Adult Patients with Acute Lymphoblastic Leukemia (ALL), Shimizu, Hiroaki;Hatsumi, Nahoko;Takada, Satoru;Ishizaki, Takuma;Yokohama, Akihiko;Saitoh, Takayuki;Sakura, Toru;Handa, Hiroshi, 2018, BLOOD, 132

  DOI
• Matrix Metalloproteinase and Tissue Inhibitor of Metalloproteinases Is Associated with Multiple Myeloma Progression, Prognosis and Extramedullary Plasmacytoma, Ishihara, Rei;Murakami, Yuki;Homma, Kazuki;Watanabe, Saki;Oda, Tsukasa;Sunaga, Masanobu;Yamane, Eiko;Kobayashi, Nobuhiko;Osaki, Yohei;Ishizaki, Takuma;Shimizu, Hiroaki;Iriuchishima, Hirono;Koiso, Hiromi;Tsukamoto, Norifumi;Yokohama, Akihiko;Nanami, Gotoh;Ino, Rumi;Saitoh, Takayuki;Murakami, Hirokazu;Handa, Hiroshi, 2018, BLOOD, 132

  DOI
• Tumor long-axis diameter and SUVmax predict long-term responders in 90Y-ibritumomab tiuxetan monotherapy, Tsukamoto, Norifumi;Yokohama, Akihiko;Higuchi, Tetsuya;Mitsui, Takeki;Koiso, Hiromi;Takizawa, Makiko;Shimizu, Hiroaki;Ishizaki, Takuma;Matsumoto, Morio;Toyama, Kohtaro;Sakura, Tohru;Ogura, Hidemi;Saitoh, Takayuki;Ishida, Fumihiro;Murakami, Hirokazu;Tsushima, Yoshito;Handa, Hiroshi, 2019, INTERNATIONAL JOURNAL OF HEMATOLOGY, 109, 1, 91, 97

  DOI
• Prognostic impact of trisomy 21 in follicular lymphoma, Mitsui, Takeki;Yokohama, Akihiko;Koiso, Hiromi;Saito, Akio;Toyama, Kohtaro;Shimizu, Hiroaki;Ishizaki, Takuma;Irisawa, Hiroyuki;Takizawa, Makiko;Saitoh, Takayuki;Murayama, Kayoko;Matsumoto, Morio;Handa, Hiroshi;Hirato, Junko;Kojima, Masaru;Murakami, Hirokazu;Tsukamoto, Norifumi, 2019, BRITISH JOURNAL OF HAEMATOLOGY, 184, 4, 570, 577

  DOI
• Evaluation of the Revised International Staging System (R-ISS) in Japanese patients with multiple myeloma, Ozaki, Shuji;Handa, Hiroshi;Saitoh, Takayuki;Murakami, Hirokazu;Itagaki, Mitsuhiro;Asaoku, Hideki;Suzuki, Kenshi;Isoda, Atsushi;Matsumoto, Morio;Sawamura, Morio;Sunami, Kazutaka;Takezako, Naoki;Hagiwara, Shotaro;Kuroda, Yoshiaki;Chou, Takaaki;Nagura, Eiichi;Shimizu, Kazuyuki, 2019, ANNALS OF HEMATOLOGY, 98, 7, 1703, 1711

  DOI
• Patients assigned to VGPR, PR, and SD in the IMWG response category are composed of heterogeneous population when assessed by the heavy/light chain assay, Kamiya, Yoshikazu;Chou, Takaaki;Murakami, Hirokazu;Handa, Hiroshi;Ozaki, Shuji;Shimazaki, Chihiro;Fuchida, Shin-ichi;Okada, Jun;Itoh, Junji;Sugiyama, Satoru;Shimizu, Kazuyuki, 2019, HEMATOLOGICAL ONCOLOGY, 37, 3, 316, 318

  DOI
• Outcomes of patients with t(11;14) multiple myeloma: An International Myeloma Working Group (IMWG) multicenter study., Durie, Brian G.;Goldschmidt, Hartmut;Mateos, Maria-Victoria;Gonzalez, Veronica;Du, Juan;Kim, Kihyun;Merlini, Giampaolo;Mangiacavalli, Silvia;Min, Chang Ki;Dimopoulos, Meletios A.;Kastritis, Efstathios;Ludwig, Heinz;Esteves, Graca;Handa, Hiroshi;Escalante, Fernando;de Larrea Rodriguez, Carlos Fernandez;Delforge, Michel;Cameron, Chris;Rajkumar, S. Vincent;Kumar, Shaji, 2019, JOURNAL OF CLINICAL ONCOLOGY, 37, 15
• Initial extramedullary myeloma impacts overall survival via affecting post progression survival, Takei, Hisashi;Koiso, Hiromi;Matsumoto, Morio;Murayama, Kayoko;Shimizu, Hiroaki;Ishizaki, Takuma;Saitoh, Takayuki;Saito, Akio;Kobayashi, Nobuhiko;Iriuchishima, Hirono;Ishikawa, Tetsuya;Miyazawa, Yuri;Takizawa, Makiko;Yokohama, Akihiko;Tsukamoto, Norifumi;Murakami, Hirokazu;Handa, Hiroshi, 2019, CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 19, 10, E194, E195
• Human telomerase reverse transcriptase expression in a CD34-positive hematopoietic progenitor of myelodysplastic syndrome and acute myelogenous leukemia, Handa, Hiroshi;Nishimoto, Natsumi;Inoue, Madoka;Yokohama, Akihiko;Tsukamoto, Norifumi;Saitoh, Takayuki;Murakami, Hirokazu, 2019, HEMATOLOGICAL ONCOLOGY, 37, 4, 520, 522

  DOI
• Elotuzumab plus lenalidomide and dexamethasone for newly diagnosed multiple myeloma: a randomized, open-label, phase 2 study in Japan, Kubo, Kohmei;Hori, Mitsuo;Ohta, Kensuke;Handa, Hiroshi;Hatake, Kiyohiko;Matsumoto, Morio;Hagiwara, Shotaro;Ohashi, Kazuteru;Nakaseko, Chiaki;Suzuki, Kenshi;Ito, Shigeki;Kinoshita, Gen;Shelat, Suresh G.;Miyoshi, Masafumi;Takezako, Naoki, 2020, INTERNATIONAL JOURNAL OF HEMATOLOGY, 111, 1, 65, 74

  DOI
• Safety and pharmacokinetics of quizartinib in Japanese patients with relapsed or refractory acute myeloid leukemia in a phase 1 study, Usuki, Kensuke;Handa, Hiroshi;Choi, Ilseung;Yamauchi, Takahiro;Iida, Hiroatsu;Hata, Tomoko;Ohwada, Shoichi;Okudaira, Noriko;Nakamura, Kota;Sakajiri, Sakura, 2019, INTERNATIONAL JOURNAL OF HEMATOLOGY, 110, 6, 654, 664

  DOI
• RUNX1 mutation in a patient with myelodysplastic syndrome and decreased erythrocyte expression of blood group A antigen, Hayakawa, Akira;Sano, Rie;Takahashi, Yoichiro;Kubo, Rieko;Harada, Megumi;Omata, Masato;Yokohama, Akihiko;Handa, Hiroshi;Tsukada, Junichi;Takeshita, Haruo;Tsuneyama, Hatsue;Ogasawara, Kenichi;Kominato, Yoshihiko, 2020, TRANSFUSION, 60, 1, 184, 196

  DOI
• Phase 2 Study of Tirabrutinib (ONO/GS-4059), a Second-Generation Bruton's Tyrosine Kinase Inhibitor, Monotherapy in Patients with Treatment-Naive or Relapsed/Refractory Waldenstrom Macroglobulinemia, Munakata, Wataru;Sekiguchi, Naohiro;Shinya, Rai;Suzuki, Kenshi;Handa, Hiroshi;Shibayama, Hirohiko;Endo, Tomoyuki;Terui, Yasuhito;Iwaki, Noriko;Fukuhara, Noriko;Tatetsu, Hiro;Iida, Shinsuke;Ishikawa, Takayuki;Shiibashi, Ryota;Izutsu, Koji, 2019, BLOOD, 134

  DOI
• Prospective Comparison of Azacitidine Treatment between 7-Days and 5-Days Schedules for Patients with Higher-Risk Myelodysplastic Syndromes; Results of Japan Adult Leukemia Study Group MDS212 Trial, Kiguchi, Toru;Sato, Shinya;Usuki, Kensuke;Ishiyama, Ken;Ito, Yoshikazu;Suzuki, Takahiro;Taguchi, Jun;Chiba, Shigeru;Dobashi, Nobuaki;Tomita, Akihiro;Harada, Hironori;Handa, Hiroshi;Horiike, Shigeo;Maeda, Tomoya;Matsuda, Mitsuhiro;Ichikawa, Motoshi;Hata, Tomoko;Honda, Sumihisa;Iyama, Satoshi;Suzushima, Hitoshi;Moriuchi, Yukiyoshi;Kurokawa, Toshiro;Yamauchi, Takahiro;Kiyoi, Hitoshi;Naoe, Tomoki;Miyazaki, Yasushi, 2019, BLOOD, 134

  DOI
• Overshoot of FVIII activity in patients with acquired hemophilia A who achieve complete remission, Ogawa, Yoshiyuki;Yanagisawa, Kunio;Naito, Chiaki;Uchiumi, Hideki;Ishizaki, Takuma;Shimizu, Hiroaki;Gohda, Fumito;Ieko, Masahiro;Ichinose, Akitada;Handa, Hiroshi, 2020, INTERNATIONAL JOURNAL OF HEMATOLOGY, 111, 4, 544, 549

  DOI
• Integrin alpha 7 and Extracellular Matrix Laminin 211 Interaction Promotes Proliferation of Acute Myeloid Leukemia Cells and Is Associated with Granulocytic Sarcoma, Kobayashi, Nobuhiko;Oda, Tsukasa;Takizawa, Makiko;Ishizaki, Takuma;Tsukamoto, Norifumi;Yokohama, Akihiko;Takei, Hisashi;Saitoh, Takayuki;Shimizu, Hiroaki;Honma, Kazuki;Kimura-Masuda, Kei;Kuroda, Yuko;Ishihara, Rei;Murakami, Yuki;Murakami, Hirokazu;Handa, Hiroshi, 2020, CANCERS, 12, 2

  DOI
• SLAMF3-Mediated Signaling via ERK Pathway Activation Promotes Aggressive Phenotypic Behaviors in Multiple Myeloma, Ishibashi, Mariko;Takahashi, Risa;Tsubota, Asako;Sasaki, Makoto;Handa, Hiroshi;Imai, Yoichi;Tanaka, Norina;Tsukune, Yutaka;Tanosaki, Sakae;Ito, Shigeki;Asayama, Toshio;Sunakawa, Mika;Kaito, Yuta;Kuribayashi-Hamada, Yasuko;Onodera, Asaka;Moriya, Keiichi;Komatsu, Norio;Tanaka, Junji;Odajima, Takeshi;Sugimori, Hiroki;Inokuchi, Koiti;Tamura, Hideto, 2020, MOLECULAR CANCER RESEARCH, 18, 4, 632, 643

  DOI
• Continuous lenalidomide treatment after bortezomib-melphalan-prednisolone therapy for newly diagnosed multiple myeloma, Ishida, Tadao;Kimura, Hideo;Ozaki, Shuji;Kubo, Koumei;Sunami, Kazutaka;Takezako, Naoki;Fujita, Hiroyuki;Hayashi, Toshiaki;Kiguchi, Toru;Ohashi, Kazuteru;Yamamoto, Satoshi;Takamatsu, Hiroyuki;Kosugi, Hiroshi;Ohta, Kensuke;Sakai, Rika;Handa, Hiroshi;Kondo, Seiji;Abe, Yu;Omoto, Eijiro;Mitani, Kinuko;Morita, Satoshi;Murakami, Hirokazu;Shimizu, Kazuyuki, 2020, ANNALS OF HEMATOLOGY, 99, 5, 1063, 1072

  DOI
• IgG4-related Disease with a Cardiac Mass, Matsumura, Ikuko;Mitsui, Takeki;Tahara, Kenichi;Shimizu, Hiroaki;Yanagisawa, Kunio;Ishizaki, Takuma;Koiso, Hiromi;Takizawa, Makiko;Yokohama, Akihiko;Saitoh, Takayuki;Hirato, Junko;Murakami, Hirokazu;Handa, Hiroshi;Tsukamoto, Norifumi, 2020, INTERNAL MEDICINE, 59, 9, 1203, 1209

  DOI
• Real-world management of infection during chemotherapy for acute leukemia in Japan: from the results of a nationwide questionnaire-based survey by the Japan Adult Leukemia Study Group, Kimura, Shun-ichi;Fujita, Hanako;Handa, Hiroshi;Hiramoto, Nobuhiro;Hosono, Naoko;Minamiguchi, Hitoshi;Takahashi, Tsutomu;Kato, Hideaki;Ono, Takaaki;Kanda, Yoshinobu;Kiyoi, Hitoshi;Matsumura, Itaru;Miyazaki, Yasushi;Japan Adult Leukemia Study Grp, 2020, INTERNATIONAL JOURNAL OF HEMATOLOGY, 112, 3, 409, 417

  DOI
• Clinical utility of target capture-based panel sequencing in hematological malignancies: A multicenter feasibility study, Yasuda, Takahiko;Sanada, Masashi;Nishijima, Dai;Kanamori, Takashi;Iijima, Yuka;Hattori, Hiroyoshi;Saito, Akiko;Miyoshi, Hiroaki;Ishikawa, Yuichi;Asou, Norio;Usuki, Kensuke;Hirabayashi, Shinsuke;Kato, Motohiro;Ri, Masaki;Handa, Hiroshi;Ishida, Tadao;Shibayama, Hirohiko;Abe, Masahiro;Iriyama, Chisako;Karube, Kennosuke;Nishikori, Momoko;Ohshima, Koichi;Kataoka, Keisuke;Yoshida, Kenichi;Shiraishi, Yuichi;Goto, Hiroaki;Adachi, Souichi;Kobayashi, Ryoji;Kiyoi, Hitoshi;Miyazaki, Yasushi;Ogawa, Seishi;Kurahashi, Hiroki;Yokoyama, Hisayuki;Manabe, Atsushi;Iida, Shinsuke;Tomita, Akihiro;Horibe, Keizo, 2020, CANCER SCIENCE, 111, 9, 3367, 3378

  DOI
• A multicenter, open-label, phase II study of tirabrutinib (ONO/GS-4059) in patients with Waldenstrom's macroglobulinemia, Sekiguchi, Naohiro;Rai, Shinya;Munakata, Wataru;Suzuki, Kenshi;Handa, Hiroshi;Shibayama, Hirohiko;Endo, Tomoyuki;Terui, Yasuhito;Iwaki, Noriko;Fukuhara, Noriko;Tatetsu, Hiro;Iida, Shinsuke;Ishikawa, Takayuki;Shiibashi, Ryota;Izutsu, Koji, 2020, CANCER SCIENCE, 111, 9, 3327, 3337

  DOI
• Serum Soluble SLAMF7 is Correlated With Disease Progression in Multiple Myeloma and May Affect Anti-SLAMF7 Antibody Therapy, Kaito, Yuta;Tamura, Hideto;Soeda, Saori;Asayama, Toshio;Ishibashi, Mariko;Sasaki, Makoto;Handa, Hiroshi;Imai, Yoichi;Tanaka, Junji;Tanosaki, Sakae;Ito, Shigeki;Inokuchi, Koiti, 2017, CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 17, 1, E39, E40
• Clinical Impact and Possible Immunosuppressive Function of Soluble B7-H1 (PD-L1) in Multiple Myeloma, Sunakawa, Mika;Tamura, Hideto;Ishibashi, Mariko;Sasaki, Makoto;Handa, Hiroshi;Imai, Yoichi;Tanaka, Junji;Tanosaki, Sakae;Ito, Shigeki;Inokuchi, Koiti, 2017, CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 17, 1, E110, E111
• Successful Management of Acquired Factor V Inhibitor by Monitoring Factor V Activity, Antigen, and Inhibitor Values during Immunosuppressive Therapy, Mihara, Masahiro;Ogawa, Yoshiyuki;Nagasaka, Motoo;Kobayashi, Nobuhiko;Shimizu, Hiroaki;Shinozawa, Keiko;Fukutake, Katsuyuki;Inoue, Madoka;Murakami, Masami;Handa, Hiroshi, 2020, ACTA HAEMATOLOGICA, 143, 5, 486, 490

  DOI
• Treatment outcome of myelodysplastic syndrome patients younger than 60 years old, MATSUSHIMA Takafumi;HANDA Hiroshi;YOKOHAMA Akihiko;SAKURA Tohru;OKAMOTO Kiyoshi;KAWAMURA Toshihide;TSUMITA Yuki;MURAYAMA Kayoko;ISODA Atsushi;JINBO Takahiro;HIRABAYASHI Hisami;SAWAMURA Morio;KARASAWA Masamitsu;SHIMANO Shun-ichi;TSUKAMOTO Norifumi;MIYAWAKI Shuichi;NOJIMA Yoshihisa;MURAKAMI Hirokazu, Oct. 2003, 44, 10, 1004, 1009
• Pancytopenia associated with hyperthyroidism, OGAWA Yoshiyuki;MAEKAWA Izuru;MATSUSHIMA Takafumi;TAKIZAWA Makiko;UCHIUMI Hideki;KAWAMURA Toshihide;UEKI Kazue;HANDA Hiroshi;TSUKAMOTO Norifumi;NOJIMA Yoshihisa, Apr. 2004, Nihon Naika Gakkai Zasshi, 93, 4, 777, 779
• Thalidomide treatment of patients with refractory myeloma in the institutes participating in the Japan Myeloma Study Group, MURAKAMI Hirokazu;HANDA Hiroshi;IMAI Kohzoh;KANAKURA Yuzuru;KOSAKA Masaaki;SAWAMURA Morio;SHIMAZAKI Chihiro;SUZUKI Kenshi;ISHII Akihiro;TAKAGI Toshiyuki;TANIWAKI Masashi;TOGAWA Atsushi;HATA Hiroyuki;WAKAYAMA Toshio;TAKATSUKI Kiyoshi, Jun. 2004, 45, 6, 468, 472
• Urinary 8-Hydroxy-2'-Deoxyguanosin (8-OHdG) in Patients with Chronic Liver Diseases, ISHIZAKA Miki;YOSHIDA Kensuke;NISHIMOTO Natsumi;HAMDI SALEH AL-MA'QUOL WEDAD;ISHII Chiaki;HANDA Hiroshi;OGAWARA Hatsue;NAGAMINE Takeaki;MURAKAMI Masami;MURAKAMI Hirokazu, Sep. 2004, 52, 9, 732, 736
• Unclassified mature T cell leukemia with cerebriform nuclei, TAKIZAWA Makiko;MATSUSHIMA Takafumi;YOKOHAMA Akihiko;HANDA Hiroshi;TSUKAMOTO Norifumi;KARASAWA Masamitsu;MURAKAMI Hirokazu;NOJIMA Yoshihisa, Jul. 2005, Rinsho Ketsueki, 46, 7, 486, 491
• Plasmacytoma with multiple hypervascular lesions revealed by angiography in a patient with multiple myeloma, HANDA Hiroshi;IRISAWA Hiroyuki;KOMATSUMOTO Satoru;MATSUSHIMA Takafumi;TSUKAMOTO Norifumi;NOJIMA Yoshihisa;MURAKAMI Hirokazu, Jun. 2006, 47, 6, 521, 525
• Reversible posterior leukoencephalopathy syndrome probably caused by L-asparaginase, MIYAZAWA Yuri;IRISAWA Hiroyuki;MATSUSHIMA Takafumi;MITSUI Takeki;UCHIUMI Hideki;SAITOH Takayuki;HANDA Hiroshi;KARASAWA Masamitsu;MURAKAMI Hirokazu;TSUKAMOTO Norifumi;NOJIMA Yoshihisa, Jun. 2006, Rinsho Ketsueki, 47, 6, 531, 535
• Deep vein thrombosis and pulmonary embolism in a patient with multiple myeloma treated with thalidomide and dexamethasone, MIYAZAWA Yuri;IRISAWA Hiroyuki;UCHIUMI Hideki;SAITOH Takayuki;HANDA Hiroshi;MATSUSHIMA Takafumi;TSUKAMOTO Norifumi;KARASAWA Masamitsu;MURAKAMI Hirokazu;NOJIMA Yoshihisa, Jul. 2006, 47, 7, 656, 660
• Sacroiliitis as an Initial Manifestation of Acute Myelogenous Leukemia, HOSHINO Takumi;MATSUSHIMA Takafumi;SAITOH Yasuyuki;YAMANE Arito;TAKIZAWA Makiko;IRISAWA Hiroyuki;SAITOH Takayuki;HANDA Hiroshi;TSUKAMOTO Norifumi;KARASAWA Masamitsu;MURAKAMI Hirokazu;NOJIMA Yoshihisa, Dec. 2006, 84, 5, 421, 424
• X-Linked Agammaglobulinemia Diagnosed in Adulthood : A Case Report, MITSUI Takeki;TSUKAMOTO Norifumi;KANEGANE Hirokazu;AGEMATSU Kazunaga;SEKIGAMI Tomomi;IRISAWA Hiroyuki;SAITOH Takayuki;UCHIUMI Hideki;HANDA Hiroshi;MATSUSHIMA Takafumi;KARASAWA Masamitsu;MURAKAMI Hirokazu;MIYAWAKI Toshio;NOJIMA Yoshihisa, Aug. 2006, Int. J. Hematol., 84, 2, 154, 157
• Polyclonal B-cell lymphocytosis with hairy cell appearance : hairy B-cell lymphoproliferative disorder, NAKAHASHI Hirotaka;HASHIMOTO Yoko;YAMANE Arito;IRISAWA Hiroyuki;YOKOHAMA Akihiko;SAITOH Takayuki;HANADA Hiroshi;MATSUSHIMA Takafumi;TSUKAMOTO Norifumi;KARASAWA Masamitsu;MURAKAMAI Hirokazu;NOJIMA Yoshihisa, Aug. 2007, 48, 8, 647, 651
• Prevalence and Clinical Characteristics of Acute Myeloid Leukemia Associated with Disseminated Intravascular Coagulation, UCHIUMI Hideki;MATSUSHIMA Takafumi;YAMANE Arito;DOKI Noriko;IRISAWA Hiroyuki;SAITOH Takayuki;SAKURA Tohru;JIMBO Takahiro;HANDA Hiroshi;TSUKAMOTO Norifumi;KARASAWA Masamitsu;MIYAWAKI Shuichi;MURAKAMI Hirokazu;NOJIMA Yoshihisa, Aug. 2007, 86, 2, 137, 142
• Successful treatment of azole-refractory Candida guilliermondii fungemia with a combination therapy with micafungin and liposomal amphotericin B, SAITOH Takayuki;MATSUSHIMA Takafumi;SHIMIZU Hiroyuki;OSAKI Yohei;YAMANE Arito;IRISAWA Hiroyuki;YOKOHAMA Akihiko;UCHIUMI Hideki;HANDA Hiroshi;TSUKAMOTO Norifumi;KARASAWA Masamitsu;NOJIMA Yoshihisa;MURAKAMI Hirokazu, Feb. 2008, Rinsho Ketsueki, 49, 2, 94, 98
• Development of an extramedullary plasmacytoma despite disappearing M protein in multiple myeloma by bortezomib treatment, KOISO Hiromi;TAHARA Kenichi;OSAKI Yohei;MAWATARI Momoko;SEKIGAMI Tomomi;YOKOHAMA Akihiko;SAITOH Takayuki;UCHIUMI Hideki;HANDA Hiroshi;TSUKAMOTO Norifumi;KARASAWA Masamitsu;NOJIMA Yoshihisa;MURAKAMI Hirokazu, Feb. 2009, Rinsho Ketsueki, 50, 2, 78, 82
• Characterization of immunoglobulin heavy and light chain gene expression in chronic lymphocytic leukemia and related disorders, NAKAHASHI Hirotaka;TSUKAMOTO Norifumi;HASHIMOTO Yoko;KOISO Hiromi;YOKOHAMA Akihiko;SAITOH Takayuki;UCHIUMI Hideki;HANDA Hiroshi;MURAKAMI Hirokazu;NOJIMA Yoshihisa;KARASAWA Masamitsu, Apr. 2009, Cancer Sci, 100, 4, 671, 677
• Low burden of a JAK2-V617F mutated clone in monoclonal haematopoiesis in a Japanese woman with Budd-Chiari syndrome, TOYAMA Kohtaro;KARASAWA Masamitsu;YAMANE Arito;KOISO Hiromi;YOKOHAMA Akihiko;UCHIUMI Hideki;SAITOH Takayuki;HANDA Hiroshi;SATO Ken;TAKAGI Hitoshi;MIYAWAKI Shuichi;MURAKAMI Hirokazu;NOJIMA Yoshihisa;TSUKAMOTO Norifumi, May 2009, 89, 4, 517, 522
• Randomized trial of response-oriented individualized versus fixed-schedule induction chemotherapy with idarubicin and cytarabine in adult acute myeloid leukemia : the JALSG AML95 study, OHTAKE Shigeki;MIYAWAKI Shuichi;KIYOI Hitoshi;MIYAZAKI Yasushi;OKUMURA Hirokazu;MATSUDA Shin;NAGAI Tadashi;KISHIMOTO Yuji;OKADA Masaya;TAKAHASHI Masatomo;HANDA Hiroshi;TAKEUCHI Jin;KAGEYAMA Shinichi;ASOU Norio;YAGASAKI Fumiharu;MAEDA Yasuhiro;OHNISHI Kazunori;NAOE Tomoki;OHNO Ryuzo, Mar. 2010, Int J Hematol, 91, 2, 276, 283
• Successful treatment with reduced-intensity stem cell transplantation for secondary myelofibrosis following polycythemia vera, TAHARA Kenichi;YOKOHAMA Akihiko;HANDA Hiroshi;SAITOH Takayuki;UCHIUMI Hideki;SEKIGAMI Tomomi;TOYAMA Kohtaro;MAWATARI Momoko;OSAKI Yohei;MATSUSHIMA Takafumi;KARASAWA Masamitsu;MURAKAMI Hirokazu;TSUKAMOTO Norifumi;NOJIMA Yoshihisa, Nov. 2009, The Japanese journal of clinical hematology, 50, 11, 1630, 1634
• IgM-λ multiple myeloma presenting with systemic amyloidosis, HIGETA Daisuke;YOKOHAMA Akihiko;OSAKI Youhei;TAHARA Kenichi;MAWATARI Momoko;SEKIGAMI Tomomi;KOISO Hiromi;SAITO Takayuki;UCHIUMI Hideki;HANDA Hiroshi;KARASAWA Masamitsu;MURAKAMI Hirokazu;HIRATO Jyunko;TSUKAMOTO Norifumi;NOJIMA Yoshihisa, Dec. 2009, The Japanese journal of clinical hematology, 50, 12, 1711, 1714
• Azathioprine-induced pure red cell aplasia in a systemic sclerosis patient with interstitial pneumonia, SUTO Mariko;NAGAI Yayoi;HASEGAWA Michiko;HANDA Hiroshi;ISHIKAWA Osamu, Mar. 2011, 38, 3, 285, 287
• Evaluation of Mental Stress Tests among Medical Students Based on Salivary Sample Collected Just before the National License Examination, USHIKI Kazumi;SATO Yuka;ARAI Katsuya;IDE Norihumi;MATSUI Naoki;HANDA Hiroshi;MURAKAMI Hirokazu;OGAWARA Hatsue, Feb. 2011, 59, 2, 138, 143
• Analysis of bacteremia/fungemia and pneumonia accompanying acute myelogenous leukemia from 1987 to 2001 in the Japan Adult Leukemia Study Group, YOSHIDA Minoru;AKIYAMA Nobu;FUJITA Hiroyuki;MIURA Katsuhiro;MIYATAKE Jun-ichi;HANDA Hiroshi;KITO Katsuyuki;TAKAHASHI Masatomo;SHIGENO Kazuyuki;KANDA Yoshinobu;HATSUMI Naoko;OHTAKE Shigeki;SAKAMAKI Hisashi;OHNISHI Kazunori;MIYAWAKI Shuichi;OHNO Ryuzo;NAOE Tomoki, Jan. 2011, Int J Hematol, 93, 1, 66, 73
• Glossitis by mixed infection of cytomegalovirus and herpes simplex virus during therapy for pure red cell aplasia complicated with Good syndrome, KOYA Hiroko;YOKOHAMA Akihiko;MIURA Ayaka;HOSHINO Takumi;MITSUI Takeki;KOISO Hiromi;SAITOH Takayuki;UCHIUMI Hideki;HANDA Hiroshi;HIRATO Jyunko;HIROMURA Keijyu;KARASAWA Masamitsu;MURAKAMI Hirokazu;TSUKAMOTO Norifumi;NOJIMA Yoshihisa, Aug. 2011, Rinsho Ketsueki, 52, 8, 708, 712
• TCL1A gene involvement in T-cell prolymphocytic leukemia in Japanese patients, YOKOHAMA Akihiko;SAITOH Akio;NAKAHASHI Hirotaka;MITSUI Takeki;KOISO Hiromi;KIM Yoshitora;UCHIUMI Hideki;SAITOH Takayuki;HANDA Hiroshi;JIMBO Takahiro;MURAYAMA Kayoko;SAKURA Tohru;MURAKAMI Hirokazu;KARASAWA Masamitsu;NOJIMA Yoshihisa;TSUKAMOTO Norifumi, Jan. 2012, 95, 1, 77, 85
• Long-term follow-up of EBV-positive lymphoproliferative disorders in a patient with systemic lupus erythematosus, TSUKAMOTO Norifumi;HANDA Hiroshi;YOKOHAMA Akihiko;MITSUI Takeki;SAITOH Takayuki;KOISO Hiromi;UCHIUNI Hideki;HOSHINO Takumi;KARASAWA Masamitsu;MURAKAMI Hirokazu;KOJIMA Masaru;NOJIMA Yoshihisa, Dec. 2011, 44, 4, 237, 241
• Retrospective survey on the clinical features of non-Hodgkin lymphomas in Gunma Prefecture, Japan, HASHIMOTO Yoko;YOKOHAMA Akihiko;SAITOH Akio;NAKAHASHI Hirotaka;TOYAMA Kohtaro;MITSUI Takeki;KOISO Hiromi;SAITOH Takayuki;HANDA Hiroshi;UCHIUMI Hideki;JINBO Takahiro;MURAYAMA Kayoko;TAMAKI Yoshio;MATSUMOTO Morio;SAWAMURA Morio;KARASAWA Masamitsu;MURAKAMI Hirokazu;HIRATO Junko;NOJIMA Yoshihisa;KOJIMA Masaru;TSUKAMOTO Norifumi, Mar. 2012, 53, 3, 329, 336
• Age-Related Epstein-Barr Virus-Positive Lymphoproliferative Disorders of the Orbit and Maxillary Sinus : A Case Report, MITSUI Takeki;MAWATARI Momoko;KOISO Hiromi;YOKOHAMA Akihiko;UCHIUMI Hideki;SAITOH Takayuki;HANDA Hiroshi;HIRATO Junko;KARASAWA Masamitsu;MURAKAMI Hirokazu;NOJIMA Yoshihisa;KOJIMA Masaru;NAKAMURA Shigeo;TSUKAMOTO Norifumi, Dec. 2012, Journal of Clinical and Experimental Hematopathology, 52, 3, 205, 209
• Emergence of donor-derived anti-HLA antibody and subsequent transfusion-refractory thrombocytopenia after allogeneic hematopoietic stem cell transplantation from an HLA-matched sibling donor in a patient with acute myeloid leukemia, UCHIYAMA Yuri;HOSHINO Takumi;MIHARA Masahiro;MITSUI Takeki;KOISO Hiromi;TAKIZAWA Makiko;YOKOHAMA Akihiko;SAITOH Takayuki;UCHIUMI Hideki;HANDA Hiroshi;TSUKAMOTO Norifumi;MURAKAMI Hirokazu;NOJIMA Yoshihisa, Feb. 2013, Rinsho Ketsueki, 54, 2, 214, 218
• Development of IgG4-related fisease 10 years after chemotherapy for diffuse large B cell lymphoma and longstanding bronchial asthma, MITSUI Takeki;YOKOHAMA Akihiko;KOISO Hiromi;ISHIZAKI Takuma;UCHIUMI Hideki;SAITOH Takayuki;HANDA Hiroshi;HIRATO Junko;KARASAWA Hirokazu;MURAKAMI Hirokazu;KOJIMA MASARU;NOJIMA Yoshihisa;TSUKAMOTO Norifumi, Jul. 2013, 98, 1, 122, 128
• Non-myeloablative Stem Cell Transplantation, Saito Yasuyuki;Tsukamoto Norifumi;Murakami Hirokazu;Nojima Yoshihisa;Matsushima Takafumi;Yokohama Akihiko;Saito Tatsuhiro;Doki Noriko;Kawamura Toshihide;Handa Hiroshi;Maekawa Izuru;Karasawa Masamitsu, 2003, The Kitakanto Medical Journal, 53, 4, 369, 375
• 7.当院で骨髄非破壊的前処置を用いた造血幹細胞移植(NST)を行った5症例(一般演題III)(第21回群馬移植研究会学術講演会), 斉藤 泰之;松島 孝文;河村 俊英;横濱 章彦;塚本 憲史;野島 美久;前川 出;唐沢 正光;半田 寛;村上 博和, Aug. 2003, The KITAKANTO medical journal, 53, 3, 332, 333
• 7. 転移性腎細胞癌に対しミニ移植を施行した一例（第24回群馬移植研究会学術講演会）, 齊藤 泰之;星野 匠臣;山根 有人;滝沢 牧子;入沢 寛之;斉藤 貴之;松島 孝文;塚本 憲史;野島 美久;唐沢 正光;半田 寛;村上 博和, May 2005, The Kitakanto medical journal, 55, 2, 188, 189
• Acute Myeloid Leukemia Presenting as Subcutaneous and Epidural Granulocytic Sarcoma Inside and Outside of the Frontal Bone, Iriuchishima Hirono;Nojima Yoshihisa;Handa Hiroshi;Takizawa Makiko;Yokohama Akihiko;Uchiumi Hideki;Matsushima Takafumi;Tsukamoto Norifumi;Karasawa Masamitsu;Murakami Hirokazu, 2007, The Kitakanto Medical Journal, 57, 2, 183, 185
• Sub-acute Toxicosis Caused by a Multiple Doses Tegafur/Uracil (UFT) for Suicide: A Case Report, Hagiwara Shuichi;Kurabayashi Kazutaka;Handa Hiroshi;Iino Yuichi;Ogino Takashi;Takahashi Yuga;Isaka Akira;Nameki Taro;Kagoshima Kaie;Yamada Takuro;Ishihara Kouichi;Hiraishi Hikaru, 2007, The Kitakanto Medical Journal, 57, 4, 317, 320
• Successful Treatment by All-Trans Retinoic Acid in a Patient with Acute Promyelocytic Leukemia Complicated by Liver Cirrhosis and Polycystic Kidney, Yamane Arito;Tsukamoto Norifumi;Saitoh Takayuki;Uchiumi Hideki;Handa Hiroshi;Karasawa Masamitsu;Nojima Yoshihisa;Murakami Hirokazu, 2009, Internal Medicine, 48, 18, 1691, 1694
• Primary Bilateral Adrenal Diffuse Large B-cell Lymphoma Demonstrating Adrenal Failure, Horiguchi Kazuhiko;Sasaki Atsushi;Okada Shuichi;Yamada Masanobu;Tsukamoto Norifumi;Nojima Yoshihisa;Nakazato Yoichi;Mori Masatomo;Hashimoto Koshi;Hashizume Masayuki;Masuo Takashige;Suto Mariko;Okajo Jun;Handa Hiroshi;Kaneko Yoriaki;Yokoo Hideaki, 2010, Internal Medicine, 49, 20, 2241, 2246
• Sunitinib Induced Immune Thrombocytopenia, Matsumoto Kumiko;Handa Hiroshi;Karasawa Masamitsu;Murakami Hirokazu;Matsui Hiroshi;Suzuki Kazuhiro;Tsukamoto Norifumi;Nojima Yoshihisa;Yokohama Akihiko;Yuzuriha Akinori;Toyama Kohtarou;Mitsui Takeki;Hashimoto Yoko;Koiso Hiromi;Saitoh Takayuki;Uchiumi Hideki, 2011, The Kitakanto Medical Journal, 61, 2, 175, 177
• Effect of Exercise on Urinary Levels of 8-Hydroxy-2'-deoxyguanosine (8-OHdG)., Ogawara Hatsue;Murakami Hirokazu;Sakurai Hitomi;Tomiyosi Satoko;Toda Takuma;Yamazaki Tohru;Handa Hiroshi;Morita Kimio;Arakawa Chiaki;Fukuda Harue, 2002, The Kitakanto Medical Journal, 52, 5, 351, 356
• Development of Bilateral Malleolus Skin Ulcers During Hydroxyurea Treatment in an Elderly Patient with Chronic Myelogenous Ieukemia., Handa Hiroshi;Akiba Toru;Yoshida Yasushi;Kurabayashi Hitoshi;Kubota Kazuo;Tamura Jun'ichi, 1998, The Kitakanto Medical Journal, 48, 2, 167, 169
• Differences in the JAK2 and MPL Mutation Status in the Cell Lineages of the bcr/abl-negative Chronic Myeloproliferative Neoplasm Subtypes, Toyama Kohtaro;Tsukamoto Norifumi;Karasawa Masamitsu;Yokohama Akihiko;Mitsui Takeki;Uchiumi Hideki;Saitoh Takayuki;Handa Hiroshi;Murakami Hirokazu;Nojima Yoshihisa, 2011, Internal Medicine, 50, 21, 2557, 2561
• Acyclovir encephalopathy developed after autologous peripheral blood stem cell transplantation in a patient with multiple myeloma, Mihara Masahiro;Handa Hiroshi;Tsukamoto Norifumi;Murakamii Hirokazu;Nojima Yoshihisa;Hoshino Takumi;Uchiyama Yuri;Saitoh Akio;Mitsui Takeki;Koiso Hiromi;Yokohama Akihiko;Saitoh Takayuki;Uchiumi Hideki, 2012, Journal of Hematopoietic Cell Transplantation, 1, 3, 93, 97
• Recurrent Gemella haemolysans Meningitis in a Patient with Osteomyelitis of the Clivus, Hayashi Toshimasa;Uchiumi Hideki;Yanagisawa Kunio;Ogawa Yoshiyuki;Handa Hiroshi;Tsukamoto Norifumi;Nojima Yoshihisa, 2013, Internal Medicine, 52, 18, 2145, 2147
• Prognostic Importance of the Soluble Form of IL-2 Receptorα (sIL-2Rα) and its Relationship with Surface Expression of IL-2Rα (CD25) of Lymphoma Cells in Diffuse Large B-cell Lymphoma Treated with CHOP-like Regimen with or without Rituximab : A Retrospective Analysis of 338 Cases, Hashimoto Yoko;Uchiumi Hideki;Jinbo Takahiro;Murayama Kayoko;Matsumoto Morio;Sawamura Morio;Karasawa Masamitsu;Murakami Hirokazu;Hirato Junko;Nojima Yoshihisa;Kojima Masaru;Yokohama Akihiko;Tsukamoto Norifumi;Saitoh Akio;Nakahashi Hirotaka;Toyama Kohtaro;Mitsui Takeki;Koiso Hiromi;Saitoh Takayuki;Handa Hiroshi, 2013, Journal of Clinical and Experimental Hematopathology, 53, 3, 197, 205
• A Newly Diagnosed CML-CP HBV Carrier was Safely Treated with Dasatinib and Entecavir, Takei Hisashi;Tsukamoto Norifumi;Murakami Kazuhiro;Handa Hiroshi;Nojima Yoshihisa;Mitsui Takeki;Sato Naru;Saito Akio;Hoshino Takumi;Koiso Hiromi;Takizawa Makiko;Yokohama Akihiko;Saito Takayuki, 2014, The Kitakanto Medical Journal, 64, 1, 51, 55
• Treatment outcome of myelodysplastic syndrome patients younger than 60 years old, MATSUSHIMA Takafumi;JINBO Takahiro;HIRABYASHI Hisami;SAWAMURA Morio;KARASAWA Masamitsu;SHIMANO Shun-ichi;TSUKAMOTO Norifumi;MIYAWAKI Shuichi;NOJIMA Yoshihisa;MURAKAMI Hirokazu;HANDA Hiroshi;YOKOHAMA Akihiko;SAKURA Tohru;OKAMOTO Kiyoshi;KAWAMURA Toshihide;TSUMITA Yuki;MURAYAMA Kayoko;ISODA Atsushi, 2003, Rinsho Ketsueki, 44, 10, 1004, 1009
• Thalidomide treatment of patients with refractory myeloma in the institutes participating in the Japan Myeloma Study Group, MURAKAMI Hirokazu;TAKAGI Toshiyuki;TANIWAKI Masashi;TOGAWA Atsushi;HATA Hiroyuki;WAKAYAMA Toshio;TAKATSUKI Kiyoshi;HANDA Hiroshi;IMAI Kohzoh;KANAKURA Yuzuru;KOSAKA Masaaki;SAWAMURA Morio;SHIMAZAKI Chihiro;SUZUKI Kenshi;ISHII Akihiro, 2004, Rinsho Ketsueki, 45, 6, 468, 472
• Reversible posterior leukoencephalopathy syndrome probably caused by L-asparaginase, MIYAZAWA Yuri;TSUKAMOTO Norifumi;NOJIMA Yoshihisa;IRISAWA Hiroyuki;MATSUSHIMA Takafumi;MITSUI Takeki;UCHIUMI Hideki;SAITOH Takayuki;HANDA Hiroshi;KARASAWA Masamitsu;MURAKAMI Hirokazu, 2006, Rinsho Ketsueki, 47, 6, 531, 535
• Plasmacytoma with multiple hypervascular lesions revealed by angiography in a patient with multiple myeloma, HANDA Hiroshi;IRISAWA Hiroyuki;KOMATSUMOTO Satoru;MATSUSHIMA Takafumi;TSUKAMOTO Norifumi;NOJIMA Yoshihisa;MURAKAMI Hirokazu, 2006, Rinsho Ketsueki, 47, 6, 521, 525
• Deep vein thrombosis and pulmonary embolism in a patient with multiple myeloma treated with thalidomide and dexamethasone, MIYAZAWA Yuri;NOJIMA Yoshihisa;IRISAWA Hiroyuki;UCHIUMI Hideki;SAITOH Takayuki;HANDA Hiroshi;MATSUSHIMA Takafumi;TSUKAMOTO Norifumi;KARASAWA Masamitsu;MURAKAMI Hirokazu, 2006, Rinsho Ketsueki, 47, 7, 656, 660
• Acquired hemophilia A developed at relapse of minimal change nephrotic syndrome, SHIMIZU Hiroaki;MATSUSHIMA Takafumi;TSUKAMOTO Norifumi;KARASAWA Masamitsu;MURAKAMI Hirokazu;NOJIMA Yoshihisa;SAITOH Takayuki;OSAKI Yohei;YAMANE Arito;GOHDA Fumito;IRISAWA Hiroyuki;YOKOHAMA Akihiko;UCHIUMI Hideki;HANDA Hiroshi, 2007, Rinsho Ketsueki, 48, 6, 514, 517
• Polyclonal B-cell lymphocytosis with hairy cell appearance: hairy B-cell lymphoproliferative disorder, NAKAHASHI Hirotaka;KARASAWA Masamitsu;MURAKAMAI Hirokazu;NOJIMA Yoshihisa;HASHIMOTO Yoko;YAMANE Arito;IRISAWA Hiroyuki;YOKOHAMA Akihiko;SAITOH Takayuki;HANADA Hiroshi;MATSUSHIMA Takafumi;TSUKAMOTO Norifumi, 2007, Rinsho Ketsueki, 48, 8, 647, 651
• Successful treatment with reduced-intensity stem cell transplantation for secondary myelofibrosis following polycythemia vera, TAHARA Kenichi;MATSUSHIMA Takafumi;KARASAWA Masamitsu;MURAKAMI Hirokazu;TSUKAMOTO Norifumi;NOJIMA Yoshihisa;YOKOHAMA Akihiko;HANDA Hiroshi;SAITOH Takayuki;UCHIUMI Hideki;SEKIGAMI Tomomi;TOYAMA Kohtaro;MAWATARI Momoko;OSAKI Yohei, 2009, Rinsho Ketsueki, 50, 11, 1630, 1634
• IgM-λ multiple myeloma presenting with systemic amyloidosis, HIGETA Daisuke;HANDA Hiroshi;KARASAWA Masamitsu;MURAKAMI Hirokazu;HIRATO Jyunko;TSUKAMOTO Norifumi;NOJIMA Yoshihisa;YOKOHAMA Akihiko;OSAKI Youhei;TAHARA Kenichi;MAWATARI Momoko;SEKIGAMI Tomomi;KOISO Hiromi;SAITO Takayuki;UCHIUMI Hideki, 2009, Rinsho Ketsueki, 50, 12, 1711, 1714
• Retrospective survey on the clinical features of non-Hodgkin lymphomas in Gunma Prefecture, Japan, HASHIMOTO Yoko;UCHIUMI Hideki;JINBO Takahiro;MURAYAMA Kayoko;TAMAKI Yoshio;MATSUMOTO Morio;SAWAMURA Morio;KARASAWA Masamitsu;MURAKAMI Hirokazu;HIRATO Junko;NOJIMA Yoshihisa;YOKOHAMA Akihiko;KOJIMA Masaru;TSUKAMOTO Norifumi;SAITOH Akio;NAKAHASHI Hirotaka;TOYAMA Kohtaro;MITSUI Takeki;KOISO Hiromi;SAITOH Takayuki;HANDA Hiroshi, 2012, Rinsho Ketsueki, 53, 3, 329, 336
• Clinical experience of bendamustine for adult Langerhans cell sarcoma, MIYAZAWA Yuri;TAHARA Kenichi;YUZURIHA Akinori;MIHARA Masahiro;TOYAMA Kohtaro;YOKOHAMA Akihiko;HANDA Hiroshi;JINBO Takahiro, 2014, Rinsho Ketsueki, 55, 5, 563, 569
• Successful treatment with dasatinib for polycythemia vera patient emerging BCR-ABL positive clone during 13 years of treatment, TAKIZAWA Makiko;TSUKAMOTO Norifumi;MURAKAMI Hirokazu;NOJIMA Yoshihisa;YOKOHAMA Akihiko;SEKIGAMI Tomomi;KOISO Hiromi;ISHIZAKI Takuma;MITSUI Takeki;OGAWA Yoshiyuki;SAITOH Takayuki;HANDA Hiroshi, 2014, Rinsho Ketsueki, 55, 6, 687, 691
• Polycythemia Vera Terminating in Refractory Ascites, Toyama Kohtaro;Tsukamoto Norifumi;Mitsui Takeki;Yokohama Akihiko;Saitoh Takayuki;Uchiumi Hideki;Handa Hiroshi;Sakuraya Masataka;Murakami Hirokazu;Nojima Yoshihisa, 2012, The Kitakanto Medical Journal, 62, 2, 159, 162
• Der(2)t(2 ; 11)(p21 ; q23), a Variant form of t(2 ; 11), in Biphenotypic Acute Leukemia with T Lymphoid Lineage and Myeloid Lineage Differentiation, Miyazawa Yuri;Tsukamoto Norifumi;Nojima Yoshihisa;Irisawa Hiroyuki;Matsushima Takafumi;Mitsui Takeki;Uchiumi Hideki;Saitoh Takayuki;Handa Hiroshi;Karasawa Masamitsu;Murakami Hirokazu, 2012, The Kitakanto Medical Journal, 62, 3, 287, 290
• Multiple myeloma, HANDA Hiroshi, 2014, Rinsho Ketsueki, 55, 2, 201, 212
• Relapsed primary intraocular lymphoma treated with intravitreal methotrexate and high-dose chemotherapy followed by autologous stem cell rescue, KAMIO Tadashi;HANDA Hiroshi;MURAKAMI Hirokazu;TSUKAMOTO Norifumi;NOJIMA Yoshihisa;YOKOHAMA Akihiko;HAYASHI Toshimasa;TOYAMA Kotaro;KOYA Hiroko;HOSHINO Takumi;SAITOH Takayuki;HANYUDA Naoto;MUKAI Ryou, 2014, Rinsho Ketsueki, 55, 2, 244, 248
• Aberrant micro RNA and epigenetic network are associated with progression from MGUS to multiple myeloma, HANDA Hiroshi, 2015, Rinsho Ketsueki, 56, 8, 981, 988
• Successful Treatment with Recombinant Thrombomodulin for a Case of Adult Onset Kasabach-Merritt Syndrome Caused by Left Thigh Hemangioma, Ogawa Yoshiyuki;Handa Hiroshi;Tsukamoto Norifumi;Murakami Hirokazu;Nojima Yoshihisa;Yanagisawa Kunio;Uchiumi Hideki;Ishizaki Takuma;Mitsui Takeki;Takizawa Makiko;Koiso Hiromi;Yokohama Akihiko;Saitoh Takayuki, 2015, The Kitakanto Medical Journal, 65, 3, 187, 191
• Two Cases of Intravascular Lymphoma Diagnosed by Gastrointestinal Endoscopic Biopsy, Shimoyama Yasuyuki;Hirato Junko;Yamada Masanobu;Sugimoto Kensuke;Kotake Mie;Uehara Daisuke;Kamide Yosuke;Kuribayashi Shiko;Kawamura Osamu;Kusano Motoyasu;Handa Hiroshi, 2015, Internal Medicine, 54, 24, 3145, 3149
• Primary leptomeningeal B-cell lymphoma with normal pressure hydrocephalus at diagnosis, ISHIZAKI Takuma;TSUKAMOTO Norifumi;MURAKAMI Hirokazu;NOJIMA Yoshihisa;MITSUI Takeki;UCHIYAMA Yuri;OGAWA Yoshiyuki;KOISO Hiromi;TAKIZAWA Makiko;YOKOHAMA Akihiko;SAITOH Takayuki;HANDA Hiroshi, 2015, Rinsho Ketsueki, 56, 12, 2441, 2446
• Diffuse large B-cell lymphoma of the testis relapsed 16 years after achieving complete response, NAGASAKA Isao;TSUKAMOTO Norifumi;NOJIMA Yoshihisa;MURAKAMI Hirokazu;HANDA Hiroshi;MITSUI Takeki;ISHIZAKI Takuma;KOISO Hiromi;YOKOHAMA Akihiko;SAITOH Takayuki;HIRATO Junko;IGARASHI Tadahiko;KOJIMA Masaru, 2015, Rinsho Ketsueki, 56, 12, 2447, 2451
• Monomorphic post-transplant T-lymphoproliferative disorder after autologous stem cell transplantation for multiple myeloma, ISHIKAWA Tetsuya;NOJIMA Yoshihisa;MURAKAMI Hirokazu;SHIMIZU Hiroaki;TAKEI Toshifumi;KOYA Hiroko;IRIUCHISHIMA Hirono;HOSIHO Takumi;HIRATO Junko;KOJIMA Masaru;HANDA Hiroshi, 2016, Rinsho Ketsueki, 57, 1, 36, 40
• DAMAGE OF THE FREEZING BAG DURING THAWING PERIPHERAL BLOOD STEM CELLS, Sekigami Tomomi;Iriuchishima Hirono;Takizawa Makiko;Maruhashi Takayuki;Yokote Keiko;Handa Hiroshi;Yokohama Akihiko, 2015, Japanese Journal of Transfusion and Cell Therapy, 61, 6, 513, 514
• Acquired thrombotic thrombocytopenic purpura after vascular prosthesis implantation for impending rupture of an abdominal aortic aneurysm, NAITO Chiaki;NOJIMA Yoshihisa;OGAWA Yoshiyuki;YANAGISAWA Kunio;ISHIZAKI Takuma;MIHARA Masahiro;HANDA Hiroshi;ISONISHI Ayami;HAYAKAWA Masaki;MATSUMOTO Masanori, 2016, Rinsho Ketsueki, 57, 3, 364, 368
• Development of acquired hemophilia A during maintenance therapy for immune thrombocytopenia, OGAWA Yoshiyuki;IEKO Masahiro;ICHINOSE Akitada;NOJIMA Yoshihisa;YANAGISAWA Kunio;ISHIZAKI Takuma;NAITO Chiaki;MIHARA Masahiro;HANDA Hiroshi;SHIZUKA Reiko;INOUE Madoka;NAITO Sumiyoshi, 2016, Rinsho Ketsueki, 57, 4, 456, 460
• Remission of acquired hemophilia A following radiation therapy for esophageal cancer, YANAGISAWA Kunio;NOJIMA Yoshihisa;OGAWA Yoshiyuki;MITSUI Takeki;NOGUCHI Hiroyuki;SHIMIZU Hiroaki;ISHIZAKI Takuma;HANDA Hiroshi;IEKO Masahiro;ICHINOSE Akitada, 2016, Rinsho Ketsueki, 57, 4, 451, 455
• Successful Management Preventing Severe Bleeding during the Perioperative Period for Subdural Hematoma by Using Recombinant Activated Coagulation Factor VII in a Case of Acquired Hemophilia A, Noguchi Hiroyuki;Ogawa Yoshiyuki;Yanagisawa Kunio;Ishizaki Takuma;Mihara Masahiro;Mitsui Takeki;Shimizu Hiroaki;Nojima Yoshihisa;Handa Hiroshi, 2016, The Kitakanto Medical Journal, 66, 3, 211, 215
• A Case of Acquired Hemophilia A Complicated by Hemorrhagic Gastric Ulcer Successfully Treated with Sequential Administration of Rituximab and Corticosteroid, Ogawa Yoshiyuki;Nojima Yoshihisa;Yanagisawa Kunio;Naito Chiaki;Ishizaki Takuma;Mihara Masahiro;Noguchi Hiroyuki;Mitsui Takeki;Shimizu Hiroaki;Handa Hiroshi, 2016, The Kitakanto Medical Journal, 66, 2, 149, 154
• Late-onset neutropenia after rituximab therapy in patients with autoimmune thrombotic and hemostatic disorders: a single center analysis, OGAWA Yoshiyuki;YANAGISAWA Kunio;ISHIZAKI Takuma;SHIMIZU Hiroaki;MITSUI Takeki;ICHINOSE Akitada;NOJIMA Yoshihisa;HANDA Hiroshi, 2017, Rinsho Ketsueki, 58, 1, 42, 46
• Acquired thrombotic thrombocytopenic purpura with a smoldering clinical course, NAITO Chiaki;OGAWA Yoshiyuki;YANAGISAWA Kunio;ISHIZAKI Takuma;MIHARA Masahiro;HAYAKAWA Masaki;MATSUMOTO Masanori;NOJIMA Yoshihisa;HANDA Hiroshi, 2017, Rinsho Ketsueki, 58, 2, 108, 112
• Refractory thrombotic thrombocytopenic purpura achieving complete remission with rituximab treatment, IINO Hiromasa;HANDA Hiroshi;OGAWA Yoshiyuki;YANAGISAWA Kunio;SHIMIZU Hiroaki;MITSUI Takeki;ISHIZAKI Takuma;HAYAKAWA Masaki;MATSUMOTO Masanori;NOJIMA Yoshihisa, 2017, Rinsho Ketsueki, 58, 3, 204, 209
• Acquired immune-mediated von Willebrand syndrome accompanied by antiphospholipid syndrome, KOBAYASHI Nobuhiko;OGAWA Yoshiyuki;YANAGISAWA Kunio;ISHIZAKI Takuma;UCHIUMI Hideki;SUZUKI Nobuaki;MATSUSHITA Tadashi;ICHINOSE Akitada;HANDA Hiroshi, 2017, Rinsho Ketsueki, 58, 6, 613, 618
• I. Epidemiology and Prognostic Change of Multiple Myeloma, Handa Hiroshi, 2016, Nihon Naika Gakkai Zasshi, 105, 7, 1202, 1208
• Clinical management and outcomes of completely resected stage I follicular lymphoma, Yokohama Akihiko;Hiromi;Koiso;Saitoh Takayuki;Murayama Kayoko;Matsumoto Morio;Sawamura Morio;Murakami Hirokazu;Hirato Junko;Kojima Masaru;Nojima Yoshihisa;Hashimoto Yoko;Handa Hiroshi;Tsukamoto Norifumi;Takizawa Makiko;Shimizu Hiroaki;Miyazawa Yuri;Saitoh Akio;Toyama Kohtaro;Ishizaki Takuma;Mitsui Takeki, 2018, Journal of Clinical and Experimental Hematopathology, 58, 1, 10, 16
• INTERSPECIMEN STATISTICAL COMPARISON OF ANTI-HLA ANTIBODIES USING THE FLOW CYTOMETRIC METHOD, FlowPRA^®, Nishimoto Natsumi;Maruhashi Takayuki;Iwahara Kanae;Ishikawa Reina;Susa Kozue;Sekine Yoshitaka;Handa Hiroshi;Yokohama Akihiko, 2018, Japanese Journal of Transfusion and Cell Therapy, 64, 1, 43, 49
• Giant hemophilic pseudotumors in brothers with non-severe hemophilia B, MATSUMURA Ikuko;HANDA Hiroshi;YANAGISAWA Kunio;OGAWA Yoshiyuki;SHIMIZU Hiroaki;ISHIZAKI Takuma;MITSUI Takeki;UCHIUMI Hideki;UCHIYAMA Yuri;MATSUMUTO Naomichi, 2018, Rinsho Ketsueki, 59, 3, 287, 292
• Efficacy and Safety of Intermediate dose Etoposide for Mobilization of Peripheral Blood Stem Cells in Hematopoietic Tumors, Ishizaki Takuma;Murakami Hirokazu;Tsukamoto Norifumi;Handa Hiroshi;Yokohama Akihiko;Shimizu Hiroaki;Yanagisawa Kunio;Ogawa Yoshiyuki;Mitsui Takeki;Koiso Hiromi;Takizawa Makiko;Saitoh Takayuki, 2018, The Kitakanto Medical Journal, 68, 1, 43, 47
• Congenital factor V and factor VIII deficiency discovered in an elderly patient with abnormal bleeding after trauma, OGAWA Yoshiyuki;YANAGISAWA Kunio;UCHIYAMA Yuri;MATSUMOTO Akira;INOUE Madoka;TOYAMA Kohtaro;MIYAZAWA Yuri;MATSUMOTO Naomichi;HANDA Hiroshi, 2018, Rinsho Ketsueki, 59, 4, 383, 388
• SUCCESSFUL PERIPHERAL BLOOD STEM CELL COLLECTION CAN BE PREDICTED ON THE DAY BEFORE APHERESIS, Yokohama Akihiko;Jimbo Takahiro;Ogura Hidemi;Handa Hiroshi;Ishikawa Reina;Nishimoto Natsumi;Susa Kozue;Maruhashi Takayuki;Karasawa Masamitsu;Sekigami Tomomi;Iriuchijima Hirono;Hashimoto Yoko;Takizawa Makiko;Isoda Atsushi;Mitsui Takeki;Yamane Arito;Toyama Kohtaro, 2016, Japanese Journal of Transfusion and Cell Therapy, 62, 4, 552, 559
• A Questionnaire Survey on HIV-infected Patients in Gunma University Hospital::To Understand Patients' Needs and to Establish an Integrative Care System for HIV Patients, Ogawa Yoshiyuki;Hayashi Toshimasa;Sawamura Morio;Uchiumi Hideki;Nojima Yoshihisa;Handa Hiroshi;Yanagisawa Kunio;Nakamura Akihiro;Kobayashi Mizue;Ishizaki Yoshimi;Kodama Tomoko;Hoshikawa Koumei;Tago Akihiro;Gohda Fumito, 2017, The Kitakanto Medical Journal, 67, 2, 135, 141
• Successful Treatment of Immune Reconstitution Inflammatory Syndrome with Corticosteroid for Patient with Kaposiʼs Sarcoma Extending into the Respiratory Tract and Both Lungs, ISHIKAWA Tetsuya;YANAGISAWA Kunio;OGAWA Yoshiyuki;UCHIUMI Hideki;GOHDA Fumito;HANDA Hiroshi, 2017, Kansenshogaku Zasshi, 91, 1, 25, 30
• Positron Emission Tomography/Computed Tomography before Treatment as a Predictor of ⁹⁰Y-Ibritumomab Tiuxetan Response, Yudistiro Ryan;Handa Hiroshi;Koiso Hiromi;Ishizaki Takuma;Tsushima Yoshito;Heryanto Yusri Dwi;Kodaira Sayaka;Higuchi Tetsuya;Arisaka Yukiko;Tokue Azusa;Taketomi-Takahashi Ayako;Tsukamoto Norifumi;Yokohama Akihiko, 2018, The Kitakanto Medical Journal, 68, 3, 151, 156
• Safety and management of adverse events of ixazomib/lenalidomide/dexamethasone therapy in Japanese patients with relapsed/refractory multiple myeloma, IIDA Shinsuke;SOEDA Junpei;IZUMI Tohru;AOTSUKA Nobuyuki;KOMENO Takuya;ISHIDA Tadao;SUNAMI Kazutaka;HANDA Hiroshi;BERG Deborah;KASE Yoichi, 2018, Rinsho Ketsueki, 59, 11, 2399, 2407
• Cyanamide Induced Aplastic Anemia, Osaki Yohei;Handa Hiroshi;Terasaki Yukie;Kanaya Shuhei;Tahara Kenichi;Shimizu Hiroaki;Yanagisawa Kunio;Ishizaki Takuma;Ogawa Yoshiyuki;Tsukamoto Norifumi, 2018, The Kitakanto Medical Journal, 68, 4, 261, 265
• Recurrence of acquired factor V inhibitor after four years of remission, AKASHI Naoki;ICHINOSE Akitada;HANDA Hiroshi;OGAWA Yoshiyuki;YANAGISAWA Kunio;OSAKI Yohei;SHIMIZU Hiroaki;ISHIZAKI Takuma;INOUE Madoka;MURAKAMI Masami;SOURI Masayoshi, 2019, Rinsho Ketsueki, 60, 1, 46, 50
• Looking for Niche Research:- From Telomerase to Non-coding RNA -, Handa Hiroshi, 2019, The Kitakanto Medical Journal, 69, 2, 159, 160
• Thyroid storm and exacerbation of autoimmune hemolytic anemia following childbirth, SUGISAKI Manato;HANDA Hiroshi;ISHIZAKI Takuma;IRIUCHISHIMA Hirono;SHIMIZU Hiroaki;YANAGISAWA Kunio;OGAWA Yoshiyuki;YOKOHAMA Akihiko;SAITOH Takayuki;TSUKAMOTO Norifumi, 2019, Rinsho Ketsueki, 60, 8, 924, 928
• Comparison of the interprofessional education assessment between health science' and medical students, MAKINO Takatoshi;HANDA Hiroshi;LEE Bunsuk;KOIZUMI Misako;YASUKAWA Takako;WATANABE Hideomi;SHINOZAKI Hiromitsu;HAYASHI Tomoko;OGAWARA Hatsue;ASAKAWA Yasuyoshi;IWASAKI Kiyotaka;MATSUDA Tamiko;ABE Yumiko;TOZATO Fusae, 2010, The Journal of Interprofessional Collaboration in Health and Social Care, 2, 1, 2, 11
• 2 Cases of Refractory Idiopathic Thrombocytopenic Purpura in Pregnancy, Osaki Yohei;Kameda Takashi;Handa Hiroshi;Ogawa Yoshiyuki;Morita Akihito;Higeta Daisuke;Shimizu Hiroaki;Yanagisawa Kunio;Ishizaki Takuma;Saitoh Takayuki;Tsukamoto Norifumi, 2019, The Kitakanto Medical Journal, 69, 3, 227, 232
• Picture in Clinical Hematology No. 129, 宮澤 悠里;明石 直樹;杉崎 真人;石川 哲也;石埼 卓馬;半田 寛, 2019, Rinsho Ketsueki, 60, 12, 1621, 1621
• Mediastinal abscess due to Aspergillus in a patient with atypical chronic myeloid leukemia, BCR-ABL1-negative, MIYAZAWA Yuri;ISHIKAWA Tetsuya;SUGISAKI Manato;MATSUMOTO Akira;AKASHI Naoki;NAITO Chiaki;ISHIZAKI Takuma;HANDA Hiroshi, 2020, Rinsho Ketsueki, 61, 2, 128, 130
• Positron Emission Tomography/Computed Tomography before Treatment as a Predictor of ⁹⁰Y-Ibritumomab Tiuxetan Response, Yudistiro Ryan;Handa Hiroshi;Koiso Hiromi;Ishizaki Takuma;Tsushima Yoshito;Dwi Heryanto Yusri;Kodaira Sayaka;Higuchi Tetsuya;Arisaka Yukiko;Tokue Azusa;Taketomi-Takahashi Ayako;Tsukamoto Norifumi;Yokohama Akihiko, 2020, The Kitakanto Medical Journal, 70, 1, 79, 80
• IgG4-related Disease with a Cardiac Mass, Matsumura Ikuko;Saitoh Takayuki;Hirato Junko;Murakami Hirokazu;Handa Hiroshi;Tsukamoto Norifumi;Mitsui Takeki;Tahara Kenichi;Shimizu Hiroaki;Yanagisawa Kunio;Ishizaki Takuma;Koiso Hiromi;Takizawa Makiko;Yokohama Akihiko, 2020, Internal Medicine, 59, 9, 1203, 1209
• Successful management of acquired factor V deficiency developing shortly after induction of hemodialysis, MATSUMOTO Akira;SHIMIZU Hiroaki;INOUE Madoka;HAYAKAWA Masaki;MURAKAMI Masami;ICHINOSE Akitada;HANDA Hiroshi;OGAWA Yoshiyuki;OSAKI Tsukasa;SOURI Masayoshi;YANAGISAWA Kunio;ISHIZAKI Takuma;NAITO Chiaki;ISHIKAWA Tetsuya;MIYAZAWA Yuri, 2020, Rinsho Ketsueki, 61, 5, 445, 450
• ANTI-Fy^b DETECTED AFTER PLATELET TRANSFUSION IN A PATIENT WITH MYELODYSPLASTIC SYNDROME, Iwahara Kanae;Yokohama Akihiko;Maruhashi Takayuki;Susa Kozue;Nishimoto Natsumi;Ishikawa Reina;Yokote Keiko;Iriuchishima Hirono;Sekigami Tomomi;Handa Hiroshi, 2020, Japanese Journal of Transfusion and Cell Therapy, 66, 3, 566, 570
• COVID-19 Pneumonia in a Patient in Her Seventies that Improved without Antiviral Drug Treatment： A Case Study, MIYAZAWA Yuri;YANAGISAWA Kunio;OGAWA Yoshiyuki;KOISO Hiromi;TOKUE Yutaka;HANDA Hiroshi, 2020, Kansenshogaku Zasshi, 94, 4, 568, 572
• 末梢血造血幹細胞解凍時の凍結バッグ破損, ;;;;;;, Dec. 2015, 61, 6, 513
• HIV関連認知障害(HAND)症例への神経心理学的検査と支援, ;;;;;;;;, Nov. 2015, 17, 4, 503
• 地域社会における包括的HIVケアを目指した通院患者アンケートの試み, ;;;;;;;;;, Nov. 2015, 17, 4, 534
• 多発性骨髄腫に対する自家造血幹細胞移植後に発症したT細胞性monomorphic移植後リンパ増殖性疾患, ;;;;;;;;;;, Jan. 2016, 57, 1, 36
• 急性骨髄性白血病に対する臍帯血移植後に発症した胃前庭部毛細血管拡張症の1例, ;;;;;;, May 2016, 623回, 32
• 複数の人工デバイス留置中に播種性カンジダ症・脳炎を合併した悪性リンパ腫, ;;;;, Mar. 2016, 90, 臨増, 325
• サイトメガロウイルス(CMV)網膜炎とニューモシスチス肺炎(PCP)を併発したトファシチニブ(TCZ)使用症例, ;;;;, Mar. 2016, 90, 臨増, 354
• 骨髄増殖性腫瘍の長期経過中に発症した慢性骨髄性白血病3例の検討, ;;;;;;;;;, Feb. 2016, 105, Suppl., 227
• 合成基質法による凝固第VIII因子および第IX因子活性測定試薬の性能評価, ;;;;;;;;;, Jul. 2016, 17, 学術集会, S206
• von Willebrand病初妊婦2例の妊娠分娩管理, ;;;;;;;;;;;;, May 2016, 27, 2, 238
• Inhibitor boostingにリツキシマブが著効した血栓性血小板減少性紫斑病(TTP)症例, ;;;;;;;;;;, May 2016, 27, 2, 244
• 低力価ADAMTS13インヒビター残存状態で均衡を保っている血栓性血小板減少性紫斑病の1例, ;;;;;;;;;, May 2016, 27, 2, 244
• 免疫抑制療法中に病勢再燃した自己免疫性後天性von Willebrand症候群の長期経過, ;;;;;;;;;, May 2016, 27, 2, 247
• リツキシマブによる遅発性好中球減少症を生じた後天性凝固異常症の検討, ;;;;;;;;, May 2016, 27, 2, 292
• 病因・基礎、病態解析　多発性骨髄腫におけるエピゲノム異常, 半田 寛, Apr. 2016, 6, 2, 36
• 骨髄線維症を合併した多発性骨髄腫, ;;;;;;;, Apr. 2016, 6, 2, 88
• 無痛性精巣腫大を契機に診断された精巣形質細胞腫を伴う症候性多発性骨髄腫の1例, ;;;;;;;, Jul. 2016, 625回, 37
• 【多発性骨髄腫に対する治療-その新展開】骨髄腫患者のQOL維持のための手立て, ;, Aug. 2016, 12, 3, 248
• 採取前日の末梢血CD34陽性細胞比率による末梢血幹細胞採取量の予測, ;;;;;;;;;;;;;;;;, Aug. 2016, 62, 4, 552
• 心腔内病変を有する悪性リンパ腫3例の治療経験, ;;;;;;;;;;;;;;;;;, Jun. 2016, 57, 6, 778
• 当院で経験したHairy cell様Bリンパ球増多症(HBLD)6例の臨床像, ;;;;;;;;;;;;;, Aug. 2016, 56, 91
• 腹水で発症しR-CHOP療法8コース施行後早期に胸水で再発した原発性体腔液リンパ腫類似リンパ腫の一例, ;;;;;;;;;;;;;, Aug. 2016, 56, 99
• 難治性器質化肺炎を伴い発症した有毛細胞白血病の一例, ;;;;;;;;;;;;;;, Aug. 2016, 56, 100
• 赤芽球癆を合併した顆粒リンパ球増多症の経過中にCrohn病を発症した1例, ;;;;;;;;;, Oct. 2016, 627回, 38
• 慢性期合併症対策としてのエトラビリン・ラルテグラビル2剤治療の試み, ;;;;;;;, Aug. 2016, 18, 3, 213
• リツキシマブとその後のステロイド治療により寛解達成し得た出血性胃潰瘍合併後天性血友病Aの1例, ;;;;;;;;;, May 2016, 66, 2, 149
• ドルテグラビルを含む抗HIV療法が奏効した急性HIV感染による血球貪食症候群症例, ;;;;;;;;;;, May 2016, 18, 2, 168
• 遺伝子組換え型活性型第VII因子製剤投与により慢性硬膜下血腫に対する穿頭血腫灌流除去術中の出血制御に成功した後天性血友病Aの1例, ;;;;;;;;, Aug. 2016, 66, 3, 211
• シアナミド関連再生不良性貧血と考えられた1例, ;;;;;;;;;, Dec. 2016, 629回, 43
• くすぶり型経過を示した後天性血栓性血小板減少性紫斑病, ;;;;;;;;, Feb. 2017, 58, 2, 108
• 急性GVHDに伴って認められたGAVEの1例, ;;;;;;;;;;;;;;;;, Dec. 2016, 90, Suppl., s147
• 自己免疫性血栓止血性疾患に対するリツキシマブ療法後の遅発性好中球減少症　単施設における解析, ;;;;;;;, Jan. 2017, 58, 1, 42
• 免疫再構築症候群に対してステロイド治療が有効であった高度気道狭窄合併カポジ肉腫症例, ;;;;;, Jan. 2017, 91, 1, 25
• ボリコナゾール代謝物の測定により薬物代謝能の評価を行った1例, ;;;, Jan. 2017, 91, 1, 78
• 血友病を背景とした椎間板炎・腸腰筋膿瘍へのドレナージ術について, ;;;;;, Jan. 2017, 91, 1, 111
• リツキシマブにより完全寛解に到達した難治性血栓性血小板減少性紫斑病, ;;;;;;;;;, Mar. 2017, 58, 3, 204
• 高齢Ph+ALL患者にダサチニブ治療が奏効し、並存した菌状息肉症にも有効であった1例, ;;;;, Nov. 2016, 57, 11, 2420
• リファブチン投与中にぶどう膜炎を発症したHIV感染患者2例の血中濃度解析, ;;;;;;;, Mar. 2017, 121, 臨増, 319
• 汎血球減少と白赤芽球症を呈した非分泌型骨髄腫の1例, ;;;;;, Jul. 2017, 634回, 38
• 当院における空洞・嚢胞性病変を呈したAIDS合併ニューモシスチス肺炎の検討, ;;;;;;;;;;;, Nov. 2016, 18, 4, 440
• 後天性免疫不全症候群に合併した肺アスペルギルス症の3症例, ;;;;;;;, Nov. 2016, 18, 4, 441
• クリプトコッカス髄膜炎で診断されたいきなりAIDS症例の髄液所見に関する検討, ;;;;;;;;;;;, Nov. 2016, 18, 4, 459
• 認知機能障害を合併したHIV患者の退院後の環境調整と母親への関わり, ;;;;;;;;;;;;;, Nov. 2016, 18, 4, 550
• メトトレキセートとプレドニゾロン内服中の関節リウマチ患者に発症したEBV陽性mucocutaneous ulcerの一例, ;;;;;;;;;;, May 2017, 57, 102
• 抗リン脂質抗体症候群を合併した自己免疫性の後天性von Willebrand症候群, ;;;;;;;;, Jun. 2017, 58, 6, 613
• 芽球性形質細胞様樹状細胞腫瘍の治療中にAMLへの移行を認めた1例, ;;;;;;, Aug. 2017, 58, 8, 1071
• 止血に難渋した気道出血を契機に診断された成人発症の凝固第XIII/13因子欠乏症例, ;;;;;;;, Jun. 2017, 18, 学術集会, S133
• ステロイド治療中に深部静脈血栓症と腸管気腫症を合併した後天性血友病Aの1例, ;;;;;;;;;, Jun. 2017, 18, 学術集会, S133
• 血小板数維持に難渋した妊娠合併特発性血小板減少症の2例, ;;;;;;;;;, Jun. 2017, 18, 学術集会, S218
• 群馬大学医学部附属病院の通院HIV感染者に対するアンケート調査　患者ニーズに寄り添う地域社会における包括的HIVケア体制の構築を目指して, ;;;;;;;;;;;;;, May 2017, 67, 2, 135
• 自然軽快と再燃を繰り返した後天性von Willebrand症候群(AvWS)の1例, ;;;;;;;;;;, Apr. 2017, 28, 2, 201
• 外傷時の止血困難を契機に発見された高齢の先天性第V・第VIII因子合併欠乏症の1例, ;;;;;;;, Apr. 2017, 28, 2, 212
• 当院におけるHCV感染血友病患者に対する直接作用型抗HCV薬治療に関する検討, ;;;;;;;;, Apr. 2017, 28, 2, 224
• インターフェロンα治療による長期慢性期後に急性転化した慢性骨髄性白血病の1例, ;;;;;;;;, Nov. 2017, 58, 11, 2277
• 病因・病態・予後　IgM型多発性骨髄腫　日本骨髄腫学会多施設共同後方視的調査研究, ;;;;;;;;;;;;;, Apr. 2017, 7, 1, 37
• 両眼網膜中心静脈閉塞症の所見を示した原発性マクログロブリン血症による過粘稠症候群の1例, ;;;;;, Dec. 2017, 121, 12, 923
• 認知機能障害を合併したポルトガル語母語のHIV/AIDS患者および家族との関わり, ;;;;;;;;;;, Nov. 2017, 19, 4, 388
• 言語と医療　チームで臨んだアフリカ出身AIDS患者の援助を通じて, ;;;;;;;;;;, Nov. 2017, 19, 4, 392
• ダルナビル・コビシスタット配合錠に変更後のダルナビル血中濃度の検討, ;;;;;;;;, Nov. 2017, 19, 4, 428
• ラルテグラビル投与時の錠剤粉砕等による血中濃度への影響の検討, ;;;;;;;;, Nov. 2017, 19, 4, 496
• Azacitidineによりi(17)(q10)を有するcloneが一時的に消失した骨髄異形成症候群, ;;;;;;;;;, Feb. 2018, 107, Suppl., 178
• FlowPRAを用いた抗HLA抗体検出における血清と血漿検体種間の統計学的比較検討, ;;;;;;;, Feb. 2018, 64, 1, 43
• 骨髄線維症を合併した形質細胞性腫瘍の5症例, ;;;;;;;;;;, Oct. 2017, 65, 補冊, 151
• プレリキサホル投与による末梢血幹細胞採取への影響, ;;;;;;;;;;;;;;;, Apr. 2018, 64, 2, 353
• 治療開始後速やかに発熱・貧血が改善したHIV感染症の1例, ;;;;;;, Feb. 2018, 639回, 48
• 非重症型血友病Bの兄弟に生じた巨大血友病性偽腫瘍, ;;;;;;;;;, Mar. 2018, 59, 3, 287
• 外傷後の止血不良を契機に発見された高齢者先天性第V、VIII因子複合欠乏症, ;;;;;;;;, Apr. 2018, 59, 4, 383
• 蛋白漏出胃腸症及び薬剤吸収不良の合併が疑われたAIDS関連カポジ肉腫症例, ;;;, Apr. 2018, 66, Suppl.A, 358
• 芽球性形質細胞様樹状細胞腫瘍より移行したAMLに対して臍帯血移植を施行し寛解を維持している1例, ;;;;;, May 2018, 59, 5, 617
• 分娩を契機に甲状腺クリーゼと溶血の悪化を認めた自己免疫性溶血性貧血の1例, ;;;;;;, Jul. 2018, 643回, 48
• Etoposide中等量療法による末梢血幹細胞採取, ;;;;;;;;;;;, Feb. 2018, 68, 1, 43
• 全エクソーム解析により同定されたRUNX1変異を原因とする先天性血小板減少症, ;;;;;;, May 2018, 29, 2, 177
• 寛解後4年で再発した後天性凝固第V因子インヒビターの治療経過, ;;;;;;;;;, May 2018, 29, 2, 179
• 機能的寛解達成後2年以上経過して病勢再燃した自己免疫性出血病FXIII/13症例, ;;;;;;;;, May 2018, 29, 2, 180
• Type1フォンウィルブランド病合併血友病A患児の定期補充療法, ;;;;;;;, May 2018, 29, 2, 192
• メシル酸カモスタットとトラネキサム酸の併用療法でコントロールできた慢性DIC症例, ;;;;;;, May 2018, 29, 2, 217
• 多発性骨髄腫の除外診断項目は?【rFLC正常のみでは否定できず、MGUSとの鑑別のため、骨髄中形質細胞割合の確定が必須】, ;, Dec. 2018, 4939, 60
• リンパ球増多症を契機に診断されたマントル細胞リンパ腫と濾胞性リンパ腫のComposite lymphomaの一例, ;;;;;;;;;, May 2018, 58, 109
• t(14;18)(q32;q21)が検出された血管免疫芽球性T細胞リンパ腫, ;;;;;;;;;;, May 2018, 58, 121
• Cyanamide投与に関連した再生不良性貧血の1例, ;;;;;;;;;, Nov. 2018, 68, 4, 261
• 【多発性骨髄腫の分子病態解明の進歩と新たな治療展開】多発性骨髄腫におけるエピゲノム異常, 半田 寛, Jan. 2019, 78, 1, 1
• 骨髄腫の分子病態及びゲノム・エピゲノム異常　多発性骨髄腫のエピゲノム異常, 半田 寛, May 2018, 8, 2, 61
• 成人Ph陰性ALLにおける診断時に染色体異常により同定されたクローン不均一性の臨床的意義(Clonal heterogeneity detected with metaphase cytogenetics at diagnosis in adult Ph-negative ALL), ;;;;;;;;, Sep. 2018, 59, 9, 1535
• CD5陽性DLBCLに対する自家移植の検討(Autologous stem cell transplant for patients with CD5-positive DLBCL), ;;;;;;;;;;;;;, Sep. 2018, 59, 9, 1555
• インテグリンα7の発現は急性骨髄性白血病の表現型と増殖に関連する(Integrin alpha7 expression is associated with phenotype and growth of acute myelogenous leukemia), ;;;;;;;;;;;;;;;, Sep. 2018, 59, 9, 1699
• 後天性血友病A患者における寛解後のFVIII活性オーバーシュート(Overshoot of FVIII activity after remission in patients with acquired hemophilia A), ;;;;;;;;, Sep. 2018, 59, 9, 1809
• 初回寛解から4年後に再燃した後天性凝固第V因子インヒビター, ;;;;;;;;;;, Jan. 2019, 60, 1, 46
• 【検査項目と異常値からみた-緊急・重要疾患レッドページ】(7章)血液・造血器疾患　多発性骨髄腫, ;, Apr. 2019, 63, 4, 504
• 急性心筋梗塞を契機に判明した血栓性血小板減少性紫斑病, ;;;;;;;;;;, Nov. 2018, 59, 11, 2503
• 薬害HIV感染血友病患者に合併したホジキン病, ;;;;;;;;;;, Nov. 2018, 20, 4, 571
• 群馬県におけるHIV歯科診療連携事業の整備, ;;;;;;;;;;;;, Nov. 2018, 20, 4, 581
• 【全身性疾患と腎update】(第5章)血液疾患　M蛋白血症・血液専門医の視点より, ;, Jun. 2019, 86, 増刊, 328
• 骨髄異形成症候群の一患者におけるABO式血液型抗原量低下の原因解明, ;;;;;;;;, Apr. 2019, 65, 2, 356
• 血栓性血小板減少性紫斑病を契機に診断された全身性エリテマトーデスの一例, ;;;;;;;;;, May 2019, 32, 1Suppl., 169
• 再生不良性貧血との鑑別を要した血管免疫芽球性T細胞リンパ腫の1例, ;;;;;;, May 2019, 59, 129
• 診断時に嗅神経芽細胞腫を合併した多発性骨髄腫の1例, ;;;;;;;;, May 2019, 60, 5, 529
• 多臓器に出血症状を呈した肺多形癌の1例, ;;;;;;;, Sep. 2019, 653回, 45
• 分娩を契機に甲状腺クリーゼと溶血の悪化を認めた自己免疫性溶血性貧血, ;;;;;;;;;, Aug. 2019, 60, 8, 924
• アミオダロンとICDにより再発するpulseless VT後も長期生存を得た全身性ALアミロイドーシスの1例(Long-term survival of an AL amyloidosis patient with recurrent pulseless VT treated with amiodarone and implantable cardioverter defibrillator(ICD)), ;;;;;;, May 2019, 9, 1, 124
• 血栓性微小血管症を契機に診断された全身エリテマトーデスの1例, ;;;;;;;;;, Oct. 2019, 29回, 128
• 急性前骨髄性白血病に全身性ムーコル症を発症した1例, ;;;;;, Jul. 2019, 652回, 43
• SLEに対する免疫抑制療法中に発症した中枢神経原発OII-LPD, ;;;;;, Oct. 2019, 60, 10, 1506
• 血栓性血小板減少性紫斑病(TTP)を契機に診断された全身性エリテマトーデスの1例, ;;;;;;;;, Oct. 2019, 123, 10, 1593
• Picture in Clinical Hematology(No.129)　寛解後に血性膿胸を来し胸水中に活発な好中球貪食像を認めた急性前骨髄球性白血病, ;;;;;, Dec. 2019, 60, 12, 1621
• Inhibitor boostingにより長期入院を要した難治性の血栓性血小板減少性紫斑病症例, ;;;;;;;;;;, May 2019, 30, 2, 426
• 血栓性血小板減少性紫斑病を契機に診断された全身性エリテマトーデスの小児例, ;;;;;;;;, May 2019, 30, 2, 426
• 全エクソーム解析により診断に結び付いた遺伝性出血性末梢血管拡張症の1家系, ;;;;;;;, May 2019, 30, 2, 431
• 維持透析導入後早期に発症した後天性凝固第V因子インヒビター症例, ;;;;;;;;;;;;;;, May 2019, 30, 2, 443
• 本態性血小板血症にBurkitt lymphomaを合併した1症例, ;;;;;;;;, Oct. 2019, 67, 補冊, 278
• 治療抵抗性妊娠合併特発性血小板減少性紫斑病の2例, ;;;;;;;;;;, Aug. 2019, 69, 3, 227
• 急性骨髄性白血病終末期患者と家族の希望を叶えるための支援　都内の大学病院で出産を終えた妹と赤ちゃんに会いたい, ;;;;;;;;;;, Aug. 2019, 69, 3, 269
• 骨髄異形成症候群の一患者におけるABO式血液型抗原量低下の原因解明, ;;;;;;, Aug. 2019, 69, 3, 302
• 非定型慢性骨髄性白血病経過中に発症したアスペルギルス縦隔膿瘍, ;;;;;;;, Feb. 2020, 61, 2, 128
• 透析導入期に播種性結核でAIDS発症となった長期ウイルス抑制中のHIV症例, ;;;;;;, Mar. 2020, 94, 2, 262
• 血液透析導入後早期に発症した自己免疫性凝固第V/5因子欠乏症の管理, ;;;;;;;;;;;;;;, May 2020, 61, 5, 445
• 3種の活性化部分トロンボプラスチン時間測定試薬を用いた全自動血液凝固測定装置CS-5100による凝固波形解析の基礎的性能評価, ;;;;;;;;;, Jun. 2020, 21, 学術集会, S138
• 3種のプロトロンビン試薬を用いた全自動血液凝固測定装置CS-5100による凝固波形解析の基礎的性能評価, ;;;;;;;;;, Jun. 2020, 21, 学術集会, S138
• 薬害HIV感染血友病B患者に合併したホジキンリンパ腫, ;;;;;;;;;;, Feb. 2020, 22, 1, 36
• エミシズマブによる出血抑制下でインヒビターの自然消失を認めた高齢の軽症血友病A症例, ;;;;;;;;;;;;;, May 2020, 31, 2, 250
• 経時的な抗FXIII自己抗体の測定をガイドとして治療を遂行した自己免疫性凝固第XIII因子欠乏症例, ;;;;;;;;;;;, May 2020, 31, 2, 252
• 後天性凝固第X因子欠乏、線溶異常を契機にALアミロイドーシスの診断に至った一症例, ;;;;;;;;;;;;, May 2020, 31, 2, 256
• 群馬県におけるHIV歯科診療連携事業の現状報告　施設スタッフアンケート結果より, ;;;;;;;;;;;;, Nov. 2019, 21, 4, 452
• 薬害HIV/HCV共感染血友病患者の肝細胞癌に対する重粒子線治療, ;;;;;;;;;;;;;;;;;;, Nov. 2019, 21, 4, 494
• 本邦初のHIV-2サブタイプAインド流行株症例, ;;;;;;;;;;;;, Nov. 2019, 21, 4, 523
• 群馬県におけるHIV歯科診療連携事業の現状報告　患者アンケート結果より, ;;;;;;;;;;;;;, Nov. 2019, 21, 4, 548
• 血小板製剤輸血後に抗Fybを検出した骨髄異形成症候群の1症例, ;;;;;;;;;, Jun. 2020, 66, 3, 566
• 無治療で改善した70代のCOVID-19肺炎の1例, ;;;;;, Jul. 2020, 94, 4, 568
• 複視を契機に発見され超音波内視鏡下穿刺吸引術が診断に有用だったびまん性大細胞型B細胞リンパ腫の1例, ;;;;;;;;;;;;;, Jul. 2020, 360回, 31
• IL-10 promoter region-592A/C genotype increases the risk of multiple myeloma in Japanese patients., Saitoh, Takayuki;Kasamatsu, Tetsuhiro;Matsuoka, Hitomi;Endoh, Miyuki;Inoue, Madoka;Yamane, Arito;Irisawa, Hiroyuki;Handa, Hiroshi;Matsushima, Takafumi;Tsukamoto, Norifumi;Karasawa, Masamitsu;Ogawara, Hatsue;Nojima, Yoshihisa;Murakami, Hirokazu, 2006, BLOOD, 108, 11, 342B, 342B
• Hodgkin lymphoma accompanied by aplastic anemia and polyclonal expansion of large granular lymphocytes, Saitoh, Takayuki;Matsushima, Takafumi;Yamane, Arito;Sakuraya, Masataka;Irisawa, Hiroyuki;Yokohama, Akihiko;Handa, Hiroshi;Tsukamoto, Norifumi;Karasawa, Masamitsu;Nojima, Yoshihisa;Murakami, Hirokazu, 2007, ACTA HAEMATOLOGICA, 117, 4, 238, 241

  DOI
• Clinical significance of Th1/Th2 ratio in patients with myelodysplastic syndrome, Ogawara, Hatsue;Hamdi, Wedad;Kasamatsu, Tetsuhiro;Inoue, Madoka;Handa, Hiroshi;Saito, Takayuki;Matsushima, Takafumi;Tsukamoto, Norifumi;Nojima, Yoshihisa;Murakami, Hirokazu, 2007, INTERNATIONAL JOURNAL OF LABORATORY HEMATOLOGY, 29, 93, 93
• IL-10-592 polymorphism predicts the clinical outcome of Japanese patients with multiple myeloma and MGUS, Kasamatsu, Tetsuhiro;Saitoh, Takayuki;Handa, Hiroshi;Matsushima, Takafumi;Tsukamoto, Norifumi;Karasawa, Masamitsu;Ogawara, Hatsue;Sawamura, Morio;Nojima, Yohihisa;Murakami, Hirokazu, 2007, BLOOD, 110, 11, 263B, 263B
• The Influence of Polymorphisms of Interleukin-17F Genes on the Susceptibility and Clinical Significanse of Chronic Idiopathic Thrombocytopenic Purpura, Saitoh, Takayuki;Kasamatsu, Tetsuhiro;Yokohama, Akihiko;Handa, Hiroshi;Tsukamoto, Norifumi;Karasawa, Masamitsu;Ogawara, Hatsue;Nojima, Yoshihisa;Murakami, Hirokazu, 2008, BLOOD, 112, 11, 1175, 1175
• Characterization of immunoglobulin heavy and light chain gene expression in chronic lymphocytic leukemia and related disorders, Nakahashi, Hirotaka;Tsukamoto, Norifumi;Hashimoto, Yoko;Koiso, Hiromi;Yokohama, Akihiko;Saitoh, Takayuki;Uchiumi, Hideki;Handa, Hiroshi;Murakami, Hirokazu;Nojima, Yoshihisa;Karasawa, Masamitsu, 2009, CANCER SCIENCE, 100, 4, 671, 677

  DOI
• The Influence of Polymorphisms of Interleukin-17F Genes On the Susceptibility and Clinical Outcome of Multiple Myeloma., Saitoh, Takayuki;Kasamatsu, Tetsuhiro;Yokohama, Akihiko;Handa, Hiroshi;Tsukamoto, Norifumi;Karasawa, Masamitsu;Ogawara, Hatsue;Nojima, Yoshihisa;Murakami, Hirokazu, 2009, BLOOD, 114, 22, 709, 710
• Hairy Cell Leukemia-Related Disorders Consistently Show Low CD27 Expression, Hashimoto, Yoko;Tsukamoto, Norifumi;Nakahashi, Hirotaka;Yokohama, Akihiko;Saitoh, Takayuki;Handa, Hiroshi;Matsushima, Takafumi;Murakami, Hirokazu;Nojima, Yoshihisa;Karasawa, Masamitsu, 2009, PATHOLOGY & ONCOLOGY RESEARCH, 15, 4, 615, 621

  DOI
• Flow cytometric detection of human telomerase reverse transcriptase (hTERT) expression in a subpopulation of bone marrow cells, Handa, Hiroshi;Matsushima, Takafumi;Nishimoto, Natsumi;Inoue, Madoka;Saitoh, Takayuki;Yokohama, Akihiko;Tsukamoto, Norifumi;Mitsui, Takeki;Nakahashi, Hirotaka;Toyama, Kotaro;Karasawa, Masamitsu;Ogawara, Hatsue;Nojima, Yoshihisa;Murakami, Hirokazu, 2010, LEUKEMIA RESEARCH, 34, 2, 177, 183

  DOI
• Primary Bilateral Adrenal Diffuse Large B-cell Lymphoma Demonstrating Adrenal Failure, Horiguchi, Kazuhiko;Hashimoto, Koshi;Hashizume, Masayuki;Masuo, Takashige;Suto, Mariko;Okajo, Jun;Handa, Hiroshi;Kaneko, Yoriaki;Yokoo, Hideaki;Sasaki, Atsushi;Okada, Shuichi;Yamada, Masanobu;Tsukamoto, Norifumi;Nojima, Yoshihisa;Nakazato, Yoichi;Mori, Masatomo, 2010, INTERNAL MEDICINE, 49, 20, 2241, 2246

  DOI
• Azathioprine-induced pure red cell aplasia in a systemic sclerosis patient with interstitial pneumonia, Suto, Mariko;Nagai, Yayoi;Hasegawa, Michiko;Handa, Hiroshi;Ishikawa, Osamu, 2011, JOURNAL OF DERMATOLOGY, 38, 3, 285, 287

  DOI
• Significantly Reduced Circulating Plasmacytoid Dendritic Cells In Patients with Primary and Helicobacter Pylori-Associated Immune Thrombocytopenia., Saito, Akio;Yokohama, Akihiko;Osaki, Yohei;Ogawa, Yoshiyuki;Mitsui, Takeki;Uchiumi, Hideki;Saitoh, Takayuki;Handa, Hiroshi;Sawamura, Morio;Karasawa, Masamitsu;Murakami, Hirokazu;Nojima, Yoshihisa;Tsukamoto, Norifumi, 2010, BLOOD, 116, 21, 1048, 1049
• Successful Treatment of Autoimmune Hemolytic Anemia Associated with Multicentric Castleman Disease by Anti-Interleukin-6 Receptor Antibody (Tocilizumab) Therapy, Yuzuriha, Akinori;Saitoh, Takayuki;Koiso, Hiromi;Mitsui, Takeki;Uchiumi, Hideki;Yokohama, Akihiko;Handa, Hiroshi;Kojima, Masaru;Tsukamoto, Norifumi;Karaswa, Masamitsu;Murakami, Hirokazu;Nojima, Yoshihisa, 2011, ACTA HAEMATOLOGICA, 126, 3, 147, 150

  DOI
• Circulating plasmacytoid dendritic cells in patients with primary and Helicobacter pylori-associated immune thrombocytopenia, Saito, Akio;Yokohama, Akihiko;Osaki, Yohei;Ogawa, Yoshiyuki;Nakahashi, Hirotaka;Toyama, Kohtaro;Mitsui, Takeki;Hashimoto, Yoko;Koiso, Hiromi;Uchiumi, Hideki;Saitoh, Takayuki;Handa, Hiroshi;Sawamura, Morio;Karasawa, Masamitsu;Murakami, Hirokazu;Tsukamoto, Norifumi;Nojima, Yoshihisa, 2012, EUROPEAN JOURNAL OF HAEMATOLOGY, 88, 4, 340, 349

  DOI
• Follicular Lymphoma Presenting with Marked Splenomegaly: Report of Three Cases, Koiso, Hiromi;Yokohama, Akihiko;Mitsui, Takeki;Saitoh, Takayuki;Handa, Hiroshi;Murakami, Hirokazu;Hirato, Junko;Kojima, Masaru;Nojima, Yoshihisa;Tsukamoto, Norifumi, 2012, ACTA HAEMATOLOGICA, 128, 1, 47, 52

  DOI
• Clinical significance of granulocytic sarcoma in adult patients with acute myeloid leukemia, Shimizu, Hiroaki;Saitoh, Takayuki;Hatsumi, Nahoko;Takada, Satoru;Yokohama, Akihiko;Handa, Hiroshi;Jimbo, Tkahiro;Sakura, Toru;Tsukamoto, Norifumi;Murakami, Hirokazu;Miyawaki, Shuichi;Nojima, Yoshihisa, 2012, CANCER SCIENCE, 103, 8, 1513, 1517

  DOI
• The Murine Stem Cell Virus Promoter Drives Correlated Transgene Expression in the Leukocytes and Cerebellar Purkinje Cells of Transgenic Mice, Oue, Miho;Handa, Hiroshi;Matsuzaki, Yasunori;Suzue, Kazutomo;Murakami, Hirokazu;Hirai, Hirokazu, 2012, PLOS ONE, 7, 11

  DOI
• Biological Features and Plasticity of CD56-Positive Dendritic-Like Cells: relationship to Blastic Plasmacytoid Dendritic Cell Neoplasm, Osaki, Yohei;Yokohama, Akihiko;Saitoh, Akio;Tahara, Kenichi;Yanagisawa, Kunio;Ogawa, Yoshiyuki;Ishizaki, Takuma;Mitsui, Takeki;Koiso, Hiromi;Takizawa, Makiko;Uchiumi, Hideki;Murakami, Hirokazu;Saitoh, Takayuki;Tsukamoto, Norifumi;Handa, Hiroshi;Nojima, Yoshihisa, 2012, BLOOD, 120, 21
• Prevalence of extramedullary relapses is higher after allogeneic stem cell transplantation than after chemotherapy in adult patients with acute myeloid leukemia, Shimizu, Hiroaki;Saitoh, Takayuki;Hatsumi, Nahoko;Takada, Satoru;Handa, Hiroshi;Jimbo, Takahiro;Sakura, Toru;Miyawaki, Shuichi;Nojima, Yoshihisa, 2013, LEUKEMIA RESEARCH, 37, 11, 1477, 1481

  DOI
• Methylation and Hydroxymethylation Status of Tumor Suppressor Genes and Common Fragile Sites Genes in Acute Myeloid Leukemia, Handa, Hiroshi;Suda, Itsumi;Kaneko, Ayaka;Masuda, Yuta;Kimura, Kei;Kuroda, Yuko;Kasamatsu, Tetsuhiro;Minato, Yusuke;Tahara, Kenichi;Shimizu, Hiroaki;Ishizaki, Takuma;Mitsui, Takeki;Yokohama, Akihiko;Koiso, Hiromi;Takizawa, Makiko;Saitoh, Takayuki;Hatsumi, Naoko;Takada, Satoru;Sakura, Toru;Tsukamoto, Norifumi;Nojima, Yoshihisa;Murakami, Hirokazu, 2014, BLOOD, 124, 21
• Long Non-Coding RNA MALAT1 Is Associated with the Progression of Multiple Myeloma and Induced By Cellular Stress, Kuroda, Yuko;Kimura, Kei;Masuda, Yuta;Yamane, Arito;Hattori, Hikaru;Tahara, Kenichi;Kaneko, Ayaka;Suda, Itsumi;Takahashi, Noriyuki;Nanami, Gotoh;Nagai, Kie;Nagashima, Tomomi;Takizawa, Makiko;Koiso, Hiromi;Ishizaki, Takuma;Mitsui, Takeki;Iriuchishima, Hirono;Saitoh, Takayuki;Shimizu, Hiroaki;Yokohama, Akihiko;Tsukamoto, Norifumi;Kasamatsu, Tetsuhiro;Minato, Yusuke;Nojima, Yoshihisa;Murakami, Hirokazu;Handa, Hiroshi, 2015, BLOOD, 126, 23
• Th1 Polarization of Cytokine and Cytokine Receptor Polymorphisms Affect the Susceptibility and Severity of ITP, Takahashi, Noriyuki;Saitoh, Takayuki;Gotoh, Nanami;Kimura, Kei;Kuroda, Yuko;Nagai, Kie;Nagashima, Tomomi;Kasamatsu, Tetsuhiro;Minato, Yusuke;Shimizu, Hiroaki;Ishizaki, Takuma;Yokohama, Akihiko;Takizawa, Makiko;Koiso, Hiromi;Mitsui, Takeki;Tsukamoto, Norifumi;Handa, Hiroshi;Murakami, Hirokazu, 2015, BLOOD, 126, 23
• Differences in Expression Patterns of DNMTs and TSG Proteins in Lymphoid Tissue Section Play an Important Role in Their Association, Alkebsi, Lobna;Handa, Hiroshi;Tahara, Kenichi;Shimizu, Hiroaki;Ishizaki, Takuma;Yanagisawa, Kunio;Takayuki, Saitoh;Kasamatsu, Tetsuhiro;Takizawa, Makiko;Murakami, Hirokazu, 2015, BLOOD, 126, 23
• Loop Regulation Between microRNAs and Epigenetics Underlie microRNA Dysregulation in Multiple Myeloma and Is Associated with the Disease Progression, Kimura, Kei;Kuroda, Yuko;Masuda, Yuta;Yamane, Arito;Hattori, Hikaru;Tahara, Kenichi;Kaneko, Ayaka;Suda, Itsumi;Takahashi, Noriyuki;Gotoh, Nanami;Nagai, Kie;Nagashima, Tomomi;Saitoh, Takayuki;Iriuchishima, Hirono;Takizawa, Makiko;Koiso, Hiromi;Ishizaki, Takuma;Mitsui, Takeki;Shimizu, Hiroaki;Yokohama, Akihiko;Tsukamoto, Norifumi;Kasamatsu, Tetsuhiro;Minato, Yusuke;Nojima, Yoshihisa;Murakami, Hirokazu;Handa, Hiroshi, 2015, BLOOD, 126, 23
• Polymorphisms of IL-10 affect the severity and prognosis of myelodysplastic syndrome, Kasamatsu, Tetsuhiro;Saitoh, Takayuki;Minato, Yusuke;Shimizu, Hiroaki;Yokohama, Akihiko;Tsukamoto, Norifumi;Handa, Hiroshi;Sakura, Toru;Murakami, Hirokazu, 2016, EUROPEAN JOURNAL OF HAEMATOLOGY, 96, 3, 245, 251

  DOI
• Th2 Cytokine Polymorphisms, IL-4-590 CC Genotype and IL-10RB K47E, Increase the Requirement of Second-Line Treatment for Chronic ITP, Kitamura, Yuya;Saitoh, Takayuki;Ino, Rumi;Honma, Kazuki;Nagashima, Tomomi;Takahashi, Noriyuki;Gotoh, Nanami;Kasamatsu, Tetsuhiro;Ishizaki, Takuma;Takizawa, Makiko;Yokohama, Akihiko;Shimizu, Hiroaki;Handa, Hiroshi;Tsukamoto, Norifumi;Murakami, Hirokazu, 2016, BLOOD, 128, 22
• Base Excision Repair Gene OGG1 Affects the Relapse Risk of Acute Myeloid Leukemia, Gotoh, Nanami;Saitoh, Takayuki;Takahashi, Noriyuki;Ino, Rumi;Kitamura, Yuya;Honma, Kazuki;Nagashima, Tomomi;Kasamatsu, Tetsuhiro;Hoshino, Takumi;Sakura, Toru;Takizawa, Makiko;Yokohama, Akihiko;Shimizu, Hiroaki;Handa, Hiroshi;Tsukamoto, Norifumi;Murakami, Hirokazu, 2016, BLOOD, 128, 22
• One-Time Administration of Recombinant Human Erythropoietin Decreases B Cell in Human Peripheral Blood, Nagashima, Tomomi;Yokohama, Akihiko;Nagai, Kie;Ino, Rumi;Takahashi, Noriyuki;Kasamatsu, Tetsuhiro;Sekigami, Tomomi;Iriuchishima, Hirono;Takizawa, Makiko;Handa, Hiroshi;Saitoh, Takayuki;Murakami, Hirokazu, 2016, BLOOD, 128, 22
• The cytokine polymorphisms affecting Th1/Th2 increase the susceptibility to, and severity of, chronic ITP, Takahashi, Noriyuki;Saitoh, Takayuki;Gotoh, Nanami;Nitta, Yasuhiro;Alkebsi, Lobna;Kasamatsu, Tetsuhiro;Minato, Yusuke;Yokohama, Akihiko;Tsukamoto, Norifumi;Handa, Hiroshi;Murakami, Hirokazu, 2017, BMC IMMUNOLOGY, 18

  DOI
• PROGRAMMED CELL DEATH 1 GENE POLYMORPHISMS ASSOCIATED WITH THE CLINICAL FEATURES OF MULTIPLE MYELOMA, Kasamatsu, Tetsuhiro;Awata, Maaya;Kanai, Yukihiro;Murata, Keisuke;Matsumoto, Morio;Sawamura, Morio;Takizawa, Makiko;Yokohama, Akihiko;Gotoh, Nanami;Handa, Hiroshi;Saitoh, Takayuki;Murakami, Hirokazu, 2017, INTERNATIONAL JOURNAL OF LABORATORY HEMATOLOGY, 39, 52, 52
• Recurrent alterations of the WW domain containing oxidoreductase gene spanning the common fragile site FRA16D in multiple myeloma and monoclonal gammopathy of undetermined significance, Handa, Hiroshi;Sasaki, Yoshiko;Hattori, Hikaru;Alkebsi, Lobna;Kasamatsu, Tetsuhiro;Saitoh, Takayuki;Mitsui, Takeki;Yokohama, Akihiko;Tsukamoto, Norifumi;Matsumoto, Morio;Murakami, Hirokazu, 2017, ONCOLOGY LETTERS, 14, 4, 4372, 4378

  DOI
• Long non-coding RNA MALAT1 is an inducible stress response gene associated with extramedullary spread and poor prognosis of multiple myeloma, Handa, Hiroshi;Kuroda, Yuko;Kimura, Kei;Masuda, Yuta;Hattori, Hikaru;Alkebsi, Lobna;Matsumoto, Morio;Kasamatsu, Tetsuhiro;Kobayashi, Nobuhiko;Tahara, Ken-ichi;Takizawa, Makiko;Koiso, Hiromi;Ishizaki, Takuma;Shimizu, Hiroaki;Yokohama, Akihiko;Tsukamoto, Norifumi;Saito, Takayuki;Murakami, Hirokazu, 2017, BRITISH JOURNAL OF HAEMATOLOGY, 179, 3, 449, 460

  DOI
• Retrospective analysis of prognostic factors for Waldenstrom macroglobulinemia: a multicenter cooperative study in Japan, Saito, Akio;Isoda, Atsushi;Kojima, Masaru;Yokohama, Akihiko;Tsukune, Yutaka;Sasaki, Makoto;Ito, Shigeki;Ohtsu, Akihiro;Koike, Michiaki;Murayama, Kayoko;Moriya, Keiichi;Tamura, Hideto;Matsumoto, Morio;Nakahashi, Hirotaka;Tanosaki, Sakae;Sakura, Tohru;Kawamura, Toshihide;Miyanaga, Tomomi;Nakamura, Naoya;Murakami, Hirokazu;Handa, Hiroshi;Tsukamoto, Norifumi, 2017, INTERNATIONAL JOURNAL OF HEMATOLOGY, 106, 5, 681, 690

  DOI
• Effect of ruxolitinib therapy on the quality-of-life of Japanese patients with myelofibrosis, Oritani, Kenji;Ohishi, Kohshi;Okamoto, Shinichiro;Kirito, Keita;Komatsu, Norio;Tauchi, Tetsuzo;Handa, Hiroshi;Saito, Shigeki;Takenaka, Katsuto;Shimoda, Kazuya;Okada, Hikaru;Amagasaki, Taro;Wakase, Shiho;Shimozuma, Kojiro;Akashi, Koichi, 2018, CURRENT MEDICAL RESEARCH AND OPINION, 34, 3, 531, 537

  DOI
• PDCD1 and CTLA4 polymorphisms affect the susceptibility to, and clinical features of, chronic immune thrombocytopenia, Kasamatsu, Tetsuhiro;Ino, Rumi;Takahashi, Noriyuki;Gotoh, Nanami;Minato, Yusuke;Takizawa, Makiko;Yokohama, Akihiko;Handa, Hiroshi;Saitoh, Takayuki;Tsukamoto, Norifumi;Murakami, Hirokazu, 2018, BRITISH JOURNAL OF HAEMATOLOGY, 180, 5, 705, 714

  DOI
• IL17A and IL23R gene polymorphisms affect the clinical features and prognosis of patients with multiple myeloma, Kasamatsu, Tetsuhiro;Kimoto, Mari;Takahashi, Noriyuki;Minato, Yusuke;Gotoh, Nanami;Takizawa, Makiko;Matsumoto, Morio;Sawamura, Morio;Yokohama, Akihiko;Handa, Hiroshi;Tsukamoto, Norifumi;Saitoh, Takayuki;Murakami, Hirokazu, 2018, HEMATOLOGICAL ONCOLOGY, 36, 1, 196, 201

  DOI
• A novel GFI1B mutation at the first zinc finger domain causes congenital macrothrombocytopenia, Uchiyama, Yuri;Ogawa, Yoshiyuki;Kunishima, Shinji;Shiina, Masaaki;Nakashima, Mitsuko;Yanagisawa, Kunio;Yokohama, Akihiko;Imagawa, Eri;Miyatake, Satoko;Mizuguchi, Takeshi;Takata, Atsushi;Miyake, Noriko;Ogata, Kazuhiro;Handa, Hiroshi;Matsumoto, Naomichi, 2018, BRITISH JOURNAL OF HAEMATOLOGY, 181, 6, 843, 847

  DOI
• Polymorphism of IL-10 receptor beta affects the prognosis of multiple myeloma patients treated with thalidomide and/or bortezomib, Kasamatsu, Tetsuhiro;Saitoh, Takayuki;Ino, Rumi;Gotoh, Nanami;Mitsui, Takeki;Shimizu, Hiroaki;Matsumoto, Morio;Sawamura, Morio;Yokohama, Akihiko;Handa, Hiroshi;Tsukamoto, Norifumi;Murakami, Hirokazu, 2017, HEMATOLOGICAL ONCOLOGY, 35, 4, 711, 718

  DOI
• Short-term administration of recombinant human erythropoietin decreases B cell number in human peripheral blood, Nagashima, Tomomi;Yokohama, Akihiko;Nagai, Kie;Kasamatsu, Tetsuhiro;Gotoh, Nanami;Iriuchishima, Hirono;Sekigami, Tomomi;Saitoh, Takayuki;Handa, Hiroshi;Tsukamoto, Norifumi;Murakami, Hirokazu, 2018, TRANSFUSION AND APHERESIS SCIENCE, 57, 2, 208, 214

  DOI
• Association between OGG1 S326C CC genotype and elevated relapse risk in acute myeloid leukemia, Gotoh, Nanami;Saitoh, Takayuki;Takahashi, Noriyuki;Kasamatsu, Tetsuhiro;Minato, Yusuke;Lobna, Alkebsi;Oda, Tsukasa;Hoshino, Takumi;Sakura, Toru;Shimizu, Hiroaki;Takizawa, Makiko;Handa, Hiroshi;Yokohama, Akihiko;Tsukamoto, Norifumi;Murakami, Hirokazu, 2018, INTERNATIONAL JOURNAL OF HEMATOLOGY, 108, 3, 246, 253

  DOI
• Unsuppressed serum albumin levels may jeopardize the clinical relevance of the international staging system to patients with light chain myeloma, Kasamatsu, Tetsuhiro;Ozaki, Shuji;Saitoh, Takayuki;Konishi, Jun;Sunami, Kazutaka;Itagaki, Mitsuhiro;Asaoku, Hideki;Cho, Takaaki;Handa, Hiroshi;Hagiwara, Shotaro;Wakayama, Toshio;Negoro, Akiko;Takezako, Naoki;Harada, Naoko;Kuroda, Yoshiaki;Nakaseko, Chiaki;Miyake, Takaaki;Inoue, Nobumasa;Hata, Hiroyuki;Shimazaki, Chihiro;Ohno, Tatsuharu;Kuroda, Junya;Murayama, Tohru;Kobayashi, Takahiro;Abe, Masahiro;Ishida, Tadao;Nagura, Eiich;Shimizu, Kazuyuki, 2018, HEMATOLOGICAL ONCOLOGY, 36, 5, 792, 800

  DOI
• Long Non-Coding A NEAT1 Is Upregulated By Heat Shock Factor 1 (HSF1) and Associated with Multiple Myeloma Progression, Watanabe, Saki;Oda, Tsukasa;Kuroda, Yuko;Homma, Kazuki;Murakami, Yuki;Ishihara, Rei;Yamane, Eiko;Sunaga, Masanobu;Kobayashi, Nobuhiko;Osaki, Yohei;Ishizaki, Takuma;Shimizu, Hiroaki;Koiso, Hiromi;Iriuchishima, Hirono;Takizawa, Makiko;Yokohama, Akihiko;Tsukamoto, Norifumi;Nanami, Gotoh;Ino, Rumi;Saitoh, Takayuki;Murakami, Hirokazu;Handa, Hiroshi, 2018, BLOOD, 132

  DOI
• Thalidomide maintenance therapy in Japanese myeloma patients: a multicenter, phase II clinical trial (COMET study), Murakami, Hirokazu;Kasamatsu, Tetsuhiro;Murakami, Jun;Kiguchi, Toru;Kanematsu, Takeshi;Ogawa, Daisuke;Takamatsu, Hiroyuki;Handa, Hiroshi;Ozaki, Shuji;Miki, Hirokazu;Takahashi, Takeshi;Takeo, Takaaki;Yamauchi, Tatsuya;Morishita, Takanobu;Kosugi, Hiroshi;Shimizu, Kazuyuki, 2019, INTERNATIONAL JOURNAL OF HEMATOLOGY, 109, 4, 409, 417

  DOI
• Malignancy-Associated Hypercalcemia Related with Receptor Activator of NF-kappa B Ligand (RANKL) Expression in T-Cell Acute Lymphoblastic Leukemia, Tahara, Kenichi;Koiso, Hiromi;Osaki, Yo-hei;Sekigami, Tomomi;Yokohama, Akihiko;Saitoh, Takayuki;Tsukamoto, Norifumi;Murakami, Hirokazu;Abe, Masahiro;Handa, Hiroshi, 2019, ACTA HAEMATOLOGICA, 141, 3, 135, 137

  DOI
• Activin A: a novel urinary biomarker of renal impairment in multiple myeloma, Iriuchishima, Hirono;Maeshima, Akito;Takahashi, Shunsuke;Ishizaki, Takuma;Yokohama, Akihiko;Tsukamoto, Norifumi;Saitoh, Takayuki;Murakami, Hirokazu;Handa, Hiroshi, 2019, BIOSCIENCE REPORTS, 39

  DOI
• Thalidomide maintenance therapy in Japanese myeloma patients: a multicenter, phase II clinical trial (COMET study) (vol 109, pg 409, 2019), Murakami, Hirokazu;Kasamatsu, Tetsuhiro;Murakami, Jun;Kiguchi, Toru;Kanematsu, Takeshi;Ogawa, Daisuke;Takamatsu, Hiroyuki;Handa, Hiroshi;Ozaki, Shuji;Miki, Hirokazu;Takahashi, Takeshi;Takeo, Takaaki;Yamauchi, Tatsuya;Morishita, Takanobu;Kosugi, Hiroshi;Shimizu, Kazuyuki, 2019, INTERNATIONAL JOURNAL OF HEMATOLOGY, 110, 1, 125, 126

  DOI
• PDCD1 and PDCD1LG1 polymorphisms affect the susceptibility to multiple myeloma, Kasamatsu, Tetsuhiro;Awata, Maaya;Ishihara, Rei;Murakami, Yuki;Gotoh, Nanami;Matsumoto, Morio;Sawamura, Morio;Yokohama, Akihiko;Handa, Hiroshi;Tsukamoto, Norifumi;Saitoh, Takayuki;Murakami, Hirokazu, 2020, CLINICAL AND EXPERIMENTAL MEDICINE, 20, 1, 51, 62

  DOI
• Feasibility study to establish diagnostic biomarkers for relapsed refractory multiple myeloma, Yasui, Hiroshi;Kobayashi, Masayuki;Sato, Kota;Ishida, Tadao;Tamura, Hideto;Handa, Hiroshi;Sasaki, Makoto;Kawamata, Toyotaka;Makiyama, Junya;Yokoyama, Kazuaki;Tojo, Arinobu;Imai, Yoichi, 2019, CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 19, 10, E84, E84
• The Role and Function of microRNA in the Pathogenesis of Multiple Myeloma, Handa, Hiroshi;Murakami, Yuki;Ishihara, Rei;Kimura-Masuda, Kei;Masuda, Yuta, 2019, CANCERS, 11, 11

  DOI
• PARP1 V762A polymorphism affects the prognosis of myelodysplastic syndromes, Gotoh, Nanami;Minato, Yusuke;Saitoh, Takayuki;Takahashi, Noriyuki;Kasamatsu, Tetsuhiro;Souma, Kana;Oda, Tsukasa;Hoshino, Takumi;Sakura, Toru;Ishizaki, Takuma;Shimizu, Hiroaki;Takizawa, Makiko;Yokohama, Akihiko;Tsukamoto, Norifumi;Handa, Hiroshi;Murakami, Hirokazu, 2020, EUROPEAN JOURNAL OF HAEMATOLOGY, 104, 6, 526, 537

  DOI
• Genomic analysis of multiple myeloma using targeted capture sequencing in the Japanese cohort, Kanamori, Takashi;Sanada, Masashi;Ri, Masaki;Ueno, Hiroo;Nishijima, Dai;Yasuda, Takahiko;Tachita, Takuto;Narita, Tomoko;Kusumoto, Shigeru;Inagaki, Atsushi;Ishihara, Rei;Murakami, Yuki;Kobayashi, Nobuhiko;Shiozawa, Yusuke;Yoshida, Kenichi;Nakagawa, Masahiro M.;Nannya, Yasuhito;Shiraishi, Yuichi;Chiba, Kenichi;Tanaka, Hiroko;Miyano, Satoru;Horibe, Keizo;Handa, Hiroshi;Ogawa, Seishi;Iida, Shinsuke, 2020, BRITISH JOURNAL OF HAEMATOLOGY, 191, 5, 755, 763

  DOI
• Once-weekly vs. twice-weekly carfilzomib dosing in a subgroup of Japanese relapsed and refractory multiple myeloma patients from a randomized phase 3 trial (ARROW) and comparison with ENDEAVOR, Takezako, Naoki;Shibayama, Hirohiko;Handa, Hiroshi;Hagiwara, Shotaro;Ozaki, Shuji;Suzuki, Kenshi;Kosugi, Hiroshi;Ri, Masaki;Sugiura, Isamu;Choi, Ilseung;Miyamoto, Toshihiro;Iida, Shinsuke, 2021, INTERNATIONAL JOURNAL OF HEMATOLOGY, 113, 2, 219, 230

  DOI
• Th1 Cytokine Polymorphism Gene: TNF-Alpha-857C/T Affects the Pathogenesis and Progression of Acute Myeloid Leukemia, Soma, Kana;Nanami, Gotoh;Kasamatsu, Tetsuhiro;Murakami, Yuki;Ishihara, Rei;Awata, Maaya;Yamane, Eiko;Sunaga, Masanobu;Asao, Yuta;Hashimoto, Nao;Ogawa, Yoshiyuki;Shimizu, Hiroaki;Ishizaki, Takuma;Yokohama, Akihiko;Tsukamoto, Norifumi;Handa, Hiroshi;Sakura, Toru;Takada, Satoru;Saitoh, Takayuki, 2019, BLOOD, 134

  DOI
• Impact of Continuous and Maintenance Therapy on Survival Outcome in Patients with Newly Diagnosed Multiple Myeloma: A Multicenter Retrospective Collaborative Study of the Japanese Society of Myeloma, Ozaki, Shuji;Handa, Hiroshi;Saitoh, Takayuki;Sunami, Kazutaka;Ishida, Tadao;Suzuki, Kenshi;Narita, Tomoko;Iida, Shinsuke;Nakamura, Yuichi;Suzuki, Kazuhito;Nishimura, Noriko;Murakami, Hirokazu;Shimizu, Kazuyuki, 2019, BLOOD, 134

  DOI
• P53 Pathway Activation Mediated High c-MAF Expression Is Associated with Overall and Post-Progression Survival in Multiple Myeloma, Yamane, Eiko;Oda, Tsukasa;Sunaga, Masanobu;Murakami, Yuki;Ishihara, Rei;Asao, Yuta;Masuda, Yuta;Watanabe, Saki;Kobayashi, Nobuhiko;Takei, Hisashi;Osaki, Yohei;Nanami, Gotoh;Kasamatsu, Tetsuhiro;Shimizu, Hiroaki;Ishizaki, Takuma;Koiso, Hiromi;Takizawa, Makiko;Ogawa, Yoshiyuki;Yokohama, Akihiko;Tsukamoto, Norifumi;Saitoh, Takayuki;Murakami, Hirokazu;Handa, Hiroshi, 2019, BLOOD, 134

  DOI
• Serum Soluble CD86, Still a Prognostic Factor in the Novel Agent Era in Multiple Myeloma Patients, Is Produced By Myeloma Cells with High CD86 Variant 3 Expression, Ishibashi, Mariko;Kinoshita, Ryosuke;Inokuchi, Koiti;Handa, Hiroshi;Sasaki, Makoto;Komatsu, Norio;Imai, Yoichi;Hiroike, Norina;Tanaka, Junji;Tanosaki, Sakae;Ito, Shigeki;Sunakawa, Mika;Asayama, Toshio;Kuribayashi-hamada, Yasuko;Morita, Rimpei;Tamura, Hideto, 2019, BLOOD, 134

  DOI
• DNA Polymerases Pol theta/Pol eta Involved in Error-Prone DNA Repair Are Highly Expressed in Multiple Myeloma and Upregulated By DNA Damage, Sunaga, Masanobu;Oda, Tsukasa;Yamane, Eiko;Ishihara, Rei;Murakami, Yuki;Watanabe, Saki;Asao, Yuta;Masuda, Yuta;Takei, Hisashi;Kobayashi, Nobuhiko;Osaki, Yohei;Nanami, Gotoh;Kasamatsu, Tetsuhiro;Koiso, Hiromi;Takizawa, Makiko;Shimizu, Hiroaki;Ishizaki, Takuma;Ogawa, Yoshiyuki;Yokohama, Akihiko;Tsukamoto, Norifumi;Saitoh, Takayuki;Murakami, Hirokazu;Handa, Hiroshi, 2019, BLOOD, 134

  DOI
• Risk Factors for Central Nervous System (CNS) Relapse after Autologous Stem Cell Transplant (ASCT) in Diffuse Large B-Cell Lymphoma (DLBCL), Terasaki, Yukie;Shimizu, Hiroaki;Miyazawa, Yuri;Toyama, Kohtaro;Koiso, Hiromi;Yokohama, Akihiko;Matsumoto, Morio;Ogura, Hidemi;Naito, Chiaki;Tsukamoto, Norifumi;Handa, Hiroshi, 2019, BLOOD, 134

  DOI
• Distinct, Ethnic, Clinical, and Genetic Characteristics of Myelodysplastic Syndromes with Der(1;7), Okuda, Rurika;Makishima, Hideki;Nannya, Yasuhito;Ochi, Yotaro;Yoshizato, Tetsuichi;Nagata, Yasunobu;Yoshida, Kenichi;Sanada, Masashi;Takeda, June;Saiki, Ryunosuke;Shiraishi, Yuichi;Miyano, Satoru;Kern, Wolfgang;Baer, Constance;Nadarajah, Niroshan;Haferlach, Claudia;Atsuta, Yoshiko;Kasahara, Senji;Handa, Hiroshi;Chiba, Shigeru;Haferlach, Torsten;Ogawa, Seishi, 2019, BLOOD, 134

  DOI
• Clinical Significance of Additional Cytogenetic Abnormalities (ACA) at Disease Progression in Patients with High-Risk Myelodysplastic Syndrome (MDS) Treated with Azacitidine, Naito, Chiaki;Shimizu, Hiroaki;Miyazawa, Yuri;Ishizaki, Takuma;Yokohama, Akihiko;Saito, Takayuki;Tsukamoto, Norifumi;Handa, Hiroshi, 2019, BLOOD, 134

  DOI
• Extramedullary Relapses after Allogeneic Stem Cell Transplant (allo-SCT) in Adult Patients with Acute Lymphoblastic Leukemia (ALL), Shimizu, Hiroaki;Ishizaki, Takuma;Hatsumi, Nahoko;Takada, Satoru;Yokohama, Akihiko;Saitoh, Takayuki;Sakura, Toru;Handa, Hiroshi, 2019, BLOOD, 134

  DOI
• Aberrant BUB1 Overexpression Promotes Mitotic Segregation Errors and Chromosomal Instability in Multiple Myeloma, Fujibayashi, Yuto;Isa, Reiko;Nishiyama, Daichi;Sakamoto-Inada, Natsumi;Kawasumi, Norichika;Yamaguchi, Junko;Kuwahara-Ota, Saeko;Matsumura-Kimoto, Yayoi;Tsukamoto, Taku;Chinen, Yoshiaki;Shimura, Yuji;Kobayashi, Tsutomu;Horiike, Shigeo;Taniwaki, Masafumi;Handa, Hiroshi;Kuroda, Junya, 2020, CANCERS, 12, 8

  DOI
• EWSR1 overexpression is a pro-oncogenic event in multiple myeloma, Nishiyama, Daichi;Chinen, Yoshiaki;Isa, Reiko;Fujibayashi, Yuto;Kuwahara-Ota, Saeko;Yamaguchi, Junko;Takimoto-Shimomura, Tomoko;Matsumura-Kimoto, Yayoi;Tsukamoto, Taku;Shimura, Yuji;Kobayashi, Tsutomu;Horiike, Shigeo;Taniwaki, Masafumi;Handa, Hiroshi;Kuroda, Junya, 2021, INTERNATIONAL JOURNAL OF HEMATOLOGY, 113, 3, 381, 394

  DOI
• Long Noncoding RNA PVT1 Is Regulated by Bromodomain Protein BRD4 in Multiple Myeloma and Is Associated with Disease Progression, Handa, Hiroshi;Honma, Kazuki;Oda, Tsukasa;Kobayashi, Nobuhiko;Kuroda, Yuko;Kimura-Masuda, Kei;Watanabe, Saki;Ishihara, Rei;Murakami, Yuki;Masuda, Yuta;Tahara, Ken-ichi;Takei, Hisashi;Kasamatsu, Tetsuhiro;Saitoh, Takayuki;Murakami, Hirokazu, 2020, INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 21, 19

  DOI
• Efficient detection of copy-number variations using exome data: Batch- and sex-based analyses, Uchiyama, Yuri;Yamaguchi, Daisuke;Iwama, Kazuhiro;Miyatake, Satoko;Hamanaka, Kohei;Tsuchida, Naomi;Aoi, Hiromi;Azuma, Yoshiteru;Itai, Toshiyuki;Saida, Ken;Fukuda, Hiromi;Sekiguchi, Futoshi;Sakaguchi, Tomohiro;Lei, Ming;Ohori, Sachiko;Sakamoto, Masamune;Kato, Mitsuhiro;Koike, Takayoshi;Takahashi, Yukitoshi;Tanda, Koichi;Hyodo, Yuki;Honjo, Rachel S.;Bertola, Debora Romeo;Kim, Chong Ae;Goto, Masahide;Okazaki, Tetsuya;Yamada, Hiroyuki;Maegaki, Yoshihiro;Osaka, Hitoshi;Ngu, Lock-Hock;Siew, Ch'ng G.;Teik, Keng W.;Akasaka, Manami;Doi, Hiroshi;Tanaka, Fumiaki;Goto, Tomohide;Guo, Long;Ikegawa, Shiro;Haginoya, Kazuhiro;Haniffa, Muzhirah;Hiraishi, Nozomi;Hiraki, Yoko;Ikemoto, Satoru;Daida, Atsuro;Hamano, Shin-ichiro;Miura, Masaki;Ishiyama, Akihiko;Kawano, Osamu;Kondo, Akane;Matsumoto, Hiroshi;Okamoto, Nobuhiko;Okanishi, Tohru;Oyoshi, Yukimi;Takeshita, Eri;Suzuki, Toshifumi;Ogawa, Yoshiyuki;Handa, Hiroshi;Miyazono, Yayoi;Koshimizu, Eriko;Fujita, Atsushi;Takata, Atsushi;Miyake, Noriko;Mizuguchi, Takeshi;Matsumoto, Naomichi, 2021, HUMAN MUTATION, 42, 1, 50, 65

  DOI
• Deficiency of mannose-binding lectin is a risk of Pneumocystis jirovecii pneumonia in a natural history cohort of people living with HIV/AIDS in Northern Thailand, Yanagisawa, Kunio;Wichukchinda, Nuanjun;Tsuchiya, Naho;Yasunami, Michio;Rojanawiwat, Archawin;Tanaka, Hidenori;Saji, Hiroh;Ogawa, Yoshiyuki;Handa, Hiroshi;Pathipvanich, Panita;Ariyoshi, Koya;Sawanpanyalert, Pathom, 2020, PLOS ONE, 15, 12

  DOI
• Pathological and molecular analysis of a composite lymphoma of mantle cell lymphoma and Epstein-Barr virus-positive follicular lymphoma, Miyazawa, Yuri;Yokohama, Akihiko;Ishizaki, Takuma;Tsukamoto, Norifumi;Koshi, Hiromi;Hirato, Junko;Handa, Hiroshi, 2021, INTERNATIONAL JOURNAL OF HEMATOLOGY, 113, 4, 592, 599

  DOI
• DNA-double strand breaks enhance the expression of major histocompatibility complex class II through the ATM-NF-kappa Beta-IRF1-CIITA pathway, Oda, Tsukasa;Nakamura, Ruri;Kasamatsu, Tetsuhiro;Gotoh, Nanami;Okuda, Keiko;Saitoh, Takayuki;Handa, Hiroshi;Murakami, Hirokazu;Yamashita, Takayuki, 2022, CANCER GENE THERAPY, 29, 2, 225, 240

  DOI
• IDO2 rs10109853 polymorphism affects the susceptibility to multiple myeloma, Kasamatsu, Tetsuhiro;Hashimoto, Nao;Sakaya, Nao;Awata-Shiraiwa, Maaya;Ishihara, Rei;Murakami, Yuki;Masuda, Yuta;Gotoh, Nanami;Nagai, Kazue;Oda, Tsukasa;Yokohama, Akihiko;Saitoh, Takayuki;Handa, Hiroshi;Tsukamoto, Norifumi;Hayashi, Kunihiko;Murakami, Hirokazu, 2021, CLINICAL AND EXPERIMENTAL MEDICINE, 21, 2, 323, 329

  DOI
• Clonal evolution detected with conventional cytogenetic analysis is a potent prognostic factor in adult patients with relapsed Philadelphia chromosome-negative acute lymphoblastic leukemia, Shimizu, Hiroaki;Yokohama, Akihiko;Ishizaki, Takuma;Hatsumi, Nahoko;Takada, Satoru;Saitoh, Takayuki;Sakura, Toru;Handa, Hiroshi, 2021, LEUKEMIA RESEARCH, 103

  DOI
• Expression of activated integrin beta 7 in multiple myeloma patients, Hosen, Naoki;Yoshihara, Satoshi;Takamatsu, Hiroyuki;Ri, Masaki;Nagata, Yasuyuki;Kosugi, Hiroshi;Shimomura, Yoshimitsu;Hanamura, Ichiro;Fuji, Shigeo;Minauchi, Koichiro;Kuroda, Junya;Suzuki, Rikio;Nishimura, Noriko;Uoshima, Nobuhiko;Nakamae, Hirohisa;Kawano, Yawara;Mizuno, Ishikazu;Gomyo, Hiroshi;Suzuki, Kenshi;Ozaki, Shuji;Nakamura, Shingen;Imai, Yoichi;Kizaki, Masahiro;Negoro, Eiju;Handa, Hiroshi;Iida, Shinsuke, 2021, INTERNATIONAL JOURNAL OF HEMATOLOGY, 114, 1, 3, 7

  DOI
• Propensity-score matched analysis of the efficacy of maintenance/continuous therapy in newly diagnosed patients with multiple myeloma: a multicenter retrospective collaborative study of the Japanese Society of Myeloma, Ozaki, Shuji;Handa, Hiroshi;Koiso, Hiromi;Saitoh, Takayuki;Sunami, Kazutaka;Ishida, Tadao;Suzuki, Kenshi;Narita, Tomoko;Iida, Shinsuke;Nakamura, Yuichi;Suzuki, Kazuhito;Nishimura, Noriko;Murakami, Hirokazu;Shimizu, Kazuyuki, 2022, JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 148, 1, 191, 203

  DOI
• Circulating cell-free DNA in the peripheral blood plasma of patients is an informative biomarker for multiple myeloma relapse, Yasui, Hiroshi;Kobayashi, Masayuki;Sato, Kota;Kondoh, Kanya;Ishida, Tadao;Kaito, Yuta;Tamura, Hideto;Handa, Hiroshi;Tsukune, Yutaka;Sasaki, Makoto;Komatsu, Norio;Tanaka, Norina;Tanaka, Junji;Kizaki, Masahiro;Kawamata, Toyotaka;Makiyama, Junya;Yokoyama, Kazuaki;Imoto, Seiya;Tojo, Arinobu;Imai, Yoichi, 2021, INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 26, 11, 2142, 2150

  DOI
• A nationwide survey on central nervous system multiple myeloma in Japan: analysis of prognostic and treatment factors that impact survival, Yamashita, Takeshi;Takamatsu, Hiroyuki;Kawamura, Koji;Sunami, Kazutaka;Hagiwara, Shotaro;Itagaki, Mitsuhiro;Takahashi, Tsutomu;Kondo, Tadakazu;Ikeda, Takashi;Watakabe-Inamoto, Kyoko;Handa, Hiroshi;Imaizumi, Yoshitaka;Kuroda, Junya;Murakami, Jun;Nakamura, Yuichi;Nakazawa, Hideyuki;Ozaki, Shuji;Okura, Miyuki;Takeuchi, Masami;Nagai, Hirokazu;Hanamura, Ichiro;Nakao, Shinji;Iida, Shinsuke, 2021, BRITISH JOURNAL OF HAEMATOLOGY, 195, 2, 217, 229

  DOI
• Model-based analysis to support dose selection of pevonedistat (PEV) combined with azacitidine (AZA) in patients (pts) with higher-risk myelodysplastic syndromes (MDS)/chronic myelomonocytic leukemia (CMML) and acute myeloid leukemia (AML)., Zhou, Xiaofei;Mould, Diane R.;Zhao, Dan;Sekeres, Mikkael A.;Ades, Lionel;Swords, Ronan T.;Handa, Hiroshi;Fram, Robert J.;Faller, Douglas V.;Tsukurov, Olga;Gupta, Neeraj, 2021, JOURNAL OF CLINICAL ONCOLOGY, 39, 15

  DOI
• An Autopsy Case of Multicentric Castleman Disease Presenting with Severe Jaundice, Yamazaki, Yuichi;Yoshida, Yuka;Shimizu, Megumi;Kobayashi, Takeshi;Tojima, Hiroki;Sato, Ken;Kakizaki, Satoru;Handa, Hiroshi;Yokoo, Hideaki;Uraoka, Toshio, 2021, INTERNAL MEDICINE, 60, 22, 3615, 3620

  DOI
• Reduction of blood group an antigen on erythrocytes in a patient with myelodysplastic syndrome harboring somatic mutations in RUNX1 and GATA2, Hayakawa, Akira;Sano, Rie;Takahashi, Yoichiro;Okawa, Takafumi;Kubo, Rieko;Harada, Megumi;Fukuda, Haruki;Yokohama, Akihiko;Handa, Hiroshi;Kawabata-Iwakawa, Reika;Tsuneyama, Hatsue;Tsukada, Junichi;Kominato, Yoshihiko, 2022, TRANSFUSION, 62, 2, 469, 480

  DOI
• The Efficacy and Safety of Caplacizumab in Japanese Patients with Immune-Mediated Thrombotic Thrombocytopenic Purpura (iTTP): An Open-Label, Phase 2/3 Study, Miyakawa, Yoshitaka;Imada, Kazunori;Ichikawa, Satoshi;Uchiyama, Hitoji;Ueda, Yasunori;Yonezawa, Akihito;Fujitani, Shigeki;Handa, Hiroshi;Matsushita, Tadashi;Asakura, Hidesaku;Nishio, Kenji;Suzuki, Kodai;Hashimoto, Yasuhiro;Ohshima, Shinobu;Tahara, Sayaka;Tanaka, Tomoyuki;Matsumoto, Masanori, 2021, BLOOD, 138

  DOI
• Allogeneic Stem Cell Transplantation Conditioned with Myeloablative Regimens Containing Total Body Irradiation in Adolescent and Young Adult Patients with Philadelphia Chromosome-Negative Acute Lymphoblastic Leukemia Who Were Treated with Pediatric-Type Chemotherapy, Shimizu, Hiroaki;Kato, Jun;Kimura, Shun-ichi;Tachibana, Takayoshi;Hatano, Kaoru;Usuki, Kensuke;Taguchi, Jun;Hagihara, Maki;Tsukada, Nobuhiro;Harada, Kaito;Takahashi, Satoshi;Takada, Satoru;Sakaida, Emiko;Fujisawa, Shin;Onoda, Masahiro;Aotsuka, Nobuyuki;Handa, Hiroshi;Hatta, Yoshihiro;Nakaseko, Reiko;Yano, Shingo;Ohashi, Kazuteru;Kanda, Yoshinobu, 2021, BLOOD, 138

  DOI
• Outcomes of Transplant-Eligible Patients with Myelodysplastic Syndrome-Refractory Anemia with Excess Blasts Registered in a Prospective Observational Study: The JALSG-CS11-MDS-SCT, Nakagawa, Noriharu;Ishiyama, Ken;Usuki, Kensuke;Takada, Satoru;Tomikawa, Tatsuki;Handa, Hiroshi;Katsuoka, Yuna;Hirano, Daiki;Sezaki, Nobuo;Sumi, Masahiko;Fujisawa, Shin;Taniguchi, Yasuhiro;Yoshimura, Takuro;Ohtsuka, Eiichi;Takase, Ken;Suehiro, Youko;Ota, Shuichi;Kajiguchi, Tomohiro;Maeda, Tomoya;Yamamoto, Masahide;Ohtake, Shigeki;Katsumi, Akira;Kiyoi, Hitoshi;Matsumura, Itaru;Miyazaki, Yasushi, 2021, BLOOD, 138

  DOI
• Prognostic Impacts of Additional Cytogenetic Abnormalities Acquired at the First Relapse in Adult Patients with Acute Myeloid Leukemia Undergoing Allogeneic Stem Cell Transplant in Second Complete Remission, Shimizu, Hiroaki;Mukae, Junichi;Shingai, Naoki;Toya, Takashi;Najima, Yuho;Kobayashi, Takeshi;Hatsumi, Nahoko;Takada, Satoru;Handa, Hiroshi;Haraguchi, Kyoko;Okuyama, Yoshiki;Sakamaki, Hisashi;Ohashi, Kazuteru;Doki, Noriko, 2021, BLOOD, 138

  DOI
• ETNK1 mutations defines a subclass of der(1;7)(q10;p10) in myelodysplastic syndromes, Okuda, Rurika;Nannya, Yasuhito;Ochi, Yotaro;Chonabayashi, Kazuhisa;Makishima, Hideki;Nagata, Yasunobu;Sanada, Masashi;Shiraishi, Yuichi;Miyano, Satoru;Atsuta, Yoshiko;Kasahara, Senji;Handa, Hiroshi;Chiba, Shigeru;Ohyashiki, Kazuma;Ogawa, Seishi, 2022, CANCER SCIENCE, 113, 824, 824
• Two-year outcomes of tirabrutinib monotherapy in Waldenstrom's macroglobulinemia, Sekiguchi, Naohiro;Rai, Shinya;Munakata, Wataru;Suzuki, Kenshi;Handa, Hiroshi;Shibayama, Hirohiko;Endo, Tomoyuki;Terui, Yasuhito;Iwaki, Noriko;Fukuhara, Noriko;Tatetsu, Hiro;Iida, Shinsuke;Ishikawa, Takayuki;Iguchi, Daisuke;Izutsu, Koji, 2022, CANCER SCIENCE, 113, 6, 2085, 2096

  DOI
• Prospective comparison of 5-and 7-day administration of azacitidine for myelodysplastic syndromes: a JALSG MDS212 trial, Miyazaki, Yasushi;Kiguchi, Toru;Sato, Shinya;Usuki, Kensuke;Ishiyama, Ken;Ito, Yoshikazu;Suzuki, Takahiro;Taguchi, Jun;Chiba, Shigeru;Dobashi, Nobuaki;Tomita, Akihiro;Harada, Hironori;Handa, Hiroshi;Horiike, Shigeo;Maeda, Tomoya;Matsuda, Mitsuhiro;Ichikawa, Motoshi;Hata, Tomoko;Honda, Sumihisa;Iyama, Satoshi;Suzushima, Hitoshi;Moriuchi, Yukiyoshi;Kurokawa, Toshiro;Yokota, Kenichi;Ohtake, Shigeki;Yamauchi, Takahiro;Matsumura, Itaru;Kiyoi, Hitoshi;Naoe, Tomoki;Japan Adult Leukemia Study Grp, 2022, INTERNATIONAL JOURNAL OF HEMATOLOGY, 116, 2, 228, 238

  DOI
• Pevonedistat in East Asian patients with acute myeloid leukemia or myelodysplastic syndromes: a phase 1/1b study to evaluate safety, pharmacokinetics and activity as a single agent and in combination with azacitidine, Handa, Hiroshi;Cheong, June-Won;Onishi, Yasushi;Iida, Hiroatsu;Kobayashi, Yukio;Kim, Hyeoung-Joon;Chiou, Tzeon-Jye;Izutsu, Koji;Tsukurov, Olga;Zhou, Xiaofei;Faessel, Helene;Yuan, Ying;Sedarati, Farhad;Faller, Douglas V.;Kimura, Akiko;Wu, Shang-Ju, 2022, JOURNAL OF HEMATOLOGY & ONCOLOGY, 15, 1

  DOI
• Volasertib as a monotherapy or in combination with azacitidine in patients with myelodysplastic syndrome, chronic myelomonocytic leukemia, or acute myeloid leukemia: summary of three phase I studies, Platzbecker, Uwe;Chromik, Joerg;Kroenke, Jan;Handa, Hiroshi;Strickland, Stephen;Miyazaki, Yasushi;Wermke, Martin;Sakamoto, Wataru;Tachibana, Yoshifumi;Taube, Tillmann;Germing, Ulrich, 2022, BMC CANCER, 22, 1

  DOI
• Real-World Effectiveness of Bortezomib Plus Dexamethasone in Patients with t(11;14) Positive Multiple Myeloma, Emechebe, Nnadozie;Kumar, Shaji;Goldschmidt, Hartmut;Victoria Mateos, Maria;Du, Juan;Kim, Kihyun;Merlini, Giampaolo;Dimopolous, Meletios A.;Ludwig, Heinz;Handa, Hiroshi;Fernandez de Larrea, Carlos;Reece, Donna E.;Chen, Wenming;Raje, Noopur S.;Karve, Sudeep;Arriola, Emma;Ross, Jeremy A.;Durie, Brian G. M., 2021, BLOOD, 138

  DOI
• Systemic Lupus Erythematosus Presenting With Thrombotic Thrombocytopenic Purpura at Onset: A Case Report, Takagi, Yoko;Kobayashi, Yasuko;Hirakata, Ayako;Takei, Mariko;Ogasawara, Satoshi;Yajima, Chikage;Ikeuchi, Yuka;Matsumoto, Akira;Ogawa, Yoshiyuki;Handa, Hiroshi;Matsumoto, Masanori;Arakawa, Hirokazu;Takizawa, Takumi, 2022, FRONTIERS IN PEDIATRICS, 10

  DOI
• Antibody therapy for multiple myeloma, HANDA Hiroshi, 2021, Rinsho Ketsueki, 62, 8, 1167, 1177
• An Autopsy Case of Multicentric Castleman Disease Presenting with Severe Jaundice, Yamazaki Yuichi;Yoshida Yuka;Shimizu Megumi;Kobayashi Takeshi;Tojima Hiroki;Sato Ken;Kakizaki Satoru;Handa Hiroshi;Yokoo Hideaki;Uraoka Toshio, 2021, Internal Medicine, advpub, 0, 3615, 3620
• 【慢性疾患となった骨髄腫-どのように診断するか?　どのように付き合っていくか?】骨髄腫治療薬の温故知新　アルキル化薬とステロイド, ;;;, Oct. 2017, 120, 4, 865
• IFN-γ+874T/A遺伝子多型は低リスク骨髄異形成症候群の病態に関与する, ;;;;;;;;;, Jun. 2017, 18, 学術集会, S185
• 多発性骨髄腫患者における免疫チェックポイント遺伝子の多型解析, ;;;;;;;;;, Jun. 2017, 18, 学術集会, S195
• 多発性骨髄腫におけるlong non-cording RNA NEAT1とMALAT1の発現, ;;;;;;;;;, Jun. 2017, 18, 学術集会, S195
• 多発性骨髄腫におけるMatrix metalloproteinase(MMP)及びtissue inhibitor of metalloproteinases(TIMP)の発現, ;;;;;;;;;, Jun. 2017, 18, 学術集会, S196
• 多発性骨髄腫細胞株におけるc-Myc作用阻害によるmicroRNA-29発現の変化, ;;;;;;;;;, Jun. 2017, 18, 学術集会, S196
• 多発性骨髄腫におけるc-MycとLong non coding RNA PVT1の発現, ;;;;;;;;;, Jun. 2017, 18, 学術集会, S197
• 急性骨髄性白血病患者における多機能蛋白APE1遺伝子多型解析, ;;;;;;;;;, Jun. 2017, 18, 学術集会, S209
• PD-1およびCTLA-4遺伝子多型は慢性免疫性血小板減少症の発症および症状に関与する, ;;;;;;;;;, Jun. 2017, 18, 学術集会, S218
• PD-1およびPD-L1遺伝子多型は多発性骨髄腫の髄外病変の合併および重症度に関与する, ;;;;;;;;;;;;, Aug. 2017, 67, 3, 267
• Th1サイトカイン多型は骨髄異形成症候群の重症度に関与する, ;;;;;;;;;;;;;;;, Aug. 2017, 67, 3, 267
• Th1サイトカインTNF-α-857C/Tは特発性血小板減少性紫斑病の発症リスクに関与する, ;;;;;;;;;;;;;;, Aug. 2017, 67, 3, 276
• DNA架橋剤メラファランは多発性骨髄腫細胞株において主要組織適合抗原クラスII(MHC II)の転写活性化因子CIITAの発現を促進する, ;;;;;;;;;, Dec. 2017, 2017年度, [2P
• TNF-α-857C/Tは特発性血小板減少性紫斑病の発症リスクを上昇させる, ;;;;;;;;;, Jun. 2018, 19, 学術集会, S134
• 多発性骨髄腫におけるlong non-cording RNA MALAT1とNEAT1およびNEAT1_2の発現, ;;;;;;;;, Jun. 2018, 19, 学術集会, S157
• 多発性骨髄腫細胞株におけるmicroRNA-29,34 familyの発現制御機構, ;;;;;;;;, Jun. 2018, 19, 学術集会, S158
• 多発性骨髄腫におけるPD-1、PD-L1およびCTLA-4遺伝子多型解析, ;;;;;;;;;;;;, May 2018, 8, 2, 137
• PNA clamp PCR法を用いたリンパ形質細胞性リンパ種におけるCXCR4遺伝子変異の同定(Detection of CXCR4 mutation by PNA clamp PCR method on FFPE samples of lymphoplasmacytic lymphoma), ;;;;;;;;;;;, Sep. 2018, 59, 9, 1655
• 大気micro-PIXE法を用いた急性前骨髄性白血病細胞内微量元素の動態解析　アントラサイクリン系抗腫瘍薬とDNAメチル基転移酵素阻害剤が急性前骨髄性白血病細胞に及ぼす影響, ;;;;;;;, Oct. 2018, 55回, 179
• 多発性骨髄腫におけるDNAポリメラーゼの発現, ;;;;;;;;;, Jun. 2019, 20, 学術集会, S88
• リンパ形質細胞性リンパ腫におけるホルマリン固定パラフィン包埋標本を用いた遺伝子変異の検出および検体の評価, ;;;;;;;;;, Jun. 2019, 20, 学術集会, S114
• 多発性骨髄腫におけるc-MAFおよびMAFBの発現, ;;;;;;;;;, Jun. 2019, 20, 学術集会, S118
• 多発性骨髄腫におけるProgrammed Cell Death Ligand-1(PD-L1)およびPD-L2の発現, ;;;;;;;;;, Jun. 2019, 20, 学術集会, S119
• Th1サイトカインTNF-α-857C>Tは急性骨髄性白血病の発症リスク、臨床背景、予後に関与する, ;;;;;, Jun. 2019, 20, 学術集会, S157
• 多発性骨髄腫細胞株におけるmicroRNA-29、34 familyの発現制御機構, ;;;;;;;;;;;;;;;;;, Aug. 2018, 68, 3, 201
• 多発性骨髄腫における髄外形質細胞腫とMatrix metalloproteinase(MMP)及びtissue inhibitor of metalloproteinases(TIMP)の発現, ;;;;;;;;;;;;;;;;;, Aug. 2018, 68, 3, 213
• DNA損傷修復応答に関与するDNAポリメラーゼPOLQとPOLHの多発性骨髄腫における発現, ;;;;;;;;;;;;;;;;;;;;;;;;;, Aug. 2019, 69, 3, 296
• 末梢血幹細胞採取におけるSphingosine-1-phosphateの関与, ;;;;;;;;;;;;, Aug. 2019, 69, 3, 300
• Th1サイトカイン遺伝子多型は慢性免疫性血小板減少症(cITP)の重症度に影響する, ;;;;;;;;;, Aug. 2019, 69, 3, 301
• Triple-class refractory多発性骨髄腫に対するXPO1阻害薬selinexor, 半田 寛, May 2020, 80, 5, 739
• 【多発性骨髄腫の最新情報】多発性骨髄腫におけるエピゲノム異常, 半田 寛, Oct. 2017, 34, 4, 46
• 早期胃癌の内視鏡切除後に凝固能的完全寛解を得た後天性血友病Aの一例, ;;;;;;;;;;;, Sep. 2020, 361回, 22
• 後天性凝固第X因子欠乏、線溶異常を契機にALアミロイドーシスの診断に至った一症例, ;;;;;;;;;;;;, May 2020, 31, 2, 256
• 薬害HIV/HCV共感染血友病患者の肝細胞癌に対する重粒子線治療, ;;;;;;;;;;;;;;;;;;, Nov. 2019, 21, 4, 494
• 【再発・難治性多発性骨髄腫治療の最前線-イサツキシマブの登場-】多発性骨髄腫診療の変遷　治療の現状と課題　化学療法、移植、分子標的療法, 半田 寛, Mar. 2021, 41, 3, 231
• plerixafor時代の動員前末梢血CD34陽性細胞数測定の意義, ;;;;;;;;;;;;;, May 2021, 67, 2, 318
• 多発性骨髄腫の髄外進展におけるTIMP1の影響, ;;;;;;;;, Aug. 2021, 22, 学術集会, S165
• 健常者T細胞における薬剤誘導性細胞老化の検討, ;;;;;;;;;, Aug. 2021, 22, 学術集会, S187
• 多発性骨髄腫に対する免疫抗体療法, 半田 寛, Aug. 2021, 62, 8, 1167
• azacitidine投与によるA抗原性の回復, ;;;;;;;;, Aug. 2021, 67, 4, 507
• 骨髄腫に対する新規薬剤を用いた治療は、有効な限り投与を継続するべきか?　骨髄腫に対する新規薬剤を用いた治療は可能であれば疾患進行まで継続するべきである, ;, Feb. 2022, 5104, 48
• 【多発性骨髄腫および類縁疾患の病態解析と治療の進歩】Frailty評価に基づく高齢者骨髄腫治療, ;, Apr. 2022, 84, 4, 495
• NFKB1-94ins/delATTGは急性骨髄性白血病のリスクと予後不良に関連する(NFKB1-94 ins/del ATTG is associated with the risk of AML and poor prognosis), ;;;;;;;;;;;;, Sep. 2021, 83回, PS
• 先天性プロテインC欠乏症における抗凝固療法継続の必要性ついての検討(Requirement of permanent anticoagulation therapy for congenital protein C deficiency), ;;;;;;;;;, Sep. 2021, 83回, OS3
• ABO式血液型抗原量低下を示した骨髄異形成症候群の機序の解析, ;;;;;;;;;;;;, Apr. 2022, 68, 2, 280
• アレムツズマブを投与した再発難治CD52陽性T細胞性前リンパ球性白血病(T-PLL), ;;;;;;;;;;;;, May 2022, 63, 5, 504
• Efficient detection of copy-number variations using exome data: Batch- and sex-based analyses., Uchiyama Yuri;Yamaguchi Daisuke;Iwama Kazuhiro;Miyatake Satoko;Hamanaka Kohei;Tsuchida Naomi;Aoi Hiromi;Azuma Yoshiteru;Itai Toshiyuki;Saida Ken;Fukuda Hiromi;Sekiguchi Futoshi;Sakaguchi Tomohiro;Lei Ming;Ohori Sachiko;Sakamoto Masamune;Kato Mitsuhiro;Koike Takayoshi;Takahashi Yukitoshi;Tanda Koichi;Hyodo Yuki;Honjo Rachel S;Bertola Debora Romeo;Kim Chong Ae;Goto Masahide;Okazaki Tetsuya;Yamada Hiroyuki;Maegaki Yoshihiro;Osaka Hitoshi;Ngu Lock-Hock;Siew Ch'ng G;Teik Keng W;Akasaka Manami;Doi Hiroshi;Tanaka Fumiaki;Goto Tomohide;Guo Long;Ikegawa Shiro;Haginoya Kazuhiro;Haniffa Muzhirah;Hiraishi Nozomi;Hiraki Yoko;Ikemoto Satoru;Daida Atsuro;Hamano Shin-Ichiro;Miura Masaki;Ishiyama Akihiko;Kawano Osamu;Kondo Akane;Matsumoto Hiroshi;Okamoto Nobuhiko;Okanishi Tohru;Oyoshi Yukimi;Takeshita Eri;Suzuki Toshifumi;Ogawa Yoshiyuki;Handa Hiroshi;Miyazono Yayoi;Koshimizu Eriko;Fujita Atsushi;Takata Atsushi;Miyake Noriko;Mizuguchi Takeshi;Matsumoto Naomichi, 11 Nov. 2020, Human mutation, 42, 1

  DOI
• Deficiency of mannose-binding lectin is a risk of Pneumocystis jirovecii pneumonia in a natural history cohort of people living with HIV/AIDS in Northern Thailand., Yanagisawa Kunio;Wichukchinda Nuanjun;Tsuchiya Naho;Yasunami Michio;Rojanawiwat Archawin;Tanaka Hidenori;Saji Hiroh;Ogawa Yoshiyuki;Handa Hiroshi;Pathipvanich Panita;Ariyoshi Koya;Sawanpanyalert Pathom, 23 Dec. 2020, PloS one, 15, 12

  DOI
• Clonal evolution detected with conventional cytogenetic analysis is a potent prognostic factor in adult patients with relapsed Philadelphia chromosome-negative acute lymphoblastic leukemia., Shimizu Hiroaki;Yokohama Akihiko;Ishizaki Takuma;Hatsumi Nahoko;Takada Satoru;Saitoh Takayuki;Sakura Toru;Handa Hiroshi, 14 Feb. 2021, Leukemia research, 103

  DOI
• DNA-double strand breaks enhance the expression of major histocompatibility complex class II through the ATM-NF-κΒ-IRF1-CIITA pathway., Oda Tsukasa;Nakamura Ruri;Kasamatsu Tetsuhiro;Gotoh Nanami;Okuda Keiko;Saitoh Takayuki;Handa Hiroshi;Murakami Hirokazu;Yamashita Takayuki, 22 Feb. 2021, Cancer gene therapy, 29, 2

  DOI
• IDO2 rs10109853 polymorphism affects the susceptibility to multiple myeloma., Kasamatsu Tetsuhiro;Hashimoto Nao;Sakaya Nao;Awata-Shiraiwa Maaya;Ishihara Rei;Murakami Yuki;Masuda Yuta;Gotoh Nanami;Nagai Kazue;Oda Tsukasa;Yokohama Akihiko;Saitoh Takayuki;Handa Hiroshi;Tsukamoto Norifumi;Hayashi Kunihiko;Murakami Hirokazu, 12 Mar. 2021, Clinical and experimental medicine, 21, 2

  DOI
• Expression of activated integrin β7 in multiple myeloma patients., Hosen Naoki;Yoshihara Satoshi;Takamatsu Hiroyuki;Ri Masaki;Nagata Yasuyuki;Kosugi Hiroshi;Shimomura Yoshimitsu;Hanamura Ichiro;Fuji Shigeo;Minauchi Koichiro;Kuroda Junya;Suzuki Rikio;Nishimura Noriko;Uoshima Nobuhiko;Nakamae Hirohisa;Kawano Yawara;Mizuno Ishikazu;Gomyo Hiroshi;Suzuki Kenshi;Ozaki Shuji;Nakamura Shingen;Imai Yoichi;Kizaki Masahiro;Negoro Eiju;Handa Hiroshi;Iida Shinsuke, 17 May 2021, International journal of hematology, 114, 1

  DOI
• Propensity-score matched analysis of the efficacy of maintenance/continuous therapy in newly diagnosed patients with multiple myeloma: a multicenter retrospective collaborative study of the Japanese Society of Myeloma., Ozaki Shuji;Handa Hiroshi;Koiso Hiromi;Saitoh Takayuki;Sunami Kazutaka;Ishida Tadao;Suzuki Kenshi;Narita Tomoko;Iida Shinsuke;Nakamura Yuichi;Suzuki Kazuhito;Nishimura Noriko;Murakami Hirokazu;Shimizu Kazuyuki, 02 Jun. 2021, Journal of cancer research and clinical oncology, 148, 1

  DOI
• An Autopsy Case of Multicentric Castleman Disease Presenting with Severe Jaundice., Yamazaki Yuichi;Yoshida Yuka;Shimizu Megumi;Kobayashi Takeshi;Tojima Hiroki;Sato Ken;Kakizaki Satoru;Handa Hiroshi;Yokoo Hideaki;Uraoka Toshio, 05 Jun. 2021, Internal medicine (Tokyo, Japan), 60, 22

  DOI
• Primary central nervous system lymphoma in a patient with neuropsychiatric systemic lupus erythematosus receiving mycophenolate mofetil: A case report and literature review., Sakairi Toru;Nakasatomi Masao;Watanabe Mitsuharu;Hamatani Hiroko;Ikeuchi Hidekazu;Kaneko Yoriaki;Handa Hiroshi;Hiromura Keiju, Modern rheumatology case reports, 6, 1

  DOI
• Prospective comparison of 5- and 7-day administration of azacitidine for myelodysplastic syndromes: a JALSG MDS212 trial., Miyazaki Yasushi;Kiguchi Toru;Sato Shinya;Usuki Kensuke;Ishiyama Ken;Ito Yoshikazu;Suzuki Takahiro;Taguchi Jun;Chiba Shigeru;Dobashi Nobuaki;Tomita Akihiro;Harada Hironori;Handa Hiroshi;Horiike Shigeo;Maeda Tomoya;Matsuda Mitsuhiro;Ichikawa Motoshi;Hata Tomoko;Honda Sumihisa;Iyama Satoshi;Suzushima Hitoshi;Moriuchi Yukiyoshi;Kurokawa Toshiro;Yokota Kenichi;Ohtake Shigeki;Yamauchi Takahiro;Matsumura Itaru;Kiyoi Hitoshi;Naoe Tomoki; , 04 May 2022, International journal of hematology, 116, 2

  DOI
• Volasertib as a monotherapy or in combination with azacitidine in patients with myelodysplastic syndrome, chronic myelomonocytic leukemia, or acute myeloid leukemia: summary of three phase I studies., Platzbecker Uwe;Chromik Joerg;Krönke Jan;Handa Hiroshi;Strickland Stephen;Miyazaki Yasushi;Wermke Martin;Sakamoto Wataru;Tachibana Yoshifumi;Taube Tillmann;Germing Ulrich, 21 May 2022, BMC cancer, 22, 1

  DOI
• Successful Treatment of Immune Reconstitution Inflammatory Syndrome with Corticosteroid for Patient with Kaposiʼs Sarcoma Extending into the Respiratory Tract and Both Lungs, ISHIKAWA Tetsuya;YANAGISAWA Kunio;OGAWA Yoshiyuki;UCHIUMI Hideki;GOHDA Fumito;HANDA Hiroshi, Jan. 2017, Kansenshogaku Zasshi, 91, 1, 25, 30
• 慢性疾患となった骨髄腫-どのように診断するか?　どのように付き合っていくか? 骨髄腫治療薬の温故知新 アルキル化薬とステロイド, 村上 博和;笠松 哲光;齋藤 貴之;半田 寛, Oct. 2017, 120, 4, 865, 869
• Refractory thrombotic thrombocytopenic purpura complicated with multiple cerebral infarction, KAJITA Mikiya;OGAWA Yoshiyuki;MATSUMOTO Akira;NAITO Chiaki;MIHARA Masahiro;ISHIKAWA Tetsuya;KOBAYASHI Nobuhiko;MIYAZAWA Yuri;ISHIZAKI Takuma;SHIMIZU Tatsuya;SAKAI Kazuya;HAYAKAWA Masaki;MATSUMOTO Masanori;HANDA Hiroshi, 2022, Rinsho Ketsueki, 63, 1, 55, 61
• NFKB1-94ins/delATTGは急性骨髄性白血病のリスクと予後不良に関連する(NFKB1-94 ins/del ATTG is associated with the risk of AML and poor prognosis), ;;;;;;;;;;;;, Sep. 2021, 83回, PS
• 中枢神経再発高リスクび漫性大細胞型B細胞リンパ腫に対する中枢神経再発予防効果の単施設解析(A single-center analysis of central nervous system prophylaxis for diffuse large B cell lymphoma), ;;;;;;;, Sep. 2021, 83回, OS1
• び漫性大細胞型B細胞性リンパ腫治療開始前大腰筋体積の予後への影響(Assessment of the muscles psoas major volume at diagnosis for diffuse large B cell lymphoma), ;;;;;;, Sep. 2021, 83回, BPA
• 高齢悪性リンパ腫患者の新規フレイリティ評価指標の探索研究(Exploratory study for a novel frailty assessment index for elderly patients with malignant lymphoma), ;;;;;;;;;;;;;;;;, Sep. 2021, 83回, OS2
• 先天性プロテインC欠乏症における抗凝固療法継続の必要性ついての検討(Requirement of permanent anticoagulation therapy for congenital protein C deficiency), ;;;;;;;;;, Sep. 2021, 83回, OS3
• MDVレセプトデータベースを用いた国内の多発性骨髄腫患者における実臨床下での治療パターンおよび臨床転帰の検討(Real world treatment patterns and clinical outcomes in multiple myeloma patients from the MDV claims database in Japan), ;;;;;, May 2021, 11, 2, 103
• 【1ページでわかる内科疾患の診療ノート-"あたりまえ"のなかにある大事な視点】(第3章)血液　骨髄腫, 半田 寛, Apr. 2022, 129, 4, 681
• COVID-19 mRNAワクチン接種後に発症した後天性血友病A, ;;;;;;;;;;, May 2022, 33, 2, 246
• 当院における後天性血友病Aの免疫抑制療法に関する臨床的検討, ;;;;;;;;;;;;, May 2022, 33, 2, 297
• 当院における後天性血友病Aのリハビリテーションと転帰に関する臨床的検討, ;;;;;;;;;;;, May 2022, 33, 2, 297
• ABO式血液型抗原量低下を示した骨髄異形成症候群の機序の解析, ;;;;;;;;;;;;, Apr. 2022, 68, 2, 280
• 【見逃さない!潜んでいる血液疾患-気づきのためのポイント集】骨髄腫, 半田 寛, Jun. 2022, 40, 6, 591
• 慢性リンパ性白血病と異なるクローンから発生したリヒター症候群の1例, ;;;;;;;;;, May 2022, 63, 5, 507
• Tissue inhibitor of metalloproteinase 1(TIMP1)は骨髄腫の進行と線維芽細胞の浸潤能に関与する(Tissue inhibitor of metalloproteinase 1(TIMP1) is associated with myeloma progression and fibroblast invasive capacity), ;;;;;;;;;;;;, May 2022, 12, 3, 157
• 化学療法が奏効したIgMアミロイドーシス+リンパ形質細胞リンパ腫の一例(Favorable response of chemotherapy for IgM amyloidosis with lymphoplasmacytic lymphoma), ;;;;;, May 2022, 12, 3, 192
• 当院におけるT細胞リンパ腫の中枢再発に対する検討, ;;;;;;;;;;;;, Jun. 2022, 62, 102

MISC

• Association between OGG1 S326C CC genotype and elevated relapse risk in acute myeloid leukemia., Nanami Gotoh,Takayuki Saitoh,Noriyuki Takahashi,Tetsuhiro Kasamatsu,Yusuke Minato,Alkebsi Lobna,Tsukasa Oda,Takumi Hoshino,Toru Sakura,Hiroaki Shimizu,Makiko Takizawa,Hiroshi Handa,Akihiko Yokohama,Norifumi Tsukamoto,Hirokazu Murakami, Sep. 2018, International journal of hematology, 108, 3, 246, 253

  DOI
• Clinical management and outcomes of completely resected stage I follicular lymphoma., Akihiko Yokohama,Yoko Hashimoto,Makiko Takizawa,Hiroaki Shimizu,Yuri Miyazawa,Akio Saitoh,Kohtaro Toyama,Takuma Ishizaki,Takeki Mitsui,Takayuki Saitoh,Kayoko Murayama,Morio Matsumoto,Morio Sawamura,Hirokazu Murakami,Junko Hirato,Masaru Kojima,Yoshihisa Nojima,Hiroshi Handa,Norifumi Tsukamoto, 16 Mar. 2018, Journal of clinical and experimental hematopathology : JCEH, 58, 1, 10, 16

  DOI
• Short-term administration of recombinant human erythropoietin decreases B cell number in human peripheral blood., Tomomi Nagashima,Akihiko Yokohama,Kie Nagai,Tetsuhiro Kasamatsu,Nanami Gotoh,Hirono Iriuchishima,Tomomi Sekigami,Takayuki Saitoh,Hiroshi Handa,Norifumi Tsukamoto,Hirokazu Murakami, Apr. 2018, Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis, 57, 2, 208, 214

  DOI
• PDCD1 and CTLA4 polymorphisms affect the susceptibility to, and clinical features of, chronic immune thrombocytopenia., Tetsuhiro Kasamatsu,Rumi Ino,Noriyuki Takahashi,Nanami Gotoh,Yusuke Minato,Makiko Takizawa,Akihiko Yokohama,Hiroshi Handa,Takayuki Saitoh,Norifumi Tsukamoto,Hirokazu Murakami, Mar. 2018, British journal of haematology, 180, 5, 705, 714

  DOI
• Association between OGG1 S326C CC genotype and elevated relapse risk in acute myeloid leukemia., Nanami Gotoh,Takayuki Saitoh,Noriyuki Takahashi,Tetsuhiro Kasamatsu,Yusuke Minato,Alkebsi Lobna,Tsukasa Oda,Takumi Hoshino,Toru Sakura,Hiroaki Shimizu,Makiko Takizawa,Hiroshi Handa,Akihiko Yokohama,Norifumi Tsukamoto,Hirokazu Murakami, Sep. 2018, International journal of hematology, 108, 3, 246, 253

  DOI
• Clinical management and outcomes of completely resected stage I follicular lymphoma., Akihiko Yokohama,Yoko Hashimoto,Makiko Takizawa,Hiroaki Shimizu,Yuri Miyazawa,Akio Saitoh,Kohtaro Toyama,Takuma Ishizaki,Takeki Mitsui,Takayuki Saitoh,Kayoko Murayama,Morio Matsumoto,Morio Sawamura,Hirokazu Murakami,Junko Hirato,Masaru Kojima,Yoshihisa Nojima,Hiroshi Handa,Norifumi Tsukamoto, 16 Mar. 2018, Journal of clinical and experimental hematopathology : JCEH, 58, 1, 10, 16

  DOI
• Short-term administration of recombinant human erythropoietin decreases B cell number in human peripheral blood., Tomomi Nagashima,Akihiko Yokohama,Kie Nagai,Tetsuhiro Kasamatsu,Nanami Gotoh,Hirono Iriuchishima,Tomomi Sekigami,Takayuki Saitoh,Hiroshi Handa,Norifumi Tsukamoto,Hirokazu Murakami, Apr. 2018, Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis, 57, 2, 208, 214

  DOI
• T cell large granular lymphocyte (LGL) leukemia associated with Behcet's disease: high expression of sFasL and IL-18 of CD8 LGL, Takayuki Saitoh,Takafumi Matsushima,Yoriaki Kaneko,Akihiko Yokohama,Hiroshi Handa,Norifumi Tsukamoto,Masamitsu Karasawa,Yoshihisa Nojima,Hirokazu Murakami, Jul. 2008, ANNALS OF HEMATOLOGY, 87, 7, 585, 586, Report scientific journal

  DOI
• Hodgkin lymphoma presenting with various immunologic abnormalities, including autoimmune hepatitis, Hashimoto's thyroiditis, autoimmune hemolytic anemia, and immune thrombocytopenia, Takayuki Saitoh,Takafumi Matsushima,Yasuyuki Saito,Arito Yamane,Akihiko Yokohama,Hiroyuki Irisawa,Hiroshi Handa,Norifumi Tsukamoto,Masamitsu Karasawa,Masaru Kojima,Yoshihisa Nojima,Hirokazu Murakami, Feb. 2008, CLINICAL LYMPHOMA & MYELOMA, 8, 1, 62, 64

  DOI
• Two Cases of Intravascular Lymphoma Diagnosed by Gastrointestinal Endoscopic Biopsy, Yasuyuki Shimoyama,Kensuke Sugimoto,Mie Kotake,Daisuke Uehara,Yosuke Kamide,Shiko Kuribayashi,Osamu Kawamura,Motoyasu Kusano,Hiroshi Handa,Junko Hirato,Masanobu Yamada, 2015, INTERNAL MEDICINE, 54, 24, 3145, 3149

  DOI
• Two Cases of Intravascular Lymphoma Diagnosed by Gastrointestinal Endoscopic Biopsy, Yasuyuki Shimoyama,Kensuke Sugimoto,Mie Kotake,Daisuke Uehara,Yosuke Kamide,Shiko Kuribayashi,Osamu Kawamura,Motoyasu Kusano,Hiroshi Handa,Junko Hirato,Masanobu Yamada, 2015, INTERNAL MEDICINE, 54, 24, 3145, 3149

  DOI
• Gene polymorphisms of mannose-binding lectin confer susceptibility to Pneumocystis pneumonia in HIV-infected patients, Kunio Yanagisawa,Yoshiyuki Ogawa,Hideki Uchiumi,Fumito Gohda,Momoko Mawatari,Takuma Ishizaki,Takeki Mitsui,Akihiko Yokohama,Hiroshi Handa,Norifumi Tsukamoto,Yoshihisa Nojima, Nov. 2015, JOURNAL OF INFECTION AND CHEMOTHERAPY, 21, 11, 769, 775

  DOI
• High Percentage of Regulatory T Cells before and after Vitamin B-12 Treatment in Patients with Pernicious Anemia, Satoru Watanabe,Norifumi Ide,Hatsue Ogawara,Akihiko Yokohama,Takeki Mitsui,Hiroshi Handa,Hiromi Koiso,Norifumi Tsukamoto,Takayuki Saitoh,Hirokazu Murakami, 2015, ACTA HAEMATOLOGICA, 133, 1, 83, 88

  DOI
• High Percentage of Regulatory T Cells before and after Vitamin B-12 Treatment in Patients with Pernicious Anemia, Satoru Watanabe,Norifumi Ide,Hatsue Ogawara,Akihiko Yokohama,Takeki Mitsui,Hiroshi Handa,Hiromi Koiso,Norifumi Tsukamoto,Takayuki Saitoh,Hirokazu Murakami, 2015, ACTA HAEMATOLOGICA, 133, 1, 83, 88

  DOI
• A multinational, open-label, phase 2 study of ruxolitinib in Asian patients with myelofibrosis: Japanese subset analysis, Kenji Oritani,Shinichiro Okamoto,Tetsuzo Tauchi,Shigeki Saito,Kohshi Ohishi,Hiroshi Handa,Katsuto Takenaka,Prashanth Gopalakrishna,Taro Amagasaki,Kazuo Ito,Koichi Akashi, Mar. 2015, INTERNATIONAL JOURNAL OF HEMATOLOGY, 101, 3, 295, 304

  DOI
• A multinational, open-label, phase 2 study of ruxolitinib in Asian patients with myelofibrosis: Japanese subset analysis, Kenji Oritani,Shinichiro Okamoto,Tetsuzo Tauchi,Shigeki Saito,Kohshi Ohishi,Hiroshi Handa,Katsuto Takenaka,Prashanth Gopalakrishna,Taro Amagasaki,Kazuo Ito,Koichi Akashi, Mar. 2015, INTERNATIONAL JOURNAL OF HEMATOLOGY, 101, 3, 295, 304

  DOI
• Efficacy and safety of ruxolitinib in Asian patients with myelofibrosis, Chul Won Jung,Lee-Yung Shih,Zhijian Xiao,Jin Jie,Hsin-An Hou,Xin Du,Ming-Chung Wang,Seonyang Park,Ki-Seong Eom,Kenji Oritani,Shinichiro Okamoto,Tetsuzo Tauchi,Jin Seok Kim,Daobin Zhou,Shigeki Saito,Junmin Li,Hiroshi Handa,Li Jianyong,Kohshi Ohishi,Ming Hou,Wu Depei,Katsuto Takenaka,Ting Liu,Yu Hu,Taro Amagasaki,Kazuo Ito,Prashanth Gopalakrishna,Koichi Akashi, Jul. 2015, LEUKEMIA & LYMPHOMA, 56, 7, 2067, 2074

  DOI
• Efficacy and safety of ruxolitinib in Asian patients with myelofibrosis, Chul Won Jung,Lee-Yung Shih,Zhijian Xiao,Jin Jie,Hsin-An Hou,Xin Du,Ming-Chung Wang,Seonyang Park,Ki-Seong Eom,Kenji Oritani,Shinichiro Okamoto,Tetsuzo Tauchi,Jin Seok Kim,Daobin Zhou,Shigeki Saito,Junmin Li,Hiroshi Handa,Li Jianyong,Kohshi Ohishi,Ming Hou,Wu Depei,Katsuto Takenaka,Ting Liu,Yu Hu,Taro Amagasaki,Kazuo Ito,Prashanth Gopalakrishna,Koichi Akashi, Jul. 2015, LEUKEMIA & LYMPHOMA, 56, 7, 2067, 2074

  DOI
• A new staging system to predict prognosis of patients with multiple myeloma in an era of novel therapeutic agents, Hirono Iriuchishima,Takayuki Saitoh,Hiroshi Handa,Atsushi Isoda,Morio Matsumoto,Morio Sawamura,Atsushi Iwasaki,Chiaki Ushie,Hikaru Hattori,Yoshiko Sasaki,Takeki Mitsui,Akihiko Yokohama,Norifumi Tsukamoto,Hirokazu Murakami,Yoshihisa Nojima, Feb. 2015, EUROPEAN JOURNAL OF HAEMATOLOGY, 94, 2, 145, 151

  DOI
• A new staging system to predict prognosis of patients with multiple myeloma in an era of novel therapeutic agents, Hirono Iriuchishima,Takayuki Saitoh,Hiroshi Handa,Atsushi Isoda,Morio Matsumoto,Morio Sawamura,Atsushi Iwasaki,Chiaki Ushie,Hikaru Hattori,Yoshiko Sasaki,Takeki Mitsui,Akihiko Yokohama,Norifumi Tsukamoto,Hirokazu Murakami,Yoshihisa Nojima, Feb. 2015, EUROPEAN JOURNAL OF HAEMATOLOGY, 94, 2, 145, 151

  DOI
• Trends of survival in patients with multiple myeloma in Japan: a multicenter retrospective collaborative study of the Japanese Society of Myeloma, S. Ozaki,H. Handa,T. Saitoh,H. Murakami,M. Itagaki,H. Asaoku,K. Suzuki,A. Isoda,M. Matsumoto,M. Sawamura,J. Konishi,K. Sunami,N. Takezako,S. Hagiwara,Y. Kuroda,T. Chou,E. Nagura,K. Shimizu, Sep. 2015, BLOOD CANCER JOURNAL, 5, e349, Report scientific journal

  DOI
• Trends of survival in patients with multiple myeloma in Japan: a multicenter retrospective collaborative study of the Japanese Society of Myeloma, S. Ozaki,H. Handa,T. Saitoh,H. Murakami,M. Itagaki,H. Asaoku,K. Suzuki,A. Isoda,M. Matsumoto,M. Sawamura,J. Konishi,K. Sunami,N. Takezako,S. Hagiwara,Y. Kuroda,T. Chou,E. Nagura,K. Shimizu, Sep. 2015, BLOOD CANCER JOURNAL, 5, e349, Report scientific journal

  DOI
• Low burden of a JAK2-V617F mutated clone in monoclonal haematopoiesis in a Japanese woman with Budd-Chiari syndrome, Kohtaro Toyama,Masamitsu Karasawa,Arito Yamane,Hiromi Koiso,Akihiko Yokohama,Hideki Uchiumi,Takayuki Saitoh,Hiroshi Handa,Ken Sato,Hitoshi Takagi,Shuichi Miyawaki,Hirokazu Murakami,Yoshihisa Nojima,Norifumi Tsukamoto, May 2009, INTERNATIONAL JOURNAL OF HEMATOLOGY, 89, 4, 517, 522

  DOI
• Low burden of a JAK2-V617F mutated clone in monoclonal haematopoiesis in a Japanese woman with Budd-Chiari syndrome, Kohtaro Toyama,Masamitsu Karasawa,Arito Yamane,Hiromi Koiso,Akihiko Yokohama,Hideki Uchiumi,Takayuki Saitoh,Hiroshi Handa,Ken Sato,Hitoshi Takagi,Shuichi Miyawaki,Hirokazu Murakami,Yoshihisa Nojima,Norifumi Tsukamoto, May 2009, INTERNATIONAL JOURNAL OF HEMATOLOGY, 89, 4, 517, 522

  DOI
• Characterization of immunoglobulin heavy and light chain gene expression in chronic lymphocytic leukemia and related disorders, Hirotaka Nakahashi,Norifumi Tsukamoto,Yoko Hashimoto,Hiromi Koiso,Akihiko Yokohama,Takayuki Saitoh,Hideki Uchiumi,Hiroshi Handa,Hirokazu Murakami,Yoshihisa Nojima,Masamitsu Karasawa, Apr. 2009, CANCER SCIENCE, 100, 4, 671, 677

  DOI
• Characterization of immunoglobulin heavy and light chain gene expression in chronic lymphocytic leukemia and related disorders, Hirotaka Nakahashi,Norifumi Tsukamoto,Yoko Hashimoto,Hiromi Koiso,Akihiko Yokohama,Takayuki Saitoh,Hideki Uchiumi,Hiroshi Handa,Hirokazu Murakami,Yoshihisa Nojima,Masamitsu Karasawa, Apr. 2009, CANCER SCIENCE, 100, 4, 671, 677

  DOI
• Hairy Cell Leukemia-Related Disorders Consistently Show Low CD27 Expression, Yoko Hashimoto,Norifumi Tsukamoto,Hirotaka Nakahashi,Akihiko Yokohama,Takayuki Saitoh,Hiroshi Handa,Takafumi Matsushima,Hirokazu Murakami,Yoshihisa Nojima,Masamitsu Karasawa, Dec. 2009, PATHOLOGY & ONCOLOGY RESEARCH, 15, 4, 615, 621

  DOI
• Hairy Cell Leukemia-Related Disorders Consistently Show Low CD27 Expression, Yoko Hashimoto,Norifumi Tsukamoto,Hirotaka Nakahashi,Akihiko Yokohama,Takayuki Saitoh,Hiroshi Handa,Takafumi Matsushima,Hirokazu Murakami,Yoshihisa Nojima,Masamitsu Karasawa, Dec. 2009, PATHOLOGY & ONCOLOGY RESEARCH, 15, 4, 615, 621

  DOI
• Successful Treatment by All-Trans Retinoic Acid in a Patient with Acute Promyelocytic Leukemia Complicated by Liver Cirrhosis and Polycystic Kidney, Arito Yamane,Norifumi Tsukamoto,Takayuki Saitoh,Hideki Uchiumi,Hiroshi Handa,Masamitsu Karasawa,Yoshihisa Nojima,Hirokazu Murakami, 2009, INTERNAL MEDICINE, 48, 18, 1691, 1694

  DOI
• Successful Treatment by All-Trans Retinoic Acid in a Patient with Acute Promyelocytic Leukemia Complicated by Liver Cirrhosis and Polycystic Kidney, Arito Yamane,Norifumi Tsukamoto,Takayuki Saitoh,Hideki Uchiumi,Hiroshi Handa,Masamitsu Karasawa,Yoshihisa Nojima,Hirokazu Murakami, 2009, INTERNAL MEDICINE, 48, 18, 1691, 1694

  DOI
• Autologous Peripheral Blood Stem Cell Transplantation to Treat CHOP-Refractory Aggressive Subcutaneous Panniculitis-Like T Cell Lymphoma, Hirotaka Nakahashi,Norifumi Tsukamoto,Arito Yamane,Takayuki Saitoh,Hideki Uchiumi,Hiroshi Handa,Masamitsu Karasawa,Hirokazu Murakami,Masaru Kojima,Yoshihisa Nojima, 2009, ACTA HAEMATOLOGICA, 121, 4, 239, 242

  DOI
• Clinical significance of regulatory T cells in patients with myelodysplastic syndrome, Wedad Hamdi,Hatsue Ogawara,Hiroshi Handa,Norifumi Tsukamoto,Yoshihisa Nojima,Hirokazu Murakami, Mar. 2009, EUROPEAN JOURNAL OF HAEMATOLOGY, 82, 3, 201, 207

  DOI
• Clinical significance of regulatory T cells in patients with myelodysplastic syndrome, Wedad Hamdi,Hatsue Ogawara,Hiroshi Handa,Norifumi Tsukamoto,Yoshihisa Nojima,Hirokazu Murakami, Mar. 2009, EUROPEAN JOURNAL OF HAEMATOLOGY, 82, 3, 201, 207

  DOI
• Characterization of CD56(+) Dendritic-Like Cells: A Normal Counterpart of Blastic Plasmacytoid Dendritic Cell Neoplasm?, Yohei Osaki,Akihiko Yokohama,Akio Saito,Kenichi Tahara,Kunio Yanagisawa,Yoshiyuki Ogawa,Takuma Ishizaki,Takeki Mitsui,Hiromi Koiso,Makiko Takizawa,Hideki Uchiumi,Takayuki Saitoh,Hiroshi Handa,Hirokazu Murakami,Norifumi Tsukamoto,Yoshihisa Nojima, Nov. 2013, PLOS ONE, 8, 11, UNSP e81722

  DOI
• Characterization of CD56(+) Dendritic-Like Cells: A Normal Counterpart of Blastic Plasmacytoid Dendritic Cell Neoplasm?, Yohei Osaki,Akihiko Yokohama,Akio Saito,Kenichi Tahara,Kunio Yanagisawa,Yoshiyuki Ogawa,Takuma Ishizaki,Takeki Mitsui,Hiromi Koiso,Makiko Takizawa,Hideki Uchiumi,Takayuki Saitoh,Hiroshi Handa,Hirokazu Murakami,Norifumi Tsukamoto,Yoshihisa Nojima, Nov. 2013, PLOS ONE, 8, 11, UNSP e81722

  DOI
• Development of IgG4-related disease 10 years after chemotherapy for diffuse large B cell lymphoma and longstanding bronchial asthma, Takeki Mitsui,Akihiko Yokohama,Hiromi Koiso,Takuma Ishizaki,Hideki Uchiumi,Takayuki Saitoh,Hiroshi Handa,Junko Hirato,Masamitsu Karasawa,Hirokazu Murakami,Masaru Kojima,Yoshihisa Nojima,Norifumi Tsukamoto, Jul. 2013, INTERNATIONAL JOURNAL OF HEMATOLOGY, 98, 1, 122, 128

  DOI
• Development of IgG4-related disease 10 years after chemotherapy for diffuse large B cell lymphoma and longstanding bronchial asthma, Takeki Mitsui,Akihiko Yokohama,Hiromi Koiso,Takuma Ishizaki,Hideki Uchiumi,Takayuki Saitoh,Hiroshi Handa,Junko Hirato,Masamitsu Karasawa,Hirokazu Murakami,Masaru Kojima,Yoshihisa Nojima,Norifumi Tsukamoto, Jul. 2013, INTERNATIONAL JOURNAL OF HEMATOLOGY, 98, 1, 122, 128

  DOI
• IL17A and IL23R gene polymorphisms affect the clinical features and prognosis of patients with multiple myeloma., Tetsuhiro Kasamatsu,Mari Kimoto,Noriyuki Takahashi,Yusuke Minato,Nanami Gotoh,Makiko Takizawa,Morio Matsumoto,Morio Sawamura,Akihiko Yokohama,Hiroshi Handa,Norifumi Tsukamoto,Takayuki Saitoh,Hirokazu Murakami, Feb. 2018, Hematological oncology, 36, 1, 196, 201

  DOI
• Recurrent Gemella haemolysans Meningitis in a Patient with Osteomyelitis of the Clivus, Toshimasa Hayashi,Hideki Uchiumi,Kunio Yanagisawa,Yoshiyuki Ogawa,Hiroshi Handa,Norifumi Tsukamoto,Yoshihisa Nojima, 2013, INTERNAL MEDICINE, 52, 18, 2145, 2147

  DOI
• Recurrent Gemella haemolysans Meningitis in a Patient with Osteomyelitis of the Clivus, Toshimasa Hayashi,Hideki Uchiumi,Kunio Yanagisawa,Yoshiyuki Ogawa,Hiroshi Handa,Norifumi Tsukamoto,Yoshihisa Nojima, 2013, INTERNAL MEDICINE, 52, 18, 2145, 2147

  DOI
• Prognosis of acute myeloid leukemia transformed from myelodysplastic syndromes: A multicenter retrospective study, Namiko Okuyama,Wolfgang R. Sperr,Katalin Kadar,Sietske Bakker,Gergely Szombath,Hiroshi Handa,Hideto Tamura,Asaka Kondo,Peter Valent,Judit Varkonyi,Arjan van de Loosdrecht,Kiyoyuki Ogata, Aug. 2013, LEUKEMIA RESEARCH, 37, 8, 862, 867

  DOI
• Prognosis of acute myeloid leukemia transformed from myelodysplastic syndromes: A multicenter retrospective study, Namiko Okuyama,Wolfgang R. Sperr,Katalin Kadar,Sietske Bakker,Gergely Szombath,Hiroshi Handa,Hideto Tamura,Asaka Kondo,Peter Valent,Judit Varkonyi,Arjan van de Loosdrecht,Kiyoyuki Ogata, Aug. 2013, LEUKEMIA RESEARCH, 37, 8, 862, 867

  DOI
• Distinctive disease subgroups according to differentiation stages in adult patients with T-cell acute lymphoblastic leukemia, Hiroaki Shimizu,Hiroshi Handa,Nahoko Hatsumi,Satoru Takada,Takayuki Saitoh,Toru Sakura,Shuichi Miyawaki,Yoshihisa Nojima, Apr. 2013, EUROPEAN JOURNAL OF HAEMATOLOGY, 90, 4, 301, 307

  DOI
• Distinctive disease subgroups according to differentiation stages in adult patients with T-cell acute lymphoblastic leukemia, Hiroaki Shimizu,Hiroshi Handa,Nahoko Hatsumi,Satoru Takada,Takayuki Saitoh,Toru Sakura,Shuichi Miyawaki,Yoshihisa Nojima, Apr. 2013, EUROPEAN JOURNAL OF HAEMATOLOGY, 90, 4, 301, 307

  DOI
• DNMT3B7 expression related to MENT expression and its promoter methylation in human lymphomas, Lobna Alkebsi,Hiroshi Handa,Yoshiko Sasaki,Yohei Osaki,Kunio Yanagisawa,Yoshiaki Ogawa,Akihiko Yokohama,Hikaru Hattori,Hiromi Koiso,Takayuki Saitoh,Takeki Mitsui,Norifumi Tsukamoto,Yoshihisa Nojima,Hirokazu Murakami, Dec. 2013, LEUKEMIA RESEARCH, 37, 12, 1662, 1667

  DOI
• DNMT3B7 expression related to MENT expression and its promoter methylation in human lymphomas, Lobna Alkebsi,Hiroshi Handa,Yoshiko Sasaki,Yohei Osaki,Kunio Yanagisawa,Yoshiaki Ogawa,Akihiko Yokohama,Hikaru Hattori,Hiromi Koiso,Takayuki Saitoh,Takeki Mitsui,Norifumi Tsukamoto,Yoshihisa Nojima,Hirokazu Murakami, Dec. 2013, LEUKEMIA RESEARCH, 37, 12, 1662, 1667

  DOI
• Prevalence of extramedullary relapses is higher after allogeneic stem cell transplantation than after chemotherapy in adult patients with acute myeloid leukemia, Hiroaki Shimizu,Takayuki Saitoh,Nahoko Hatsumi,Satoru Takada,Hiroshi Handa,Takahiro Jimbo,Toru Sakura,Shuichi Miyawaki,Yoshihisa Nojima, Nov. 2013, LEUKEMIA RESEARCH, 37, 11, 1477, 1481

  DOI
• Prevalence of extramedullary relapses is higher after allogeneic stem cell transplantation than after chemotherapy in adult patients with acute myeloid leukemia, Hiroaki Shimizu,Takayuki Saitoh,Nahoko Hatsumi,Satoru Takada,Hiroshi Handa,Takahiro Jimbo,Toru Sakura,Shuichi Miyawaki,Yoshihisa Nojima, Nov. 2013, LEUKEMIA RESEARCH, 37, 11, 1477, 1481

  DOI
• Flow cytometric detection of human telomerase reverse transcriptase (hTERT) expression in a subpopulation of bone marrow cells, Hiroshi Handa,Takafumi Matsushima,Natsumi Nishimoto,Madoka Inoue,Takayuki Saitoh,Akihiko Yokohama,Norifumi Tsukamoto,Takeki Mitsui,Hirotaka Nakahashi,Kotaro Toyama,Masamitsu Karasawa,Hatsue Ogawara,Yoshihisa Nojima,Hirokazu Murakami, Feb. 2010, LEUKEMIA RESEARCH, 34, 2, 177, 183

  DOI
• Flow cytometric detection of human telomerase reverse transcriptase (hTERT) expression in a subpopulation of bone marrow cells, Hiroshi Handa,Takafumi Matsushima,Natsumi Nishimoto,Madoka Inoue,Takayuki Saitoh,Akihiko Yokohama,Norifumi Tsukamoto,Takeki Mitsui,Hirotaka Nakahashi,Kotaro Toyama,Masamitsu Karasawa,Hatsue Ogawara,Yoshihisa Nojima,Hirokazu Murakami, Feb. 2010, LEUKEMIA RESEARCH, 34, 2, 177, 183

  DOI
• Primary Bilateral Adrenal Diffuse Large B-cell Lymphoma Demonstrating Adrenal Failure, Kazuhiko Horiguchi,Koshi Hashimoto,Masayuki Hashizume,Takashige Masuo,Mariko Suto,Jun Okajo,Hiroshi Handa,Yoriaki Kaneko,Hideaki Yokoo,Atsushi Sasaki,Shuichi Okada,Masanobu Yamada,Norifumi Tsukamoto,Yoshihisa Nojima,Yoichi Nakazato,Masatomo Mori, 2010, INTERNAL MEDICINE, 49, 20, 2241, 2246

  DOI
• Primary Bilateral Adrenal Diffuse Large B-cell Lymphoma Demonstrating Adrenal Failure, Kazuhiko Horiguchi,Koshi Hashimoto,Masayuki Hashizume,Takashige Masuo,Mariko Suto,Jun Okajo,Hiroshi Handa,Yoriaki Kaneko,Hideaki Yokoo,Atsushi Sasaki,Shuichi Okada,Masanobu Yamada,Norifumi Tsukamoto,Yoshihisa Nojima,Yoichi Nakazato,Masatomo Mori, 2010, INTERNAL MEDICINE, 49, 20, 2241, 2246

  DOI
• Randomized trial of response-oriented individualized versus fixed-schedule induction chemotherapy with idarubicin and cytarabine in adult acute myeloid leukemia: the JALSG AML95 study, Shigeki Ohtake,Shuichi Miyawaki,Hitoshi Kiyoi,Yasushi Miyazaki,Hirokazu Okumura,Shin Matsuda,Tadashi Nagai,Yuji Kishimoto,Masaya Okada,Masatomo Takahashi,Hiroshi Handa,Jin Takeuchi,Shinichi Kageyama,Norio Asou,Fumiharu Yagasaki,Yasuhiro Maeda,Kazunori Ohnishi,Tomoki Naoe,Ryuzo Ohno, Mar. 2010, INTERNATIONAL JOURNAL OF HEMATOLOGY, 91, 2, 276, 283

  DOI
• Randomized trial of response-oriented individualized versus fixed-schedule induction chemotherapy with idarubicin and cytarabine in adult acute myeloid leukemia: the JALSG AML95 study, Shigeki Ohtake,Shuichi Miyawaki,Hitoshi Kiyoi,Yasushi Miyazaki,Hirokazu Okumura,Shin Matsuda,Tadashi Nagai,Yuji Kishimoto,Masaya Okada,Masatomo Takahashi,Hiroshi Handa,Jin Takeuchi,Shinichi Kageyama,Norio Asou,Fumiharu Yagasaki,Yasuhiro Maeda,Kazunori Ohnishi,Tomoki Naoe,Ryuzo Ohno, Mar. 2010, INTERNATIONAL JOURNAL OF HEMATOLOGY, 91, 2, 276, 283

  DOI
• Presentation of extramedullary Philadelphia chromosome-positive biphenotypic acute leukemia as testicular mass: Response to imatinib-combined chemotherapy, Takayuki Saitoh,Takafumi Matsushima,Hirono Iriuchishima,Arito Yamane,Hiroyuki Irisawa,Hiroshi Handa,Norifumi Tsukamoto,Masamitsu Karasawa,Yoshihisa Nojima,Hirokazu Murakami, Dec. 2006, LEUKEMIA & LYMPHOMA, 47, 12, 2667, 2669, Report scientific journal

  DOI
• Sacroiliitis as an initial manifestation of acute myelogenons leukemia, Takumi Hoshino,Takafumi Matsushima,Yasuyuki Saitoh,Arito Yamane,Makiko Takizawa,Hiroyuki Irisawa,Takayuki Saitoh,Hiroshi Handa,Norifumi Tsukamoto,Masamitsu Karasawa,Hirokazu Murakami,Yoshihisa Nojima, Dec. 2006, INTERNATIONAL JOURNAL OF HEMATOLOGY, 84, 5, 421, 424

  DOI
• X-linked agammaglobulinemia diagnosed in adulthood: A case report, Takeki Mitsui,Norifumi Tsukamoto,Hirokazu Kanegane,Kazunaga Agematsu,Tomomi Sekigami,Hiroyuki Irisawa,Takayuki Saitoh,Hideki Uchiumi,Hiroshi Handa,Takafumi Matsushima,Masamitsu Karasawa,Hirokazu Murakami,Toshio Miyawaki,Yoshihisa Nojima, Aug. 2006, INTERNATIONAL JOURNAL OF HEMATOLOGY, 84, 2, 154, 157

  DOI
• X-linked agammaglobulinemia diagnosed in adulthood: A case report, Takeki Mitsui,Norifumi Tsukamoto,Hirokazu Kanegane,Kazunaga Agematsu,Tomomi Sekigami,Hiroyuki Irisawa,Takayuki Saitoh,Hideki Uchiumi,Hiroshi Handa,Takafumi Matsushima,Masamitsu Karasawa,Hirokazu Murakami,Toshio Miyawaki,Yoshihisa Nojima, Aug. 2006, INTERNATIONAL JOURNAL OF HEMATOLOGY, 84, 2, 154, 157

  DOI
• Copper deficiency pancytopenia with infectious complications after hemolytic anemia, Takayuki Saitoh,Takafumi Matsushima,Kohtaro Toyama,Aarito Yamane,Hiroyuki Irisawa,Hiroshi Handa,Norifumi Tsukamoto,Masamitsu Karasawa,Yoshihisa Nojima,Hirokazu Murakami, Dec. 2006, ANNALS OF HEMATOLOGY, 85, 12, 881, 882, Report scientific journal

  DOI
• Copper deficiency pancytopenia with infectious complications after hemolytic anemia, Takayuki Saitoh,Takafumi Matsushima,Kohtaro Toyama,Aarito Yamane,Hiroyuki Irisawa,Hiroshi Handa,Norifumi Tsukamoto,Masamitsu Karasawa,Yoshihisa Nojima,Hirokazu Murakami, Dec. 2006, ANNALS OF HEMATOLOGY, 85, 12, 881, 882, Report scientific journal

  DOI
• Small-bowel perforation accompanied by Aspergillus endocarditis in a patient with angioimmunoblastic T-cell lymphoma, Takayuki Saitoh,Takafumi Matsushima,Asuka Matsuo,Akihiko Yokohama,Hiroyuki Irisawa,Hiroshi Handa,Norifumi Tsukamoto,Masamitsu Karasawa,Yoshihisa Nojima,Hirokazu Murakami, Jan. 2007, ANNALS OF HEMATOLOGY, 86, 1, 71, 73, Report scientific journal

  DOI
• Small-bowel perforation accompanied by Aspergillus endocarditis in a patient with angioimmunoblastic T-cell lymphoma, Takayuki Saitoh,Takafumi Matsushima,Asuka Matsuo,Akihiko Yokohama,Hiroyuki Irisawa,Hiroshi Handa,Norifumi Tsukamoto,Masamitsu Karasawa,Yoshihisa Nojima,Hirokazu Murakami, Jan. 2007, ANNALS OF HEMATOLOGY, 86, 1, 71, 73, Report scientific journal

  DOI
• Hodgkin lymphoma accompanied by aplastic anemia and polyclonal expansion of large granular lymphocytes, Takayuki Saitoh,Takafumi Matsushima,Arito Yamane,Masataka Sakuraya,Hiroyuki Irisawa,Akihiko Yokohama,Hiroshi Handa,Norifumi Tsukamoto,Masamitsu Karasawa,Yoshihisa Nojima,Hirokazu Murakami, 2007, ACTA HAEMATOLOGICA, 117, 4, 238, 241

  DOI
• Low-dose thalidomide plus low-dose dexamethasone therapy in patients with refractory multiple myeloma, Hirokazu Murakami,Hiroshi Handa,Masahiro Abe,Sinsuke Iida,Akihiro Ishii,Takayuki Ishikawa,Tadao Ishida,Masatsugu Oota,Shuji Ozaki,Masaaki Kosaka,Akira Sakai,Morio Sawamura,Chihiro Shimazaki,Kazuyuki Shimizu,Toshiyuki Takagi,Hiroyuki Hata,Takashi Fukuhara,Hiroshi Fujii,Akira Miyata,Toshio Wakayama,Kiyoshi Takatsuki, Sep. 2007, EUROPEAN JOURNAL OF HAEMATOLOGY, 79, 3, 234, 239

  DOI
• Low-dose thalidomide plus low-dose dexamethasone therapy in patients with refractory multiple myeloma, Hirokazu Murakami,Hiroshi Handa,Masahiro Abe,Sinsuke Iida,Akihiro Ishii,Takayuki Ishikawa,Tadao Ishida,Masatsugu Oota,Shuji Ozaki,Masaaki Kosaka,Akira Sakai,Morio Sawamura,Chihiro Shimazaki,Kazuyuki Shimizu,Toshiyuki Takagi,Hiroyuki Hata,Takashi Fukuhara,Hiroshi Fujii,Akira Miyata,Toshio Wakayama,Kiyoshi Takatsuki, Sep. 2007, EUROPEAN JOURNAL OF HAEMATOLOGY, 79, 3, 234, 239

  DOI
• Prevalence and clinical characteristics of acute myeloid leukemia associated with disseminated intravascular coagulation, Hideki Uchiumi,Takafumi Matsushima,Arito Yamane,Noriko Doki,Hiroyuki Irisawa,Takayuki Saitoh,Tohru Sakura,Takahiro Jimbo,Hiroshi Handa,Norifumi Tsukamoto,Masamitsu Karasawa,Shuichi Miyawaki,Hirokazu Murakami,Yoshihisa Nojima, Aug. 2007, INTERNATIONAL JOURNAL OF HEMATOLOGY, 86, 2, 137, 142

  DOI
• Prevalence and clinical characteristics of acute myeloid leukemia associated with disseminated intravascular coagulation, Hideki Uchiumi,Takafumi Matsushima,Arito Yamane,Noriko Doki,Hiroyuki Irisawa,Takayuki Saitoh,Tohru Sakura,Takahiro Jimbo,Hiroshi Handa,Norifumi Tsukamoto,Masamitsu Karasawa,Shuichi Miyawaki,Hirokazu Murakami,Yoshihisa Nojima, Aug. 2007, INTERNATIONAL JOURNAL OF HEMATOLOGY, 86, 2, 137, 142

  DOI
• JAK2-V617F mutation analysis of granulocytes and platelets from patients with chronic myeloproliferative disorders: advantage of studying platelets, Kohtaro Toyama,Masamitsu Karasawa,Arito Yamane,Hiroyuki Irisawa,Akihiko Yokohama,Takayuki Saitoh,Hiroshi Handa,Takafumi Matsushima,Morio Sawamura,Shuichi Miyawaki,Hirokazu Murakami,Yoshihisa Nojima,Norifumi Tsukamoto, Oct. 2007, BRITISH JOURNAL OF HAEMATOLOGY, 139, 1, 64, 69

  DOI
• JAK2-V617F mutation analysis of granulocytes and platelets from patients with chronic myeloproliferative disorders: advantage of studying platelets, Kohtaro Toyama,Masamitsu Karasawa,Arito Yamane,Hiroyuki Irisawa,Akihiko Yokohama,Takayuki Saitoh,Hiroshi Handa,Takafumi Matsushima,Morio Sawamura,Shuichi Miyawaki,Hirokazu Murakami,Yoshihisa Nojima,Norifumi Tsukamoto, Oct. 2007, BRITISH JOURNAL OF HAEMATOLOGY, 139, 1, 64, 69

  DOI
• The usefulness of F-18-fluorodeoxyglucose positron emission tomography (F-18-FDG-PET) and a comparison of F-18-FDG-PET with (67)gallium scintigraphy in the evaluation of lymphoma - Relation to histologic subtypes-based on the World Health Organization Classification, Norifumi Tsukamoto,Masaru Kojima,Masatoshi Hasegawa,Noboru Oriuchi,Takafumi Matsushima,Akihiko Yokohama,Takayuki Saitoh,Hiroshi Handa,Keigo Endo,Hirokazu Murakami, Aug. 2007, CANCER, 110, 3, 652, 659

  DOI
• High Th1/Th2 ratio in patients with multiple myeloma, H Ogawara,H Handa,T Yamazaki,T Toda,K Yoshida,N Nishimoto,WHS Al-ma'Quol,Y Kaneko,T Matsushima,N Tsukamoto,Y Nojima,M Matsumoto,M Sawamura,H Murakami, Feb. 2005, LEUKEMIA RESEARCH, 29, 2, 135, 140

  DOI
• High Th1/Th2 ratio in patients with multiple myeloma, H Ogawara,H Handa,T Yamazaki,T Toda,K Yoshida,N Nishimoto,WHS Al-ma'Quol,Y Kaneko,T Matsushima,N Tsukamoto,Y Nojima,M Matsumoto,M Sawamura,H Murakami, Feb. 2005, LEUKEMIA RESEARCH, 29, 2, 135, 140

  DOI
• Pericardial graft vs. host disease in a patient with myelodysplastic syndrome following peripheral blood stem cell transplantation, Y Saito,T Matsushima,N Doki,Y Tsumita,M Takizawa,A Yokohama,H Handa,N Tsukamoto,M Karasawa,H Murakami,Y Nojima, Jul. 2005, EUROPEAN JOURNAL OF HAEMATOLOGY, 75, 1, 65, 67

  DOI
• Follicular Lymphoma Presenting with Marked Splenomegaly: Report of Three Cases, Hiromi Koiso,Akihiko Yokohama,Takeki Mitsui,Takayuki Saitoh,Hiroshi Handa,Hirokazu Murakami,Junko Hirato,Masaru Kojima,Yoshihisa Nojima,Norifumi Tsukamoto, 2012, ACTA HAEMATOLOGICA, 128, 1, 47, 52

  DOI
• The Murine Stem Cell Virus Promoter Drives Correlated Transgene Expression in the Leukocytes and Cerebellar Purkinje Cells of Transgenic Mice, Miho Oue,Hiroshi Handa,Yasunori Matsuzaki,Kazutomo Suzue,Hirokazu Murakami,Hirokazu Hirai, Nov. 2012, PLOS ONE, 7, 11

  DOI
• The Murine Stem Cell Virus Promoter Drives Correlated Transgene Expression in the Leukocytes and Cerebellar Purkinje Cells of Transgenic Mice, Miho Oue,Hiroshi Handa,Yasunori Matsuzaki,Kazutomo Suzue,Hirokazu Murakami,Hirokazu Hirai, Nov. 2012, PLOS ONE, 7, 11

  DOI
• Circulating plasmacytoid dendritic cells in patients with primary and Helicobacter pylori-associated immune thrombocytopenia, Akio Saito,Akihiko Yokohama,Yohei Osaki,Yoshiyuki Ogawa,Hirotaka Nakahashi,Kohtaro Toyama,Takeki Mitsui,Yoko Hashimoto,Hiromi Koiso,Hideki Uchiumi,Takayuki Saitoh,Hiroshi Handa,Morio Sawamura,Masamitsu Karasawa,Hirokazu Murakami,Norifumi Tsukamoto,Yoshihisa Nojima, Apr. 2012, EUROPEAN JOURNAL OF HAEMATOLOGY, 88, 4, 340, 349

  DOI
• Circulating plasmacytoid dendritic cells in patients with primary and Helicobacter pylori-associated immune thrombocytopenia, Akio Saito,Akihiko Yokohama,Yohei Osaki,Yoshiyuki Ogawa,Hirotaka Nakahashi,Kohtaro Toyama,Takeki Mitsui,Yoko Hashimoto,Hiromi Koiso,Hideki Uchiumi,Takayuki Saitoh,Hiroshi Handa,Morio Sawamura,Masamitsu Karasawa,Hirokazu Murakami,Norifumi Tsukamoto,Yoshihisa Nojima, Apr. 2012, EUROPEAN JOURNAL OF HAEMATOLOGY, 88, 4, 340, 349

  DOI
• Clinical significance of granulocytic sarcoma in adult patients with acute myeloid leukemia, Hiroaki Shimizu,Takayuki Saitoh,Nahoko Hatsumi,Satoru Takada,Akihiko Yokohama,Hiroshi Handa,Tkahiro Jimbo,Toru Sakura,Norifumi Tsukamoto,Hirokazu Murakami,Shuichi Miyawaki,Yoshihisa Nojima, Aug. 2012, CANCER SCIENCE, 103, 8, 1513, 1517

  DOI
• Clinical significance of granulocytic sarcoma in adult patients with acute myeloid leukemia, Hiroaki Shimizu,Takayuki Saitoh,Nahoko Hatsumi,Satoru Takada,Akihiko Yokohama,Hiroshi Handa,Tkahiro Jimbo,Toru Sakura,Norifumi Tsukamoto,Hirokazu Murakami,Shuichi Miyawaki,Yoshihisa Nojima, Aug. 2012, CANCER SCIENCE, 103, 8, 1513, 1517

  DOI
• Multicenter validation of a reproducible flow cytometric score for the diagnosis of low-grade myelodysplastic syndromes: results of a European LeukemiaNET study, Matteo G. Della Porta,Cristina Picone,Cristiana Pascutto,Luca Malcovati,Hideto Tamura,Hiroshi Handa,Magdalena Czader,Sylvie Freeman,Paresh Vyas,Anna Porwit,Leonie Saft,Theresia M. Westers,Canan Alhan,Claudia Cali,Arjan A. van de Loosdrecht,Kiyoyuki Ogata, Aug. 2012, HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 97, 8, 1209, 1217

  DOI
• Multicenter validation of a reproducible flow cytometric score for the diagnosis of low-grade myelodysplastic syndromes: results of a European LeukemiaNET study, Matteo G. Della Porta,Cristina Picone,Cristiana Pascutto,Luca Malcovati,Hideto Tamura,Hiroshi Handa,Magdalena Czader,Sylvie Freeman,Paresh Vyas,Anna Porwit,Leonie Saft,Theresia M. Westers,Canan Alhan,Claudia Cali,Arjan A. van de Loosdrecht,Kiyoyuki Ogata, Aug. 2012, HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 97, 8, 1209, 1217

  DOI
• TCL1A gene involvement in T-cell prolymphocytic leukemia in Japanese patients, Akihiko Yokohama,Akio Saitoh,Hirotaka Nakahashi,Takeki Mitsui,Hiromi Koiso,Yoshitora Kim,Hideki Uchiumi,Takayuki Saitoh,Hiroshi Handa,Takahiro Jimbo,Kayoko Murayama,Tohru Sakura,Hirokazu Murakami,Masamitsu Karasawa,Yoshihisa Nojima,Norifumi Tsukamoto, Jan. 2012, INTERNATIONAL JOURNAL OF HEMATOLOGY, 95, 1, 77, 85

  DOI
• TCL1A gene involvement in T-cell prolymphocytic leukemia in Japanese patients, Akihiko Yokohama,Akio Saitoh,Hirotaka Nakahashi,Takeki Mitsui,Hiromi Koiso,Yoshitora Kim,Hideki Uchiumi,Takayuki Saitoh,Hiroshi Handa,Takahiro Jimbo,Kayoko Murayama,Tohru Sakura,Hirokazu Murakami,Masamitsu Karasawa,Yoshihisa Nojima,Norifumi Tsukamoto, Jan. 2012, INTERNATIONAL JOURNAL OF HEMATOLOGY, 95, 1, 77, 85

  DOI
• Ribosome-lamella complex of leukemic cells in a patient with aggressive NK cell leukemia, N Hatsumi,T Saitoh,A Yokohama,H Uchiumi,T Matsushima,N Tsukamoto,Y Nojima,M Karasawa,H Handa,H Ogawara,H Murakami, Nov. 2002, ULTRASTRUCTURAL PATHOLOGY, 26, 6, 415, 417

  DOI
• CD7+ and CD56+ myeloid/natural killer cell precursor acute leukemia treated with idarubicin and cytosine arabinoside, H Handa,S Motohashi,K Isozumi,S Komatsumoto,M Nara, 2002, ACTA HAEMATOLOGICA, 108, 1, 47, 52

  DOI
• CD7+ and CD56+ myeloid/natural killer cell precursor acute leukemia treated with idarubicin and cytosine arabinoside, H Handa,S Motohashi,K Isozumi,S Komatsumoto,M Nara, 2002, ACTA HAEMATOLOGICA, 108, 1, 47, 52

  DOI
• TCR V beta repertoire analysis in CD56(+) CD16(dim/-) T-cell large granular lymphocyte leukaemia: association with CD4 single and CD4/CD8 double positive phenotypes, M Karasawa,T Mitsui,A Isoda,Y Tsumita,H Irisawa,A Yokohama,H Handa,T Matsushima,N Tsukamoto,H Murakami,Y Nojima, Nov. 2003, BRITISH JOURNAL OF HAEMATOLOGY, 123, 4, 613, 620

  DOI
• Prevalence and clinical characteristics of myelodysplastic syndrome with bone marrow eosinophilia or basophilia, T Matsushima,H Handa,A Yokohama,J Nagasaki,H Koiso,Y Kin,Y Tanaka,T Sakura,N Tsukamoto,M Karasawa,K Itoh,H Hirabayashi,M Sawamura,S Shinonome,S Shimano,S Miyawaki,Y Nojima,H Murakami, May 2003, BLOOD, 101, 9, 3386, 3390

  DOI
• Prevalence and clinical characteristics of myelodysplastic syndrome with bone marrow eosinophilia or basophilia, T Matsushima,H Handa,A Yokohama,J Nagasaki,H Koiso,Y Kin,Y Tanaka,T Sakura,N Tsukamoto,M Karasawa,K Itoh,H Hirabayashi,M Sawamura,S Shinonome,S Shimano,S Miyawaki,Y Nojima,H Murakami, May 2003, BLOOD, 101, 9, 3386, 3390

  DOI
• High Th1/Th2 ratio in patients with chronic idiopathic thrombocytopenic purpura, H Ogawara,H Handa,K Morita,M Hayakawa,J Kojima,H Amagai,Y Tsumita,Y Kaneko,N Tsukamoto,Y Nojima,H Murakami, Oct. 2003, EUROPEAN JOURNAL OF HAEMATOLOGY, 71, 4, 283, 288

  DOI
• High Th1/Th2 ratio in patients with chronic idiopathic thrombocytopenic purpura, H Ogawara,H Handa,K Morita,M Hayakawa,J Kojima,H Amagai,Y Tsumita,Y Kaneko,N Tsukamoto,Y Nojima,H Murakami, Oct. 2003, EUROPEAN JOURNAL OF HAEMATOLOGY, 71, 4, 283, 288

  DOI
• Durable remission induced by rituximab-containing chemotherapy in a patient with primary refractory Burkitt's lymphoma, A Yokohama,N Tsukamoto,H Uchiumi,H Handa,T Matsushima,M Karasawa,H Murakami,Y Nojima, Feb. 2004, ANNALS OF HEMATOLOGY, 83, 2, 120, 123

  DOI
• Characteristic expansion of CD45RA(+) CD27(-) CD28(-) CCR7(-) lymphocytes with stable natural killer (NK) receptor expression in NK- and T-cell type lymphoproliferative disease of granular lymphocytes, T Mitsui,Maekawa\, I,A Yamane,T Ishikawa,H Koiso,A Yokohama,H Handa,T Matsushima,N Tsukamoto,H Murakami,Y Nojima,M Karasawa, Jul. 2004, BRITISH JOURNAL OF HAEMATOLOGY, 126, 1, 55, 62

  DOI
• Characteristic expansion of CD45RA(+) CD27(-) CD28(-) CCR7(-) lymphocytes with stable natural killer (NK) receptor expression in NK- and T-cell type lymphoproliferative disease of granular lymphocytes, T Mitsui,Maekawa\, I,A Yamane,T Ishikawa,H Koiso,A Yokohama,H Handa,T Matsushima,N Tsukamoto,H Murakami,Y Nojima,M Karasawa, Jul. 2004, BRITISH JOURNAL OF HAEMATOLOGY, 126, 1, 55, 62

  DOI
• Raltegravir is safely used with long-term viral suppression for HIV-infected patients on hemodialysis: a pharmacokinetic study, Kunio Yanagisawa,Daisuke Nagano,Yoshiyuki Ogawa,Hideki Uchiumi,Tetsuya Shigehara,Kazuhisa Saruki,Hiroshi Handa,Takuya Araki,Koujirou Yamamoto,Yoshihisa Nojima, Mar. 2016, AIDS, 30, 6, 970, 972, Report scientific journal

  DOI
• Primary Plasma Cell Leukemia in the Era of Novel Agents: A Multicenter Study of the Japanese Society of Myeloma, Hirono Iriuchishima,Shuji Ozaki,Jun Konishi,Morio Matsumoto,Kayoko Murayama,Fumihiko Nakamura,Go Yamamoto,Hiroshi Handa,Takayuki Saitoh,Eiichi Nagura,Kazuyuki Shimizu,Yoshihisa Nojimaa,Hirokazu Murakami, 2016, ACTA HAEMATOLOGICA, 135, 2, 113, 121

  DOI
• Primary Plasma Cell Leukemia in the Era of Novel Agents: A Multicenter Study of the Japanese Society of Myeloma, Hirono Iriuchishima,Shuji Ozaki,Jun Konishi,Morio Matsumoto,Kayoko Murayama,Fumihiko Nakamura,Go Yamamoto,Hiroshi Handa,Takayuki Saitoh,Eiichi Nagura,Kazuyuki Shimizu,Yoshihisa Nojimaa,Hirokazu Murakami, 2016, ACTA HAEMATOLOGICA, 135, 2, 113, 121

  DOI
• Chromosome 16q genes CDH1, CDH13 and ADAMTS18 are correlated and frequently methylated in human lymphoma, Lobna Alkebsi,Hiroshi Handa,Akihiko Yokohama,Takayuki Saitoh,Norifumi Tsukamoto,Hirokazu Murakami, Nov. 2016, ONCOLOGY LETTERS, 12, 5, 3523, 3530

  DOI
• Chromosome 16q genes CDH1, CDH13 and ADAMTS18 are correlated and frequently methylated in human lymphoma, Lobna Alkebsi,Hiroshi Handa,Akihiko Yokohama,Takayuki Saitoh,Norifumi Tsukamoto,Hirokazu Murakami, Nov. 2016, ONCOLOGY LETTERS, 12, 5, 3523, 3530

  DOI
• Polymorphisms of IL-10 affect the severity and prognosis of myelodysplastic syndrome, Tetsuhiro Kasamatsu,Takayuki Saitoh,Yusuke Minato,Hiroaki Shimizu,Akihiko Yokohama,Norifumi Tsukamoto,Hiroshi Handa,Toru Sakura,Hirokazu Murakami, Mar. 2016, EUROPEAN JOURNAL OF HAEMATOLOGY, 96, 3, 245, 251

  DOI
• Polymorphisms of IL-10 affect the severity and prognosis of myelodysplastic syndrome, Tetsuhiro Kasamatsu,Takayuki Saitoh,Yusuke Minato,Hiroaki Shimizu,Akihiko Yokohama,Norifumi Tsukamoto,Hiroshi Handa,Toru Sakura,Hirokazu Murakami, Mar. 2016, EUROPEAN JOURNAL OF HAEMATOLOGY, 96, 3, 245, 251

  DOI
• SF3B1 and IGHV gene mutation status predict poor prognosis in Japanese CLL patients, Takeki Mitsui,Hiromi Koiso,Hirotaka Nakahashi,Akio Saitoh,Hiroaki Shimizu,Takuma Ishizaki,Yoshiyuki Ogawa,Makiko Takizawa,Akihiko Yokohama,Takayuki Saitoh,Takahiro Jinbo,Hidemi Ogura,Hiroshi Handa,Morio Sawamura,Tohru Sakura,Masamitsu Karasawa,Hirokazu Murakami,Yoshihisa Nojima,Norifumi Tsukamoto, Feb. 2016, INTERNATIONAL JOURNAL OF HEMATOLOGY, 103, 2, 219, 226

  DOI
• SF3B1 and IGHV gene mutation status predict poor prognosis in Japanese CLL patients, Takeki Mitsui,Hiromi Koiso,Hirotaka Nakahashi,Akio Saitoh,Hiroaki Shimizu,Takuma Ishizaki,Yoshiyuki Ogawa,Makiko Takizawa,Akihiko Yokohama,Takayuki Saitoh,Takahiro Jinbo,Hidemi Ogura,Hiroshi Handa,Morio Sawamura,Tohru Sakura,Masamitsu Karasawa,Hirokazu Murakami,Yoshihisa Nojima,Norifumi Tsukamoto, Feb. 2016, INTERNATIONAL JOURNAL OF HEMATOLOGY, 103, 2, 219, 226

  DOI
• Incidence and clinical background of hepatitis B virus reactivation in multiple myeloma in novel agents' era, Yutaka Tsukune,Makoto Sasaki,Takeshi Odajima,Atsushi Isoda,Morio Matsumoto,Michiaki Koike,Hideto Tamura,Keiichi Moriya,Shigeki Ito,Maki Asahi,Yoichi Imai,Junji Tanaka,Hiroshi Handa,Hiromi Koiso,Sakae Tanosaki,Jian Hua,Masao Hagihara,Yuriko Yahata,Satoko Suzuki,Sumio Watanabe,Hiroki Sugimori,Norio Komatsu, Sep. 2016, ANNALS OF HEMATOLOGY, 95, 9, 1465, 1472

  DOI
• Incidence and clinical background of hepatitis B virus reactivation in multiple myeloma in novel agents' era, Yutaka Tsukune,Makoto Sasaki,Takeshi Odajima,Atsushi Isoda,Morio Matsumoto,Michiaki Koike,Hideto Tamura,Keiichi Moriya,Shigeki Ito,Maki Asahi,Yoichi Imai,Junji Tanaka,Hiroshi Handa,Hiromi Koiso,Sakae Tanosaki,Jian Hua,Masao Hagihara,Yuriko Yahata,Satoko Suzuki,Sumio Watanabe,Hiroki Sugimori,Norio Komatsu, Sep. 2016, ANNALS OF HEMATOLOGY, 95, 9, 1465, 1472

  DOI
• Successful Treatment of Epstein-Barr Virus-Associated Lymphoproliferative Disorder with Rituximab in a Patient Undergoing Immunosuppressive Therapy for Aplastic Anemia, Hiroaki Shimizu,Nobuhiko Kobayashi,Masahiro Mihara,Hirono Iriuchishima,Takuma Ishizaki,Yoshihisa Kojima,Hiroshi Handa, 2016, ACTA HAEMATOLOGICA, 136, 3, 174, 177

  DOI
• Successful Treatment of Epstein-Barr Virus-Associated Lymphoproliferative Disorder with Rituximab in a Patient Undergoing Immunosuppressive Therapy for Aplastic Anemia, Hiroaki Shimizu,Nobuhiko Kobayashi,Masahiro Mihara,Hirono Iriuchishima,Takuma Ishizaki,Yoshihisa Kojima,Hiroshi Handa, 2016, ACTA HAEMATOLOGICA, 136, 3, 174, 177

  DOI
• Interleukin-17F gene polymorphism in patients with chronic immune thrombocytopenia, Takayuki Saitoh,Norifumi Tsukamoto,Hiromi Koiso,Takeki Mitsui,Akihiko Yokohama,Hiroshi Handa,Masamitsu Karasawa,Hatsue Ogawara,Yoshihisa Nojima,Hirokazu Murakami, Sep. 2011, EUROPEAN JOURNAL OF HAEMATOLOGY, 87, 3, 253, 258

  DOI
• Interleukin-17F gene polymorphism in patients with chronic immune thrombocytopenia, Takayuki Saitoh,Norifumi Tsukamoto,Hiromi Koiso,Takeki Mitsui,Akihiko Yokohama,Hiroshi Handa,Masamitsu Karasawa,Hatsue Ogawara,Yoshihisa Nojima,Hirokazu Murakami, Sep. 2011, EUROPEAN JOURNAL OF HAEMATOLOGY, 87, 3, 253, 258

  DOI
• Long-term follow-up of EBV-positive lymphoproliferative disorders in a patient with systemic lupus erythematosus, Norifumi Tsukamoto,Hiroshi Handa,Akihiko Yokohama,Takeki Mitsui,Takayuki Saitoh,Hiromi Koiso,Hideki Uchiumi,Takumi Hoshino,Masamitsu Karasawa,Hirokazu Murakami,Masaru Kojima,Yoshihisa Nojima, Dec. 2011, MEDICAL MOLECULAR MORPHOLOGY, 44, 4, 237, 241

  DOI
• Long-term follow-up of EBV-positive lymphoproliferative disorders in a patient with systemic lupus erythematosus, Norifumi Tsukamoto,Hiroshi Handa,Akihiko Yokohama,Takeki Mitsui,Takayuki Saitoh,Hiromi Koiso,Hideki Uchiumi,Takumi Hoshino,Masamitsu Karasawa,Hirokazu Murakami,Masaru Kojima,Yoshihisa Nojima, Dec. 2011, MEDICAL MOLECULAR MORPHOLOGY, 44, 4, 237, 241

  DOI
• Interleukin-10 gene polymorphism reflects the severity of chronic immune thrombocytopenia in Japanese patients, T. Saitoh,T. Kasamatsu,M. Inoue,T. Mitsui,H. Koiso,A. Yokohama,H. Handa,T. Matsushima,N. Tsukamoto,M. Karasawa,H. Ogawara,Y. Nojima,H. Murakami, Oct. 2011, INTERNATIONAL JOURNAL OF LABORATORY HEMATOLOGY, 33, 5, 526, 532

  DOI
• Interleukin-10 gene polymorphism reflects the severity of chronic immune thrombocytopenia in Japanese patients, T. Saitoh,T. Kasamatsu,M. Inoue,T. Mitsui,H. Koiso,A. Yokohama,H. Handa,T. Matsushima,N. Tsukamoto,M. Karasawa,H. Ogawara,Y. Nojima,H. Murakami, Oct. 2011, INTERNATIONAL JOURNAL OF LABORATORY HEMATOLOGY, 33, 5, 526, 532

  DOI
• Successful Treatment of Autoimmune Hemolytic Anemia Associated with Multicentric Castleman Disease by Anti-Interleukin-6 Receptor Antibody (Tocilizumab) Therapy, Akinori Yuzuriha,Takayuki Saitoh,Hiromi Koiso,Takeki Mitsui,Hideki Uchiumi,Akihiko Yokohama,Hiroshi Handa,Masaru Kojima,Norifumi Tsukamoto,Masamitsu Karaswa,Hirokazu Murakami,Yoshihisa Nojima, 2011, ACTA HAEMATOLOGICA, 126, 3, 147, 150

  DOI
• Successful Treatment of Autoimmune Hemolytic Anemia Associated with Multicentric Castleman Disease by Anti-Interleukin-6 Receptor Antibody (Tocilizumab) Therapy, Akinori Yuzuriha,Takayuki Saitoh,Hiromi Koiso,Takeki Mitsui,Hideki Uchiumi,Akihiko Yokohama,Hiroshi Handa,Masaru Kojima,Norifumi Tsukamoto,Masamitsu Karaswa,Hirokazu Murakami,Yoshihisa Nojima, 2011, ACTA HAEMATOLOGICA, 126, 3, 147, 150

  DOI
• Differences in the JAK2 and MPL Mutation Status in the Cell Lineages of the bcr/abl-negative Chronic Myeloproliferative Neoplasm Subtypes, Kohtaro Toyama,Masamitsu Karasawa,Akihiko Yokohama,Takeki Mitsui,Hideki Uchiumi,Takayuki Saitoh,Hiroshi Handa,Hirokazu Murakami,Yoshihisa Nojima,Norifumi Tsukamoto, 2011, INTERNAL MEDICINE, 50, 21, 2557, 2561

  DOI
• Differences in the JAK2 and MPL Mutation Status in the Cell Lineages of the bcr/abl-negative Chronic Myeloproliferative Neoplasm Subtypes, Kohtaro Toyama,Masamitsu Karasawa,Akihiko Yokohama,Takeki Mitsui,Hideki Uchiumi,Takayuki Saitoh,Hiroshi Handa,Hirokazu Murakami,Yoshihisa Nojima,Norifumi Tsukamoto, 2011, INTERNAL MEDICINE, 50, 21, 2557, 2561

  DOI
• Analysis of bacteremia/fungemia and pneumonia accompanying acute myelogenous leukemia from 1987 to 2001 in the Japan Adult Leukemia Study Group, Minoru Yoshida,Nobu Akiyama,Hiroyuki Fujita,Katsuhiro Miura,Jun-ichi Miyatake,Hiroshi Handa,Katsuyuki Kito,Masatomo Takahashi,Kazuyuki Shigeno,Yoshinobu Kanda,Naoko Hatsumi,Shigeki Ohtake,Hisashi Sakamaki,Kazunori Ohnishi,Shuichi Miyawaki,Ryuzo Ohno,Tomoki Naoe, Jan. 2011, INTERNATIONAL JOURNAL OF HEMATOLOGY, 93, 1, 66, 73

  DOI
• Analysis of bacteremia/fungemia and pneumonia accompanying acute myelogenous leukemia from 1987 to 2001 in the Japan Adult Leukemia Study Group, Minoru Yoshida,Nobu Akiyama,Hiroyuki Fujita,Katsuhiro Miura,Jun-ichi Miyatake,Hiroshi Handa,Katsuyuki Kito,Masatomo Takahashi,Kazuyuki Shigeno,Yoshinobu Kanda,Naoko Hatsumi,Shigeki Ohtake,Hisashi Sakamaki,Kazunori Ohnishi,Shuichi Miyawaki,Ryuzo Ohno,Tomoki Naoe, Jan. 2011, INTERNATIONAL JOURNAL OF HEMATOLOGY, 93, 1, 66, 73

  DOI
• Philadelphia chromosome-positive mixed phenotype acute leukemia in the imatinib era, Hiroaki Shimizu,Akihiko Yokohama,Nahoko Hatsumi,Satoru Takada,Hiroshi Handa,Toru Sakura,Yoshihisa Nojima, Oct. 2014, EUROPEAN JOURNAL OF HAEMATOLOGY, 93, 4, 297, 301

  DOI
• Philadelphia chromosome-positive mixed phenotype acute leukemia in the imatinib era, Hiroaki Shimizu,Akihiko Yokohama,Nahoko Hatsumi,Satoru Takada,Hiroshi Handa,Toru Sakura,Yoshihisa Nojima, Oct. 2014, EUROPEAN JOURNAL OF HAEMATOLOGY, 93, 4, 297, 301

  DOI
• Normal karyotype acute myeloid leukemia with the CD7+CD15+CD34+HLA-DR + immunophenotype is a clinically distinct entity with a favorable outcome, Noriyoshi Iriyama,Norio Asou,Yasushi Miyazaki,Shunichiro Yamaguchi,Shinya Sato,Toru Sakura,Tomoya Maeda,Hiroshi Handa,Masatomo Takahashi,Shigeki Ohtake,Yoshihiro Hatta,Hisashi Sakamaki,Sumihisa Honda,Tomohiko Taki,Masafumi Taniwaki,Shuichi Miyawaki,Kazunori Ohnishi,Yukio Kobayashi,Tomoki Naoe, Jun. 2014, ANNALS OF HEMATOLOGY, 93, 6, 957, 963

  DOI
• Normal karyotype acute myeloid leukemia with the CD7+CD15+CD34+HLA-DR + immunophenotype is a clinically distinct entity with a favorable outcome, Noriyoshi Iriyama,Norio Asou,Yasushi Miyazaki,Shunichiro Yamaguchi,Shinya Sato,Toru Sakura,Tomoya Maeda,Hiroshi Handa,Masatomo Takahashi,Shigeki Ohtake,Yoshihiro Hatta,Hisashi Sakamaki,Sumihisa Honda,Tomohiko Taki,Masafumi Taniwaki,Shuichi Miyawaki,Kazunori Ohnishi,Yukio Kobayashi,Tomoki Naoe, Jun. 2014, ANNALS OF HEMATOLOGY, 93, 6, 957, 963

  DOI
• Clinical features and prognostic impact of PRDM16 expression in adult acute myeloid leukemia, Genki Yamato,Hiroki Yamaguchi,Hiroshi Handa,Norio Shiba,Machiko Kawamura,Satoshi Wakita,Koiti Inokuchi,Yusuke Hara,Kentaro Ohki,Jun Okubo,Myoung-Ja Park,Manabu Sotomatsu,Hirokazu Arakawa,Yasuhide Hayashi, Nov. 2017, GENES CHROMOSOMES & CANCER, 56, 11, 800, 809

  DOI
• Clinical features and prognostic impact of PRDM16 expression in adult acute myeloid leukemia, Genki Yamato,Hiroki Yamaguchi,Hiroshi Handa,Norio Shiba,Machiko Kawamura,Satoshi Wakita,Koiti Inokuchi,Yusuke Hara,Kentaro Ohki,Jun Okubo,Myoung-Ja Park,Manabu Sotomatsu,Hirokazu Arakawa,Yasuhide Hayashi, Nov. 2017, GENES CHROMOSOMES & CANCER, 56, 11, 800, 809

  DOI
• Recurrent alterations of the WW domain containing oxidoreductase gene spanning the common fragile site FRA16D in multiple myeloma and monoclonal gammopathy of undetermined significance, Hiroshi Handa,Yoshiko Sasaki,Hikaru Hattori,Lobna Alkebsi,Tetsuhiro Kasamatsu,Takayuki Saitoh,Takeki Mitsui,Akihiko Yokohama,Norifumi Tsukamoto,Morio Matsumoto,Hirokazu Murakami, Oct. 2017, ONCOLOGY LETTERS, 14, 4, 4372, 4378

  DOI
• Recurrent alterations of the WW domain containing oxidoreductase gene spanning the common fragile site FRA16D in multiple myeloma and monoclonal gammopathy of undetermined significance, Hiroshi Handa,Yoshiko Sasaki,Hikaru Hattori,Lobna Alkebsi,Tetsuhiro Kasamatsu,Takayuki Saitoh,Takeki Mitsui,Akihiko Yokohama,Norifumi Tsukamoto,Morio Matsumoto,Hirokazu Murakami, Oct. 2017, ONCOLOGY LETTERS, 14, 4, 4372, 4378

  DOI
• Cytomegalovirus retinitis followed by immune recovery uveitis in an elderly patient with rheumatoid arthritis undergoing administration of methotrexate and tofacitinib combination therapy, Kunio Yanagisawa,Yoshiyuki Ogawa,Mayumi Hosogai,Daisuke Todokoro,Takeki Mitsui,Akihiko Yokohama,Shoji Kishi,Hiroshi Handa, Aug. 2017, JOURNAL OF INFECTION AND CHEMOTHERAPY, 23, 8, 572, 575

  DOI
• Cytomegalovirus retinitis followed by immune recovery uveitis in an elderly patient with rheumatoid arthritis undergoing administration of methotrexate and tofacitinib combination therapy, Kunio Yanagisawa,Yoshiyuki Ogawa,Mayumi Hosogai,Daisuke Todokoro,Takeki Mitsui,Akihiko Yokohama,Shoji Kishi,Hiroshi Handa, Aug. 2017, JOURNAL OF INFECTION AND CHEMOTHERAPY, 23, 8, 572, 575

  DOI
• The cytokine polymorphisms affecting Th1/Th2 increase the susceptibility to, and severity of, chronic ITP, Noriyuki Takahashi,Takayuki Saitoh,Nanami Gotoh,Yasuhiro Nitta,Lobna Alkebsi,Tetsuhiro Kasamatsu,Yusuke Minato,Akihiko Yokohama,Norifumi Tsukamoto,Hiroshi Handa,Hirokazu Murakami, May 2017, BMC IMMUNOLOGY, 18, 1, 26

  DOI
• Randomized phase 3 study of elotuzumab for relapsed or refractory multiple myeloma: ELOQUENT-2 Japanese patient subanalysis, K. Suzuki,K. Sunami,K. Ohashi,S. Iida,T. Mori,H. Handa,K. Matsue,M. Miyoshi,E. Bleickardt,M. Matsumoto,M. Taniwaki, Mar. 2017, BLOOD CANCER JOURNAL, 7, e540, Report scientific journal

  DOI
• Randomized phase 3 study of elotuzumab for relapsed or refractory multiple myeloma: ELOQUENT-2 Japanese patient subanalysis, K. Suzuki,K. Sunami,K. Ohashi,S. Iida,T. Mori,H. Handa,K. Matsue,M. Miyoshi,E. Bleickardt,M. Matsumoto,M. Taniwaki, Mar. 2017, BLOOD CANCER JOURNAL, 7, e540, Report scientific journal

  DOI
• Long non-coding RNA MALAT1 is an inducible stress response gene associated with extramedullary spread and poor prognosis of multiple myeloma, Hiroshi Handa,Yuko Kuroda,Kei Kimura,Yuta Masuda,Hikaru Hattori,Lobna Alkebsi,Morio Matsumoto,Tetsuhiro Kasamatsu,Nobuhiko Kobayashi,Ken-ichi Tahara,Makiko Takizawa,Hiromi Koiso,Takuma Ishizaki,Hiroaki Shimizu,Akihiko Yokohama,Norifumi Tsukamoto,Takayuki Saito,Hirokazu Murakami, Nov. 2017, BRITISH JOURNAL OF HAEMATOLOGY, 179, 3, 449, 460

  DOI
• Polymorphism of IL-10 receptor beta affects the prognosis of multiple myeloma patients treated with thalidomide and/or bortezomib, Tetsuhiro Kasamatsu,Takayuki Saitoh,Rumi Ino,Nanami Gotoh,Takeki Mitsui,Hiroaki Shimizu,Morio Matsumoto,Morio Sawamura,Akihiko Yokohama,Hiroshi Handa,Norifumi Tsukamoto,Hirokazu Murakami, Dec. 2017, HEMATOLOGICAL ONCOLOGY, 35, 4, 711, 718

  DOI
• Management of infection during chemotherapy for acute leukemia in Japan: a nationwide questionnaire-based survey by the Japan Adult Leukemia Study Group, Shun-ichi Kimura,Hiroyuki Fujita,Hideaki Kato,Nobuhiro Hiramoto,Naoko Hosono,Tsutomu Takahashi,Kazuyuki Shigeno,Naoko Hatsumi,Hitoshi Minamiguchi,Junichi Miyatake,Hiroshi Handa,Nobu Akiyama,Yoshinobu Kanda,Minoru Yoshida,Hitoshi Kiyoi,Yasushi Miyazaki,Tomoki Naoe, Nov. 2017, SUPPORTIVE CARE IN CANCER, 25, 11, 3515, 3521

  DOI
• Management of infection during chemotherapy for acute leukemia in Japan: a nationwide questionnaire-based survey by the Japan Adult Leukemia Study Group, Shun-ichi Kimura,Hiroyuki Fujita,Hideaki Kato,Nobuhiro Hiramoto,Naoko Hosono,Tsutomu Takahashi,Kazuyuki Shigeno,Naoko Hatsumi,Hitoshi Minamiguchi,Junichi Miyatake,Hiroshi Handa,Nobu Akiyama,Yoshinobu Kanda,Minoru Yoshida,Hitoshi Kiyoi,Yasushi Miyazaki,Tomoki Naoe, Nov. 2017, SUPPORTIVE CARE IN CANCER, 25, 11, 3515, 3521

  DOI
• Overexpression of B-cell lymphoma 6 alters gene expression profile in a myeloma cell line and is associated with decreased DNA damage response, Kenichi Tahara,Makiko Takizawa,Arito Yamane,Yohei Osaki,Takuma Ishizaki,Takeki Mitsui,Akihiko Yokohama,Takayuki Saitoh,Norifumi Tsukamoto,Morio Matsumoto,Hirokazu Murakami,Yoshihisa Nojima,Hiroshi Handa, Aug. 2017, CANCER SCIENCE, 108, 8, 1556, 1564

  DOI
• Overexpression of B-cell lymphoma 6 alters gene expression profile in a myeloma cell line and is associated with decreased DNA damage response, Kenichi Tahara,Makiko Takizawa,Arito Yamane,Yohei Osaki,Takuma Ishizaki,Takeki Mitsui,Akihiko Yokohama,Takayuki Saitoh,Norifumi Tsukamoto,Morio Matsumoto,Hirokazu Murakami,Yoshihisa Nojima,Hiroshi Handa, Aug. 2017, CANCER SCIENCE, 108, 8, 1556, 1564

  DOI
• Phase 1 study of ixazomib alone or combined with lenalidomide-dexamethasone in Japanese patients with relapsed/refractory multiple myeloma, Kenshi Suzuki,Hiroshi Handa,Takaaki Chou,Kenichi Ishizawa,Takatoshi Takubo,Yoichi Kase, Apr. 2017, INTERNATIONAL JOURNAL OF HEMATOLOGY, 105, 4, 445, 452

  DOI
• Phase 1 study of ixazomib alone or combined with lenalidomide-dexamethasone in Japanese patients with relapsed/refractory multiple myeloma, Kenshi Suzuki,Hiroshi Handa,Takaaki Chou,Kenichi Ishizawa,Takatoshi Takubo,Yoichi Kase, Apr. 2017, INTERNATIONAL JOURNAL OF HEMATOLOGY, 105, 4, 445, 452

  DOI
• Histone deacetylase inhibitors suppress ABO transcription in vitro, leading to reduced expression of the antigens, Yoichiro Takahashi,Rieko Kubo,Rie Sano,Tamiko Nakajima,Keiko Takahashi,Momoko Kobayashi,Hiroshi Handa,Junichi Tsukada,Yoshihiko Kominato, Mar. 2017, TRANSFUSION, 57, 3, 554, 562

  DOI
• Successful Management of a Patient with Autoimmune Hemorrhaphilia due to Anti-Factor XIII/13 Antibodies Complicated by Pulmonary Thromboembolism, Yoshiyuki Ogawa,Kunio Yanagisawa,Masayoshi Souri,Masahiro Mihara,Chiaki Naito,Makiko Takizawa,Takuma Ishizaki,Takeki Mitsui,Hiroshi Handa,Tsukasa Osaki,Yoshihisa Nojima,Akitada Ichinose, 2017, ACTA HAEMATOLOGICA, 137, 3, 141, 147

  DOI
• Successful Management of a Patient with Autoimmune Hemorrhaphilia due to Anti-Factor XIII/13 Antibodies Complicated by Pulmonary Thromboembolism, Yoshiyuki Ogawa,Kunio Yanagisawa,Masayoshi Souri,Masahiro Mihara,Chiaki Naito,Makiko Takizawa,Takuma Ishizaki,Takeki Mitsui,Hiroshi Handa,Tsukasa Osaki,Yoshihisa Nojima,Akitada Ichinose, 2017, ACTA HAEMATOLOGICA, 137, 3, 141, 147

  DOI
• Retrospective analysis of prognostic factors for Waldenstrom macroglobulinemia: a multicenter cooperative study in Japan, Akio Saito,Atsushi Isoda,Masaru Kojima,Akihiko Yokohama,Yutaka Tsukune,Makoto Sasaki,Shigeki Ito,Akihiro Ohtsu,Michiaki Koike,Kayoko Murayama,Keiichi Moriya,Hideto Tamura,Morio Matsumoto,Hirotaka Nakahashi,Sakae Tanosaki,Tohru Sakura,Toshihide Kawamura,Tomomi Miyanaga,Naoya Nakamura,Hirokazu Murakami,Hiroshi Handa,Norifumi Tsukamoto, Nov. 2017, INTERNATIONAL JOURNAL OF HEMATOLOGY, 106, 5, 681, 690

  DOI
• Epigenetic repression of miR-375 is the dominant mechanism for constitutive activation of the PDPK1/RPS6KA3 signalling axis in multiple myeloma, Shotaro Tatekawa,Yoshiaki Chinen,Masaki Ri,Tomoko Narita,Yuji Shimura,Yayoi Matsumura-Kimoto,Taku Tsukamoto,Tsutomu Kobayashi,Eri Kawata,Nobuhiko Uoshima,Tomohiko Taki,Masafumi Taniwaki,Hiroshi Handa,Shinsuke Iida,Junya Kuroda, Aug. 2017, BRITISH JOURNAL OF HAEMATOLOGY, 178, 4, 534, 546

  DOI
• Epigenetic repression of miR-375 is the dominant mechanism for constitutive activation of the PDPK1/RPS6KA3 signalling axis in multiple myeloma, Shotaro Tatekawa,Yoshiaki Chinen,Masaki Ri,Tomoko Narita,Yuji Shimura,Yayoi Matsumura-Kimoto,Taku Tsukamoto,Tsutomu Kobayashi,Eri Kawata,Nobuhiko Uoshima,Tomohiko Taki,Masafumi Taniwaki,Hiroshi Handa,Shinsuke Iida,Junya Kuroda, Aug. 2017, BRITISH JOURNAL OF HAEMATOLOGY, 178, 4, 534, 546

  DOI
• Clinical characteristics and outcomes of acquired hemophilia A: experience at a single center in Japan, Yoshiyuki Ogawa,Kunio Yanagisawa,Hideki Uchiumi,Takuma Ishizaki,Takeki Mitsui,Fumito Gouda,Masahiro Ieko,Akitada Ichinose,Yoshihisa Nojima,Hiroshi Handa, Jul. 2017, INTERNATIONAL JOURNAL OF HEMATOLOGY, 106, 1, 82, 89

  DOI
• Clinical characteristics and outcomes of acquired hemophilia A: experience at a single center in Japan, Yoshiyuki Ogawa,Kunio Yanagisawa,Hideki Uchiumi,Takuma Ishizaki,Takeki Mitsui,Fumito Gouda,Masahiro Ieko,Akitada Ichinose,Yoshihisa Nojima,Hiroshi Handa, Jul. 2017, INTERNATIONAL JOURNAL OF HEMATOLOGY, 106, 1, 82, 89

  DOI
• Successful management of perioperative hemostasis in a patient with Glanzmann thrombasthenia who underwent a right total mastectomy, Yoshiyuki Ogawa,Shinji Kunishima,Kunio Yanagisawa,Yohei Osaki,Yuri Uchiyama,Naomichi Matsumoto,Hideaki Tokiniwa,Jun Horiguchi,Yoshihisa Nojima,Hiroshi Handa, Feb. 2017, INTERNATIONAL JOURNAL OF HEMATOLOGY, 105, 2, 221, 225

  DOI
• Successful management of perioperative hemostasis in a patient with Glanzmann thrombasthenia who underwent a right total mastectomy, Yoshiyuki Ogawa,Shinji Kunishima,Kunio Yanagisawa,Yohei Osaki,Yuri Uchiyama,Naomichi Matsumoto,Hideaki Tokiniwa,Jun Horiguchi,Yoshihisa Nojima,Hiroshi Handa, Feb. 2017, INTERNATIONAL JOURNAL OF HEMATOLOGY, 105, 2, 221, 225

  DOI
• Sacroiliitis as an initial manifestation of acute myelogenous leukemia, Hoshino T,Matsushima T,Saitoh Y,Yamane A,Takizawa M,Irisawa H,Saitoh T,Handa H,Tsukamoto N,Karasawa M,Murakami H,Nojima Y, 2006, 84, 5, 421, 424

  DOI
• 微小変化型ネフローゼ症候群の再燃時に発症した後天性血友病A, 清水啓明,斉藤貴之,大崎洋平,山根有人,合田史,入澤寛之,横濱彰彦,内海英貴,半田寛,松島孝文,塚本憲史,唐沢正光,村上博和,野島美久, 2007, 48, 6, 514, 517

  DOI
• Combination chemotherapy of ranimustine, doxorubicine,and dexamethasone for relapsing multiple myeloma -a pilot study., Murakami H,Yamane A,Sawamura M,Matsumoto M,Murayama K,Shimano S,Jinbo T,Yokohama A,Uchiumi H,Handa H,Matsushima,Tsukamoto N,Morita K,Karasawa M,Ogawara H,Nojima Y, 2003, 34, 1-6, 39, 46
• Clinical Significance of neutrophil apoptosis in peripheral blood of patients with type 2 diabetes mellitus., Sudo C,Ogawara H,Saleh AW,Nishimoto N,Utsugi T,Ooyama Y,Fukumura Y,Murakami M,Handa H,Tomono S,Murakami H, 2007, 13, 3, 108, 112

  DOI
• L-asparaginaseにより発症したと考えられるreversible posterior leukoencephalopathy syndrome, 宮澤 悠里,入澤 寛之,松島 孝文,三井 健揮,内海 英貴,斉藤 貴之,半田 寛,唐沢 正光,村上 博和,塚本 憲史,野島 美久, 2006, 47, 6, 531, 535

  DOI
• 血管造影にてmultiple hypervascular lesionを呈した形質細胞腫を伴う多発性骨髄腫, 半田 寛,入澤 寛之,小松本 悟,松島 孝文,塚本 憲史,野島 美久,村上 博和, 2006, 47, 6, 521, 525

  DOI
• 多発性骨髄腫の新しい治療, 半田 寛,村上 博和,小河原 はつ江, 2005, 6, :, 1, 95, 104
• 多発性骨髄腫の治療の進歩, 半田 寛,村上 博和, 2003, 第13巻, 第10号, 57, 70
• 60歳以下の骨髄異形成症候群症例の治療成績, 松島孝文,半田 寛,横濱章彦,佐倉徹,岡本潔,河村俊英,積田由紀,村山佳予子,磯田淳,神保貴宏,平林久美,沢村守夫,唐沢正光,島野俊一,塚本 憲史,宮脇修一,野島 美久,村上 博和, 2003, 44, 10, 1004, 1009

  DOI
• 運動負荷による尿中8-ﾋﾄﾞﾛｷｼ-2’-ﾃﾞｵｷｼｸﾞｱﾉｼﾝ(8-OHdG)値の変動, 小河原はつ江,櫻井仁美,冨吉聡子,戸田拓磨,山崎徹,半田寛,森田公夫,荒川千秋,福田春枝,村上博和, 2002, 52, 5, 351, 356

  DOI
• 多発性骨髄腫に対するサリドマイド療法, 半田 寛,村上 博和, 2005, 第3巻, 第2号, (40-47)
• 血管新生阻害剤としてのサリドマイド, 半田 寛,村上 博和, 2005, 第2巻, 第1号, (57-63)
• 日本骨髄腫研究会参加施設におけるサリドマイド治療の現状と成績, 半田 寛,村上 博和, 2004, 第45巻 第6号 468-472

  DOI
• 汎血球減少を合併した甲状腺機能亢進症の一例, 小川 孔幸,前川 出,松島 孝文,滝沢 牧子,内海 英貴,河村 俊英,植木 嘉衛,半田 寛,塚本 憲史,野島 美久, 2004, 93, 4, 145, 147
• Cancer Frontier 分子標的治療 2006 ～最近の進歩～ 3.プロテアソーム阻害剤（骨髄腫）, 村上 博和,半田 寛,小河原 はつ江, 2006, p63-70
• What's going on 「再発多発性骨髄腫に対するボルテゾミブ治療がデキサメタゾン大量療法より優れていることを示した論文」, 半田 寛,村上 博和, 2006, 3,, 1, (115-117)
• What's going on「初発の多発性骨髄腫に対してサリドマイド＋デキサメタゾン療法が、デキサメタゾン単独療法より優れていることを示した多施設共同臨床第三相試験の論文」, 半田 寛,村上 博和, 2006, 3, 2, (99-101
• 脳回状核を有する分類不能成熟Ｔ細胞性白血病, 滝沢 牧子,松島 孝文,横濱 章彦,半田 寛,塚本 憲史,唐沢 正光,村上 博和,野島 美久, 2005, 46, 7, 486, 491

  DOI
• 肝疾患における尿中8-ﾋﾄﾞﾛｷｼ-2'-ﾃﾞｵｷｼｸﾞｱﾉｼﾝ(8-OHdG)の検討, 半田 寛,石坂 美紀,小河原 はつ江,村上 正巳,村上 博和, 2004, 52, 9, 732, 736
• サリドマイド：過去、現在そして未来, 半田 寛,村上 博和, 2004, 第208巻 第13号1039-1044
• 多発性骨髄腫の薬物療法, 半田 寛,村上 博和, 2002, 第17巻, 第8号, 44, 48
• 海外臨床報告「多発性骨髄腫における顎骨壊死(ONJ)：その臨床的特徴と危険因子に関する論文」, 村上 博和,半田 寛, 2006, 17:, 10, 11
• 多発性骨髄腫の治療指針, 村上博和,半田寛,斉藤貴之, 2007, 65, 12, 2167, 2176
• T cell large granular lymphocyte (LGL) leukemia associated with Behcet's disease: high expression of sFasL and IL-18 of CD8 LGL, Saitoh T,Matsushima T,Kaenko Y,Yokohama A,Handa H,Tsukamoto N,Karasawa M,Nojima Y,Murakami H, 2008, 87, 7, 585, 586

  DOI
• ビスフォスフォネート製剤, 半田寛,村上博和, 2007, 54, 3, 373, 380
• Thalidomide、Dexamethasone併用療法中に深部静脈血栓症、肺動脈血栓症を発症した多発性骨髄腫, 宮澤悠里,入澤寛之,内海英貴,斉藤貴之,半田寛,松島孝文,塚本憲史,唐沢正光,村上博和,野島美久, 2006, 47, 7, 656, 660

  DOI
• Successful treatment with voriconazole of Aspergillus meningitis in a patient with acute myeloid leukemia, Saitoh T,Matsushima T,Shimizu H,Yokohama A,Irisawa H,Handa H,Tsukamoto N,Karasawa M,Nojima Y,Murakami H, 2007

  DOI
• Presentation of extramedullary Philadelphia chromosome-positive biphenotypic acute leukemia as testicular mass: Response to imatinib-combined chemotherapy., Saitoh T,Matsushima T,Iriuchishima H,Yamane A,Irisawa H,Handa H,Tsukamoto N,Karasawa M,Nojima Y,Murakami H, 2006, 47, 12, 2667, 2669

  DOI
• Identification of inherited macrothrombocytopenias based on mean platelet volume among patients diagnosed with idiopathic thrombocytopenia., Gohda F,Uchiumi H,Handa H,Matsushima T,Tsukamoto N,Morita K,Amagai H,Murakami M,Murakami H,Nojima Y,Karasawa M, 2006

  DOI
• The effects of 13-cis retinoic acid and interferon-alpha in chronic myelogenous leukemia cells in vivo in patients, HANDA HIROSHI,Raza A,Preisler HD, 1997, 21 1087-1096

  DOI
• Effects of physical therapy on cytokines and two color analysis-lymphocytes subsets in patients with cerebrovascular disease, HANDA HIROSHI,KURABAYASHI HITOSHI,TAMURA JUNICHI, 1999, 30 31-37
• The relative extent and propensity of CD34+ vs. CD34- cells undergo apoptosis in myelodysplastic marrows, HANDA HIROSHI,Mundle S,Raza A,Preisler HD, 1999, 69 (3) 152-159
• Comparison of three protocols for breathing exercises during immersion in 38 degrees C water for chronic obstructive pulmonary disease, HANDA HIROSHI,KURABAYASHI HITOSHI, 1998, 77 145-148

  DOI
• Intussuception as a complication of chronic lymphocytic leukemia, HANDA HIROSHI,MURAKAMI HIROKAZU,TAMURA JUNICHI,MATSUSHIMA TAKAFUMI, 1998, 29 237-240
• Bcl-2 and c-myc expression, cell cycle kinetics and apoptosis during the progression of chronic myelogenous leukemia from diagnosis to blastic phase, HANDA HIROSHI,Raza A,Preisler HD, 1997, 21 479-489

  DOI
• Accuracy of immunohistochemistry and flow cytometry in estimating the proportion of leukemic cells in S phase in chronic myeloid leukemia, HANDA HIROSHI, 1996, 22, 431-437
• Successful treatment of concomitant acute myeloblastic leukemia and adenoid cystic carcinoma of the palate, HANDA HIROSHI,MURAKAMI HIROKAZU,MATSUSHIMA TAKAFUMI, 1993, 21: 102-104
• Primary Hodgkin's disease of the bone presenting with and extra dural tumor, HANDA HIROSHI,MURAKAMI HIROKAZU, 1994, 92: 148-149
• Acute idiopathic thrombocytopenic purpura presenting a high serum level of immunoglobulin E and eosinophilia in an elderly patient, HANDA HIROSHI,KURABAYASHI HITOSHI,TAMURA JUNICHI, 1998, 29 93-96
• IgM-lamda multiple myeloma presenting with systemic amyloidosis, Higeta D,Yokohama A,Osaki Y,Tahara K,Mawatari M,Sekigami T,Koiso H,Saito T,Uchiumi H,Handa H,Karasawa M,Murakami H,Hirato J,Tsukamoto N,Nojima Y, 2009, 50, 12, 1711, 1714

  DOI
• Successful treatment with reduced intensity stem cell transplantation for secondary myelofibrosis following polycythemia vera, Tahara K,Yokohama A,Handa H,Saitoh T,Uchiumi H,Sekigami T,Toyama K,Mawatari M,Osaki Y,Matsushima T,Karasawa M,Murakami H,Tsukamoto N,Nojima Y, 2009, 50, 11, 1630, 1634

  DOI
• Development of an extramedullary plasmacytoma despite dissapearing M protein in multiple myeloma by bortezomib treatment, Koiso H,Tahara K,Osaki Y,Mawatari M,Sekigami T,Yokohama A,Saitoh T,Handa H,Tsukamoto N,Karasawa M,Nojima Y,Murakami H, 2009, 50, 2, 78, 82

  DOI
• Clinical significance of Th1/Th2 ratio in patients with myelodysplastic syndrome, 2009, 31, 6, 201, 207

  DOI
• 特集 骨髄腫患者治療のために～2．骨髄腫の症候―適切な診療のために, 半田寛, 2008, 4, 3, 210, 213
• All Trans Retinoic Acidにより完全寛解を得た高齢者APLの一例, 半田 寛, 1993, 30: 146-149

  DOI
• A randomized comparison of 4 courses of standard-dose multiagent chemotherapy versus 3 courses of high-dose cytarabine alone in postremission therapy for acute myeloid leukemia in adults: the JALSG AML201 Study., Miyawaki S,Ohtake S,Fujisawa S,Kiyoi H,Shinagawa K,Usui N,Sakura T,Miyamura K,Nakaseko C,Miyazaki Y,Fujieda A,Nagai T,Yamane T,Taniwaki M,Takahashi M,Yagasaki F,Kimura Y,Asou N,Sakamaki H,Handa H,Honda S,Ohnishi K,Naoe T,Ohno R, 2011, 24, 117, 2366, 72

  DOI
• Randomized study of induction therapy comparing standard-dose idarubicin with high-dose daunorubicin in adult patients with previously untreated acute myeloid leukemia: the JALSG AML201 Study., Ohtake S,Miyawaki S,Fujita H,Kiyoi H,Shinagawa K,Usui N,Okumura H,Miyamura K,Nakaseko C,Miyazaki Y,Fujieda A,Nagai T,Yamane T,Taniwaki M,Takahashi M,Yagasaki F,Kimura Y,Asou N,Sakamaki H,Handa H,Honda S,Ohnishi K,Naoe T,Ohno R, 2011, 24, 117, 2358, 65

  DOI
• [Retrospective survey on the clinical features of non-Hodgkin lymphomas in Gunma Prefecture, Japan]., Hashimoto Y,Yokohama A,Saitoh A,Nakahashi H,Toyama K,Mitsui T,Koiso H,Saitoh T,Handa H,Uchiumi H,Jinbo T,Murayama K,Tamaki Y,Matsumoto M,Sawamura M,Karasawa M,Murakami H,Hirato J,Nojima Y,Kojima M,Tsukamoto N, 2012, 53, 3, 329, 36

  DOI
• [Diagnosis and prognostic factors in patients with multiple myeloma]., Murakami H,Yokohama A,Saitoh T,Tsukamoto N,Handa H, 2012, 70, Suppl 2:, 584-8.
• Age-related Epstein-Barr Virus-positive lymphoproliferative disorders of the orbit and maxillary sinus : a case report., Mitsui T,Mawatari M,Koiso H,Yokohama A,Uchiumi H,Saitoh T,Handa H,Hirato J,Karasawa M,Murakami H,Kojima M,Nakamura S,Nojima Y,Tsukamoto N, 2012, 52(3), 3, 205, 9

  DOI
• Emergence of donor-derived anti-HLA antibody and subsequent transfusion-refractory thrombocytopenia after allogeneic hematopoietic stem cell transplantation from an HLA-matched sibling donor in a patient with acute myeloid leukemia, Uchiyama Y,Hoshino T,Mihara M,Mitsui T,Koiso H,Takizawa M,Yokohama A,Saitoh T,Uchiumi H,Handa H,Tsukamoto N,Murakami H,Nojima Y, 2013, 54, 2, 214, 218

  DOI
• IL17A and IL23R gene polymorphisms affect the clinical features and prognosis of patients with multiple myeloma, Kasamatsu\, Tetsuhiro,Kimoto\, Mari,Takahashi\, Noriyuki,Minato\, Yusuke,Gotoh\, Nanami,Takizawa\, Makiko,Matsumoto\, Morio,Sawamura\, Morio,Yokohama\, Akihiko,Handa\, Hiroshi,Tsukamoto\, Norifumi,Saitoh\, Takayuki,Murakami\, Hirokazu, 2018, 36, 1, 196, 201

  DOI
• Collision of metastatic malignant melanoma and acute myelogenous leukemia in the bone marrow, Kobayashi\, Nobuhiko,Shimizu\, Hiroaki,Hirato\, Junko,Handa\, Hiroshi, 2018, 107, 3, 257, 259

  DOI
• Successful hemostatic management of major surgery for cervical spondylotic myelopathy in a patient with severe factor XI deficiency., Ogawa Y,Yanagisawa K,Uchiyama Y,Akashi N,Mieda T,Iizuka H,Inoue M,Shizuka R,Murakami M,Matsumoto N,Handa H, 2018, in press

  DOI
• [Evaluation of mental stress tests among medical students based on salivary sample collected just before the national license examination]., Ushiki K,Sato Y,Arai K,Ide N,Matsui N,Handa H,Murakami H,Ogawara H, 2011, 59, 2, 138, 43
• [Glossitis by mixed infection of cytomegalovirus and herpes simplex virus during therapy for pure red cell aplasia complicated with Good syndrome]., Koya H,Yokohama A,Miura A,Hoshino T,Mitsui T,Koiso H,Saitoh T,Uchiumi H,Handa H,Hirato J,Hiromura K,Karasawa M,Murakami H,Tsukamoto N,Nojima Y, 2011, 52, 8, 708, 12

  DOI
• Markedly improved outcomes and acceptable toxicity in adolescents and young adults with acute lymphoblastic leukemia following treatment with a pediatric protocol: a phase II study by the Japan Adult Leukemia Study Group, Hayakawa F,Sakura T,Yujiri T,Kondo E,Fujimaki K,Sasaki O,Miyatake J,Handa H,Ueda Y,Aoyama Y,Takada S,Tanaka Y,Usui N,Miyawaki S,Suenobu S,Horibe K,Kiyoi H,Ohnishi K,Miyazaki Y,Ohtake S,Kobayashi Y,Matsuo K,Naoe T,Japan Adult Leukemia Study Group (JALSG, 2014, 4, e252

  DOI
• Gene polymorphisms of mannose-binding lectin confer susceptibility to Pneumocystis pneumonia in HIV-infected patients, Yanagisawa\, Kunio,Ogawa\, Yoshiyuki,Uchiumi\, Hideki,Gohda\, Fumito,Mawatari\, Momoko,Ishizaki\, Takuma,Mitsui\, Takeki,Yokohama\, Akihiko,Handa\, Hiroshi,Tsukamoto\, Norifumi,Nojima\, Yoshihisa, 2015, 21, 11, 769, 775

  DOI
• Infectious complications in adults undergoing intensive chemotherapy for acute myeloid leukemia in 2001-2005 using the Japan Adult Leukemia Study Group AML201 protocols, Kato H,Fujita H,Akiyama N,Kimura SI,Hiramoto N,Hosono N,Takahashi T,Shigeno K,Minamiguchi H,Miyatake J,Handa H,Kanda Y,Yoshida M,Miyawaki S,Ohtake S,Naoe T,Kiyoi H,Matsumura I,Miyazaki Y,Japan Adult Leukemia,Study Group, 2018, in press

  DOI
• Darunavir concentration in PBMCs may be a better indicator of drug exposure in HIV patients, Daisuke Nagano,Takuya Araki,Kunio Yanagisawa,Yoshiyuki Ogawa,Fumito Gohda,Hideki Uchiumi,Hiroshi Handa,Tomonori Nakamura,Koujirou Yamamoto, 2018, 74, 8, 1055, 1060

  DOI
• Role of exosomes as a proinflammatory mediator in the development of EBV-associated lymphoma, Higuchi H,Yamakawa N,Imadome KI,Yahata T,Kotaki R,Ogata J,Kakizaki M,Fujita K,Lu J,Yokoyama K,Okuyama K,Sato A,Takamatsu M,Kurosaki N,Alba SM,Azhim A,Horie R,Watanabe T,Kitamura T,Ando K,Kashiwagi T,Matsui T,Okamoto A,Handa H,Kuroda M,Nakamura N,Kotani A, 2018, 131, 23, 2552, 2567

  DOI
• Bortezomib maintenance therapy in transplant-ineligible myeloma patients who plateaued after bortezomib-based induction therapy: a multicenter phase II clinical trial, Isoda\, Atsushi,Murayama\, Kayoko,Ito\, Shigeki,Kohara\, Yoichi,Iino\, Masaki,Miyazawa\, Yuri,Matsumoto\, Morio,Handa\, Hiroshi,Imai\, Yosuke,Ishiguro\, Takuro,Izumita\, Wataru,Kitano\, Kiyoshi,Hirabayashi\, Yukio,Nakazawa\, Hideyuki,Ishida\, Fumihiro,Mitsumori\, Toru,Kirito\, Keita,Chou\, Takaaki,Murakami,Hirokazu, 2018, 108, 1, 39, 46

  DOI
• A Rare Case of Chronic Active Epstein-Barr Virus (EBV) Infection Accompanied by the Infiltration of EBV-infected CD8(+) T Cells into the Muscle, Kobayashi\, Nobuhiko,Mitsui\, Takeki,Ogawa\, Yoshiyuki,Iriuchishima\, Hirono,Takizawa\, Makiko,Yokohama\, Akihiko,Saitoh\, Takayuki,Koiso\, Hiromi,Tsukamoto\, Norifumi,Murakami\, Hirokazu,Nojima\, Yoshihisa,Handa\, Hiroshi, 2018, 40, 3, E171-E175

  DOI
• PDCD1 and CTLA4 polymorphisms affect the susceptibility to, and clinical features of, chronic immune thrombocytopenia, Kasamatsu\, Tetsuhiro,Ino\, Rumi,Takahashi\, Noriyuki,Gotoh\, Nanami,Minato\, Yusuke,Takizawa\, Makiko,Yokohama\, Akihiko,Handa\, Hiroshi,Saitoh\, Takayuki,Tsukamoto\, Norifumi,Murakami\, Hirokazu, 2018, 180, 5, 705, 714

  DOI
• Clonal evolution detected with conventional cytogenetic analysis is a potent prognostic factor in adult patients with relapsed AML, Shimizu\, Hiroaki,Yokohama\, Akihiko,Ishizaki\, Takuma,Hatsumi\, Nahoko,Takada\, Satoru,Saitoh\, Takayuki,Sakura\, Toru,Nojima\, Yoshihisa,Handa\, Hiroshi, 2018, 36, 1, 252, 257

  DOI
• Effect of ruxolitinib therapy on the quality-of-life of Japanese patients with myelofibrosis, Oritani\, Kenji,Ohishi\, Kohshi,Okamoto\, Shinichiro,Kirito\, Keita,Komatsu\, Norio,Tauchi\, Tetsuzo,Handa\, Hiroshi,Saito\, Shigeki,Takenaka\, Katsuto,Shimoda\, Kazuya,Okada\, Hikaru,Amagasaki\, Taro,Wakase\, Shiho,Shimozuma\, Kojiro,Akashi\, Koichi, 2018, 34, 3, 531, 537

  DOI
• Evaluation of the dose and efficacy of ruxolitinib in Japanese patients with myelofibrosis, Kirito\, Keita,Okamoto\, Shinichiro,Ohishi\, Kohshi,Tauchi\, Tetsuzo,Handa\, Hiroshi,Saito\, Shigeki,Takenaka\, Katsuto,Shimoda\, Kazuya,Oritani\, Kenji,Akashi\, Koichi,Okada\, Hikaru,Amagasaki\, Taro,Suzuki\, Kazuyuki,Yonezu\, Toshio,Komatsu\, Norio, 2018, 107, 1, 92, 97

  DOI
• Ruxolitinib is effective and safe in Japanese patients with hydroxyurea-resistant or hydroxyurea-intolerant polycythemia vera with splenomegaly, Kirito\, Keita,Suzuki\, Kenshi,Miyamura\, Koichi,Takeuchi\, Masahiro,Handa\, Hiroshi,Okamoto\, Shinichiro,Gadbaw\, Brian,Yamauchi\, Kyosuke,Amagasaki\, Taro,Ito\, Kazuo,Hino\, Masayuki, 2018, 107, 2, 173, 184

  DOI
• Switching to nilotinib is associated with deeper molecular responses in chronic myeloid leukemia chronic phase with major molecular responses to imatinib: STAT1 trial in Japan, Noguchi\, Shinsuke,Nakaseko\, Chiaki,Nishiwaki\, Kaichi,Ogasawara\, Hitoshi,Ohishi\, Kohshi,Tokuhira\, Michihide,Noguchi\, Masaaki,Kimura\, Hideo,Handa\, Hiroshi,Mitani\, Kinuko,Miura\, Masatomo,Wakita\, Hisashi,Takahashi\, Naoto, 2018, 108, 2, 176, 183

  DOI
• Hodgkin lymphoma accompanied by aplastic anemia and polyclonal expression of large granular lymphocytes, Saitoh T,Matsushima T,Yamane A,Sakuraya M,Irisawa H,Handa H,Tsukamoto N,Karasawa M,Nojima Y,Murakami H, 2007, Acta Haematologica, 117, 4, 238, 241

  DOI
• Combination chemotherapy of ranimustine, doxorubicine,and dexamethasone for relapsing multiple myeloma -a pilot study., Murakami H,Yamane A,Sawamura M,Matsumoto M,Murayama K,Shimano S,Jinbo T,Yokohama A,Uchiumi H,Handa H,Matsushima,Tsukamoto N,Morita K,Karasawa M,Ogawara H,Nojima Y, 2003, Journal of Medicine, 34, 1-6, 39, 46
• Clinical Significance of neutrophil apoptosis in peripheral blood of patients with type 2 diabetes mellitus., Sudo C,Ogawara H,Saleh AW,Nishimoto N,Utsugi T,Ooyama Y,Fukumura Y,Murakami M,Handa H,Tomono S,Murakami H, 2007, Laboratoy Hematology, 13, 3, 108, 112

  DOI
• TCR Vbeta repertoire analysis in CD56+ CD16dim/- T-cell large granular lymphocyte leukaemia: association with CD4 single and CD4/CD8 double positive phenotypes., KARASAWA MASAMITSUMitsui T,Isoda A,Tsumita Y,Irisawa H,YOKOHAMA AKIHIKO,HANDA HIROSHI,MATSUSHIMA TAKAFUMI,TSUKAMOTO,NORIFUMI,MURAKAMI HIROKAZU,NOJIMA YOSHIHISA, 2003, Br J Haematol., 123, 4, 613, 620

  DOI
• Ribosome lamella complex of leukemic cells in a patient with aggressive NK cell leukemia, Hatsumi N,Saitho T,Yokohama A,UCHIUMI H,MATSUSHIMA T,TSUKAMOTO N,KARASAWA M,NOJIMA Y,Handa H,OGAWARA H,Murakami H, 2002, Ultrastructural Pathology, 26, 415, 417

  DOI
• Pericardial graft vs. host disease in a patient with myelodysplastic syndrome following peri-pheral blood stem cell transplantation., TSUKAMOTO,NORIFUMI,MATSUSHIMA TAKAFUMI,NOJIMA YOSHIHISA,Saitou Yasuyuki,YOKOHAMA AKIHIKO,HANDA HIROSHI,KARASAWA MASAMITSU,MURAKAMI HIROKAZU, 2005, European Journal of Haematology, 75, 65, 67

  DOI
• Durable remission induced by Rituximab-containing chemotherapy in a patient with primary refractory Burkitt's lymphoma., Yokohama A,TSUKAMOTO N,UCHIUMI H,Handa H,MATSUSHIMA T,KARASAWA M,MURAKAMI H,NOJIMA YOSHIHISA, 2004, Annals of Hematology, 83, 120, 123

  DOI
• Hodgkin Lymphoma presenting with various immunologic abnormalities, including autoimmune hepatitis, Hashimoto's thyroiditis, autoimmune hemolytic anemia, and immune thrombocytopenia, Saitoh T,Matsushima T,Sato Y,Yamane A,Yokohama A,Irisawa H,Handa H,Tsukamoto N,Karasawa M,Kojima M,Nojima Y,Murakami H, 2008, Clinical Lymphoma Myeloma, 8, 1, 62, 64

  DOI
• Successful treatment with voriconazole of Aspergillus meningitis in a patient with acute myeloid leukemia, Saitoh T,Matsushima T,Shimizu H,Yokohama A,Irisawa H,Handa H,Tsukamoto N,Karasawa M,Nojima Y,Murakami H, 2007, Ann Hematol

  DOI
• The usefulness of (18)F-fluorodeoxyglucose positron emission tomography ((18)F-FDG-PET) and a comparison of (18)F-FDG-pet with (67)gallium scintigraphy in the evaluation of lymphoma: relation to histologic subtypes based on the World Health Organizatio・・・, Tsukamoto N,Kojima M,Hasegawa M,Oriuchi N,Matsushima T,Yokohama A,Saitoh T,Handa H,Endo K,Murakami H, 2007, Cancer, 110, 652, 659
• Identification of inherited macrothrombocytopenias based on mean platelet volume among patients diagnosed with idiopathic thrombocytopenia., Gohda F,Uchiumi H,Handa H,Matsushima T,Tsukamoto N,Morita K,Amagai H,Murakami M,Murakami H,Nojima Y,Karasawa M, 2006, Thromb Res.

  DOI
• The effects of 13-cis retinoic acid and interferon-alpha in chronic myelogenous leukemia cells in vivo in patients, HANDA HIROSHI,Raza A,Preisler HD, 1997, Leukemia Research, 21 1087-1096

  DOI
• Effects of physical therapy on cytokines and two color analysis-lymphocytes subsets in patients with cerebrovascular disease, HANDA HIROSHI,KURABAYASHI HITOSHI,TAMURA JUNICHI, 1999, Journal of Medicine, 30 31-37
• The relative extent and propensity of CD34+ vs. CD34- cells undergo apoptosis in myelodysplastic marrows, HANDA HIROSHI,Mundle S,Raza A,Preisler HD, 1999, International Journal of Hematology, 69 (3) 152-159
• Comparison of three protocols for breathing exercises during immersion in 38 degrees C water for chronic obstructive pulmonary disease, HANDA HIROSHI,KURABAYASHI HITOSHI, 1998, American Journal of Physical Medicine and Rehabilitaiton, 77 145-148

  DOI
• Intussuception as a complication of chronic lymphocytic leukemia, HANDA HIROSHI,MURAKAMI HIROKAZU,TAMURA JUNICHI,MATSUSHIMA TAKAFUMI, 1998, Journal of Medicine, 29 237-240
• Bcl-2 and c-myc expression, cell cycle kinetics and apoptosis during the progression of chronic myelogenous leukemia from diagnosis to blastic phase, HANDA HIROSHI,Raza A,Preisler HD, 1997, Leukemia Research, 21 479-489

  DOI
• Accuracy of immunohistochemistry and flow cytometry in estimating the proportion of leukemic cells in S phase in chronic myeloid leukemia, HANDA HIROSHI, 1996, Leukemia and Lymphoma, 22, 431-437
• Successful treatment of concomitant acute myeloblastic leukemia and adenoid cystic carcinoma of the palate, HANDA HIROSHI,MURAKAMI HIROKAZU,MATSUSHIMA TAKAFUMI, 1993, The Journal of International Medical Research, 21: 102-104
• Primary Hodgkin's disease of the bone presenting with and extra dural tumor, HANDA HIROSHI,MURAKAMI HIROKAZU, 1994, Acta Haematologica, 92: 148-149
• Acute idiopathic thrombocytopenic purpura presenting a high serum level of immunoglobulin E and eosinophilia in an elderly patient, HANDA HIROSHI,KURABAYASHI HITOSHI,TAMURA JUNICHI, 1998, Journal of Medicine, 29 93-96
• IgM-lamda multiple myeloma presenting with systemic amyloidosis, Higeta D,Yokohama A,Osaki Y,Tahara K,Mawatari M,Sekigami T,Koiso H,Saito T,Uchiumi H,Handa H,Karasawa M,Murakami H,Hirato J,Tsukamoto N,Nojima Y, 2009, Rinsho Ketsueki, 50, 12, 1711, 1714

  DOI
• Successful treatment with reduced intensity stem cell transplantation for secondary myelofibrosis following polycythemia vera, Tahara K,Yokohama A,Handa H,Saitoh T,Uchiumi H,Sekigami T,Toyama K,Mawatari M,Osaki Y,Matsushima T,Karasawa M,Murakami H,Tsukamoto N,Nojima Y, 2009, Rinsho Ketsueki, 50, 11, 1630, 1634

  DOI
• Autologous peripheral blood stem cell transplantation to treat CHOP-refractory aggressive subcutaneous panniculiis-like T cell lymphoma, Nakahashi H,Tsukamoto N,Yamane A,Saitoh T,Uchiumi H,Handa H,Karasawa M,Murakami H,Kojima M,Nojima Y, 2009, Acta Hematologica, 121, 4, 239, 242

  DOI
• Development of an extramedullary plasmacytoma despite dissapearing M protein in multiple myeloma by bortezomib treatment, Koiso H,Tahara K,Osaki Y,Mawatari M,Sekigami T,Yokohama A,Saitoh T,Handa H,Tsukamoto N,Karasawa M,Nojima Y,Murakami H, 2009, Rinsho Ketsuekki, 50, 2, 78, 82

  DOI
• Clinical significance of Th1/Th2 ratio in patients with myelodysplastic syndrome, 2009, International Journal of Laboratory Hematology, 31, 6, 201, 207

  DOI
• A randomized comparison of 4 courses of standard-dose multiagent chemotherapy versus 3 courses of high-dose cytarabine alone in postremission therapy for acute myeloid leukemia in adults: the JALSG AML201 Study., Miyawaki S,Ohtake S,Fujisawa S,Kiyoi H,Shinagawa K,Usui N,Sakura T,Miyamura K,Nakaseko C,Miyazaki Y,Fujieda A,Nagai T,Yamane T,Taniwaki M,Takahashi M,Yagasaki F,Kimura Y,Asou N,Sakamaki H,Handa H,Honda S,Ohnishi K,Naoe T,Ohno R, 2011, Blood, 24, 117, 2366, 72

  DOI
• Randomized study of induction therapy comparing standard-dose idarubicin with high-dose daunorubicin in adult patients with previously untreated acute myeloid leukemia: the JALSG AML201 Study., Ohtake S,Miyawaki S,Fujita H,Kiyoi H,Shinagawa K,Usui N,Okumura H,Miyamura K,Nakaseko C,Miyazaki Y,Fujieda A,Nagai T,Yamane T,Taniwaki M,Takahashi M,Yagasaki F,Kimura Y,Asou N,Sakamaki H,Handa H,Honda S,Ohnishi K,Naoe T,Ohno R, 2011, Blood, 24, 117, 2358, 65

  DOI
• [Retrospective survey on the clinical features of non-Hodgkin lymphomas in Gunma Prefecture, Japan]., Hashimoto Y,Yokohama A,Saitoh A,Nakahashi H,Toyama K,Mitsui T,Koiso H,Saitoh T,Handa H,Uchiumi H,Jinbo T,Murayama K,Tamaki Y,Matsumoto M,Sawamura M,Karasawa M,Murakami H,Hirato J,Nojima Y,Kojima M,Tsukamoto N, 2012, Rinsho Ketsueki., 53, 3, 329, 36

  DOI
• Follicular lymphoma presenting with marked splenomegaly: report of three cases., Koiso H,Yokohama A,Mitsui T,Saitoh T,Handa H,Murakami H,Hirato J,Kojima M,Nojima Y,Tsukamoto N, 2012, Acta Haematologica, 128, 1, 47, 52

  DOI
• [Diagnosis and prognostic factors in patients with multiple myeloma]., Murakami H,Yokohama A,Saitoh T,Tsukamoto N,Handa H, 2012, Nihon Rinsho., 70, Suppl 2:, 584-8.
• Age-related Epstein-Barr Virus-positive lymphoproliferative disorders of the orbit and maxillary sinus : a case report., Mitsui T,Mawatari M,Koiso H,Yokohama A,Uchiumi H,Saitoh T,Handa H,Hirato J,Karasawa M,Murakami H,Kojima M,Nakamura S,Nojima Y,Tsukamoto N, 2012, J Clin Exp Hematop., 52(3), 3, 205, 9

  DOI
• Emergence of donor-derived anti-HLA antibody and subsequent transfusion-refractory thrombocytopenia after allogeneic hematopoietic stem cell transplantation from an HLA-matched sibling donor in a patient with acute myeloid leukemia, Uchiyama Y,Hoshino T,Mihara M,Mitsui T,Koiso H,Takizawa M,Yokohama A,Saitoh T,Uchiumi H,Handa H,Tsukamoto N,Murakami H,Nojima Y, 2013, Rinsho Ketsueki, 54, 2, 214, 218

  DOI
• Raltegravir is safely used with long-term viral suppression for HIV-infected patients on hemodialysis: a pharmacokinetic study, Yanagisawa\, Kunio,Nagano\, Daisuke,Ogawa\, Yoshiyuki,Uchiumi\, Hideki,Shigehara\, Tetsuya,Saruki\, Kazuhisa,Handa\, Hiroshi,Araki\, Takuya,Yamamoto\, Koujirou,Nojima\, Yoshihisa, 2016, AIDS, 30, 6, 970, 972

  DOI
• Long non-coding RNA MALAT1 is an inducible stress response gene associated with extramedullary spread and poor prognosis of multiple myeloma, Handa\, Hiroshi,Kuroda\, Yuko,Kimura\, Kei,Masuda\, Yuta,Hattori\, Hikaru,Alkebsi\, Lobna,Matsumoto\, Morio,Kasamatsu\, Tetsuhiro,Kobayashi\, Nobuhiko,Tahara\, Ken-ichi,Takizawa\, Makiko,Koiso\, Hiromi,Ishizaki\, Takuma,Shimizu\, Hiroaki,Yokohama\, Akihiko,Tsukamoto\, Norifumi,Saito\, Takayuki,Murakami\, Hirokazu, 2017, BRITISH JOURNAL OF HAEMATOLOGY, 179, 3, 449, 460

  DOI
• Collision of metastatic malignant melanoma and acute myelogenous leukemia in the bone marrow, Kobayashi\, Nobuhiko,Shimizu\, Hiroaki,Hirato\, Junko,Handa\, Hiroshi, 2018, INTERNATIONAL JOURNAL OF HEMATOLOGY, 107, 3, 257, 259

  DOI
• Successful hemostatic management of major surgery for cervical spondylotic myelopathy in a patient with severe factor XI deficiency., Ogawa Y,Yanagisawa K,Uchiyama Y,Akashi N,Mieda T,Iizuka H,Inoue M,Shizuka R,Murakami M,Matsumoto N,Handa H, 2018, INTERNATIONAL JOURNAL OF HEMATOLOGY, in press

  DOI
• [Evaluation of mental stress tests among medical students based on salivary sample collected just before the national license examination]., Ushiki K,Sato Y,Arai K,Ide N,Matsui N,Handa H,Murakami H,Ogawara H, 2011, Rinsho Byori, 59, 2, 138, 43
• [Glossitis by mixed infection of cytomegalovirus and herpes simplex virus during therapy for pure red cell aplasia complicated with Good syndrome]., Koya H,Yokohama A,Miura A,Hoshino T,Mitsui T,Koiso H,Saitoh T,Uchiumi H,Handa H,Hirato J,Hiromura K,Karasawa M,Murakami H,Tsukamoto N,Nojima Y, 2011, Rinsho Ketsueki., 52, 8, 708, 12

  DOI
• Markedly improved outcomes and acceptable toxicity in adolescents and young adults with acute lymphoblastic leukemia following treatment with a pediatric protocol: a phase II study by the Japan Adult Leukemia Study Group, Hayakawa F,Sakura T,Yujiri T,Kondo E,Fujimaki K,Sasaki O,Miyatake J,Handa H,Ueda Y,Aoyama Y,Takada S,Tanaka Y,Usui N,Miyawaki S,Suenobu S,Horibe K,Kiyoi H,Ohnishi K,Miyazaki Y,Ohtake S,Kobayashi Y,Matsuo K,Naoe T,Japan Adult Leukemia Study Group (JALSG, 2014, BLOOD CANCER JOURNAL, 4, e252

  DOI
• Polymorphism of IL-10 receptor beta affects the prognosis of multiple myeloma patients treated with thalidomide and/or bortezomib, Kasamatsu\, Tetsuhiro,Saitoh\, Takayuki,Ino\, Rumi,Gotoh\, Nanami,Mitsui\, Takeki,Shimizu\, Hiroaki,Matsumoto\, Morio,Sawamura\, Morio,Yokohama\, Akihiko,Handa\, Hiroshi,Tsukamoto\, Norifumi,Murakami\, Hirokazu, 2017, HEMATOLOGICAL ONCOLOGY, 35, 4, 711, 718

  DOI
• The cytokine polymorphisms affecting Th1/Th2 increase the susceptibility to, and severity of, chronic ITP, Takahashi\, Noriyuki,Saitoh\, Takayuki,Gotoh\, Nanami,Nitta\, Yasuhiro,Alkebsi\, Lobna,Kasamatsu\, Tetsuhiro,Minato\, Yusuke,Yokohama\, Akihiko,Tsukamoto\, Norifumi,Handa\, Hiroshi,Murakami\, Hirokazu, 2017, BMC IMMUNOLOGY, 18, 1, 26

  DOI
• Histone deacetylase inhibitors suppress ABO transcription in vitro, leading to reduced expression of the antigens, Takahashi\, Yoichiro,Kubo\, Rieko,Sano\, Rie,Nakajima\, Tamiko,Takahashi\, Keiko,Kobayashi\, Momoko,Handa\, Hiroshi,Tsukada\, Junichi,Kominato\, Yoshihiko, 2017, TRANSFUSION, 57, 3, 554, 562

  DOI
• Infectious complications in adults undergoing intensive chemotherapy for acute myeloid leukemia in 2001-2005 using the Japan Adult Leukemia Study Group AML201 protocols, Kato H,Fujita H,Akiyama N,Kimura SI,Hiramoto N,Hosono N,Takahashi T,Shigeno K,Minamiguchi H,Miyatake J,Handa H,Kanda Y,Yoshida M,Miyawaki S,Ohtake S,Naoe T,Kiyoi H,Matsumura I,Miyazaki Y,Japan Adult Leukemia,Study Group, 2018, SUPPORTIVE CARE IN CANCER, in press

  DOI
• Darunavir concentration in PBMCs may be a better indicator of drug exposure in HIV patients, Daisuke Nagano,Takuya Araki,Kunio Yanagisawa,Yoshiyuki Ogawa,Fumito Gohda,Hideki Uchiumi,Hiroshi Handa,Tomonori Nakamura,Koujirou Yamamoto, 2018, EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 74, 8, 1055, 1060

  DOI
• Role of exosomes as a proinflammatory mediator in the development of EBV-associated lymphoma, Higuchi H,Yamakawa N,Imadome KI,Yahata T,Kotaki R,Ogata J,Kakizaki M,Fujita K,Lu J,Yokoyama K,Okuyama K,Sato A,Takamatsu M,Kurosaki N,Alba SM,Azhim A,Horie R,Watanabe T,Kitamura T,Ando K,Kashiwagi T,Matsui T,Okamoto A,Handa H,Kuroda M,Nakamura N,Kotani A, 2018, BLOOD, 131, 23, 2552, 2567

  DOI
• Bortezomib maintenance therapy in transplant-ineligible myeloma patients who plateaued after bortezomib-based induction therapy: a multicenter phase II clinical trial, Isoda\, Atsushi,Murayama\, Kayoko,Ito\, Shigeki,Kohara\, Yoichi,Iino\, Masaki,Miyazawa\, Yuri,Matsumoto\, Morio,Handa\, Hiroshi,Imai\, Yosuke,Ishiguro\, Takuro,Izumita\, Wataru,Kitano\, Kiyoshi,Hirabayashi\, Yukio,Nakazawa\, Hideyuki,Ishida\, Fumihiro,Mitsumori\, Toru,Kirito\, Keita,Chou\, Takaaki,Murakami,Hirokazu, 2018, INTERNATIONAL JOURNAL OF HEMATOLOGY, 108, 1, 39, 46

  DOI
• A Rare Case of Chronic Active Epstein-Barr Virus (EBV) Infection Accompanied by the Infiltration of EBV-infected CD8(+) T Cells into the Muscle, Kobayashi\, Nobuhiko,Mitsui\, Takeki,Ogawa\, Yoshiyuki,Iriuchishima\, Hirono,Takizawa\, Makiko,Yokohama\, Akihiko,Saitoh\, Takayuki,Koiso\, Hiromi,Tsukamoto\, Norifumi,Murakami\, Hirokazu,Nojima\, Yoshihisa,Handa\, Hiroshi, 2018, JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY, 40, 3, E171-E175

  DOI
• Clonal evolution detected with conventional cytogenetic analysis is a potent prognostic factor in adult patients with relapsed AML, Shimizu\, Hiroaki,Yokohama\, Akihiko,Ishizaki\, Takuma,Hatsumi\, Nahoko,Takada\, Satoru,Saitoh\, Takayuki,Sakura\, Toru,Nojima\, Yoshihisa,Handa\, Hiroshi, 2018, HEMATOLOGICAL ONCOLOGY, 36, 1, 252, 257

  DOI
• Effect of ruxolitinib therapy on the quality-of-life of Japanese patients with myelofibrosis, Oritani\, Kenji,Ohishi\, Kohshi,Okamoto\, Shinichiro,Kirito\, Keita,Komatsu\, Norio,Tauchi\, Tetsuzo,Handa\, Hiroshi,Saito\, Shigeki,Takenaka\, Katsuto,Shimoda\, Kazuya,Okada\, Hikaru,Amagasaki\, Taro,Wakase\, Shiho,Shimozuma\, Kojiro,Akashi\, Koichi, 2018, CURRENT MEDICAL RESEARCH AND OPINION, 34, 3, 531, 537

  DOI
• Evaluation of the dose and efficacy of ruxolitinib in Japanese patients with myelofibrosis, Kirito\, Keita,Okamoto\, Shinichiro,Ohishi\, Kohshi,Tauchi\, Tetsuzo,Handa\, Hiroshi,Saito\, Shigeki,Takenaka\, Katsuto,Shimoda\, Kazuya,Oritani\, Kenji,Akashi\, Koichi,Okada\, Hikaru,Amagasaki\, Taro,Suzuki\, Kazuyuki,Yonezu\, Toshio,Komatsu\, Norio, 2018, INTERNATIONAL JOURNAL OF HEMATOLOGY, 107, 1, 92, 97

  DOI
• Ruxolitinib is effective and safe in Japanese patients with hydroxyurea-resistant or hydroxyurea-intolerant polycythemia vera with splenomegaly, Kirito\, Keita,Suzuki\, Kenshi,Miyamura\, Koichi,Takeuchi\, Masahiro,Handa\, Hiroshi,Okamoto\, Shinichiro,Gadbaw\, Brian,Yamauchi\, Kyosuke,Amagasaki\, Taro,Ito\, Kazuo,Hino\, Masayuki, 2018, INTERNATIONAL JOURNAL OF HEMATOLOGY, 107, 2, 173, 184

  DOI
• Switching to nilotinib is associated with deeper molecular responses in chronic myeloid leukemia chronic phase with major molecular responses to imatinib: STAT1 trial in Japan, Noguchi\, Shinsuke,Nakaseko\, Chiaki,Nishiwaki\, Kaichi,Ogasawara\, Hitoshi,Ohishi\, Kohshi,Tokuhira\, Michihide,Noguchi\, Masaaki,Kimura\, Hideo,Handa\, Hiroshi,Mitani\, Kinuko,Miura\, Masatomo,Wakita\, Hisashi,Takahashi\, Naoto, 2018, INTERNATIONAL JOURNAL OF HEMATOLOGY, 108, 2, 176, 183

  DOI

Books etc

• 造血器腫瘍治療－これは困ったぞどうしよう！, 2006
• 造血器腫瘍治療－これは困ったぞどうしよう！, 2009
• 造血器腫瘍治療 これは困ったぞどうしよう ２版 原発性マクログロブリン血症患者の意識が朦朧としてきた。血清IgM値が11g/dlある。さてどうしよう？, 2010
• EBM血液疾患の治療2010-2011 形質細胞性白血病に対する治療は, 2010
• これ血液悪性疾患？自分の守備範囲？ 非専門医のための見分け方, 2010

Presentations

• フローサイトメトリーによる骨髄異形成症候群、急性白血病におけるテロメラーゼ逆転写酵素の発現検討, 第67回日本血液学会 第47回日本臨床血液学会, 2005
• 多発性骨髄腫におけるIL-10の多型解析, 日本検査血液学会, 2006
• ３カラーフローサイトメトリー（FACS) による造血器腫瘍のテロメラーゼ逆転写酵素（TERT）発現の検討, 第６回日本検査血液学会学術集会, 2005
• 骨髄腫細胞株のテロメラーゼ活性に対するサリドマイドの効果, 第65回日本血液学会 第45回日本臨床血液学会, 2003
• 多発性骨髄腫細胞に対するサイクリン依存性キナーゼ阻害剤（CDK inhibitor）R-Roscovitineの抗腫瘍効果, 第7回日本検査血液学会学術集会, 2006
• Clinical significance of Th1/Th2 ratio in patients with multiple myeloma, XVIth International Symposium on Technical Innovations in Laboratory Hematology, 2003
• Clinical significance of neutrophil apoptosis in peripheral blood in patients with type 2 diabetes mellitus, XVIIIth International Symposium on Technological Innovations in Laboratory Hematology, 2005
• ２型糖尿病患者における末梢血好中球アポトーシスの検討, 第５回日本検査血液学会学術集会, 2004
• 多発性骨髄腫細胞に対するサイクリン依存性キナーゼ阻害剤（CDK inhibitor) R-Roscovitineの抗腫瘍効果, 第30回日本骨髄腫研究会, 2005
• 慢性骨髄増殖性疾患の顆粒球、血小板におけるJAK2遺伝子変異とX染色体遺伝子によるクローン性の解析, 第68回／第48回日本血液学会臨床血液学会合同総会, 2006
• Rituximabが奏功したANCA陽性腎炎合併慢性リンパ性白血病の一例, 第65回／第45回日本血液学会臨床血液学会合同総会, 2003
• 少量thalidomide+少量dexamethasone併用療法による難治性多発性骨髄腫の治療研究, 第68回日本血液学会、第48回日本臨床血液学会 合同総会, 2006
• フローサイトメトリーによるAML,MDSのCD34+CD38-幹細胞分画におけるテロメラーゼ逆転写酵素発現検討, 第69回日本血液学会 第49回日本臨床血液学会 合同総会, 2007
• 多発性骨髄腫のCaveolin発現制御シグナルの検討, 第69回日本血液学会, 2007
• R-Roscovitneは骨髄腫細胞株をCaspase、JNK依存性、非依存性にアポトーシスを誘導する, 第69回日本血液学会, 2007
• 本態性血小板血症の血小板におけるJAK2遺伝子変異の検討とその優位性, 第69回日本血液学会, 2007
• Hairy B-cell lymphoproliferative disorder (HBLD)におけるHLA-DRとVH遺伝子の解析, 第69回日本血液学会, 2007
• 骨髄異形成症候群における制御性T細胞測定の臨床的意義, 第69回日本血液学会第49回日本臨床血液学会, 2007
• 当科で経験した乳癌関連二次性白血病の5例の検討, 第69回日本血液学会, 2007
• 特発性血小板減少性紫斑病におけるIL-10多型解析, 第69回日本血液学会, 2007
• 骨髄異形成症候群におけるTh1/Th2比の臨床的意義, 第68回／第48回日本血液学会臨床血液学会合同総会, 2006
• 仙腸関節炎を初発症状として発症した骨髄異形成症候群(MDS), 第67回／第47回日本血液学会臨床血液学会合同総会, 2005
• 骨髄異形成症候群(MDS)における発熱症例に検討., 第66回／第46回日本血液学会臨床血液学会合同総会, 2004
• 骨髄中の好酸球（Eos）、好塩基球（Bas）比率の増加を伴う骨髄異形成症候群（MDS）症例, 第49回北関東医学会総会, 2002
• 悪性リンパ腫におけるFDG-PETの有用性：SUV値と病理組織型との関係, 第68回／第48回日本血液学会臨床血液学会合同総会, 2006
• 悪性リンパ腫におけるFDG-PET の有用性とその限界, 第66回／第46回日本血液学会臨床血液学会合同総会, 2004
• 血球減少症例のCD45 blast gatingを用いた骨髄細胞の評価, 第68回／第48回日本血液学会臨床血液学会合同総会, 2006
• 髄外腫瘤形成(granulocytic sarcoma, GS)を伴った急性骨髄性白血病(AML)における同種造血幹細胞移植の検討, 第29回日本造血細胞移植学会総会, 2007
• 骨髄非破壊的同種造血幹細胞移植後の再発に対してドナーリンパ球輸注(DLI)が有効であったホジキンリンパ種の一例, 第27回日本造血細胞移植学会総会, 2004
• HUMARA 遺伝子を指標とした異性間骨髄移植におけるキメリズムの長期解析, 第66回／第46回日本血液学会臨床血液学会合同総会, 2004
• 多発性骨髄腫の新しい治療, 第5回日本検査血液学会学術集会, 2004
• Coagulopathy in HLA-DR antigen-negative acute myeloid leukemia, American Society of Hematology, 46th Annual Meeting, 2004
• Flow cytometric detection of human telomerase reverse transcriptase expression in CD34 positive precursor fraction in myelodysplastic syndrome bone marrow., American Society of Hematology, 48th Annual Meeting, 2006
• IL-10 promoter resion -592A/C genotype increases the risk of myeloma in Japanese patients., American Society of Hematology, 48th Annual Meeting, 2006
• Reduction in Th2 cell numbers induces depression of normal immunoglobulin in patients with multiple myeloma, American Society of Hematology, 45th Annual Meeting, 2003
• Aggressive lymphomaとの鑑別が困難であったt(8;14)陽性multiple myeloma, 第64回／第44回日本血液学会臨床血液学会合同総会, 2002
• Detection of human telomerase reverse transcriptase (hTERT) protein expression in bone marrow cells of hematological disorder by flow cytometry, American Society of Hematology, 46th Annual Meeting, 2004
• 顆粒リンパ球増多症における細胞表面GPI アンカー型蛋白質の発現, 第67回／第47回日本血液学会臨床血液学会合同総会, 2005
• ワークショップ15「「日本骨髄腫研究会参加施設におけるサリドマイド治療の現状と成績」, 第66回日本血液学会総会、第46回日本臨床血液学会総会同時開催, 2004
• 悪性リンパ腫におけるFDG-PETの有用性とその限界, 第66回日本血液学会総会 第66回日本血液学会 第46回日本臨床血液学会 合同総会, 2004
• 二次元レーザー散乱光を用いた血小板減少症における巨大血小板のスクリーニング, 第66回／第46回日本血液学会臨床血液学会合同総会, 2004
• 慢性の経過を経ているSezary 様形態を呈するT-PLL と考えられる一例, 第66回／第46回日本血液学会臨床血液学会合同総会, 2004
• 初診時にPh1染色体を認めたAcute Myeloid Leukemia (AML)の4例とBCR-ABL mRNAの定量, 第65回／第45回日本血液学会臨床血液学会合同総会, 2003
• NKおよびT細胞性顆粒リンパ球増加症はNK受容体を有するCD45RA+,CD27-,CD28-, CCR7-細胞の増殖による, 第65回日本血液学会総会, 2003
• 多発性骨髄腫におけるTh1/Th2比の検討（第２報）, 第６５回日本血液学会・第４５回日本臨床血液学会総会, 2003
• 骨髄中の好酸球、好塩基球増加を伴うMDS症例, 第99回日本内科学会総会, 2002
• 慢性リンパ性白血病(CLL)における細胞表面CD38の発現と臨床病態, 第64回／第44回日本血液学会臨床血液学会合同総会, 2002
• 慢性リンパ性白血病における免疫グロブリン重鎖および軽鎖遺伝子の解析, 第68回／第48回日本血液学会臨床血液学会合同総会, 2006
• リンパ腫におけるC/EBPalpha における役割, 第67回／第47回日本血液学会臨床血液学会合同総会, 2005
• 細胞表面CD27 抗原陰性はHairy cell leukemia およびそのvariant に特徴的な所見である, 第67回／第47回日本血液学会臨床血液学会合同総会, 2005
• フローサイトメトリーによる多発性骨髄腫、MGUSにおけるテロメラーゼ逆転写酵素(TERT)蛋白発現の検討, 第68回日本血液学会、第48回日本臨床血液学会 合同総会, 2006
• 多発性骨髄腫細胞に対するサイクリン依存性キナーゼ阻害剤(CDK inhibitor) R-Roscovitineの抗腫瘍効果, 第68回日本血液学会、第48回日本臨床血液学会 合同総会, 2006
• 多発性骨髄腫におけるIL-10の多型解析, 第69回日本血液学会, 2007
• Human telomerase reverse transcriptase (hTERT) expression detected by flow cytometry in CD34 positive progenitor fraction in myelodysplasitc syndorme and acute myeloid leukemia, 15th Congress of the European Hematology Association, 2010
• Association between micro-RNA and epigenetic modifiers DNA methyltransferases (DNMTs), histone deacetylases (HDACs) in multiple myeloma (MM) and monoclonal gammmopathy with undetermined significance (MGUS), American Society of Hematology, 2012
• Mircro-RNA expression is associated with expression of DNA methyltransferases and anti-apoptotic gene mcl-1 in multiple myeloma and monoclonal gammopathy with undetermined significance (MGUS), European Hematology Association (EHA), 2012
• Clinical significance of Th1/Th2 ratio in patients with multiple myeloma, XVIth International Symposium on Technical Innovations in Laboratory Hematology, 2003
• Clinical significance of neutrophil apoptosis in peripheral blood in patients with type 2 diabetes mellitus, XVIIIth International Symposium on Technological Innovations in Laboratory Hematology, 2005
• Coagulopathy in HLA-DR antigen-negative acute myeloid leukemia, American Society of Hematology, 46th Annual Meeting, 2004
• Flow cytometric detection of human telomerase reverse transcriptase expression in CD34 positive precursor fraction in myelodysplastic syndrome bone marrow., American Society of Hematology, 48th Annual Meeting, 2006
• IL-10 promoter resion -592A/C genotype increases the risk of myeloma in Japanese patients., American Society of Hematology, 48th Annual Meeting, 2006
• Reduction in Th2 cell numbers induces depression of normal immunoglobulin in patients with multiple myeloma, American Society of Hematology, 45th Annual Meeting, 2003
• Detection of human telomerase reverse transcriptase (hTERT) protein expression in bone marrow cells of hematological disorder by flow cytometry, American Society of Hematology, 46th Annual Meeting, 2004
• Human telomerase reverse transcriptase (hTERT) expression detected by flow cytometry in CD34 positive progenitor fraction in myelodysplasitc syndorme and acute myeloid leukemia, 15th Congress of the European Hematology Association, 2010
• Association between micro-RNA and epigenetic modifiers DNA methyltransferases (DNMTs), histone deacetylases (HDACs) in multiple myeloma (MM) and monoclonal gammmopathy with undetermined significance (MGUS), American Society of Hematology, 2012
• Mircro-RNA expression is associated with expression of DNA methyltransferases and anti-apoptotic gene mcl-1 in multiple myeloma and monoclonal gammopathy with undetermined significance (MGUS), European Hematology Association (EHA), 2012